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The canonical vertebrate neurotrophin receptors — the Trk and p75NTR protein families — have not 
been found in Drosophila, thus it is unclear how neurotrophic signalling is implemented in fruit flies. 
The aim of my thesis was to investigate whether candidate receptors evolutionarily related to Trks or 
p75NTR may function as DNT receptors in fruit flies. The Drosophila neurotrophins DNT1 and DNT2 
are known ligands for Toll6 and Toll7. Trk receptors comprise an extracellular ligand-binding module 
composed of Leucine-rich repeat domains and Immunoglobulin motifs (LIGs), and an intracellular 
tyrosine kynase (TyrK) signalling domain. Throughout evolution, domain shuffling resulted in 
different forms of Trk in vertebrates and invertebrates. The Drosophila genome encodes 9 members 
of the LIG superfamily of proteins, including the Kekkons (Keks), which are phylogenetically most 
similar to the Trks but lack the TyrK.  Using in situ hybridisation, antibody labelling, genetic 
interactions and locomotion assays, I showed that of 12 candidate receptors the six Keks were the 
most promising to interact with DNTs. After generating overexpression constructs and loss of 
function mutants for the keks, I showed that: (1) overexpression of kek2, kek3 and kek6 could rescue 
the semi-lethality of DNT1DNT2 double mutants; (2) Kek3, Kek4 and Kek6 interacted with DNT2 
ligand eliciting a luciferase readout in S2 cells; (3) and that kek3, kek4 and kek6 interacted genetically 
with DNT1 and DNT2. I subsequently focused on kek6 and kek4. Kek6 was distributed in pioneer 
neurons and motor neurons. Both loss and gain of kek6 function affected embryonic motor neuron 
targeting and larval locomotion behaviour. Using genetic rescues, I showed that Kek6 functions 
downstream of the DNTs and upstream of Ras and PI3K in axon targeting. Surprisingly, Kek4 was 
found to be distributed and function in the larval ring gland. Loss of kek4 function delayed 
developmental timing, whereas overexpression of kek4 advanced development. This was caused by 
kek4 inhibiting juvenile hormone signalling, since kek4 overexpression resulted in the upregulation of 
the ecdysone target Broad-Core in the fat body. Together, data reveal that the Keks have functions in 
CNS development and regulation of organism growth. They interact with the DNTs, strongly 
suggesting that they may function as DNT receptors. The work uncovers functional conservation of 
the LIG module in neurodevelopment despite domain shuffling throughout the animal kingdom. 
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CHAPTER 1 
INTRODUCTION 
The canonical vertebrate neurotrophin receptors — the Trk and p75NTR protein families — 
have not been found in Drosophila. Nonetheless, Drosophila has neurotrophins, thus posing a 
biological problem: how is neurotrophic signalling implemented in flies?  
The Trk protein family is formed of transmembrane receptors with intracellular tyrosine 
kinase (TyrK) domains and with extracellular ligand-binding Leucine Rich Repeat (LRR) and 
Immunoglobulin (Ig) domains (i.e. LIG receptors; Huang and Reichardt (2001)). Studies to 
date searched for Drosophila Trks using hybridisation-based cDNA library screens for 
homology to the signalling TyrK, identifying dRor and dTrk (Oishi et al., 1997, Pulido et al., 
1992). However, phylogenetic analysis of the full sequences of these candidates revealed 
them to be phylogenetically unrelated to the Trk family. Furthermore, dTrk was found to 
encode a catalytically dead kinase, and subsequently renamed Off-Track (Kroiher et al., 
2001). Proteomic analyses have also detected no conserved TyrK of the Trk family in flies 
(Manning et al., 2002). Thus, no TyrK of the Trk family and no full length Trks have been 
identified in Drosophila. 
Throughout evolution, the Trk superfamily has diversified through protein domain shuffling, 
yielding four protein families with distinct domain architectures — the Rors, muscle-specific 
kinases (Musks), Ddrs and the Trks (Sossin, 2006). Domain shuffling has also yielded 
different forms of Trks throughout the invertebrates, from TyrK-only Trk-like architectures in 
the mollusc Aplysia to a full length Aplysia Trk (Kassabov et al., 2013, Ormond et al., 2004, 
Wilson, 2009). Domain shuffling has also generated proteins unique to the insects which have 
retained some, but not all, of the Trk family protein domains. These are the Drosophila LIG 
(dLIG) proteins, which contain only the extracellular LIG module of Trks. They also resemble 
the naturally occurring truncated Trk isoforms, which lack an intracellular TyrK (Ohira and 
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Hayashi, 2009). Phylogenetic comparison of the Drosophila dLIGs to the vertebrate LIGs 
identifies the six member Kekkon (Kek) protein family as phylogenetically related to the Trks 
(Mandai et al., 2009). The Kek proteins form a single clade together with the Trks and are 
more similar to them than all other vertebrate and dLIGs are to each other. In my thesis I will 
ask: are the Keks functional Trks in Drosophila?  
There is evidence that neurotrophic and gliatrophic signalling operates throughout the 
invertebrates. Some of the evidence is circumstantial: for example, in molluscs, L-EGF 
induces neurite outgrowth in culture and facilitates central nervous system (CNS) repair, and 
cysteine rich neurotrophic factor (CRNF) can interact with p75NTR in vitro (Fainzilber et al., 
1996, Hermann et al., 2000). There is, however, functional in vivo evidence of neurotrophism 
in fruit flies. In Drosophila, the EGF ligands Spitz and Vein are required for midline and 
longitudinal glia survival, respectively (Bergmann et al., 2002, Hidalgo et al., 2001); the 
secreted ligand netrin is required for motor axon targeting (Mitchell et al., 1996, Newquist et 
al., 2013); and DmMANF regulates dopaminergic neuron survival (Palgi et al., 2009). 
The Drosophila neurotrophins DNT1 and DNT2 were identified by homology to vertebrate 
brain-derived neurotrophic factor (BDNF; Zhu et al. (2008)). DNT1 and DNT2 regulate 
neuronal survival in the CNS, motor axon targeting and synaptogenesis (Sutcliffe et al., 2013, 
Zhu et al., 2008). It was recently shown that DNT1 and DNT2 are ligands for Toll7 and Toll6, 
which can signal via NFκB (McIlroy et al., 2013). Nonetheless, the role of Trk-like dLIG 
proteins remains unexplored. 
Given their similarities to the Trks, the aim of my thesis was to investigate the roles of the 
dLIGs in the nervous system to determine whether they have Trk-like functions, and whether 
they can interact with the DNTs to function as DNT receptors. 
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1.1 Neurotrophin signalling 
1.1.1 Neurotrophism, neurotrophins and neurotrophic factors 
Neurotrophism is the process whereby neuronal innervation targets secrete finite 
concentrations of trophic factors to control axonal targeting and neuronal survival — neurons 
that receive neurotrophic support survive, whereas mistargeted neurons undergo apoptosis 
(Levi-Montalcini, 1987).  
For clarity, a distinction must be made between the neurotrophins and neurotrophic factors. A 
neurotrophic factor is any trophic factor that regulates the survival of neurons (gliatrophic 
factors, conversely, regulate the survival of glia; Huang and Reichardt (2001)). 
Neurotrophins, meanwhile, are a family of neurotrophic factors defined by a specific structure 
— including a cleaved pro-domain and a characteristic cysteine knot (CysKnot) — that is 
absent from other neurotrophic factors (Figure 1.1; Bradshaw et al. (1993)).The first known 
neurotrophin, nerve growth factor (NGF), was identified as the secreted molecule that induced 
fibril growth of chick neurons in culture upon addition of mouse tumour tissue (Levi-
Montalcini and Hamburger, 1951). NGF contains 6 key cysteine residues, all involved in 
intrachain disulphide bonds (Angeletti and Bradshaw, 1971, Bradshaw et al., 1993). This 
disulphide core is the founding member of a distinct family of CysKnot structure, since the 
separate TGFβ and PDGF CysKnot families both contain 8 key cysteine residues (Daopin et 
al., 1992, Oefner et al., 1992, Sun, 1995). Subsequent neurotrophins were identified by 
sequence homology with NGF, including the CysKnot (Jones and Reichardt, 1990, Rosenfeld 
et al., 1995). 
In mammals, there are four neurotrophins — NGF, BDNF, NT-3 and NT-4/5 (Huang and 
Reichardt, 2001). The structures and sizes of vertebrate neurotrophins are shown in Figure 
1.1. NT-4 was discovered in Xenopus laevis and NT-5 in rat, and both have since been shown 
to be structural orthologues (Berkemeier et al., 1991, Hallbook et al., 1991). The distributions 
Pro-domain NGF CysKnot
Cleavage by 
Plasmin, MMPs
Mature neurotrophin
Pro-neurotrophin
NGF CysKnot
NGF CysKnot
NGF CysKnot
NGF 241 aa
12
8
23
2
13
3
24
0
247 aa
257 aa
210 aa
BDNF
NT-3
NT-4
The structures of all four vertebrate neurotrophins are shown. NGF, BDNF, NT-3 and NT-4 are synthesised 
as pro-neurotrophins, including a pro-domain. The pro-domain is cleaved to produce a mature 
neurotrophin. Peptide lengths and cleavage positions are indicated. The peptide sequence of the 
neurotrophin family CysKnot is shown, with the six key Cysteine residues highlighted in red.
Pro-domain
Pro-domain
Pro-domain
FHRGEFSVCDSVSVWVGDKTTATDIKGKEVMVLGEVNINNSVFKQYFFETKCRDPNPVDS 
GCRGIDSKHWNSYCTTTHTFVKALTMDGKQAAWRFIRIDTACVC 
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14
4
24
9
SHRGEYSVCDSESLWVTDKSSAIDIRGHQVTVLGEIKTGNSPVKQYFYETRCKEARPVKN 
GCRGIDDKHWNSQCKTSQTYVRALTSENNKLVGWRWIRIDTSCVCA 
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SRRGELAVCDAVSGWVTDRRTAVDLRGREVEVLGEVPAAGGSPLRQYFFETRCKADNAEE 
GGPGAGGGGCRGVDRRHWVSECKAKQSYVRALTADAQGRVGWRWIRIDTACVCT 
Figure 1.1  Vertebrate neurotrophin structures
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of neurotrophins throughout the chordates suggests that the neurotrophin family duplicated 
twice within the vertebrates: NGF, BDNF, NT-3 and NT-4/5 are present throughout the 
tetrapods (although NT-4/5 is absent in birds), NT-6 and NT-7 are found only in bony fish, 
and cartilaginous fish have only BDNF and NT-3 (Hallbook, 1999). Outside of the 
vertebrates, neurotrophins have been found in the lamprey (Lf-NT) and hagfish (Mg-NT), 
which diverged from the vertebrate lineage 460 million years ago (Hallböök et al., 1998, 
Kumar and Hedges, 1998). Thus, NGF and NT-3 formed from the duplication of one ancestral 
neurotrophin, and BDNF and NT-4/5 from a separate ancestral gene, both occurring between 
the branch of jawless fish (hagfish and lampreys) and the branch of the cartilaginous fish 
(Hallbook, 1999). NT-6/7 likely arose separately within the bony fish lineage, and the 
ancestral neurotrophins were subsequently lost (Hallbook, 1999).  
Neurotrophins function as dimers and bind the Trk family of receptors, p75NTR and sortilin 
(Shen and Maruyama, 2011, Vilar et al., 2009). Neurotrophin–receptor interactions are 
unusual in that they are promiscuous (Figure 1.2). Furthermore, all four neurotrophins bind to 
p75NTR, and signalling can be transduced by interaction between the Trks and p75NTR, 
although evidence of TrkB and TrkC interactions with p75NTR is unclear (Wehrman et al., 
2007). p75NTR can also interact with sortilin upon ligand binding (Skeldal et al., 2012). 
Neurotrophins are secreted as precursor forms of 30–35kDa, called pro-neurotrophins, which 
are proteolytically cleaved to produce shorter, mature proteins of 12–13kDa (Lu et al., 2005, 
Seidah et al., 1996). Amino acid positions of proteolytic cleavage are shown in Figure 1.1. 
Pro-neurotrophins promote cell death through p75NTR, whereas cleaved neurotrophins bind 
TrkA– p75NTR heterodimers, or p75NTR or Trk homodimers, to promote cell survival and 
manifest neurotrophic phenotypes (Chao, 2003). NGF–TrkA signalling, for example, is 
required for survival of nociceptive and sensory neurons in the skin (Smeyne et al., 1994). 
Targeting roles of neurotrophism are illustrated by, for example, the BDNF/TrkB-dependent 
navigation of retinal axon growth cones in chick embryos (Ernst et al., 2000). In addition to 
Figure 1.2  Vertebrate Trk signalling pathways
Neurotrophins bind in promiscuous combinations with the Trk and p75NTR neurotrophin 
receptors. Ligand-receptor binding leads to downstream PLCγ1, ERK, PI3K and NFκB 
signalling, which promote neuronal development. Apoptosis is promoted by p75NTR via the 
JNK pathway. Pathway crosstalk is observed and indicated by grey arrows. See main text for 
references. Domains: Ig, immunoglobulin; LRR, leucine-rich repeat; TNFR, tumour necrosis factor 
receptor; TyrK, tyrosine kinase.
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neuronal survival, neurotrophins are crucial for neuronal differentiation, axonal and dendritic 
growth, synaptogenesis and long term potentiation (Huang and Reichardt, 2001). The 
neurotrophins are also implicated in behaviour, memory and learning (Chao et al., 2006). 
Aberrant neurotrophin function is linked with a number of neurological pathologies, including 
neurodegenerative diseases and psychiatric disorders (Chao et al., 2006, Levi-Montalcini, 
1976, Siggers et al., 1976).  
Neurotrophins were recently found in insects (see Chapter 1.1.3). However, insect Trk 
receptors have been presumed to be absent (see Chapters 1.2.4 and 1.4.2; Manning et al. 
(2002)).  
Nonetheless, a number of key points contribute to the complexity of neurotrophin signalling, 
and suggest that Trk or Trk-like proteins can be found in Drosophila: 1) Although the 
Drosophila neurotrophins can signal through Toll proteins (see Chapter 1.1.3), vertebrate 
neurotrophic ligand–receptor interactions are promiscuous. Alternative DNT receptors may 
yet be found. 2) The Trk superfamily predates the origin of vertebrates and Trk proteins are 
found in non-insect invertebrates (see Chapter 1.4). 3) Domain shuffling from ancestral Trk 
superfamily proteins has yielded modern Trks in vertebrates and novel proteins containing 
neurotrophin-binding modules in the Drosophila proteome (see Chapters 1.4 and 1.5). Some 
of these novel Drosophila proteins cluster phylogenetically with the vertebrate Trks (see 
Chapter 1.4.2; Mandai et al. (2009)). Because of these points, this thesis searched for 
functional Trk or Trk-like proteins in Drosophila, to solve this knowledge gap. 
1.1.2 Neurotrophin signalling in neural development 
Autophosphorylation of specific tyrosine residues following ligand binding allows the binding 
of adaptor proteins that link dimerized Trks to intracellular signalling pathways (Huang and 
Reichardt, 2001). Depending on signalling context, which is controlled by co-receptors and 
cell type, Trks may activate the mitogen-activated protein kinase (MAPK), 
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phosphatidylinositol 3-kinase (PI3K)/Akt and/or phospholipase Cγ (PLCγ) pathways (Figure 
1.2): 
- Trk activation by NGF leads to receptor phosphorylation and PLCγ1 recruitment 
(Vetter et al., 1991). Phosphorylated PLCγ1 subsequently catalyses the hydrolysis of 
phospholipids to inositol trisphosphate (IP3) and diacylglycerol (DAG), both of which 
can activate protein kinase C, leading to downstream promotion of neurite growth and 
cytoskeletal rearrangements (Huang and Reichardt, 2001, Mellor and Parker, 1998). 
Protein kinase C (PKC) can promote the Extracellular signal-regulated kinase (ERK) 
pathway via Raf (Corbit et al., 1999).  
- Ligand-dependent ERK signalling is more directly initiated upon recruitment of the 
TyrK adaptor SHC, which binds the Ras guanine exchange factor (GEF) SOS 
complex, leading to downstream activation of Ras, cRaf, MEK and ERK (Kaplan and 
Miller, 2000). ERK activation is required for neuronal differentiation and, via the 
cAMP response element-binding protein (CREB) pathway, neuronal survival 
(Dworkin and Mantamadiotis, 2010, Xing et al., 1998). The SOS complex also 
mediates the activation of Rac, and thereby downstream cytoskeletal rearrangements 
via Rho (Nimnual et al., 1998).  
- Neuronal survival and differentiation can be mediated via PI3K, which requires 
activation by Ras (Diering et al., 2013). Motor neuron excitability and nerve terminal 
growth are both regulated by PI3K activity, although the former requires Ras activity, 
whereas the latter is activated via p85 (Johnson et al., 2012). Ras signalling via PI3K 
further promotes SOS-mediated activation of Rac and subsequent cytoskeletal 
rearrangement. Cleaved neurotrophins also bind p75NTR and TrkA to promote neuronal 
survival via NFkB (Maggirwar et al., 1998). 
By contrast, pro-apoptotic signalling via neurotrophin-mediated p75NTR signalling occurs via 
the JNK pathway and BAD. Apoptosis is induced by the executioner proteins BAX and BAK, 
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which are functionally redundant (Oltvai et al., 1993, Wei et al., 2001). BAX undergoes 
conformational changes to bind the mitochondrial outer membrane (MOM), where it creates a 
pore, releasing lipids and proteins (such as cytochrome c) from the mitochondrial 
intermembrane space (Kuwana et al., 2002). MOM permeabilization is the final commitment 
step in apoptosis (Shamas-Din et al., 2013). JNK signalling via p53 activates the transcription 
of BAX (Miyashita and Reed, 1995). 
BAX membrane localization and insertion is prevented by sequestration by the anti-apoptotic 
protein BCL-XL, thereby halting apoptosis (Billen et al., 2008). BCL-XL, in turn, can be 
sequestered by binding to GDP-bound BAD, thereby permitting apoptosis (Aloyz et al., 
1998). BAD is deactivated downstream of mature neurotrophin signalling by both ERK and 
the PI3K target Akt (Datta et al., 1997, Huang and Reichardt, 2001). 
1.1.3 Neurotrophins and neurotrophism in insects 
Trophic interactions are required for nervous system development in Drosophila (Beck and 
Fainzilber, 2002, Hidalgo, 2002). For example, the EGFR ligand Vein is secreted by MP2 
pioneer neurons and is required for longitudinal glia survival (Hidalgo et al., 2001). A second 
ligand of EGFR, Spitz, is derived from axons and required for midline glia survival 
(Bergmann et al., 2002). The growth cone guidance cue Netrin, a neurotrophic factor, is 
secreted from the Drosophila midline and required for commissure formation and motor axon 
targeting (Mitchell et al., 1996, Hiramoto et al., 2000). Furthermore, Netrin gradients are 
required for neuronal survival within the CNS, and correct axon guidance can be rescued in 
Netrin loss of function mutants by blocking apoptosis (Newquist et al., 2013). Last, flies 
lacking the secreted neurotrophic factor DmMANF exhibit embryonic dopaminergic neuron 
cell death (Palgi et al., 2009). However, neurotrophic factors were not found in flies until 
recently.  
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The Toll ligand Spz was found to contain an NGF domain as far back as 1998, but its 
similarity with the blood-clotting factor coagulogen in the horseshoe crab delayed 
investigation into its possible neurotrophic roles (Hu, 2004, Inamori et al., 2004, Parker et al., 
2001, Weber et al., 2003). Coagulogen does not form a functional CysKnot dimer, a feature of 
the vertebrate neurotrophins, whereas Spz does (Mizuguchi et al., 1998). Nevertheless, it is 
interesting that both coagulogen and BDNF are cleaved by a common proteolytic cascade 
(Pang et al., 2004, Skrzypiec et al., 2008). A family of six spz paralogues was identified in 
Drosophila (Parker et al., 2001). 
Subsequently, using sequence-based homology searches of the recently sequenced genomes, 
DNT1 (Spz2) and DNT2 (Spz5) were identified as homologues of vertebrate BDNF, the most 
conserved vertebrate neurotrophin (Götz et al., 1992, Zhu et al., 2008). Structural analysis 
confirmed that DNT1, DNT2 and Spz are closely related to the mammalian NTs, and of these, 
structure-based alignment revealed that the CysKnot sequences of DNT1 and DNT2 are more 
closely related to the vertebrate neurotrophins than that of Spz (Zhu et al., 2008). Structural 
alignment of the CysKnots further revealed that Spz3, Spz4 and Spz6 are too far diverged 
from the vertebrate neurotrophins. The DNTs also have functional conservation relative to the 
mammalian NTs. DNT1 and DNT2 are secreted from the embryonic midline and embryonic 
muscles, and DNT1 protein is detected in the larval lamina and adult central brain; they are 
target-derived functional neurotrophins required for motor axon targeting, synaptogenesis at 
the neuromuscular junction (NMJ) and regulation of naturally occurring cell death of neurons 
(Sutcliffe et al., 2013, Zhu et al., 2008). Phylogenetic comparison of the neurotrophins and 
Spz-related functional neurotrophins group the proteins into two separate clades, together 
forming the neurotrophin superfamily (Wilson, 2009). 
Tolls do not signal via an intracellular TyrK (Dolan et al., 2007). Instead, Toll signals to the 
NFkB pathway through a Toll/Interleukin-1 receptor (TIR) domain. As such, they 
functionally resemble p75NTR. Compared with related mammalian receptors, mammalian 
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p75NTR has increased affinity for the Drosophila TIR adaptor protein dTRAF2, suggesting 
that Toll family and p75NTR signalling may be evolutionarily linked (Zapata et al., 2000). Spz 
binding to Toll stimulates the expression of drosomycin, which is involved in the immune 
response to fungal infection, via the NFκB homologue Dif (Hu, 2004, Manfruelli et al., 1999, 
Meng et al., 1999). Alongside their immune role, dif and the second NFκB homologue dorsal 
are also expressed in the nervous system, and Spz–Toll binding-induced Dorsal nuclear 
translocation has a role in dorsoventral patterning (Ayyar et al., 2007, Beramendi et al., 2005, 
Cantera et al., 1999, DeLotto and DeLotto, 1998, Mindorff et al., 2007). The inhibitor of 
Dorsal and Dif, Cactus, is enriched at the NMJ, and is necessary for normal locomotion 
(Beramendi et al., 2005).  
It was recently revealed that the DNTs can interact with Toll6 and Toll7 to activate Dif and 
Dorsal signalling (McIlroy et al., 2013). toll6 and toll7 are expressed in the ventral cord 
(VNC) and brain of embryos and larvae, and in the adult brain. In embryos and larvae, Toll6 
and Toll7 are distributed in motor neurons and interneurons. Like DNT2e0344DNT141 double 
mutants, toll6;toll7 double mutants are also semi-lethal when bred at 18°C in combination 
with the TM6B balancer, and this semi-lethality can be rescued by the neuronal 
overexpression of activated toll6 or toll7 alleles (McIlroy et al., 2013). toll6 and toll7 loss of 
function mutations lead to an increase in neuronal cell death in the embryonic VNC and axon 
targeting phenotypes in motor axons, and toll6;toll7 double mutant larvae display locomotion 
phenotypes (McIlroy et al., 2013). Co-immunoprecipitation of co-transfected Toll receptors 
and DNT ligands in S2 cell culture confirmed that Toll7 and Toll6 can bind DNT1 and 
DNT2, respectively (McIlroy et al., 2013). 
1.1.4 Neurotrophins in the systemic control of growth 
An often overlooked aspect of the neurotrophins is that their roles are not restricted to the 
CNS or peripheral nervous system (PNS) (Calza et al., 2003, Levi-Montalcini et al., 1990). 
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NGF could link the nervous, endocrine and immune systems (Tometten et al., 2005). 
Concordantly, Trks have been shown to have neurotrophin-independent roles, and the 
molluscan LTrk is enriched in endocrine cells (Schecterson and Bothwell, 2010, Schecterson 
et al., 2010, van Kesteren et al., 1998). Furthermore, p75NTR and the Trks are distributed in 
tissues derived from all three germ layers (Thomson et al., 1988). 
NGF has roles in autonomic nervous system regulation (Levi-Montalcini, 1976, Siggers et al., 
1976). Aberrant NGF function also contributes to autoimmune diseases, such as lupus (Aloe 
et al., 1994, Bracci-Laudiero et al., 1993, Levi-Montalcini et al., 1990). During pregnancy, 
environmental stress triggers progesterone-dependent NGF production, leading to cytokine 
production and apoptosis (Tometten et al., 2005). Reciprocally, NGF is upregulated in 
arthritic joint synovial fluid by cytokines during inflammation (Aloe et al., 1992, Aloe et al., 
1993, Triaca and Tirassa, 2003). NGF levels are also increased in the cerebrospinal fluid of 
multiple sclerosis patients (Laudiero et al., 1992), and NGF can itself function in the immune 
system as a cytokine-like molecule, whereupon it induces mast cell proliferation (Aloe and 
Levi-Montalcini, 1977). Last, the mammalian Toll-like receptors (TLRs) have roles in both 
the neuroendocrine and immune systems as well as the microglia and neurons of the 
hippocampus: TLRs are detected in neurons and endocrine cells of the hypothalamus, as well 
as adipocytes and the islets of Langerhans, and autoimmune thyroid disease is linked to TLR 
misregulation (Kanczkowski et al., 2008).  
1.2 Domain Shuffling in the Evolution of Receptors 
1.2.1 Principles of Domain Shuffling 
Natural selection reassigns biological components for novel purposes (Jacob, 1977). One such 
manifestation of evolutionary ‘tinkering’ is protein domain shuffling. The concept of the 
protein domain as a structural unit was first proposed in 1970, on the elucidation of the 
structure of IgG (Edelman, 1970, Williams and Barclay, 1988). Each variable and constant 
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homology region within the molecule was shown to contain one intrachain disulphide bond 
that stabilises the regions with similar, but separate, tertiary structures. These structures are 
now known as Ig domains. Over time, the term domain has acquired other definition 
variations such as the nouns ‘fold’, ‘motif’ and ‘signature sequence’ (Doolittle, 1995). Here, I 
use the term ‘domain’ to mean a discrete, heritable protein sequence motif that forms a 
conserved tertiary structure; ‘domain architecture’ to mean structures that arise from protein 
domain combinations; and ‘module’ as a multidomain functional unit (Hartwell et al., 1999). 
The protein domain is a basic evolutionary unit from which proteins are built (Vogel et al., 
2005). The architecture that arises from multiple domain arrangements is the fundamental 
order of protein functional complexity and underlies the concept of modular biology (Buljan 
and Bateman, 2009, Hartwell et al., 1999, Vogel et al., 2005). Protein domains and 
multidomain modules have been both co-opted throughout evolution for novel purposes, and 
often retained owing to evolutionary functional relevance (Bashton and Chothia, 2007, Basu 
et al., 2008, Doolittle, 1995, Ekman et al., 2007, Patthy, 1999, Soding and Lupas, 2003). 
Thus, protein domain shuffling might drive the evolution of complexity independently of 
genome expansion and faster than protein reinvention (Hallböök et al., 2006, Vogel and 
Chothia, 2006, Bjorklund et al., 2005, Bornberg-Bauer et al., 2005, Hartwell et al., 1999, 
Moore et al., 2008, Soding and Lupas, 2003). For example, rearrangements of modules 
resulted in the evolution of the multiple protein blood-clotting cascade (Patthy, 1985).  
Expansion of distinct protein domain architectures (both permutations and domain 
combinations) has accelerated in metazoa, particularly in animals (Ekman et al., 2007). These 
changes in protein domain architecture can occur by several genetic mechanisms: for 
example, shuffling of single domain-encoding exons by recombination of exon-flanking 
introns, alternative splicing of multiple domain-encoding exons, and retrotransposition 
(Moore et al., 2008, Patthy, 1999, Doolittle, 1995). Approximately 5% of protein domains 
form promiscuous combinations with other domains, and these domains are generally 
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involved in protein–protein interactions and signalling pathways, suggesting that their 
promiscuous co-option was a consequence of their usefulness in many biological contexts 
(Basu et al., 2008, Bjorklund et al., 2005, Marcotte et al., 1999). However, conservation of 
domain architectures may only be possible with concordant ligand evolution, since novel 
receptors will be quickly lost without the corresponding pairing of at least one ligand, co-
receptor or adaptor protein (Sossin, 2006). 
This thesis focuses on receptors with the LIG module and its constituent domains: LRRs and 
Ig domains. This introduction also considers TyrKs, as LIG modules and TyrKs constitute the 
Trk neurotrophin receptors. The hypothesis is that the Trk receptor family diversified in the 
course of evolution, resulting in partial Trk-like proteins in fruit flies that might have 
conserved binding to neurotrophin family ligands and nervous system functions. 
1.2.2 Leucine Rich Repeats 
The primary function of LRRs is ligand binding (Kobe and Deisenhofer, 1995, Kobe and 
Kajava, 2001). LRR proteins can also form dimers, suggesting that alternative modes of 
binding to LRRs may underlie signalling (Scott et al., 2006). LRR-containing receptor kinases 
may form dimers with LRR-containing receptor-like proteins that lack an intracellular 
signalling domain — for example, CLV1–CLV2 heterodimers are suggested to suppress stem 
cell differentiation in plants, and Sas may interact with the phosphatase Ptp10D in Drosophila 
axon guidance (Torii, 2004, Lee et al., 2013).  
Proteins containing extracellular LRRs (eLRRs) are involved in diverse functions, such as cell 
adhesion and signalling, platelet aggregation, neuronal development, axon guidance and the 
immune response (Chen et al., 2006, Ko and Kim, 2007, Ma et al., 2006, Nurnberger et al., 
2004). For example, the LRR-containing proteins Nogo-66 receptor, Slit, AMIGO, LINGO, 
netrin G1 ligand (NGL1) and the neuronal LRR (NLRR) family have roles in neurite 
outgrowth, axon guidance and targeting, and migration (Ko and Kim, 2007). 
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Mutant alleles of genes encoding proteins with eLRRs result in defects in axon guidance and 
cell migration (Slit/Robo; Long et al. (2004)), myelination (LINGO1;Mi et al. (2005), 
neuronal survival (Trks and Netrin; Conover and Yancopoulos (1997), Newquist et al. 
(2013)), plasticity and nerve regeneration (Nogo; McGee et al. (2005)), and learning and 
memory (NLRR4; Bando et al. (2005)). Indeed, LRR-containing proteins are defective in 
many human diseases and disorders, including schizophrenia, hyperthyroidism and the 
autoimmune condition Graves’ disease, and loss of function of trkA is a cause of congenital 
insensitivity to pain (CIPA; de Wit et al. (2011), Matsushima et al. (2005)). Furthermore, 
upregulation of trkB is associated with multiple myeloma, neuroblastoma and lung 
adenocarcinoma (Gupta et al., 2013). 
The LRR family is greatly expanded in mammals, and to a lesser extent flies, compared to the 
worm (Dolan et al., 2007). In the Drosophila proteome, 9 of the 66 eLRR-containing proteins 
contain at least one additional Ig domain (Dolan et al., 2007). 16 of the 66 Drosophila eLRRs 
share homology with the eLRRs of Toll proteins. Of these 16, 9 contain an intracellular TIR 
domain (Dolan et al., 2007). It is interesting to note that certain protein families have 
expanded faster than others in certain species: Drosophila has 9 LIGs, whereas humans have 
38, and there are 9 Drosophila, 13 human and 253 sea urchin Toll-related eLRRs (Buckley 
and Rast, 2012, Dolan et al., 2007). The functional consequence of such protein family 
expansions is uncertain. Within the LIGs, many families and architectures are unique to 
mammals, including the AMIGO family; others have expanded mainly in mammals (flies 
have one copy of the Lambik LIG protein, whereas mice encode LRIG1, LRIG2 and LRIG3; 
Nilsson et al. (2001)); and the Kek family has expanded in insects only (Derheimer et al., 
2004, Dolan et al., 2007).  
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1.2.3 Immunoglobulin domains 
Ig domains form a structure stabilised by disulphide bonds (Buljan and Bateman, 2009, 
Edelman, 1970). On the basis of sequence and structural similarities, four sets of Ig domains 
were identified: Ig-C1 domains are exclusive to vertebrates, whereas Ig-C2 predate the 
protostome–deuterostome split; and I and V-set Ig domains are the most ancient (Buljan and 
Bateman, 2009, Williams and Barclay, 1988). Ig domain-containing proteins have been 
identified in the parazoa, often with kinase domains. Consequently, the ancestral Ig-
containing protein is predicted to have had a role in signalling (Gamulin et al., 1994). Like 
LRRs, Igs can be strung together in tandem repeats (Vogel and Hedgecock (2001)). 
Ig domains have adhesion functions at the cell surface, forming heterophilic and homophilic 
interactions between Ig-containing molecules across opposing membranes that underlie 
neuronal cell elongation and migration, fasciculation and synapse maintenance (Lin et al., 
1994b, Patel et al., 1987, Snow et al., 1988, Rougon and Hobert, 2003, Williams and Barclay, 
1988, Zipursky and Grueber, 2013). Trk Ig domains can bind to neurotrophins in vitro and in 
vivo (Bothwell, 2006, Holden et al., 1997, Urfer et al., 1995). Furthermore, polysialic acid–
NCAM (neuronal cell adhesion molecule; the vertebrate orthologue of Drosophila FasII), 
which is rich in Ig domains, enhances and facilitates BDNF activation of TrkB (Muller et al., 
2000). 
Drosophila has 142 Ig-containing proteins, of which half belong to families of at least two 
closely related proteins derived by gene duplication (Vogel, 2003). In some cases, these 
duplications were followed by the loss or gain of domains. One of the largest of these families 
is the insect-specific Kek protein family.  
1.2.4 Tyrosine Kinases 
Protein kinases are crucial biological signalling components, accounting for 1.5–2.5% of 
eukaryotic genes (Hanks and Hunter, 1995, Manning et al., 2002). The two most common 
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protein kinases, protein-serine/threonine and TyrKs, constitute 67% and 17%, respectively, of 
the kinome (Braconi Quintaje and Orchard, 2008). 
All major kinase groups and most kinase families, including two-thirds of TyrKs, are shared 
among metazoa (Manning et al., 2002, Miranda-Saavedra and Barton, 2007). Most TyrK gene 
duplications occurred rapidly before the radiata–bilateria divergence (Suga et al., 1997). Gene 
duplications in tetrapods have been slower, indicating that selection pressures on TyrK 
evolution have varied and may be species-specific. Indeed, unlike Ig and LRR complements, 
C. elegans has twice as many kinases as the fly and there are no fly specific kinase families 
(Morrison, 2000). Reasons for such accelerated selection in the worm are unknown. 
Transmembrane receptor TyrKs (RTKs), which contain an intracellular TyrK, evolved before 
the divergence of protostomes and deuterostomes, since sponges contain multiple RTKs, 
including RTKs with extracellular Ig domains (Muller et al., 1999). Whereas RTKs belonging 
to the PDGFR, FGFR, Ret, ALK and EGFR families are present in both Drosophila and 
humans, no functional Trk-like RTKs have been found in Drosophila (Loren et al., 2001, 
Manning et al., 2002, Schweitzer and Shilo, 1997). 
1.3 LIGs in vertebrates 
Many metazoan LIG protein families are specific to or enlarged in the mammalian lineage 
(Dolan et al., 2007). Here, I focus on the vertebrate LIGs that contain only eLRR and Ig 
domains (Figure 1.3), and do not describe NLRR and PAL proteins, which contain further 
fibronectin type III (FN3) repeats (Chen et al., 2006). 
1.3.1 Trk receptors 
The Trk protein family functions as vertebrate neurotrophin receptors (Huang and Reichardt, 
2001). In addition to an extracellular LIG module, TrkA, TrkB and TrkC each contain an 
intracellular TyrK (Figure 1.3). Both the LRR and Ig domains have been shown to be required 
TrkA-C AMIGO1-3 LINGO1 NGL1 LRRC4 LRIG1-3 Linx
3-4 5-7
9-13 8-10 6-7 5-6
14-17
Cysteine-rich region
LRR TyrK
Ig domain
Figure 1.3  Vertebrate LIG proteins
Vertebrate Leucine rich repeat (LRR) and Immunoglobulin (Ig) domain-containing LIG
proteins are shown. Extracellular, up. Domain architectures are based on sequences available 
at UniProt and conrmed using the SMART online tool. Variation in LRR number in the 
literature is indicated. TyrK, tyrosine kinase. For references, see text.
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for neurotrophin binding in vitro (Bothwell, 2006, Kobe and Deisenhofer, 1994, Windisch et 
al., 1995), whereas the Ig domain is sufficient for nerve growth factor (NGF) binding in vivo 
(Bothwell, 2006, Holden et al., 1997, Urfer et al., 1995). Neurotrophin binding to the Trk 
receptors shows ligand–receptor promiscuity: NGF interacts with TrkA, BDNF and 
neurotrophin-4/5 (NT-4/5) interact with TrkB, and NT-3 predominantly interacts with TrkC, 
although it can also bind to both TrkA and TrkB (Huang and Reichardt, 2001). Downstream 
signalling of the Trk receptors upon ligand binding, and the evolution of the Trk receptors, are 
discussed below. 
1.3.2 Non-Trk vertebrate LIGs 
The AMIGO family comprise 5 LRRs and 1 Ig-C2 domain and form homophilic and 
heterophilic interactions. AMIGO1 is expressed exclusively in the brain, whereas AMIGO2 
(also known as Alivin-1) and AMIGO3 are enriched in the brain and in other tissues, such as 
breast and ovaries (Chen et al., 2006). Ectopic production of substrate-bound AMIGO1 
promotes neuron inflammation, whereas elevated levels of soluble AMIGO1 inhibit 
fasciculation (Chen et al., 2012, Kuja-Panula et al., 2003). Upregulation of both AMIGO1 and 
AMIGO2 reduces neuronal apoptosis (Ono et al., 2003, Chen et al., 2012). Unlike Trks, 
AMIGOs have no known intracellular signalling motifs. 
LINGO1 is a localized co-receptor of Nogo receptor–p75NTR interactions, which inhibit 
neuronal regulation and brain injury (Filbin, 2003, Mi et al., 2005). LINGO1 is enriched in 
the limbic system and neocortex, particularly following BDNF binding (Carim-Todd et al., 
2003, Trifunovski et al., 2004). 
NGL1 binds the GPI-anchored axon guidance molecule Netrin G1 and is enriched in the 
cerebral cortex (de Wit et al., 2011). The role of NGL1 is unclear (Chen et al., 2006). 
LRRC4 was initially considered to be the vertebrate orthologue of the Drosophila protein 
Kek1. LRRC4 protein is restricted to the adult mammalian brain, with a developmentally 
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regulated temporal expression profile (Zhang et al., 2005). LRRC4 induces a cell cycle delay, 
thereby suppressing tumorigenesis. 
LRIG proteins contain 14 LRRs and 3 Ig domains, and cluster to the 3p14.3 chromosome, 
which is often deleted in human cancers (Guo et al., 2004, Hedman et al., 2002). LRIG1 is 
enriched in the brain in addition to many other tissues, such as skin, kidneys and the stomach, 
where LRIG2 and LRIG3 are also distributed. LRIGs are present in fish and Ciona, and are 
therefore ancestral to the chordate–urochordate split (Guo et al., 2004). LRIG1 interacts with 
EGF receptors and thus shares functional similarity with Kek1 (see below; Laederich (2004)). 
Unlike Kek1, however, LRIG1 upregulation induces EGFR degradation by ubiquitin E3 
ligases, and LRIG1 is therefore a negative regulator of TyrK receptor signalling (Gur et al., 
2004, Laederich, 2004). 
Linx (also known as ISLR2) is localized to sensory and motor neurons and interacts with the 
Trks and Ret, another RTK (Mandai et al., 2009). Linx mutant mice have axonal guidance 
defects akin to those of NGF- and Trk-null mice. The role of Linx in the specificity of 
projections and the presence of most vertebrate LIGs in the nervous system highlight the 
importance of LIGs in nervous system development. Nonetheless, phylogenetic analysis of 
vertebrate and fruit fly LIGs cluster LRRC4 and the AMIGO, LINGO and LRIG families into 
the same clade as the Drosophila protein Lambik, whereas the Drosophila Kek family form a 
distinct clade with the vertebrate Trks (Mandai et al., 2009). According to this phylogeny, 
Linx is an outlier of the Trk/Kek clade. 
1.4 Evolution of the neurotrophin receptors 
1.4.1 Domain shuffling in the Trk superfamily 
In addition to the Trk neurotrophin receptors and LIG proteins, the Trk superfamily comprises 
the Ror, Musk and Ddr families, which are predicted to have evolved from a common 
ancestral kinase (Figure 1.4; Sossin (2006)). 
Ddr Ror/Musk/Trk precursor
Trk superfamily ancestor
Extracellular
Intracellular ?
Ror Musk Trk Trk.T1
Alternative 
splicing
Cysteine-rich region
LRR
TyrK
Discoidin domain
Frizzled/Kringle domain
Ig domain
Figure 1.4  Trk superfamily evolution by domain shuing
The ancestral Trk protein is predicted to have contained an extracellular Frizzled/Kringle 
domain and an intracellular tyrosine kinase (TyrK). The ancestral protein subsequently 
divided into two lineages: Ddr proteins swapped the extracellular Frizzled/Kringle domain for 
a Discoidin domain, whereas the precursor to the Ror, Musk and Trk families acquired an 
additional immunoglobulin (Ig) domain. Subsequent domain shuing of this precursor 
yielded the three modern protein families. LRR, Leucine rich repeat. Domain shuing likely 
occurred by intronic and genomic recombination, alternative splicing. See main text for 
references.
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Ror proteins comprise an extracellular Frizzled/Kringle and Ig domain and an intracellular 
kinase domain. Fly, rat, mouse and human genomes all encode two Ror proteins, whereas C. 
elegans only encodes one, CAM-1, suggesting that a second Ror was lost in the worm lineage 
(Forrester, 2002). CAM-1 has roles in neuronal cell migration and is associated with defects 
in axon outgrowth (Forrester et al., 1999). Vertebrate Rors are also involved in neurite 
outgrowth, but more generally are involved in cell migration and development, as mRor2 
knockouts have limb, bone and heart defects and die shortly after birth (Takeuchi et al., 2000). 
The structure of Drosophila dRor differs from mammalian Rors in that it lacks an 
extracellular Ig domain, although this is likely to reflect a recent loss since the Ig domain is 
present in the bee Ror (Forrester, 2002, Sossin, 2006). dRor may have Trk-like functions in 
the fly, although the dRor TyrK does not belong to the Trk TyrK family (Jaaro et al., 2001, 
Manning et al., 2002). 
Musk proteins comprise three extracellular Ig domains, a Frizzled/Kringle domain and an 
intracellular kinase domain (Figure 1.4; Sossin (2006)). Mammalian Musk proteins are 
expressed in muscles, and cluster neurotransmitter receptors and proteins involved in 
presynaptic differentiation and synapse formation (Burden et al., 2013, DeChiara et al., 1996). 
By contrast, zebrafish Musk (also known as Unplugged) induces cellular changes in the 
extracellular environment around future neuron target locations prior to growth cone arrival 
(Zhang et al., 2004). 
Ddr proteins comprise an extracellular discoidin domain and an intracellular kinase domain 
(Figure 1.4; Sossin (2006)). Ddrs have crucial roles in cell migration, proliferation and 
differentiation (Sossin, 2006). Ddr1 overexpression causes neurite outgrowth reduction in the 
mouse cerebellum (Bhatt et al., 2000). However, Ddr proteins are more commonly involved 
in cell–extracellular matrix (ECM) communication, since the ligand of mammalian DDR1 and 
DDR2 is collagen (Vogel et al., 1997, Vogel, 1999).  
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Given the presence of a sponge Ddr, C. elegans CAM-1 and Drosophila dRor, the ancestral 
protein of the Trk superfamily likely predates both the protostome–deuterostome and 
parazoa–metazoa evolutionary divides (Sossin, 2006). It is predicted that the vertebrate Trks 
arose from two separate genome duplications (Hallbook, 1999). TrkA and TrkC arose from 
the duplication of one ancestral Trk, whereas TrkB and a now-defunct TrkB sister gene arose 
from a separate duplication from a second ancestral Trk, both occurring between the branch of 
jawless fish and cartilaginous fish (Hallbook, 1999). 
 Genealogical analysis can be applied to the wider and older Trk superfamily in combination 
with the loss and gain of protein domains (Figure 1.4). The ancestral kinase is predicted to 
have contained an extracellular Frizzled/Kringle domain and a cytoplasmic TyrK domain, 
since these domains are found in sponge RTKs. The Ddr family first diverged from the 
ancestor of Rors, Musks and Trks, eventually swapping the Frizzled/Kringle domain for a 
Discoidin domain (Sossin, 2006). The ancestor of Rors, Musks and Trks subsequently 
acquired an Ig domain, then simultaneously split into the three separate lineages. Musks 
acquired further Ig domains, and Trks acquired LRRs. Species-specific domain shuffling 
further expanded the protein repertoire of the metazoa, for example, in the sea urchin Ror, a 
further Frizzled/Kringle domain was added; extracellular domains were lost from Aplysia Trk-
like protein (but not from ApTrk); and sea urchin Trks lack LRRs (see SpBase Annotation 
SPU_020803; Lapraz et al. (2006)). These domain modifications resulted in the divergence of 
receptor function (Hu et al., 2004). The acquisition of LRRs and Igs both predate the 
bilaterian split (Sossin, 2006).  
1.4.2 Invertebrate Trks and Trk-like proteins 
Trk receptors are present throughout the chordates, in the lamprey and in echinoderms, but are 
absent from urochordates (Figure 1.5; Hallböök et al. (1998); Lapraz et al. (2006)). C. elegans 
and Drosophila lack Trk receptors but Trk-like and full-length Trk receptors have been 
Figure 1.5  Trk proteins in the metazoa
The Trk and Trk-like isoforms throughout the metazoa are shown above the evolutionary 
family tree. Structures were determined using the SMART online tool using sequences from 
Uniprot, except Hydra Lemon (Miller and Steele, 2000), ApTrk (Kassabov et al., 2013), LTrk 
(van Kesteren et al., 1998) and Daphnia pulex Trk (Wilson, 2009). Caenorhabditis elegans Trk-1 
is predicted from the genome, but has not been characterised. Accession IDs: sea urchin 
SPU_020803; C. elegans Trk-1 UPI0000D7DC75/D1073.1A; ApTrkL Q5IJ68_APLCA/Q5IJ68; 
Sponge RTK Q9Y1Y8_9METZ/QY1Y8.
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isolated from molluscs, and Trk proteins have been identified in the sponges and crustacea 
(Beck et al., 2004, Benito-Gutiérrez et al., 2006, Bothwell, 2006, Bulloch et al., 2005, 
Kassabov et al., 2013, Ormond et al., 2004, Suga et al., 2001, van Kesteren et al., 1998, 
Wilson, 2009). These observations suggest that functional conservation of an ancestral Trk 
has persisted since the common metazoan ancestor. This is further indicated by the ability of 
the molluscan Lymnaea stagnalis Trk (LTrk; see below) to bind human NT-3 and the ability 
of the amphioxus AmphiTrk to interact with all vertebrate neurotrophins to induce Akt and 
extracellular signal-regulated kinase (ERK) signalling (Benito-Gutierrez et al., 2005, van 
Kesteren et al., 1998).  
Nonetheless, structural and functional variation has been introduced over evolutionary time. 
The LTrk ectodomain comprises 3 LRR motifs but lacks the pair of Ig-C2 domains of 
vertebrate Trks (van Kesteren et al., 1998). Instead, a putative single Ig-C1, or fragmented 
single Ig-C2 domain is present, suggesting that Ig domains in LTrk were recently lost. Indeed, 
LTrk chimaeras with added TrkC Ig-C2 domains can signal via ERK1 and ERK2 in response 
to NT-3 addition in monkey COS cells (Beck et al., 2004). Furthermore, LTrk may be 
alternatively spliced with a 100 amino acid N-terminal extension of unknown function (van 
Kesteren et al., 1998). Endogenous LTrk is located in neurons and dorsal body cells of the 
CNS in juvenile and adult Lymnaea (Bulloch et al., 2005). 
The molluscan Aplysia Trk-like protein (ApTrkL) is an RTK that lacks extracellular ligand-
binding domains (Ormond et al., 2004). ApTrkL is localized to sensory neurons and most 
likely arose by exon splicing from an ancestral Trk — the TyrK of ApTrkL is most similar to 
that of the vertebrate Trks, but the ectodomain lacks both LRRs and Ig domains (Ormond et 
al., 2004). ApTrkL can interact with serotonin in cell culture, but endogenous ligands of 
ApTrkL are unknown because of the absence of extracellular ligand-binding domains. 
Recently, a full length Trk was identified in Aplysia, formed of two extracellular Ig-C2 
domains, a single LRR and an intracellular TyrK (Kassabov et al., 2013). ApTrk is required 
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for long term facilitation and synaptogenesis, and ApTrk mRNA is alternatively spliced to 
yield different synaptic functions of the ApTrk protein. 
The domain architecture of the cephalochordate AmphiTrk resembles that of vertebrate Trks. 
However, AmphiTrk cannot activate the PLCγ pathway (Benito-Gutierrez et al., 2005, 
Benito-Gutiérrez et al., 2006). It is likely that this ability has been lost in Amphioxus but was 
present in the ancestral Trk, since ApTrk has a C terminus SH2 site required for PLCγ 
signalling (Kassabov et al., 2013). 
The lack of Drosophila Trks was initially put down to the relative ‘simplicity’ of flies 
compared with vertebrates (Jaaro et al., 2001). Furthermore, Drosophila neuronal survival 
could be mediated by alternative mechanisms, such as axon–axon contact and EGF ligand 
signalling (Benito-Gutiérrez et al., 2006, Hermann et al., 2000, Hidalgo, 2002). However, the 
genome of the crustacean Daphnia pulex encodes a Trk receptor with 2 LRR motifs and 2 Ig 
domains, thereby resembling vertebrate Trks (Wilson, 2009). This DappuTrk has an 
intracellular docking site for SHC, which signals through Ras–Raf–ERK and 
phosphatidylinositol-3-kinase (PI3K)–Akt. The arthropods, to which the crustacea and insects 
belong, therefore share a Trk-like ancestor, suggesting that Drosophila has lost canonical Trk-
like protein-encoding genes. 
Trk superfamily members were identified in Drosophila by homology with the vertebrate 
TyrK domain or by TyrK-encoding sequence hybridisation screening of cDNA libraries. 
Drosophila Nrk is an atypical Musk orthologue: it is distributed only in neurons (which 
contrasts with muscle-specific vertebrate Musk signal), and its extracellular domain resembles 
that of Ror (Oishi et al., 1997). Axonal pathfinding requires Off-track (Otk, previously known 
as DTrk), which was identified by its Trk-like TyrK domain but which is activated by 
heterophilic interaction with the semaphorin signalling system (Pulido et al., 1992, Winberg 
et al., 2001). Otk, its human orthologue CCK4 and the sponge kinase Lemon are distributed 
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throughout the nervous system, but in each protein the kinase domain is catalytically dead 
(Kroiher et al., 2001, Miller and Steele, 2000). Nrk, dRor and Otk were identified by research 
focusing on the Trk TyrK, but no Trk family TyrK is present in flies (Manning et al., 2002). 
The protostomes and deuterostomes share a common Trk-like ancestor, but modern full-
length Trks are absent from the insects. The above candidate Drosophila Trks were detected 
only from the TyrK domain: phylogenetic analysis comparing mammalian and Drosophila 
protein sequences according to extracellular domains identifies the Drosophila Kek family as 
forming a clade with the Trks (Mandai et al., 2009). The Kek proteins lack an intracellular 
signalling domain, thus are Trk-like proteins that cannot signal via canonical Trk pathways. 
The ancestral Trk, therefore, may have contained a TyrK that was subsequently lost in insects, 
or was a truncated protein that acquired a TyrK domain in other lineages. 
1.4.3 Truncated Trks 
Naturally occurring truncated forms of TrkB and TrkC that lack an intracellular TyrK are 
produced by alternative splicing of TrkB and TrkC (Fenner, 2012). Truncated TrkB.T1 binds 
BDNF with high affinity, leading to ligand internalization (Fenner, 2012, Renn et al., 2009).  
TrkB.T1 was initially thought to function solely as a dominant negative inhibitor of TrkB 
signalling (Haapasalo et al., 2001). However, TrkB.T1 has a unique expression profile 
compared to the full length TrkB.TK+. Both TrkB.TK+ and TrkB.T1 are distributed 
throughout the adult mammalian CNS, but whereas the full length receptor is expressed at 
birth, TrkB.T1 expression increases postnatally, such that T1–T1 homodimers and T1–TK+ 
heterodimers are the dominantly expressed forms in the adult brain, with TK+–TK+ 
homodimers absent (Fenner, 2012, Luberg et al., 2010, Ohira et al., 1999, Ohira and Hayashi, 
2009, Sherrard et al., 2009). BDNF is required for adult learning and memory (Bekinschtein 
et al., 2008); the absence of TK+–TK+ in adults therefore suggests that BDNF may signal via 
TrkB.T1 during learning.  
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Despite the absence of a TyrK signalling domain, the short cytoplasmic region of TrkB.T1 is 
conserved throughout the mammals, indicating that it is important for function (Ohira and 
Hayashi, 2009). Indeed, overexpression of the truncated TrkB.T1 isoform alters BDNF-
triggered calcium release and cell morphology of astrocytes, is required for cochlea 
development, increases anxiety behaviour in mice, slows the onset of motor neuron 
degeneration in mouse models, increases muscle contract motility, heightens nociception, 
decreases apoptosis in the adult cortex, increases neural progenitor proliferation, induces 
neurite outgrowth and alters dendritic spine density (Carim-Todd et al., 2009, Dorsey et al., 
2006, Dorsey et al., 2012, Gestwa et al., 1999, Haapasalo et al., 2001, Michaelsen et al., 2010, 
Ohira et al., 2007, Renn et al., 2009, Rose et al., 2003, Tervonen et al., 2006, Yanpallewar et 
al., 2012). A role for TrkB.T1 in synaptic plasticity is implied by its ability to signal via G 
proteins to PLCγ (Ohira and Hayashi, 2009, Rose et al., 2003). TrkC.T1 misregulation is also 
implicated in retinal ganglion cell death in glaucoma (Bai et al., 2010). 
The mechanism by which truncated Trks signal independently to full length receptors is not 
fully known. One known interacting partner is Rho GDP dissociation inhibitor 1 (RhoGDI1; 
Figure 1.6; Ohira et al. (2005)). RhoGDI1 inhibits the activation of RhoA, RhoB, Rac1, Rac2 
and Cdc42. These small GTPases are crucial for actin cytoskeleton regulation and mediation 
of morphological changes throughout neuronal development (Luo, 2000). Unstimulated 
TrkB.T1 sequesters RhoGDI1, thereby allowing the activation of Rho, leading to actin 
cytoskeleton rearrangements and glial morphological changes (Figure 1.6a; Ohira et al. 
(2006), Ohira et al. (2007)). BDNF addition releases RhoGDI1 to inhibit Rho signalling 
(Figure 1.6b; Ohira et al. (2006), Ohira et al. (2007), Ohira and Hayashi (2009)). By this 
mechanism it is also suggested that TrkB.T1 can signal via the p21-acivated kinase (PAK), 
MAPK and PLCγ pathways (Ohira et al., 2006, Ohira et al., 2007, Ohira and Hayashi, 2009). 
Interestingly, p75NTR can also sequester RhoGDI in vertebrates, a function that is reversed by 
NGF addition (Yamashita and Tohyama, 2003). It is also suggested that TrkB.T1 interacts 
Trk.T1
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Figure 1.6  Truncated Trk signalling
a | The naturally occurring truncated Trk splice isoform TrkB.T1 comprises an extracellular LIG 
module but lacks an intracellular tyrosine kinase. In the absence of ligand, TrkB.T1 sequesters 
Rho GDP dissociation inhibitor (RhoGDI). This permits the activation of RhoGTP signalling, 
and thereby actin cytoskeleton rearrangement and Rac, Rho and Cdc42-dependent neuronal 
development. b | BDNF stimulation releases RhoGDI, thereby inactivating RhoGTP signalling. 
GAP, GTPase-activating protein; GEF, guanine exchange factor.
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with p75NTR to cause unique phenotypes compared with full length TrkB–p75NTR interactions 
(Hartmann et al., 2004, Michaelsen et al., 2010). 
The ability of truncated Trks to signal raises the question: has domain shuffling produced 
further proteins that lack signalling domains but can function in neurotrophic contexts? 
1.4.4 Evolution of the p75NTR superfamily 
Neurotrophin signalling modulation and complexity arises from the interaction of p75NTR with 
the Trks. p75NTR comprises four extracellular TNF receptor (TNFR) domains and an 
intracellular DEATH domain (see Figure 1.2; Rabizadeh and Bredesen (2003)). The role of 
p75NTR in neurotrophin signalling is ligand-dependent: pro-neurotrophins promote cell death 
through Jnk, whereas cleaved neurotrophins promote cell survival through NFκB (Huang and 
Reichardt, 2001). p75NTR paralogues — NRH1, NRH2, PLAIDD and NRADD — can also 
modulate Trk signalling (Murray et al., 2004). These proteins are members of the TNFR 
superfamily (Bothwell, 2006). p75NTR further interacts with Nogo receptor and the LIG 
protein LINGO1 to mediate axon repellent responses to myelin proteins, as does the TNF 
receptor protein Troy (Mi et al., 2005). Troy and p75NTR do not share overall sequence 
similarity, except in their intra-transmembrane domain cysteine residues, but the ligand for 
the Troy subfamily protein EDAR is the most similar vertebrate protein to Drosophila Eiger, 
the ligand for the only Drosophila TNF receptor, Wengen (Igaki et al., 2002, Kanda et al., 
2002, Schecterson and Bothwell, 2010). This suggests that a functional interaction between 
the TNF superfamily and LIG proteins may be conserved between vertebrates and flies. 
1.5 LIGs and candidate invertebrate neurotrophin receptors 
Has domain shuffling of the ancestral Trk proteins produced novel receptors with roles in the 
nervous system of Drosophila, and that can interact with the DNTs? The primary candidates 
for such receptors are the LIGs, which contain the extracellular domains required for 
neurotrophin binding in vertebrates. The 9 dLIGs are Kek1–6, Lambik (Lbk), CG15744 and 
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CG16974 (Figure 1.7; Dolan et al. (2007)): each are studied here, in addition to three other 
candidate receptors, to address the above question. 
1.5.1 Lambik 
Lbk is a transmembrane receptor comprising a large extracellular domain containing 16–17 
LRR repeats and 2–3 Ig domains (Figure 1.7; Dolan et al. (2007). The closest vertebrate 
orthologues of Lbk are the LRIG1–3 family.  
The function of Lbk is unknown. The C. elegans orthologue SMA-10 is a positive 
extracellular regulator of bone morphogenetic protein (BMP) receptor signalling, required 
downstream of the BMP ligand DBL-1 but upstream of the BMP receptor SMA-6 (Gumienny 
et al., 2010). Drosophila lbk cDNA driven by an SMA-10 promoter rescued the body size 
defect of SMA-10 mutants to wild type body size (Gumienny et al., 2010). 
1.5.2 CG17839, Rickets and Wengen 
Three non-LIG candidates are also studied in this thesis. Rickets (Rk) and the uncharacterised 
CG17839 are studied owing to their LRR and/or Ig-rich ectodomains, through which they 
may bind ligands. Rk is a multiple LRR-containing receptor of the CysKnot neuropeptide 
ligand Bursicon (Dewey et al., 2004, Luo, 2005, Nässel and Winther, 2010). The eLRRs of 
Rk resemble those of the Trk receptors, although the transmembrane and intracellular 
domains are G protein linked. The third additional candidate, Wengen (Wgn), is the only 
Drosophila TNFR superfamily member. The Wgn ligand Eiger shares most homology with 
the vertebrate EDA ligand (see above; Bothwell (2006), Igaki et al. (2002), Kanda et al. 
(2002), Kauppila et al. (2003)). Wgn interacts with Moesin to control R2–R5 and R8 
photoreceptor axon targeting (Ruan et al., 2013). 
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Figure 1.7  Candidate neurotrophin receptors in Drosophila
a | The structures of vertebrate Trk and p75NTR receptors are shown. b | Drosophila LIG and non-LIG 
candidate receptors. Kek, Lbk, CG16974, CG15744 and Rk domain architectures are based on 
structures as stated in Dolan et al. (2007). CG17839 and Wgn structures were determined using the 
SMART online tool (EMBL) using sequences from FlyBase. Domains: FN3, bronectin 3; GPS, G protein 
receptor proteolytic site; Ig, immunoglobulin; KT, Kek terminal; LRR, leucine-rich repeat; TNFR, tumour 
necrosis factor receptor; TyrK, tyrosine kinase.
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1.5.3 The Kek protein family 
Kek1 and Kek2 were first identified by Musacchio and Perrimon (1996). They comprise 6 
eLRR repeats and one extracellular Ig domain, with divergent intracellular domains that lack 
signalling motifs. Sequence comparison between Kek proteins in other Drosophila species 
reveals that Kek1 has a conserved Kek-specific cytoplasmic ‘KT’ domain of unknown 
function (Derheimer et al., 2004). kek1 is expressed in neurons of the embryonic CNS and 
PNS (Musacchio and Perrimon, 1996). kek1 is further expressed in oocyte follicle cells and 
larval eye and wing discs (Derheimer et al., 2004, Musacchio and Perrimon, 1996, Ghiglione 
et al., 1999, Ghiglione, 2003). kek2 is expressed in dorsal cells of the embryonic VNC, in 
ventral midline cells and ventral muscle groups (Musacchio and Perrimon, 1996). kek2 is also 
expressed in neurons of the adult brain and presynaptic punctae at larval NMJs (Guan et al., 
2005). kek5 is expressed in the embryonic CNS, but kek5+ neuronal cell types have not been 
determined (Evans et al., 2009). The Kek family are putative cell adhesion proteins as they 
can form homotypic and heterotypic interactions (MacLaren et al., 2004).  
Only the roles of Kek1 and Kek5 are known. Kek1 is an antagonist of EGFR signalling 
during oogenesis, eye development and the formation of bract cells, which are required for the 
formation of mechanosensory bristles (Alvarado et al., 2004b, Alvarado et al., 2004a, 
Derheimer et al., 2004, Ghiglione et al., 1999, Ghiglione, 2003, Layalle et al., 2004, Zartman 
et al., 2009). By comparison, kek5 overexpression suppressed ectopic wing vein phenotypes 
in hypermorphs of the BMP ligand Gbb, whereas phenotypes caused by activated BMP 
receptors could not be rescued by kek5 overexpression (Evans et al., 2009). This suggested 
that Kek5 is an extracellular, rather than intracellular, antagonist of BMP signalling, although 
whether Kek5 modulates BMP receptors or is a ligand sink was not tested. eLRRs, rather than 
the Ig domains, are sufficient for Kek1 and Kek5 function (Evans et al., 2009, Alvarado et al., 
2004b). Kek6 shares conserved intracellular motifs with Kek5 (MacLaren et al., 2004), and is 
not involved in EGFR signalling (Alvarado et al., 2004a). 
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Kek1 is conserved within the Drosophila genus and in the mosquito, and orthologues of 
Kek1, Kek2, Kek5 and Kek6 are also found in the honeybee (Derheimer et al., 2004, 
MacLaren et al., 2004). Although Kek proteins were initially considered absent outside of the 
insects, they structurally resemble truncated Trks (Derheimer et al., 2004). Furthermore, 
phylogenetic analysis places the Kek family together with the Trks (Mandai et al., 2009). This 
places these two protein families closer together structurally and evolutionarily than the fly 
and mammalian Tolls (Imler and Zheng, 2004). Thus the Kek family belong to the Trk 
family, and structurally resemble truncated Trks. This thesis tests this hypothesis by 
examining the nine dLIGs, including the Trk-like Kek family, plus Rk, Wgn and CG17839. 
The thesis aimed to investigate the function of the dLIGs in the CNS, where the Trks function 
in vertebrates. It further aimed to test the ability of the dLIGs to interact with the Drosophila 
neurotrophins (DNTs), given that the ectodomain of dLIGs resembles the neurotrophin 
binding domain of the Trks. 
1.5.4 Potential signalling downstream of Keks or dLIGs 
Truncated Trks and p75NTR signal via the RhoGTPases by sequestering RhoGDI (see above). 
The RhoGTPases regulate the actin cytoskeleton, and thereby underlie axonal growth, axonal 
targeting and synaptogenesis (Luo, 2000). In neurotrophin signalling, phosphorylated Trk 
receptors recruit the SOS complex, which can mediate the activation of Rac, in addition to 
Ras–MEK–ERK signalling (see above). Indeed, NGF treatment can induce axonal branching 
through Rac1 and actin filament formation (Spillane et al., 2012), and loss of BDNF reduces 
actin filament formation in adult hippocampal neurons (Rex et al., 2007). Given their 
similarity to neurotrophin-binding receptors, and truncated Trks, it is possible that the dLIGs, 
including the Kek proteins, may signal via the RhoGTPases or RasGTPases. Here I briefly 
review the roles of the RhoGTPases and RasGTPases in axon growth and guidance. 
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The RhoGTPase family members Rho, Rac and Cdc42 were identified for unique roles in 
fibroblasts: Rho mediates stress fibre and focal adhesion formation, Rac is required for 
lamellipodia formation, and Cdc42 mediates filopodia formation (Ridley and Hall, 1992, 
Ridley et al., 1992, Kozma et al., 1995). Cdc42 activation leads to the sequential activation of 
Rac, followed by Rho (Nobes and Hall, 1995). Growth cones at the leading edge of advancing 
neurons are structurally similar to migrating fibroblasts, driven by the assembly and 
disassembly of actin filaments, crosstalk between the actin cytoskeleton and microtubules, 
and actin monomer recycling, within filopodia and lamellipodia (Lin et al., 1994a, Lowery 
and Van Vactor, 2009, Prokop et al., 2013a, Sanchez-Soriano et al., 2009, Sánchez-Soriano et 
al., 2010). In neuronal development, however, RhoGTPase functions differ depending on 
cellular context and between axonal growth and targeting. 
Axonal growth is defective in both loss and gain of function Rac and Cdc42 mutants (Govek 
et al., 2005, Hakeda-Suzuki et al., 2002, Luo et al., 1994, Ng et al., 2002). Conversely, 
dendritic growth is promoted by Cdc42 but not by Rac (Luo et al., 1996). Equivalent 
phenotypes are also observed in mutants of Rac activating GEFs, such as Trio (Bateman et al., 
2000). Rac and Cdc42 share a common signalling cascade via PAK; mutants of Drosophila 
PAK display photoreceptor axon mistargeting (Hing et al., 1999, Manser et al., 1994). Rac 
and Cdc42 also signal via separate cascades — Cdc42 via N-WASP to promote filamentous 
actin assembly, and Rac via Stathmin to mediate microtubule stabilization (Hall and Lalli, 
2010, Luo, 2000). In general, Rac and Cdc42 are required for axonal growth (Albertinazzi et 
al., 1998, Brown et al., 2000, Kuhn et al., 1998, Luo et al., 1996, Luo et al., 1994); 
conversely, Rho mediates growth cone collapse via the cytoplasmic kinase Rho-associated 
protein kinase (ROCK) in response to negative chemotactic cues, such as Sema3A (Gallo, 
2006, Kozma et al., 1997, Leeuwen et al., 1997, Yamashita et al., 1999). Indeed, activation of 
Rho induces growth cone retraction, and lipophosphatidic acid-induced neurite retraction is 
prevented in a dominant negative Rho genetic background (Jalink et al., 1994). During axon 
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guidance, loss of Rac causes motor axon guidance defects in the intersegmental nerve branch 
b (ISNb; Kaufmann et al. (1998); see below). In addition, Drosophila mushroom body 
dendrites overshoot their target in Rho loss of function mutants, suggesting that Rho 
attenuates dendritic growth (Lee et al., 2000). RhoGTPase roles in axon growth and guidance 
are cell type-specific, as loss or gain of Rac in Drosophila sensory neurons arrests axonal 
growth, whereas dominant negative Rac disrupts axon targeting but not growth in Drosophila 
motor neurons (Kaufmann et al., 1998, Luo et al., 1994). Rac and Cdc42 are also required for 
acetylcholine receptor clustering at the vertebrate NMJ (Weston et al., 2000). 
RasGTPase signalling is required for NGF-mediated axonal initiation, growth and neuronal 
survival (Hall and Lalli, 2010). Constitutively active R-Ras induces ectopic axonal sprouting 
in hippocampal neuron cultures, whereas RNAi-mediated knockdown of R-Ras inhibits axon 
formation (Oinuma et al., 2007). This function of Ras requires PI3K, which in turn promotes 
Ras upregulation via a positive feedback loop (Schwamborn and Puschel, 2004). PI3K can 
also signal via mTor to control neuronal polarization (Li et al., 2008). However, Ras 
signalling can also control neuronal architecture independently of PI3K: in sensory neurons, 
activated Raf promotes axon growth via ERK, whereas activated PI3K–Akt signalling 
promotes axon branching (Markus et al., 2002).  
1.6 Drosophila as a model organism  
Drosophila is an ideal genetic model to study neurobiology (Prokop et al., 2013b, Sánchez-
Soriano et al., 2007). Furthermore, its nervous system is amenable for experimentation, from 
histological phenotypes to behaviour (Nichols et al., 2012). Drosophila is also a simple model 
for the study of hormonal regulation, which is manifested by changes in developmental timing 
(Tennessen and Thummel, 2011b). Given the focus on the nervous system of this work, a 
behavioural output is essential for putting subcellular and cellular phenotypes into perspective 
(Guo et al., 2009, Heisenberg, 1997). This section outlines the morphology of the Drosophila 
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CNS and the ring gland as model tissues; and introduces methods for assaying phenotypes in 
axon guidance and developmental timing. 
1.6.1 The Drosophila nervous system 
The Drosophila CNS originates from neural stem cells, called neuroblasts, that are specified 
in the embryonic ectoderm and invaginate to segregate from the epidermal layer. Neuroblasts 
originate in several waves during Drosophila embryogenesis, starting from stage 9 
(Hartenstein, 1993). (See Campos-Ortega and Hartenstein (1985) for embryonic staging.) 
Neuroblasts divide into a further neuroblast and a ganglion mother cell, which further divides 
into two neurons or glia (Doe, 1992). Individual neurons and glia begin to differentiate at 
stage 12. Dorsal closure occurs at stage 15, after which the VNC shortens and thickens up to 
stage 17 (Figure 1.8a,b).  
At stage 12, early neuronal cell bodies (MP1, dMP2, vMP2 and pCC neurons) project pioneer 
axons that extend along the nerve cord, either side of the midline, to build the longitudinal 
tracts (Figure 1.8c,d) (Bate and Grunewald, 1981, Hidalgo and Brand, 1997, Lin et al., 1994b, 
Sánchez-Soriano et al., 2007). MP1 and dMP2 axons extend posteriorly along the nerve cord, 
whereas the projecting axons of pCC and vMP2 neurons build the longitudinal tracts 
anteriorly (Hidalgo and Brand, 1997). At stage 13, projecting growth cones within the VNC 
meet at segmental boundaries, and at stage 14, fascicles separate to form two separate 
pathways (Hidalgo and Brand, 1997). Subsequent rearrangements result in three longitudinal 
fascicles by stage 17 (Hidalgo and Brand, 1997). Other axons cross the midline, forming an 
anterior and posterior commissure per segment (Sánchez-Soriano et al., 2007). Growth cones 
of the pioneer commissure neurons follow guidance cues released from midline glia and 
neurons (Hummel et al., 1999). The commissures are subsequently used by midline neurons, 
such as the neuromodulatory ventral unpaired median (VUM) neurons, to guide axonal 
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Figure 1.8  The Drosophila nervous system
a | Individual neurons and glia begin to dierentiate  from stage 12 (CNS shaded).  
b | By stage 17, the embryonic ventral nerve cord (VNC) has shortened and thickened and 
the embryonic brain occupies the anterior of the embryo. c,d | Segmentally-repeating pioneer 
neurons project axons towards the anterior (pCC and vMP2) or posterior (dMP2 and MP1) to 
form the longitudinal tracts, whereas aCC and RP2 pioneer neurons project away from the 
midline (ML) to form the motor neurons. e | Motor axons project from the ladder-shaped neuropil 
of the VNC to target specic muscles. Intersegmental nerve b (ISNb) motor axons target 
muscles 6–7, 6–13 and 13–12 to form a characteristic ‘E’ shape. Not all muscles are shown. 
Regions of known DNT1, DNT2 and Spz expression are shown in blue (based on Zhu et al. 2008).
 f | ventral (v, v’), lateral (l) and dorsal (d) clusters of the PNS project from the VNC in each segment. 
LT4, lateral transverse muscle 4; SBM, segment border muscle; SN, segmental nerve; TN, 
transverse nerve; VA3, ventral acute muscle 3.See main text for references. 
Spz
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projections away from the midline into the longitudinal tracts and/or the muscle (Bossing and 
Technau, 1994).  
In the larva, the CNS comprises the central brain, two optic lobes and the VNC, which in the 
adult will form the adult central brain, optic lobes and VNC (Hartenstein, 1993). In the 
embryonic and larval VNC, the central neuropil is enwrapped by interface glia and midline 
glia, the nerves are enwrapped by peripheral glia, the cortex outside the neuropil comprises 
the neuronal cell bodies and cortex or cell body glia, and the whole VNC is enveloped by the 
sub-perineural and perineural glia (Beckervordersandforth et al., 2008). 
CNS axons can be labelled with anti-BP102, which labels the entire neuropil, revealing 
possibly all dendrites or axons along the longitudinal connectives and commissures, or anti-
Fasciclin II (ID4), which labels the pioneer neurons, the three main longitudinal connective 
fascicles and all the motor neurons. Ventral motor neurons can be identified by co-
localization with the motor neuron nuclear markers HB9 or Islet, or lim3Gal4-driven reporters 
(axons), and dorsal motor neurons can be identified by co-localization with the motor neuron 
nuclear marker Eve (Landgraf and Thor, 2006b, Odden et al., 2002). ISNb motor neuron 
nuclei are HB9+, except for the dorsal VUM neuron, which is Islet+ (Kim et al., 2009, 
Landgraf et al., 1997, Landgraf and Thor, 2006b).  
Motor neurons terminate at their muscle target, whereupon they form NMJs. The three major 
ventral motor neuron trunks exiting the embryonic VNC to the muscles are the transverse 
nerve (TN), ISN and the segmental nerve (SN), which divide into further branches, including 
the ISNb, ISNd, SNa and SNc branches (Figure 1.8e; Landgraf and Thor (2006b)). The TN 
marks the border of adjacent body segments, SN motor axons innervate muscular targets in 
the same segment as their cell body and ISN motor axons innervate muscles in adjacent 
segments (Landgraf et al., 1997, Landgraf et al., 2003, Landgraf and Thor, 2006a). TN and 
SN motor neurons innervate transverse external muscles (SNa targets the segment border 
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muscle (SBM) and lateral transverse (LT) muscles), whereas ISN motor neurons target 
longitudinal internal muscles (Landgraf et al., 1997, Landgraf et al., 2003). 
Pioneer axons of the ISN originate from aCC and RP2 motor neurons in the VNC (Figure 
1.8d; Sanchez-Soriano and Prokop (2005)). Follower neurons — including U and VUM 
motor neurons — project along the pioneer axonal tracts to fasciculate the ISN trunk 
(Landgraf et al., 1997, Sanchez-Soriano and Prokop, 2005). Conversely, the V and RP1–5 
axons fasciculate the SN trunk (Landgraf et al., 1997). By late stage 17, the ISNb motor 
neuron branch has a characteristic morphology in which three projections target muscles 12–
13, 6–13 and 6–7 (Figure 1.8e). Mistargeting of these three ISNb projections can be used as 
an assay to test the function of genes of interest in target innervation (Bateman et al., 2000, 
Kaufmann et al., 1998). Here, this paradigm is used to quantify axon misrouting resulting 
from kek6 mutations.  
DNTs are distributed in the muscle and function as trophic factors in axon targeting (Zhu et 
al., 2008). In DNT141 and DNT2e03444/Df(3R)ED6092 single mutants and DNT2e03444DNT141 
double mutants ISNb projection mistargeting increases to 40–50% penetrance, compared to 
wild type misrouting in ~20% of hemisegments (Zhu et al., 2008). ISNb projection 
mistargeting is also observed in toll631/Df(3L)XG4 and toll7P8/Df(2R)BSC22 single receptor 
mutants (McIlroy et al., 2013). Therefore, this assay is an ideal context to test the role of kek6 
in DNT signalling. 
The PNS is formed of the cell bodies and dendrites of neurons located laterally on the 
epidermis, and which extend axons towards and into the CNS, and the axons of the motor 
neurons, which have the cell bodies and dendrites located in the CNS and project their axons 
to the muscles. This pattern is repeated laterally from the midline in each hemisegment 
(Figure 1.8f). By stage 17 and from ventral to dorsal, four clusters of cells are present, 
designated the v, v′, l and d clusters and are detectable with anti-Fusch (22C10) antibodies 
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(Hidalgo et al., 1995, Ruiz-Gómez and Ghysen, 1990). The ‘l’ cluster comprises the neurons 
of the chordotonal organ, which are mechanoreceptors. (Field and Matheson, 1998). 
1.6.2 The Drosophila ring gland and developmental timing 
The larval ring gland is one of two body organs required for postembryonic insect 
development by neuroendocrine signalling (Siegmund and Korge, 2001). It is composed of 
three endocrine glands: the prothoracic gland (PG), which releases ecdysone; the corpora 
allata (CA), which releases juvenile hormone (JH) into the haemolymph; and the paired 
corpora cardiaca (CC), which releases adipokinetic hormone (AKH) with functions 
comparable to glucagon (Figure 1.9; Edgar (2006)). These glands are stimulated by 
neuropeptide release from secretory neurons that innervate the CA and PG from the 
protocerebrum (Nässel and Winther, 2010). The CA and PG have reciprocal roles in 
developmental timing throughout larval and pupal development (Tennessen and Thummel, 
2011a). 
With the exception of the CC, the glands of the ring gland are responsible for developmental 
timing: ecdysone secretion pulses from the PG further larval development, whereas the 
presence of JH acts as a brake to development, inhibiting ecdysone signalling and preventing 
pupariation until the larva is large enough to survive metamorphosis (Flatt et al., 2005, King-
Jones et al., 2005, Richard et al., 1989).  
Distinct stages and checkpoints control larval–pupal development: the minimum viable 
weight, below which the larva will not survive metamorphosis, the critical weight, which 
marks the end of feeding, an interval to cessation of growth, and the onset of larval 
wandering (Edgar, 2006). The critical weight is measured by abdominal mecahnoreceptors 
(Davidowitz et al., 2003, Nijhout, 2003). Prior to this checkpoint, insulin-like signalling 
drives and regulates growth via PI3K; beyond this checkpoint, starvation or changes in food 
nutritional quality do not halt metamorphosis (Davidowitz et al., 2003, Mirth and Riddiford, 
VNC
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neuronal signalling
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PG
CC CC
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20E
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BR-C
(Fat body)
Pupariation
Figure 1.9  The Drosophila ring gland
The larval ring gland is positioned anterior to the larval brain and is innervated by 
neurosecretory neurons from the lateral protocerebrum (LP). The ring gland comprises the 
corpus allatum (CA), which secretes juvenile hormone (JH); the prothoracic gland (PG); and the 
pair of corpora cardiaca (CC), which are involved in glucagon-like signalling. Ecdysone 
released from the PG is converted to 20-hydroxyecdysone (20E) and targets Broad-Core (BR-C), 
a transcription factor that is upregulated in the fat body to activate signalling required for 
pupariation and metamorphosis. 20E signalling is triggered by prothoracicotropic hormone 
(PTTH) release from PG-LP neurons, and is inhibited by the presence of JH. OL, optic lobe; 
VNC, ventral nerve cord. 
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2007). In Drosophila, the critical weight checkpoint is delayed if food quality is low 
throughout growth, since proceeding beyond the critical weight checkpoint precociously 
hinders chances of survival, as the pupa can no longer feed (Beadle, 1938, King-Jones et al., 
2005, Tennessen and Thummel, 2011a). During the interval to cessation of growth, larval 
volume may quadruple (Beadle, 1938, Edgar, 2006). Larval wandering is preceded by an 
intermediate surfacing transition (IST) behaviour, when larvae only temporarily leave their 
food (Wegman et al., 2010). Full wandering behaviour then follows, whereby larvae 
permanently leave the food prior to pupariation. Pupariation refers to the pre-pupal transition 
period during which the white-coloured cuticle of the final larval instar hardens. Within the 
puparia or prepupa, the epidermis detaches from the cuticle and, after 12 hours, the head 
everts. Head eversion is the beginning of the pupal state (Chadfield and Sparrow, 1984). 
In insects, the CA secretes JH into the haemolymph in response to pro- (allatotropin) and anti- 
(allatostatin) neuropeptide stimulation. However, in Drosophila, no allatotropins have been 
identified (Nässel and Winther, 2010). JH has a crucial role in maintaining larval growth, as 
flies with ablated CA pupated prematurely, had gross morphological defects and died before 
adult eclosion (Riddiford et al., 2010). Prior to the critical weight, JH suppresses ecdysone 
signalling; after this checkpoint, JH levels drop and the ecdysone signalling cascade begins, 
resulting in the cessation of feeding and onset of wandering (Dubrovsky et al., 2000, Edgar, 
2006, Flatt et al., 2005). The direct downstream targets of JH signalling are unknown, 
although mutants of the receptor Met phenocopy loss of the CA (Riddiford et al., 2010). JH 
levels rise again after metamorphosis initiation, and are required for the final stages of fat 
body histolysis (Postlethwait and Jones, 2005).  
The ecdysone cascade begins with the release of prothoracicotropic hormone (PTTH) directly 
into the PG from a pair of neurosecretory neurons that originate in the larval brain (McBrayer 
et al., 2007, Nässel and Winther, 2010, Siegmund and Korge, 2001). PTTH is a neuropeptide 
homodimer that forms a CysKnot structure resembling NGF (Nässel and Winther, 2010, 
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Noguti et al., 1995). PTTH binds the RTK Torso in the PG, and signals via the ERK cascade 
(Rewitz et al., 2009).  
PTTH–Torso signalling leads to the release of ecdysone to peripheral targets, including the fat 
body, via the haemolymph (Henrich et al., 1987, McBrayer et al., 2007, Pak et al., 1992, 
Rewitz et al., 2009). Ecdysone is subsequently processed to the active form, 20-
hydroxyecdysone (20E; Thummel and Chory (2002)). 20E activates early regulatory 
transcription factors, including Broad-Core (BR-C); this is repressed by the 20E target 
receptor DHR4, thereby creating a negative feedback loop (Ou et al., 2011). DHR4 mutants 
begin wandering earlier than controls and have smaller adult volumes (King-Jones et al., 
2005).  
PTTH transcripts are present in the larval brain throughout the L3 instar, oscillating with an 8 
hour rhythm (McBrayer et al., 2007). The brain is thus primed for metamorphic changes, 
subject to the loss of JH upon obtaining the critical weight. Three peaks of 20E release then 
follow, which correspond to the critical weight checkpoint; the onset of wandering; and the 
transcription and translation of sgs3, which adheres the pupae to solid surfaces for 
metamorphosis. Each peak activates different early onset genes (Georgel et al., 1991, Karim 
and Thummel, 1992, Warren et al., 2006).  
1.7 Aims  
The aim of my thesis was to investigate whether genes encoding non-canonical membrane 
proteins structurally and phylogenetically related to the Trks may function in fruit flies as 
receptors for Drosophila neurotrophins. 
Trk proteins are the receptors of the vertebrate neurotrophins, but are absent from Drosophila, 
despite evidence suggesting that a Trk-like protein was present in the bilaterian ancestor and 
the presence of Trks in the protostomes (Bothwell, 2006, Jaaro and Fainzilber, 2006, Sossin, 
2006). Drosophila encodes 9 LIG proteins derived by domain shuffling, of which the Kek 
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family clusters phylogenetically with the vertebrate Trks (Dolan et al., 2007, Mandai et al., 
2009). All 9 dLIGs resemble the extracellular ligand-binding structure of vertebrate Trks. 
The specific objectives were:  
(1) To characterise the expression patterns of the Trk-like dLIGs, plus CG17839, rk and wgn, 
and analyse lethality and locomotion phenotypes of available mutant alleles. From this, the 
most suitable candidates as DNT interacting partners, or neurodevelopment genes, would be 
selected for further study according to three criteria: neuronal expression, display of nervous 
system phenotypes and genetic interaction with the DNTs.  
(2) To test by expression of Kek≡Toll6 chimaeric receptors in S2 cell culture signalling 
assays whether any of the Kek proteins could potentially bind DNT1 and DNT2 and trigger a 
luciferase signalling readout.  
(3) To generate tools to enable loss and gain of function analysis of candidate genes for in 
vivo functional genetic analyses. Thus, I generated upstream activation sequence (UAS)-
containing overexpression constructs for each of the kek genes, and null mutant alleles for 
kek3, kek4 and kek6. With these tools, I tested genetic interactions between the candidate 
genes and the DNTs to determine whether the receptors were involved in similar signalling 
pathways and whether their overexpression could rescue DNT mutants.  
(4) To determine whether the candidate genes had functions in nervous system development, I 
used the mutants and overexpression constructs I generated to test their functions by 
analysing and quantifying motor axon targeting defects and locomotion behaviour in larvae in 
loss of function mutants and upon overexpression of the receptors in neurons. 
(5) I serendipitously discovered that kek4 is expressed in the ring gland, and thus I 
investigated its function in the temporal control of growth.   
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CHAPTER 2 
METHODS  
2.1 Genetics 
2.1.1 Genetic protocols 
Except where indicated, genetic protocols were carried out at 25⁰C in a 12 hour light/dark 
cycle, and stocks maintained at 18⁰C. Flies were reared on cornmeal agar medium. See Table 
2.1 for full list of fly stocks in this work, by genotype and by experiment. 
Standard fly pushing protocols were used to make chromosome X+II and II+III double 
mutant stocks, and recombinant alleles on chromosome III (Greenspan (2004); Figures 2.1–
2.3). At the F2 cross of the recombination protocol, deficiencies were used that would be 
embryonic lethal in progeny heteroallelic with the putative recombined alleles (for example, 
Df(3L)ED4342/TM6B for Df(3L)ED4342kek634/TM6B recombinants). Successful 
recombination of alleles balanced on chromosome III was verified by use of reporter lines for 
Gal4 recombinants and/or PCR as applicable. Context-specific Gal4 initiation of transgene 
expression was used for genetic overexpression (Brand and Perrimon, 1993). Genetic drivers 
used: elavGal4 (all neurons), GMRGal4 (retina), 24BGal4 (muscle) and gene promoter-
specific Gal4 lines. Transgenic P element insertions were mapped according to the protocol in 
Figure 2.4. 
2.1.2 Null mutagenesis 
Null mutants of kek3, kek4 and kek6 were generated according to the protocol of Parks et al. 
(2004) (Figures 2.5–2.7). Genetic work for the generation of the kek3 deletion was carried out 
by Alicia Hidalgo. piggyBac variants and genomic orientation were selected according to 
compatibility criteria outlined in Parks et al. (2004). In each case, the start codon of the gene 
of interest was deleted (Figures 5.1, 5.3, 5.5). Flies containing compatible piggyBac elements 
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Genetic protocol for null mutagenesis by FRT transposon mutagenesis on chromosome II. 
F1 progeny larvae with transheterozygous parental transposons were heat shocked at 370C 
for 1 hour daily to induce transposon fusion. If fusion occured in the germ line of these larvae, 
F2 progeny carried heritable gene deletions. Multiple putative deletion lines were established 
at the F3 cross by crossing 5 virgin isogenic females to 1 mutagenised male. 
Putative mutants were tested by PCR. 
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Figure 2.6  Genetic protocol: Heat-shock Flippase-mediated mutagenesis 
  Chromosome III
piggyBacA and piggyBacB denote the FRT-containing transposons that ank the deleted region
Genetic protocol for null mutagenesis by FRT transposon mutagenesis on chromosome III. 
Heat shock protocol was followed as per Figure 2.5.
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Figure 2.7  Deletion of kek3, kek4 and kek6 by FRT transposon mutagenesis
Excision of P elements by genetic and heat-shock activated Flippase-mediated recombination 
of piggyBac transposons to generate kek3, kek4 and kek6 null mutant alleles. 
a | Heat shock activated Flippase induced transposon fusion between two FRT-containing 
parental transposon lines, deleting the genomic region in between. b | Transposon fusions 
could be tested by PCR. Two sided PCRs amplify from the transposon fusion into the anking 
genomic region on both sides of the deletion. Only lines in which both fragments are 
amplied indicate a successful transposon fusion. Compatible piggyBac elements comprise 
three genetic compositions — WH, RB and XP elements — and either forward or reverse 
orientation relative to the genome; transposon fusions thus generate distinct sequences that
can be amplied by Hybrid PCR. Genomic PCR amplies the genomic region, including the 
transposon fusion, either side of the deltion. Internal genomic PCR amplies a region internal 
to the putative deletion; bands were absent in homozygous genomic DNA. Here, two-sided 
and internal genomic PCR were used to verify generated nulls. 
Table 2.1  Fly stocks 
Genotype Source Use 
Stocks 
yw  Bloomington #6420  
OregonR  Bloomington #5  
w;IF/CyO;MKRS;TM2  Bloomington #3042  
w;IF/CyO;MKRS;TM6B  Bloomington #3703  
w;IF/CyOlacZ;MKRS;TM6BlacZ  Zhu et al. 2008  
w;IF;MKRS/SM6aTM6B  Bloomington #5687, Zhu et al. 2008  
F263 vnγ3/TM3lacZ  Hidalgo et al. 2001  
Fm7/Fm7;;TM3Ser/Sb  Bloomington #8599  
P{hsFLP}1, w;Adv1/CyO  Kyoto #105670 FRT mutagenesis 
P{hsFLP}1, yw;;DrMio/TM3Sb  Kyoto #105671 FRT mutagenesis 
w;P{UAS-Cdc42.N17}3 II Bloomington #6288 UAS DN Cdc42 
UASMycAFGDP110 III Bloomington #25918 UAS DN PI3K 
w;P{UAS-Rac1.L89}6 II Bloomington #6290 UAS DN Rac1 
P{UAS-Ras85D.N17} II Bloomington #4845 UAS DN Ras85D 
w;;P{UAS-Rho1.N19}2.1 III Bloomington #7327 UAS DN Rho1 
w;P{UAS-Cdc42.V12}2 II Bloomington #6287 UAS Act Cdc42 
P{Dp110-CAAX}1, w X Bloomington #8294 UAS Act PI3K 
w;;P{UAS-Rac1.V12}1 III Bloomington #6291 UAS Act Rac1 
w;;P{UAS-Ras85D.V12} III Bloomington #4847 UAS Act Ras85D 
w;P{UAS-Rho1.V14.E40L}/CyO II Bloomington #7333 UAS Act Rho1 
Tie5  A. Lowry, Hidalgo laboratory  
Deficiencies 
15A6RA5/CyO;ry506/+  Musacchio & Perrimon, 1996 kek1 deficiency, Axon guidance 
Df(2L)15A6RM2/CyO  Musacchio & Perrimon, 1996 kek1 deficiency, Axon guidance 
Df(2L)BSC768/SM6a  Bloomington #26865 kek4 deficiency 
Df(2L)ED1050/SM6a  Kyoto #150105 kek3 deficiency 
Df(3R)ED6361/TM6B  Kyoto #150478 kek6 deficiency, rebalanced 
Df(3L)ED4342/TM6BlacZ  Bloomington #8062 DNT1/tie Deficiency 
Df(3L)Exel6101/TM6B  Bloomington #7580 DNT1 Deficiency 
Df(3L)ED6092/TM6B  Bloomington #7571 DNT2 Deficiency 
Driver lines 
24BGal4  Bloomington #1767 Muscle driver 
elavGal4  Bloomington #23867 Neurons driver 
GMRGal4  M. Freeman Eye driver 
GMRGal4;roTaulacZ  Garrity el al. 1999 Eye driver 
spz6Gal4  S. AlAhmed, Hidalgo laboratory Ring gland driver 
Reporters 
UASmCD8GFP  Kyoto #108068 Expression profiles 
UASmyrTOMATO  M. Landgraff Expression profiles 
DNT alleles 
DNT141/DNT141  Zhu et al. 2008 Survival index, Axon guidance 
DNT155/DNT155  Zhu et al. 2008 Genetics, Survival index 
DNT2e03444/DNT2e03444  Zhu et al. 2008 Survival index, Axon guidance 
DNT2e03444DNT141elavGal4/TM6BlacZ  Zhu et al. 2008 Survival index, Axon guidance 
w;UASDNT1CK3'+;+/MKRS  Zhu et al. 2008 Axon guidance 
DNT237/TM6B  J Wentzell, Hidalgo laboratory Genetics 
kek1 
15A6(ry+);ry506  Musacchio & Perrimon, 1996  
pBac{XP}kek1d03841  Harvard d03841  
kek1 overexpression 
w;;UASkek1RFP/TM2  
Cloning: This work;  
Transgenesis: BestGene #8547-1-1M  
w;UASkek1RFP/CyO;MKRS/TM6B  
Cloning: This work;  
Transgenesis: BestGene #8547-1-2M  
w;;UASkek1RFP/TM2  
Cloning: This work;  
Transgenesis: BestGene #8547-1-3M  
w;UASkek1RFP/CyO;+/MKRS * Cloning: This work;  Transgenesis: BestGene #8547-1-4M Rough eye phenotype, Axon guidance 
w;UASkek1RFP/CyO;UASkek1RFP/MKRS  
Cloning: This work;  
Transgenesis: BestGene #8547-1-5M  
w;+/CyO;UASkek1RFP/TM2  
Cloning: This work;  
Transgenesis: BestGene #8547-1-6M  
UASkek1RFP;DNT141DNT2e03444/SM6aTM6B  This work DNT rescue, Survival index 
kek2 
kek2 overexpression 
w;UASkek2RFP/CyO;MKRS or TM6B * Cloning: This work;  Transgenesis: BestGene #9179-1-1M Rough eye phenotype 
w;UASkek2RFP/CyO;MKRS/TM6B  
Cloning: This work;  
Transgenesis: BestGene #9179-1-2F  
w;UASkek2RFP/CyO;UASkek2RFP/MKRS  
Cloning: This work;  
Transgenesis: BestGene #9179-1-3M  
w;UASkek2RFP/CyO  
Cloning: This work;  
Transgenesis: BestGene #9179-1-4M  
w;UASkek2RFP/CyO  
Cloning: This work;  
Transgenesis: BestGene #9179-1-5M  
w;UASkek2RFP/CyO  
Cloning: This work;  
Transgenesis: BestGene #9179-1-7M  
UASkek2RFP;DNT141DNT2e03444/SM6aTM6B  This work DNT rescue, Survival index 
kek3 
pBac{WH}kek3f07027/CyOlacZ  Harvard f07027 Null mutagenesis 
pBac{WH}kek3f04709  Harvard f04709 Null mutagenesis 
pBac{WH}kek3f07029  Harvard f07029 Genetics, Null mutagenesis 
pBac{WH}kek3f07041  Harvard f07041 Null mutagenesis 
w;Mi{ET1}CG15256MB09797  Bloomington #27806 kek3Gal4, Expression profiles 
kek3 LOF 
kek3f07029;+/SM6aTM6B  This work Survival index, Locomotion 
kek3f07029;DNT141/SM6aTM6B  This work Kek-DNT interactions, Survival index, Locomotion 
kek3f07029;DNT2e03444/SM6aTM6B  This work Kek-DNT interactions, Survival index, Locomotion 
kek312  A Hidalgo/S Bishop, This work Survival index, Locomotion 
kek326  A Hidalgo/S Bishop, This work Survival index, Locomotion 
kek312;+/SM6aTM6B  This work Survival index 
kek326;+/SM6aTM6B  This work Survival index 
kek312;DNT155/SM6aTM6B  This work Kek-DNT interactions, Survival index 
kek326;Df(3L)Exel6101/SM6aTM6B  This work Kek-DNT interactions, Survival index 
kek312;DNT237/SM6aTM6B  This work Kek-DNT interactions, Survival index 
kek312;DNT2e0344/SM6aTM6B  This work Kek-DNT interactions, Survival index 
kek326;Df(3L)6092/SM6aTM6B  This work Kek-DNT interactions, Survival index 
kek312;roTaulacZ  This work Photoreceptor axon targeting, see Chapter 8 
kek3 overexpression 
w;;UASkek3RFP/TM6B  
Cloning: This work;  
Transgenesis: BestGene #8547-2-1M  
w;UASkek3RFP/CyO  
Cloning: This work;  
Transgenesis: BestGene #8547-2-2M  
w;;UASkek3RFP/MKRS * Cloning: This work;  Transgenesis: BestGene #8547-2-3M Locomotion, Rough eye 
UASkek3RFP;DNT141DNT2e03444/SM6aTM6B  This work DNT rescue, Survival index 
kek4 
pBac{WH}kek4f05454  Harvard f05454 Genetics, Null mutagenesis 
pBac{RB}kek4e04257  Harvard e04257 Null mutagenesis 
w;P{GT1}BG00800  Bloomington #12509 kek4Gal4, Expression profiles 
kek4 LOF 
kek4f05454;+/SM6aTM6B  This work Survival index, Locomotion 
kek4f05454;DNT155/SM6aTM6B  This work Kek-DNT interactions, Survival index, Locomotion 
kek4f05454;DNT2e03444/SM6aTM6B  This work Kek-DNT interactions, Survival index, Locomotion 
kek420  This work 
Survival index, Locomotion,  
Developmental timing, BR-C staining 
kek423  This work 
Survival index, Locomotion,  
Developmental timing, BR-C staining 
kek442/CyO  This work  
kek420;+/SM6aTM6B  This work Survival index 
kek423;+/SM6aTM6B  This work Survival index 
kek420/CyO;DNT155/TM6B  This work Kek-DNT interactions, Survival index 
kek423/CyO;Df(3L)Exel6101/TM6B  This work Kek-DNT interactions, Survival index 
kek420/CyO;DNT237/TM6B  This work Kek-DNT interactions, Survival index 
kek420/CyOlacZ;DNT2e03444/TM6BlacZ  This work Kek-DNT interactions, Survival index 
kek423/CyO;Df(3L)6092/TM6B  This work Kek-DNT interactions, Survival index 
kek4 overexpression 
w;UASkek4RFP/CyO  
Cloning: This work;  
Transgenesis: BestGene #9179-2-1M  
w;(UASkek4RFP)/CyO;(UASkek4RFP)/MKRS  
Cloning: This work;  
Transgenesis: BestGene #9179-2-2M  
w;;UASkek4RFP/MKRS * Cloning: This work;  Transgenesis: BestGene #9179-2-3M 
Developmental timing, Locomotion,  
BR-C staining, Rough eye 
UASkek4RFP;DNT141DNT2e03444/SM6aTM6B  This work DNT rescue, Survival index 
kek5 
pBac{RB}kek5e02482  Harvard e02482 Genetics 
P{GawB}NP5933  Kyoto #105058 kek5Gal4, Expression profiles 
kek5 LOF 
kek5e02482;;+/TM6B  This work Survival index, Locomotion 
kek5e02482;;DNT155/TM6B  This work Kek-DNT interactions, Survival index, Locomotion 
kek5e02482;;DNT2e03444/TM6B  This work Kek-DNT interactions, Survival index, Locomotion 
kek5 overexpression 
w;IF/CyO;UASkek5RFP/MKRS  
Cloning: This work;  
Transgenesis: BestGene #9179-3-1M  
w;;UASkek5RFP/TM6B  
Cloning: This work;  
Transgenesis: BestGene #9179-3-2M  
w;+/CyO;UASkek5RFP/TM6B  
Cloning: This work;  
Transgenesis: BestGene #9179-3-3M  
w;;UASkek5RFP/MKRS * Cloning: This work;  Transgenesis: BestGene #9179-3-4M Rough eye phenotype 
w;UASkek5  
Cloning: This work;  
Transgenesis: BestGene #9179-3-8M  
UASkek5RFP;DNT141DNT2e03444/SM6aTM6B  This work DNT rescue, Survival index 
kek6 
pBac{RB}kek6e00907  Harvard e00907 Null mutagenesis 
pBac{RB}kek6e05733  Harvard e05733 Null mutagenesis 
kek6 LOF 
kek634/TM3lacZ  This work Axon guidance 
kek634/TM6B  This work Survival index, Locomotion 
kek635/TM3lacZ  This work Axon guidance 
kek635/TM6B  This work Survival index, Locomotion 
kek634Df(3L)ED4342/TM6B  This work Kek-DNT interactions, Survival index, Locomotion 
kek634Df6092/TM6B  This work Kek-DNT interactions, Survival index, Locomotion 
Df(3R)ED6361DNT155/TM6B  This work Kek-DNT interactions, Survival index, Locomotion 
Df(3R)ED6361DNT2e03444/TM6B  This work Kek-DNT interactions, Survival index, Locomotion 
Df(3R)ED6361Tie5/TM6B  This work Kek-DNT interactions, Survival index, Locomotion 
kek63424BGal4/TM6BlacZ  This work Axon guidance, Survival index 
UASDNT1CK3'+;kek635/TM6BlacZ  This work Axon guidance, Survival index 
UASRho1V14-E4DL;kek635/TM6B  This work kek6-, Act Rho: Survival index 
UAScdc42V12;kek635/TM6BlacZ  This work kek6-, Act cdc42: Survival index 
Toll7P8;Df(3R)ED6361/SM6aTM6B  This work Future use: see Chapter 6 Discussion 
kek6 overexpression 
UASkek6RFP/Fm7  
Cloning: This work;  
Transgenesis: BestGene #8547-3-2F  
w;;UASkek6RFP/TM2  
Cloning: This work;  
Transgenesis: BestGene #8547-3-3M  
w;;UASkek6RFP/TM2 * Cloning: This work;  Transgenesis: BestGene #8547-3-4M 
Survival index, Locomotion,  
Axon guidance, Rough eye 
w;UASkek6RFP/CyO * Cloning: This work;  Transgenesis: BestGene #8547-3-5M  
w;;UASkek6RFP/MKRS  
Cloning: This work;  
Transgenesis: BestGene #8547-3-6M  
w;UASkek6RFP/CyO;UASkek6RFP/MKRS  
Cloning: This work;  
Transgenesis: BestGene #8547-3-7M  
UASkek6RFP/Fm7  
Cloning: This work;  
Transgenesis: BestGene #8547-3-8M  
w;UASkek6RFP/CyO;UASkek6RFP/MKRS  
Cloning: This work;  
Transgenesis: BestGene #8547-3-9M  
w;;UASkek6RFP/MKRS  
Cloning: This work;  
Transgenesis: BestGene #8547-3-10M  
UASkek6RFP;DNT141DNT2e03444/SM6aTM6B  This work DNT rescue, Survival index, Axon guidance 
UAScdc42N17.3;UASkek6RFP  This work UAS kek6, DN cdc42: Axon guidance, locomotion 
UASkek6RFP/CyOlacZ;UASMycAFGDP110  This work UAS kek6, DN PI3K: Axon guidance, locomotion 
UASRasN17;UASkek6RFP  This work UAS kek6, DN Ras: Axon guidance, locomotion 
UASdRacL89.6;UASkek6RFP  This work UAS kek6, DN Rac: Axon guidance, locomotion 
UASkek6RFP;UASRhoN19/SM6aTM6B  This work UAS kek6, DN Rho: Axon guidance, locomotion 
kek6 rescue 
kek634elavGal4/TM6BlacZ  This work Survival index, Axon guidance, Locomotion 
UASkek6RFP;Df(3R)ED6361/SM6aTM6B  This work Survival index, Axon guidance, Locomotion 
UASkek6RFP;kek635/SM6aTM6B  This work Survival index 
Lambik 
p{GSV2}lbkGS50104/SM1  Kyoto #204812 Genetics 
lbk LOF 
lbkGS50104;+/SM6aTM6B  This work Survival index, Locomotion 
lbkGS50104;DNT155/SM6aTM6B  This work Kek-DNT interactions, Survival index 
lbkGS50104;DNT2e03444/SM6aTM6B  This work Kek-DNT interactions, Survival index 
Rickets 
rk4  Bloomington #3590 Genetics 
rk LOF 
w;rk4;+/SM6aTM6B  This work Survival index 
w;rk4;DNT155/SM6aTM6B  This work Kek-DNT interactions, Survival index 
w;rk4;DNT2e03444/SM6aTM6B  This work Kek-DNT interactions, Survival index 
Wengen 
pBac{RB}wgne00637  Bloomington #17874 Genetics 
wgn LOF 
pBacwgne00637;;+/TM6B  This work Survival index, Locomotion 
pBacwgne00637;;DNT155/TM6B  This work Kek-DNT interactions, Survival index 
pBacwgne00637;;DNT2e03444/TM6B  This work Kek-DNT interactions, Survival index 
CG17839    
pBac{Gal4D,EYFP}CG17839PL00504  Flybase #7366 CG17839Gal4, Expression profiles 
 
Transgenic lines used in experiments are indicated with a *. 
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flanking the genes of interest were crossed such that the parental transposons were held in 
heterozygosis in combination with heat shock-inducible Flippase recombinase. F1 parental 
flies were transferred into duplicate vials 3, 5 and 7 days after crossing; heterozygous larvae 
in each vial were subjected to 7 daily 2 hour heat shocks at 37⁰C in a water bath from 2 days 
after parental crossing. Adult progeny were balanced using CyO (kek3, kek4) or TM6B (kek6) 
balancer chromosomes. At least 50 lines (Appendix III) for each putative deletion were set up 
at the F3 cross using 5 pairwise virgin females and 1 putative mutant male. Progeny were 
screened by polymerase chain reaction (PCR; Figures 5.1–5.5).  
Two methods for mutagenesis verification were used (Figure 2.7). Two-sided PCR using 
genomic DNA from heterozygous putative mutants and parental lines amplified genomic 
regions flanking the insertion sites either side of the deletion; one primer from each reaction 
hybridised within the P element insertion. Only lines from which fragments could be 
amplified on both sides of the putative deletion had undergone a transposon fusion. Internal 
genomic PCR using genomic DNA from homozygous putative mutants (kek3, kek4) or 
heterozygous mutant/deficiency stocks (kek6) amplified genomic regions internal to the 
deletion. Only lines that failed to amplify this fragment, but tested positive for fragments 
outside of the deleted region, were successful deletions. For primers used and regions of 
amplification, see Figures 5.1–5.5. 
2.1.3 Survival index 
Survival index (S.I.) calculations were applied to pupal counts to determine embryonic 
lethality resulting from mutant alleles. Alleles were balanced over TM6B or SM6aTM6B, and 
flies incubated at 18⁰C. Pupal progeny of heterozygous flies or crossed heterozygous parents 
reared in these conditions were scored for Tb– (TM6B) or Tb+ (homozygotes) markers.  
The S.I. of heterozygous flies was calculated as 2 x (number of Tb+ pupae/number of Tb– 
pupae). Heterozygous parents with viable alleles yield an expected Mendelian ratio of 1/3 Tb+ 
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(allele/allele):2/3 Tb– (allele/TM6B) progeny (TM6B/TM6B is embryonic lethal); thus, viable 
alleles yield a S.I. of 1. Alleles that impair viability produce more Tb– progeny and thus have 
survival indices <1.  
Transposon-derived alleles for use in initial survival index results (Chapter 3) are summarised 
in Table 2.2 and Figure 2.8.To determine most suitable candidate genes for further study, 
dLIG–Drosophila neurotrophin (DNT) genetic combinations were studied using viable dLIG 
alleles, in which the coding sequence or regulatory regions were disrupted by transposon 
insertion and/or point mutation. The choice of allele reflected the intention to quickly screen 
the genes for notable phenotypic differences with DNT combinations: given the lack of 
knowledge of how these alleles manifest phenotypes, initial survival index results shown in 
Chapter 3 are not intended for publication. 
2.2 Molecular biology 
Primers and plasmids used or generated in this work are listed in Tables 2.3 and 2.4, 
respectively. Origins of kek cDNAs for coding sequence amplification are given in Table 2.4. 
2.2.1 Genomic DNA isolation 
Genomic DNA was isolated from flies for null mutagenesis verification. 15 flies were 
collected under anaesthetic and chilled in 400μl DNA extraction buffer (0.1M Tris-HCl pH8, 
0.05M EDTA pH8, 1% SDS). Flies were homogenised and incubated at 37⁰C for 15 minutes. 
Samples were treated with 1μl RNaseA (4mg/ml) for 15 minutes at 37⁰C and inactivated at 
65⁰C for 15 minutes. Protein was precipitated by mixing 300μl 7.5M ammonium acetate to 
chilled samples and cooling on ice. Following centrifugation, supernatant was extracted and 
precipitated in 500μl isopropanol, cooled on ice for 10 minutes and centrifuged at 15,000rpm 
for 15 minutes. Pelleted DNA was washed in 70% ethanol, dried and dissolved in 60μl TE for 
1 hour at 65⁰C. Samples were cooled prior to use in PCR. 
Figure 2.8  Candidate gene models, P elements and probe hybridisation
Candidate DNT receptor gene models are shown. Genome locations are indicated above each 
model, including chromosome. Transposon insertion sites of alleles used in initial genetic 
studies (Figure 3.11) are indicated (red triangle). The rk4 point mutation is labelled in red. In situ 
antisense probe hybridisation is labelled in blue. Distances between Gal4 insertions and the 
start codons of corresponding genes are shown.
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Table 2.2  Summary of transposon alleles for survival index 
 
Allele Nature of allele Genomic position Known phenotypes 
kek3f07029 piggyBac transposon insertion, 3′–5′ relative to gene Intronic; 15kb upstream of ATG Viable 
kek4f05454 piggyBac transposon insertion, 5′–3′ relative to gene Exonic; 0.5kb downstream of 
ATG 
Viable 
kek5e02482 piggyBac transposon insertion, 5′–3′ relative to gene Intronic; 2kb upstream of ATG Viable 
lbkGS50104 UAS-containing transposon insertion, orientation unknown UTR; <0.5kb upstream of ATG Viable 
rk4 Missense point mutation Exonic; <2kb upstream of stop 
codon 
Viable, fertile, behavioural and 
mating phenotypes, phenotypes in 
cuticle, leg, neurons and wing 
wgne00637 Transposon insertion, 5′–3′ relative to gene Intronic; 3kb upstream of ATG Viable, fertile, neuroanatomy 
phenotypes 
 
ATG, start codon; UAS, upstream activating sequence; UTR, untranslated region. 
Table 2.3  Primers 
Primer name Sequence RE Amplifies Use 
kek1 
kek1CDSattB5'Fw GGGGACAAGTTTGTAC AAA AAA GCA GGC TCA TCC AGG AAA ATG CAT ATC A - 
2443nt (9nt+CDS, no STOP) Gateway cloning, sequencing 
kek1CDSattB3'Rv GGGGACCAC TTT GTA CAA GAA AGC TGG GTA GTC AGT TCT TGG TTT GGT TT - 
kek1seqFwd1 GCAAGATCGGCGAAATCGAG -  kek1 sequencing primer 
kek1seqFwd2 GACCGGAGATGTTGCCCATA -  kek1 sequencing primer 
kek1seqFwd3 TAACAAACAAGACGCAGCCC -  kek1 sequencing primer 
kek1seqFwd4 GATGACCTCTTCATGAAGCG -  kek1 sequencing primer 
kek1seqRev1 TCCCACAGACCCGAAGGATA -  kek1 sequencing primer 
kek1seqRev2 CATGTGATTGGGCGTCTTGC -  kek1 sequencing primer 
kek1seqRev3 ATCGATAATCCTTTCGGGGC -  kek1 sequencing primer 
kek1seqRev4 GATTTAGCAGATTCGCACGG -  kek1 sequencing primer 
kek2 
kek2CDSattB5'Fw GGGGACAAGTTTGTAC AAA AAA GCA GGC TCA ATG AGT GGT CTG CCA ATC T - 
2682nt (CDS, no STOP) Gateway cloning, sequencing 
kek2CDSattB3'Rv GGGGACCAC TTT GTA CAA GAA AGC TGG GTA AAT GTC GCT GGT TTC CTG GC - 
kek2seqFwd1 GGCACTTGTCTTTTCTCACG -  kek2 sequencing primer 
kek2seqFwd2 CAACGTTGGTGCCGAGGATA -  kek2 sequencing primer 
kek2seqFwd3 AGCAGCAGCTGCAGCTGAAT -  kek2 sequencing primer 
kek2seqFwd4 AACAGGTGCAGCCTGCCAAT -  kek2 sequencing primer 
kek2seqFwd5 CCATTCCGGAGCTGGATGAA -  kek2 sequencing primer 
kek2seqRev1 GCTGGTACTTCTCGTAGCTC -  kek2 sequencing primer 
kek2seqRev2 GACACTCTCCGCATCGTTGA -  kek2 sequencing primer 
kek2seqRev3 AAGATAATGCCGCCTCCGGC -  kek2 sequencing primer 
kek2seqRev4 CAGCCAGAAGTGGATGTCTA -  kek2 sequencing primer 
kek2seqRev5 TAAAGTTGAGGACCTGGGTG -  kek2 sequencing primer 
kek3 
kek3CDS#2Fwd GGGGACAAGTTTGTAC AAA AAA GCA GGC TCA TAT GCG ATG GCA GCG GGA A - 
3069nt (6nt+CDS, no STOP) Gateway cloning, sequencing 
kek3CDS3'endRev GGGGACCAC TTT GTA CAA GAA AGC TGG GTA GCT CTT GAA AAT ATC CTG TC - 
kek3558ntattBFw GGGGACAAGTTTGTAC AAA AAA GCA GGC TCA AAC TAT TCA AGC ACG GCC - 558nt (fragment of CDS with Gateway sequences) In situ, cDNA library detection 
kek3558ntattBRv GGGGACCAC TTT GTA CAA GAA AGC TGG GTTAC CAG CAC TTC CAT CAC CA - 
kek3upCDS-5'Fwd CAGCCACATCAACATTGGCA - 
3281nt (145nt + CDS + 50nt downstream) Gateway cloning 
kek3dwnCDS-3'Rev TTGGCGGACCAAAGTCTATC - 
kek3seqFwd1 AGTGGAACTGGATCTAAGCC -  kek3 sequencing primer 
kek3seqFwd2 GAGTGGAGGGCAGGAACATA -  kek3 sequencing primer 
kek3seqFwd3 ATCGAGATGACGGCCAGAAC -  kek3 sequencing primer 
kek3seqFwd4 GAAGACCACACCCATTGCCA -  kek3 sequencing primer 
kek3seqFwd5 CAGCGGGCCAATAGTTTCCT -  kek3 sequencing primer 
kek3seqFwd6 CGCCATGTTGAAGCGGTTAA -  kek3 sequencing primer 
kek3seqRev1 AGATGACTCGGCAGCAGTTT -  kek3 sequencing primer 
kek3seqRev2 CGAGGTCACTGGTTTGCTGT -  kek3 sequencing primer 
kek3seqRev3 AACTAGCCCCTCCTCCCAGA -  kek3 sequencing primer 
kek3seqRev4 TTGGGGTACTCCTTCCACGT -  kek3 sequencing primer 
kek3seqRev5 GTAGAGCGCCAATGAGGGTA -  kek3 sequencing primer 
kek3seqRev6 CTTTTCGACGCACCTTCGTC -  kek3 sequencing primer 
kek3FRT1.5kbupLI CAGGACGCGAATGTTGTCCT - 1.5kb with WH-WH- 2sid LI R Null verification,~1.5kb upstream of pBac[WH]kek3[f04709] 
kek3FRT2.5kbdnRI TTGGATTGAGGAGAAGCCTC - 2.7kb with WH-WH- 2sid RI F Null verification, ~2.5kb downstream of pBac[WH]kek3[f07027] 
kek3f07041Rev AGTACCCTAACCAATGCTC - ~250nt with WH-WH- 2sid LI R Null verification, ~250nt downstream of pBac[WH]f07041 
kek3FRT GP Fwd CGAAGAGAATTCAAGACGGG - 7.4kb genomic region including P element fusion, ~200nt using 
WH-WH-2sid LI R and RI F two-sided PCR primers 
Null verification, ~100nt upstream of pBac[WH]kek3[f04709] 
kek3FRT GP Rev GTGTGAAGAAGTTCATCCCC - Null verification, ~100nt downstream of pBac[WH]kek3[f07027] 
kek3intgenF GGACAGGGGCATGTGTATAT - 
543 nt 
In kek3 intron, for verifying homozygous kek3 nulls 
kek3intgenR ATTCCGGGAAGGTTGAAAGC - In kek3 intron, for verifying homozygous kek3 nulls 
kek3-EC-TM-RI CGAT-GAATTC-AGGTACAGAGTTCCAGAGAC EcoRI Kek3 juxtamembrane domain towards N terminus Chimaera cloning 
kek4 
kek4CDSattB5'Fw GGGGACAAGTTTGTAC AAA AAA GCA GGC TCA CTA GAC CTT CCG TTC CTT A (ga aaa atc tca atg) - 
1977nt (30nt+CDS, no STOP) Gateway cloning, sequencing 
kek4CDSattB3'Rv GGGGACCAC TTT GTA CAA GAA AGC TGG GTA TAT TGA GAT ATC AAC ACC AG - 
Kek4 1.6kb in Fwd TAGTTTGCCCGTTCAGTCAC - 
514nt cDNA library detection 
Kek4 2kbin Rev GGTATTGTACTTGCTTCGGG - 
kek4seqFwd1 CTGTTGCAAGCACTTCGCCA -  kek4 sequencing primer 
kek4seqFwd2 GCTCCAAGCCGGTGAAAAGT -  kek4 sequencing primer 
kek4seqFwd3 CATCCAATTCGAATGGCAGC -  kek4 sequencing primer 
kek4seqRev1 ACTCCAGAACTTAGGGCGCT -  kek4 sequencing primer 
kek4seqRev2 TATTGGGAGATCCGTGGACG -  kek4 sequencing primer 
kek4seqRev3 ACACATTGGGTAGCAGGTCG -  kek4 sequencing primer 
kek4FRT GP Fwd CTTGCCAGAGTTCCATTTGC - 100nt with WH-WH- 2sid LI F Null verification, ~100nt upstream of pBac[WH]kek4[f05454] 
kek4FRT GP Rev CAGTAGCTGTCTATAAGTTAATG - 100nt with WH-WH- 2sid RI F Null verification,  ~100nt downstream of pBac[RB]kek4[e04257] 
kek4intgenF GGAACGGAAGGTCTAGCACA - 
561nt 
In kek4 transcribed region, for verifying homozygous kek4 nulls 
kek4intgenR AATCTACTTGACATGCGCCG - Within kek4 gene span, for verifying homozygous kek4 nulls 
k4-EC-TM-EcoRI CGCG-GAATTC-TTGCAAATAAGTGTGCTGGC EcoRI Kek4 juxtamembrane domain towards N terminus Chimaera cloning 
kek5 
kek5CDSattB5'Fw 
GGGGACAAGTTTGTAC AAA AAA GCA GGC T 
AG CTA GAC GCA GAC TTA GAG 
(cca cag cca gcg atg) 
- 
2825nt (35nt+CDS, no STOP) Gateway cloning, sequencing 
kek5CDSattB3'Rv GGGGACCAC TTT GTA CAA GAA AGC TGG GTA GAC CTC GGT GCC ATC CTC GC - 
kek5seqFwd1 GCGCAACGTGATCATCAACA -  kek5 sequencing primer 
kek5seqFwd2 AAGCGGCCATTGCAGCAGTA -  kek5 sequencing primer 
kek5seqFwd3 GGTCAATCCAGTCGAGAAGC -  kek5 sequencing primer 
kek5seqFwd4 ACCACCACCAGCAGCAACAA -  kek5 sequencing primer 
kek5seqFwd5 GCAACAGCAGTTGCAACAAC -  kek5 sequencing primer 
kek5seqRev1 GTGGTTCGCAATCCCAAGTT -  kek5 sequencing primer 
kek5seqRev2 TTGGTGCCGTAGATGCCGTG -  kek5 sequencing primer 
kek5seqRev3 GGTGGTGTCCTTTTGATAGG -  kek5 sequencing primer 
kek5seqRev4 GAAGTTCTCCGATGGCACCT -  kek5 sequencing primer 
kek5seqRev5 TGGATGGTGCAGTTGCGCAA -  kek5 sequencing primer 
K5-EC-TM-BamHI CTAT-GGATCC-GCTCATCATGGTGGTGTCCT BamHI Kek5 juxtamembrane domain towards N terminus Chimaera cloning 
kek6 
kek6 5'end Fwd GGGGACAAGTTTGTAC AAA AAA GCA GGC TCA ATG CAT CGC AGC ATG GAT C - 
2508nt (CDS, no STOP) Gateway cloning, sequencing 
kek6 3'end Rev GGGGACCAC TTT GTA CAA GAA AGC TGG GTA GAG CGA CAC GAA CTC GCC AG - 
kek6seqFwd1 GTTTCCTATTCTGCCCCATC -  kek6 sequencing primer 
kek6seqFwd2 CATCGCCTCGGATAAGCTGT -  kek6 sequencing primer 
kek6seqFwd3 GAAGCATGTTGGTGCAGCAG -  kek6 sequencing primer 
kek6seqFwd4 ATACAGCAGCAGCAGCACCA -  kek6 sequencing primer 
kek6seqRev1 TTGCTGTTGCAGCTGCTGGT -  kek6 sequencing primer 
kek6seqRev2 TGCAACCTGTTGCTGTTGCG -  kek6 sequencing primer 
kek6seqRev3 TACTCCACAGCTTATCCGAG -  kek6 sequencing primer 
kek6seqRev4 CTAGGCGCTTGAGGGGATTT -  kek6 sequencing primer 
kek6FRT GP Fwd GCAGCATATGCTCCAAGCTG - 100nt with WH-WH- 2sid LI F Null verification, ~100nt upstream of pBac[RB]kek6[e00907] 
kek6FRT GP Rev CACAGTGACAGAATCCAAAC - 100nt with WH-WH- 2sid RI F Null verification, ~100nt downstream of pBac[WH]kek6[f05733] 
kek6intgenF GCCTGGACTGTTGCAGATGA - 
513nt 
In kek6 CDS, for verifying homozygous kek6 nulls 
kek6intgenR GTTGAGGAACTCCAGCAGAT - In kek6 CDS, for verifying homozygous kek6 nulls 
k6-EC-TM-BamHI GTAT-GAATTC-ACGCCGGCCTTGTTGGCATG BamHI Kek6 juxtamembrane domain towards N terminus Chimaera cloning 
lbk 
LbkCDS5’endFwd GGGGACAAGTTTGTAC AAA AAA GCA GGC TCA ATG CAC GTT TCA GCC ATA A - 3756nt (CDS, no STOP) Gateway cloning 
LbkCDS3’endRev GGGGACCAC TTT GTA CAA GAA AGC TGG GTA AAT GTC CAC TGT TGT GCA CT - 
lbk551ntattBFwd GGGGACAAGTTTGTAC AAA AAA GCA GGC T AG AAA CTA CGC ATG AGC CTG - 551nt (fragment of CDS with Gateway sequences) In situ 
lbk551ntattBRev GGGGACCAC TTT GTA CAA GAA AGC TGG GT A CCG CTC AAA TGT CCA CTG T - 
CG15744 
CG15744 5kbinFwd GGGGACAAGTTTGTAC AAA AAA GCA GGC T GG ATT GGA TAG CCT TGG TGA - 569nt (fragment of CDS) In situ 
CG15744 5kbinRev GGGGACCAC TTT GTA CAA GAA AGC TGG GT T TCG CTT CCA TCT CCA TCT C - 
CG16974 
16974Fwd548nt GGGGACAAGTTTGTAC AAA AAA GCA GGC T TA TAT GAA TCC CGA AGG CGC - 548nt (fragment of CDS with Gateway sequences) In situ 
16974Rev548nt GGGGACCAC TTT GTA CAA GAA AGC TGG GT T TGG GGG GAG TAG ATG GTA A - 
FRT mutagenesis 
WH-WH- 2sid LI R TCCAAGCGGCGACTGAGATG -  Null verification, 2-sided primers (Parks et al. 2004) 
WH-WH- 2sid RI F CCTCGATATACAGACCGATAAAAC -  Null verification, 2-sided primers (Parks et al. 2004) 
WH-RB+ hyb TGCATTTGCCTTTCGCCTTAT -  Null verification, hybrid primers (Parks et al. 2004) 
RB+WH- hyb GACGCATGATTATCTTTTACGTGAC -   Null verification, hybrid primers (Parks et al. 2004) 
Toll6 
Tl6-EcoRI-IC  CATG-GAATTC-AACTTCTGCTACAAGTCACC EcoRI Toll6 juxtamembrane domain towards C terminus Chimaera cloning 
Tl6-BamHI-IC CATG-GGATCC-AACTTCTGCTACAAGTCACC BamHI Toll6 juxtamembrane domain towards C terminus Chimaera cloning 
Toll6attB2RevTag GGGGACCAC TTT GTA CAA GAA AGC TGG GT C CGC CCA CAG GTT CTT CTG CT   Chimaera cloning 
Other primers 
UASSeqFor 
AAAGTAACCAGCAACCAAGT  Upstream of MCS in UAS element Colony PCR, Gateway cloning 
pAct5.1B4MCSFwd 
TTCCGGATTATTCATACCGTC  Upstream of MCS in actin promoter Colony PCR, Gateway cloning 
Sequences internal to gene coding sequences are underlined; start codons are in bold. Reading frames are denoted by spaced codons (lower case letters in 
parentheses are used to show sequences downstream of primers up to the start codon where appropriate). Gateway sequences are marked in orange, restriction 
enzyme sites are marked in blue.  CDS, coding sequence; MCS, multiple cloning site; UAS, upstream activating sequence. 
Table 2.4  Cloning constructs 
Construct Abbreviated name Antibiotic Inserts mRNA/Insert size Source Comments 
Kek1 3595     
pOT2-SD01674  Chloramphenicol kek1 cDNA SD01674 into pOT2 3618 BDGP For in situ 
pDONR-kek1 pDONR+kek1 Kanamycin Full length kek1 CDS from clone SD01674. No stop 
codon. In frame with Gateway sequences for subsequent 
cloning 
2443 This work Entry clone 
pAct5C-kek1-mCFP pAWC+kek1 Ampicillin Full length kek1 CDS, N-terminal Actin promoter, C-
terminal mCFP; attB sites 
(kek1 + attB = 2480) 
This work For cell culture 
pAct5C-kek1-FLAG pAWF+kek1 Ampicillin Full length kek1, N-terminal Actin promoter, C-terminal 
FLAG; attB sites 
This work For cell culture 
pUAS-kek1-mRFP pTWR+kek1 Ampicillin Full length kek1, N-terminal UAS promoter, C-terminal 
mRFP; attB sites 
This work For fly transgenesis 
Kek2 4318     
pNB40-NB7  Ampicillin kek2 cDNA NB7 into pNB40 ~4200 Musacchio & Perrimon, 
1996 
For in situ 
pDONR-kek2 pDONR+kek2 Kanamycin Full length kek2 CDS from clone NB7. No stop codon. In 
frame with Gateway sequences for subsequent cloning 
2682 This work Entry clone 
pAct5C-kek2-mCFP pAWC+kek2 Ampicillin Full length kek2 CDS, N-terminal Actin promoter, C-
terminal mCFP; attB sites 
(kek2 + attB = 2719) 
This work For cell culture 
pAct5C-kek2-FLAG pAWF+kek2 Ampicillin Full length kek2 CDS, N-terminal Actin promoter, C-
terminal FLAG; attB sites 
This work For cell culture 
pUAS-kek2-mRFP pTWR+kek2 Ampicillin Full length kek2 CDS, N-terminal UAS promoter, C-
terminal mRFP; attB sites 
This work For fly transgenesis 
Kek3 4361     
pDONR-kek3 pDONR+kek3 Kanamycin Full length kek3 CDS from GH cDNA library. No stop 
codon. In frame with Gateway sequences for subsequent 
cloning 
3069 This work Entry clone 
For in situ 
pAct5C-kek3-mCFP pAWC+kek3 Ampicillin Full length kek3 CDS, N-terminal Actin promoter, C-
terminal mCFP; attB sites 
(kek3 + attB = 3106) 
This work For cell culture 
pAct5C-kek3-FLAG pAWF+kek3 Ampicillin Full length kek3 CDS, N-terminal Actin promoter, C-
terminal FLAG; attB sites 
This work For cell culture 
pUAS-kek3-mRFP pTWR+kek3 Ampicillin Full length kek3 CDS, N-terminal UAS promoter, C-
terminal mRFP; attB sites 
This work For fly transgenesis 
pDONR-kek3ECD+TM≡ 
Toll6ICD 
pDONR+kek3≡ 
Toll6 
Kanamycin Kek3 ICD + TM domain fused to Toll6 ICD. In frame 
with Gateway sequences 
(kek3 EC: 1392) 
(toll6 IC: 1260) 
This work Entry clone, EcoRI link 
between kek and toll6 
pAct5c-kek3ECD+TM≡ 
Toll6ICD-3HA 
pAWH+kek3≡Toll6 Ampicillin Kek3 ICD + TM domain fused to Toll6 ICD, N-terminal 
Actin promoter, C-terminal 3xHA tag; attB sites 
This work For cell culture, luciferase 
assay 
Kek4 2497     
pOT2-GH27420  Chloramphenicol kek4 cDNA GH27420 into pOT2 1737 BDGP For in situ 
pDONR-kek4 pDONR+kek4 Kanamycin Full length kek4 CDS from larvae/pupae RT-PCR. No 
stop codon. In frame with Gateway sequences for 
subsequent cloning 
1977 This work Entry clone 
pAct5C-kek4-mCFP pAWC+kek4 Ampicillin Full length kek4 CDS, N-terminal Actin promoter, C-
terminal mCFP; attB sites 
(kek4 + attB = 2014) 
This work For cell culture 
pAct5C-kek4-FLAG pAWF+kek4 Ampicillin Full length kek4 CDS, N-terminal Actin promoter, C-
terminal FLAG; attB sites 
This work For cell culture 
pUAS-kek4-mRFP pTWR+kek4 Ampicillin Full length kek4 CDS, N-terminal UAS promoter, C-
terminal mRFP; attB sites 
This work For fly transgenesis 
pDONR-kek4ECD+TM≡ 
Toll6ICD 
pDONR+kek4≡ 
Toll6 
Kanamycin Kek4 ICD + TM domain fused to Toll6 ICD. In frame 
with Gateway sequences 
(kek4 EC: 1290)  
(toll6 IC: 1260) 
This work Entry clone, EcoRI link 
between kek and toll6 
pAct5c-kek4ECD+TM≡ 
Toll6ICD-3HA 
pAWH+kek4≡Toll6 Ampicillin Kek4 ICD + TM domain fused to Toll6 ICD, N-terminal 
Actin promoter, C-terminal 3xHA tag; attB sites 
This work For cell culture, luciferase 
assay 
Kek5 4357     
pDONR-kek5 pDONR+kek5 Kanamycin Full length kek5 CDS from LD cDNA library. No stop 
codon. In frame with Gateway sequences for subsequent 
cloning 
2825 This work Entry clone 
pAct5C-kek5-mCFP pAWC+kek5 Ampicillin Full length kek5 CDS, N-terminal Actin promoter, C-
terminal mCFP; attB sites 
(kek5 + attB = 2860) This work For cell culture 
pAct5C-kek5-FLAG pAWF+kek5 Ampicillin Full length kek5 CDS, N-terminal Actin promoter, C-
terminal FLAG; attB sites 
This work For cell culture 
pUAS-kek5-mRFP pTWR+kek5 Ampicillin Full length kek5 CDS, N-terminal UAS promoter, C-
terminal mRFP; attB sites 
This work For fly transgenesis 
pDONR-
kek5ECD+TM≡Toll6ICD 
pDONR+kek5≡ 
Toll6 
Kanamycin Kek5 ICD + TM domain fused to Toll6 ICD.  In frame 
with Gateway sequences 
(kek5 EC: 1302) 
(toll6 IC: 1260) 
This work Entry clone, BamHI link 
between kek and toll6 
pAct5c-kek5ECD+TM≡ 
Toll6ICD-3HA 
pAWH+kek5≡Toll6 Ampicillin Kek5 ICD + TM domain fused to Toll6 ICD, N-terminal 
Actin promoter, C-terminal 3xHA tag; attB sites 
This work For cell culture, luciferase 
assay 
Kek6 2511     
pDONR-kek6 pDONR+kek6 Kanamycin Full length kek6 CDS from GH cDNA library. No stop 
codon. In frame with Gateway sequences for subsequent 
cloning 
2508 This work Entry clone 
For in situ 
pAct5C-kek6-mCFP pAWC+kek6 Ampicillin Full length kek6 CDS, N-terminal Actin promoter, C-
terminal mCFP; attB sites 
(kek6 + attB = 2545) This work For cell culture 
pAct5C-kek6-FLAG pAWF+kek6 Ampicillin Full length kek6 CDS, N-terminal Actin promoter, C-
terminal FLAG; attB sites 
This work For cell culture 
pUAS-kek6-mRFP pTWR+kek6 Ampicillin Full length kek6 CDS, N-terminal UAS promoter, C-
terminal mRFP; attB sites 
This work For fly transgenesis 
pDONR-
kek6ECD+TM≡Toll6ICD 
pDONR+kek6≡ 
Toll6 
Kanamycin Kek6 ICD + TM domain fused to Toll6 ICD.  In frame 
with Gateway sequences 
(kek6 EC: 1284) 
(toll6 IC: 1260) 
This work Entry clone, BamHI link 
between kek and toll6 
pAct5c-kek6ECD+TM≡ 
Toll6ICD-3HA 
pAWH+kek6≡Toll6 Ampicillin Kek6 ICD + TM domain fused to Toll6 ICD, N-terminal 
Actin promoter, C-terminal 3xHA tag; attB sites 
This work For cell culture, luciferase 
assay 
Wengen 2403     
pFLC-I-RE29502  Ampicillin Wg cDNA RE29502 into pFLC-I 2425 BDGP Already in the lab 
Lambik 4423     
pDONR-lbk 551nt  Kanamycin 551nt lbk fragment from library into pDONR by Gateway 
cloning 
551 This work For in situ 
Rickets 5407     
pCR2.1-TOPO-DLGR2  Ampicillin, 
Kanamycin 
Rk cDNA into pCR2.1-TOPO 5399 Eriksen et al., 2000 For in situ 
CG15744 5952     
pDONR-CG15744 569nt   Kanamycin 569bp fragment of CG15744 from cDNA library into 
pDONR by Gateway cloning 
569 This work For in situ 
CG16974 4340     
pDONR-CG16974 548nt   Kanamycin 548nt fragment of CG16974 from cDNA library into 
pDONR by Gateway cloning 
548 This work For in situ 
DNTs    
pAct5c-DNT1 (Pro-TEV-6H-V5-
CK+CTD) 
 Ampicillin DNT1 CysKnot, Prodomain and 3′ tail, V5 and 6xHis 
tags, N terminal Actin promoter  
G. McIlroy For cell culture 
pAct5c-DNT2 (Pro-TEV-6H-V5-CK)  Ampicillin DNT2 CysKnot and Prodomain, V5 and 6xHis tags, N 
terminal Actin promoter  
G. McIlroy For cell culture 
pAct-renilla luciferase   Renilla luciferase, N terminal Actin promoter  S. Brogna For cell culture 
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2.2.2 Cloning summary 
kek1–6 coding sequences were amplified from cDNA clones (kek1, SD01674; kek2, NB7), LD 
cDNA library (kek5), GH cDNA library (kek3; kek6) or reverse transcription PCR (kek4). 
These sources were used so that the amplified fragments were uninterrupted kek exons only. 
Primers used incorporated flanking attB sites for use in Gateway cloning. kek CDS-containing 
entry clones were further recombined into one of three destination clones: pAct5c-attR-mCFP 
(pAWC), pAct5c-attR-FLAG (pAWF) or pUASt-attR-mRFP (pTWR). Details of each 
procedure in the cloning process are given below. Details of primers used and restriction 
digest verification of kek CDS cloning are given in Chapter 4. 
Protein domains of Kek3–6 and Toll6 were predicted using ProSite (ExPASy), PFAM, 
SMART, TMHMM (http://www.cbs.dtu.dk/services/TMHMM/) and TMPred (ExPASy) 
algorithms and PubMed data (Table 2.5; Figure 2.9); longest possible predicted peptide 
regions were assumed. Primers were designed to amplify the sequences that encode the 
extracellular and transmembrane domains of Kek3–6 and the intracellular domain of Toll6. A 
unique enzyme site (BamHI or EcoRI) was introduced 3′ to the kek sequence and 5′ to the 
toll6 sequence during PCR. Purified fragments were digested at these unique sites and ligated. 
In addition, attB sites were introduced during PCR to the 5′ and 3′ ends of ligated fragments 
for Gateway cloning into pDONR221 and the actin promoter-driven construct pAct5c-attR-
3xHA (pAWH; see cloning strategy, Appendix II). Encoded chimaeric proteins were designed 
to fuse 15 amino acids C-terminal to the Kek transmembrane region, halfway between the 
Toll6 transmembrane region and the Toll/Interleukin-1 receptor (TIR) domain. Full details of 
primers used and restriction digest verification of kek≡toll6 chimaeras are given in Chapter 4. 
2.2.3 PCR 
DNA was amplified from genomic DNA, cDNA clones or cDNA libraries (see above) by 
PCR. Diagnostic PCRs used Taq DNA polymerase (Invitrogen); 50μl master mixes (5μl 10X 
Figure 2.9  Protein sequences of Kek3, Kek4, Kek5, Kek6 and Toll6
Protein domains were estimated using prediction algorithms (see Table 2.5). Cysteine-rich 
regions are marked in green; LRRs in yellow; Ig domains in blue; transmembrane domains in 
red and the Toll6 TIR domain in grey.  The position of chimaera fusion between Kek 
extracellular and transmembrane domains and the Toll6 intracellular domain is noted by 
[xxxx]. Peptides used for the generation of custom antibodies to Kek3, Kek4 and Kek6 are 
indicated.
MAAGRAAATLEAPGPPSGQDIASDNSAQRRTLATKVRRKGPRPQRRLHPPLRPRLPLHLHLLLWLLCCCSQLGQL
RAECPAVCECKWKSGKESVLCLNANLTHIPQPLDAGTQLLDLSGNEIQLIPDDSFATAQLLNLQKVYLARCHLRL
IERHAFRKLINLVELDLSQNLLSAIPSLALYHVSELRELRLSGNPILRVPDDAFGHVPQLVKLELSDCRLSHIAV
RAFAGLESSLEWLKLDGNRLSEVRSGTITSLASLHGLELARNTWNCSCSLRPLRAWMLQQNIPSGIPPTCESPPR
LSGRAWDKLDVDDFACVPQIVATDTTAHGVEGRNITMSCYVEGVPQPAVKWLLKNRLIANLSAGGDGDSDSEPRT
AAATQGRKTYVVNMLRNASNLTILTADMQDAGIYTCAAENKAGKVEASVTLAVSRRPPEAPWGVRIILLGAVAAL
LLVGGSSFAAICLCSLQRRRKLRLWNSVP[xxxx]PVRRSESYEKIEMTARTRPDLGGGASCGGGSATGAGLFHD
AEEQGYLRAAHTPLNDNDAGQAAAIVNPSAGSAQRRNGDYLHVSTHCDDEEEDQQLHHHPQQQPASQHHPHPNQQ
QHQQRKGSQGHVVSASGANNSAPLEETDLHIPRLIDIGGTDSASSSISSQVDAAARLAGYAGHTWKTTPIATTKI
NSPHSKPVTSAAPSSLNTQATPYAHYGNHPADEMATSVFCSEGQESDLFDSNYPDLLDIAKYAVAQAQQEGRGQG
YAQATTTPNGGLCTLPRKLKTSGKYFRNSSDSQSPLLADNSSKYGSSTLGDGSFLNEAMGLGRRYSAESSYANYS
STATYTGGGQRANSFLNLVQSGAHQGKLLPSHLGQKPSLPSSPVQHQRSLSSAATPLLDFSALASRAAGAANTSV
AAYDYHAAQLERFLEEYRNLQDQLCKMKETCDTIRKKETPLRVAIGQSAAQLADPVMYSAASHSPKPPATSNLKT
KTLLPGQPPDPPPYWLHRNAMLKRLNGDGSAGTNGSGGSPASPQPRQDIFKS 
MAIKLSFDPCSISLKHLSLFLFKIYCLALIFRSASADWLLDCGNCHCKWNSGKKTADCRNLSLSGVPEYLSPEVQ
VLDLSHNHIFYLEENAFLTTHLQNLQKLLIRNGTLKYLNQRSFTQLQILIELDLSNNLLVDLLPNVFDCLSKVRA
IFLNGNLLQALRHGVFRNLKYLHKIELKRNRLVSIDAKAFVGVPLLSQIYLDNNELTKLRVESFQDLTKLTALSL
VENPWNCTCDLQMFRDFVIGMNLYTPPTSCHYPLQLRGRLWIEDQPEAFACKPKIVYPTLSTSINTSKENVTLIC
RVHGSPNTVIAWDYTNQVYESRSKPVKSLQKQRIYIELLREDESKIRKFGHDVFVSRLTIVNARKSDEGVYTCLA
ENPGGKDSVHISVVVQKDMERISLIDSNFFAIVCLIAMGFLSMSILFSLVTCLIFKRFKQFHPGQHTYLQ[xxxx
]PTSLPVQSPGSEEATAISALSSGVIRESKIVLDPLSAINEPSNKNYTLFKTSNSNGSEYMHTRNYKDVRLNSNT
YTENLDNQAESISSRNRELYSNIAGDREKEELKQKDELDKDSRQSSLQSTGCSRKKGQIDELQPDLLPSTQPTAL
KNINETFGPSAKKAEVNPRSKYNTNVQKYLKEKYGSVRIKNISTKEPITGVDISI 
 
MMGNRTERSGRRLGMILLLLGVLVVLMALPPPTAGTTDWMQSCGTCHCQWNSGKKSADCKNKALTKIPQDMSNEM
QVLDFAHNQIPELRREEFLLAGLPNVHKIFLRNCTIQEVHREAFKGLHILIELDLSGNRIRELHPGTFAGLEKLR
NVIINNNEIEVLPNHLFVNLSFLSRIEFRNNRLRQVQLHVFAGTMALSAISLEQNRLSHLHKETFKDLQKLMHLS
LQGNAWNCSCELQDFRDFAISKRLYTPPTDCQEPPQLRGKLWSEVPSENFACRPRILGSVRSFIEANHDNISLPC
RIVGSPRPNVTWVYNKRPLQQYDPRVRVLTSVEQMPEQPSQVLTSELRIVGVRASDKGAYTCVADNRGGRAEAEF
QLLVSGDYAGAVSASDGMGMGAIGAPTIDPQTNMFLIICLIITTLLLLLLVAVLTLFWYCRRIKTYQKDTTMMS[
xxxx]GDGLISSKMDKTHNGSMLEGSVIMEMQKSLLNEVNPVEKPPRRTDIESVDGGDDVLEIKKTLLDDTVYVA
NHSRDEEAVSVAMSDTTTTPRSRHTYVDDAYANSLPPDLLAFPARVPPTSPSMQSSQSNIPDQVIYGIRSPPSLT
SPVYTHMTPHGIYGTKTMTAPHNGFMTLQHPKSRNLALIATTNSSRQHQHHHQLQQQQQHHHHHQQQQQQQQQQQ
HPLATTSPFLPAPVVYSPATGVVMKQGYMTIPRKPRAPSWAPSTSGAAGHGSIQLSEFQSPTSPNPSETGTATTA
ELQAEPVYDNLGLRTTAGGNSTLNLTKIAGSQGGAGQQYSMRDRPLPATPSLTSVSSATNASKIYEPIHELIQQQ
QQLQQQQQQQQQRLGSMDTEPLYGVRQQGITILPGSSISGAGLGHAAYLSPGSGAAVSPSHASSSGDSPKAAKIP
PRPPPKPKKKMSVTTTRSGQGSTSQLFDDEGEDGTEV 
 
MHRSMDRRRSRTPRTLPVCWILLCLVAWTVADDWSLSCASNCTCKWTNGKKSAICSSLQLTTIPNTLSTELQVLV
LNDNHIPYLNREEFSTLGLLNLQRIYLKKSEVQYIHKESFRNLKILVEIDLSDNKLEMLDKDTFMGNDRLRILYL
NGNPLKRLAAYQFPILPHLRTLDMHDCLISYIDPMSLANLNLLEFLNLKNNLLESLSEYVFQHMANLKTLSLEEN
PWQCNCKLRKFRGWYVNSRLSSVSLVCKGPPAQKDRTWDSVDDELFGCPPRVEIFNNEEVQNIDIGSNTTFSCLV
YGDPLPEVAWELNGKILDNDNVLFESESIASDKLWSNLTVFNVTSLDAGTYACTGSNSIGSMTQNISIYLSEIVQ
HVLEKTPETFWYFGLIMGIFGTVFLLISISFVVCLCKRTTRQHRHANKAGV[xxxx]SSVSFNDQEKKLLDSSVT
TTTNDRGDSYGIDNQPTSIGMNKGDSAGMGFNQIEIHAVESHRHGSMLVQQQPQQQQVAGGGGMRQQLMQVKDST
CGMMSVPTSMAGHAHSHPAQISEEFPLNVGVFPPPPEFCSNIVPNPAFGGNIFIRVSVTQDMLDGADLNMYPDLL
NIPKRMQDVQESGAGAVAVPEGQFATLPRHTARRGILKKDTSLQQQQQQHQQQHQHQQQQQQQQIQQQQHQQLQQ
QHQPSGLYTHDEIVTYNLEASGYDPHQSGYHSNAMELPPPPPPPAVTAVVQCHHPSPNNCASCINNAPPPPSACQ
SPPVEVTPMRPLDSSAYPKYDNMGRRITASGGLGGSNLSLHDEERYENETLFGQAESQTKGMPEQSQDLHQPQEV
TQGQDKGGGPGEFVSL 
MIYYMLLILPVVLAQDQQHTTESLSTKHHQQQQLSHSNAIMGEAGVSNSQLMQPSTPARTLRPLTAGAGGDPSLY
DAPDDCHFMPAAGLDQPEIALTCNLRTVNSEFDTTNFSVIPAEHTIALHILCNDEIMAKSRLEAQSFAHLVRLQQ
LSIQYCKLGRLGRQVLDGLEQLRNLTLRTHNILWPALNFEIEADAFSVTRRLERLDLSSNNIWSLPDNIFCTLSE
LSALNMSENRLQDVNELGFRDRSKEPTNGSTESTSTTESAKKSSSSSTSCSLDLEYLDVSHNDFVVLPANGFGTL
RRLRVLSVNNNGISMIADKALSGLKNLQILNLSSNKIVALPTELFAEQAKIIQEVYLQNNSISVLNPQLFSNLDQ
LQALDLSMNQITSTWIDKNTFVGLIRLVLLNLSHNKLTKLEPEIFSDLYTLQILNLRHNQLENIAADTFAPMNNL
HTLLLSHNKLKYLDAYALNGLYVLSLLSLDNNALIGVHPDAFRNCSALQDLNLNGNQLKTVPLALRNMRHLRTVD
LGENMITVMEDSAFKGLGNLYGLRLIGNYLENITMHTFRDLPNLQILNLARNRIAVVEPGAFEMTSSIQAVRLDG
NELNDINGLFSNMPSLLWLNISDNRLESFDYGHVPSTLQWLDLHKNRLSSLSNRFGLDSELKLQTLDVSFNQLQR
IGPSSIPNSIELLFLNDNLITTVDPDTFMHKTNLTRVDLYANQITTLDIKSLRILPVWEHRALPEFYIGGNPFTC
DCNIDWLQKINHITSRQYPRIMDLETIYCKLLNNRERAYIPLIEAEPKHFLCTYKTHCFAVCHCCEFDACDCEMT
CPTNCTCFHDQTWSTNIVECSGAAYSEMPRRVPMDTSELYIDGNNFVELAGHSFLGRKNLAVLYANNSNVAHIYN
TTFSGLKRLLILHLEDNHIISLEGNEFHNLENLRELYLQSNKIASIANGSFQMLRKLEVLRLDGNRLMHFEVWQL
SANPYLVEISLADNQWSCECGYLARFRNYLGQSSEKIIDASRVSCIYNNATSVLREKNGTKCTLRDGVAHYMHTN
EIEGLLPLLLVATCAFVAFFGLIFGLFCYRHELKIWAHSTNCLM[xxxx]NFCYKSPRFVDQLDKERPNDAYFAY
SLQDEHFVNQILAQTLENDIGYRLCLHYRDVNINAYITDALIEAAESAKQFVLVLSKNFLYNEWSRFEYKSALHE
LVKRRKRVVFILYGDLPQRDIDMDMRHYLRTSTCIEWDDKKFWQKLRLALPLPNGRGNNNKRVVSGCLSGRTPSV
NMYATSHEYQAGNGGVIPPPSARYADCGSNNYATINECAAAGGGRGYKPIPTSASAAAAACKFNTMNQLSKKQQR
DLSVAGMAKTLEHQHHHNHQANRRSQHEYAVPSYLPSAAPAYDSVDYAKQQIRNNANCECVNLGTAKRAAGKNPA
SGLPSSFSSNFVPPGGASYNCKKSCSCIGDDELLCSCGGGGGIGVNLLESGTQSSVTMSSSSNNSRQPELTHYES
NLSLNDDEDEDHDQQKNLWA 
Kek3
Anti-Kek3 peptide
Anti-Kek4 peptide
Anti-Kek6 peptide
Kek4
Kek5
Kek6
Toll6
Table 2.5  Estimated protein domain spans for chimaera cloning 
 
Tool Used LRR span Ig span Transmembrane span 
Kek3 
Prosite 111-132   209-230 
161-182   234-255 
185-206 
318-427  
PFAM 136-180 
184-232 
318-428  
SMART 78-114    183-206 
113-132   207-230 
135-158   233-255 
159-182   267-317 
330-418  
PubMed 267-316 319-428  
TMHMM   No region with probability of 1; two 
possible peaks ~450-480 and ~500-520 
TMPred   441-466 
Kek4 
Prosite 73-94      171-192 
123-145  195-216 
278-387  
PFAM 194-232 279-390  
SMART 72-94       169-192 
121-144   193-216 
145-168   228-277 
291-380 404-426 
PubMed 228-277 296-387  
TMHMM   404-426 
TMPred   404-430 
Kek5 
Prosite  279-380  
PFAM 74-121 
125-175 
254-278 
279-379  
SMART 98-121    170-193 
122-145  196-217 
146-169  229-278 
291-369 13-35 
411-433 
PubMed 64-229? 
229-277 
296-376  
TMHMM   411-433 
TMPred   410-434 
Kek6 
Prosite 70-91      168-189 
120-141  192-213 
144-165  216-237 
275-367  
PFAM 116-165 
167-210 
277-370  
SMART 37-73    166-189 
69-91     190-213 
94-117   225-274 
118–141 
289-360 385-407 
PubMed 225-274 295-367  
TMHMM   385-407 
TMPred   390-411 
388-411 
SignalP   388-411 
Toll6 
Prosite 201-222   544-565 
225-246   568-589 
278-299   592-613 
302-323   615-635 
326-347   637-658 
351-372   662-683 
375-396   684-705 
401-422   708-728 
425-446   860-881 
449-470   908-929 
497-519   932-953 
520-541   956-977 
1111-1247  
PFAM 200-243? 496-542? 
278-300   544-586? 
302-345? 591-632? 
352-396? 636-683? 
401-423   683-728? 
424-470   931-980? 
1115-1243  
SMART 145-168  495-517 
199-222  518-541 
223-246  542-565 
279-299  566-589 
300-323  613-633 
324-347  638-657 
353-372  662-683 
373-398  684-705 
399-422  825-863 
423-446  906-929 
447-470  930-953 
471-494  954-977 
1112-1247 1055-1077 
PubMed 278-465 
401-649 
862-990? 
1114-1247  
TMHMM   1055-1077 
TMPred   1058-1079 
1443-1469 
 
Amino acid positions of LRRs, Ig and transmembrane domains are shown 
 41 
PCR buffer (200mM Tris-HCl pH8.4, 500mM KCl; Invitrogen), 1.5μl 50mM MgCl 
(Invitrogen), 0.5μl Taq DNA polymerase) were divided into 5x10μl reaction volumes. For kek 
CDS and kek≡toll6 chimaera cloning, Phusion High-Fidelity DNA polymerase (NEB) was 
used; 50μl reaction volumes (10μl 5X HF buffer (NEB), 0.5μl Phusion polymerase). For all 
PCR reaction mixtures, 1μl 10mM dNTP mix (Roche), 4pmol forward and reverse primers, 
1μl DNA template were used. A PTC-200 thermal cycler (MJ Research) or myCycler thermal 
cycler (BioRad) were used to run the following PCR cycle for null mutagenesis verification: 
95⁰C 1’30      (x1 cycle)  
95⁰C 45” → 55⁰C 30” → 72⁰C 1’30  (x35 cycles) 
72⁰C 10’      (x1 cycle) 
4⁰C ∞ 
Primers used for null verification are listed in Figures 5.2 and 5.4. 
Phusion polymerase PCR program: 
98⁰C 2’      (x1 cycle) 
98⁰C 30” → Tm-3⁰C 30” → 72⁰C 30”/kb  (x35 cycles) 
72⁰C 15’      (x1 cycle) 
4⁰C ∞ 
where Tm is the melting temperature of the primers 
Primers used for kek CDS amplification are marked in cloning maps, Appendix II. Primers for 
kek≡toll6 chimaera amplification are listed in chimaera cloning strategy, Appendix II. 
2.2.4 Reverse Transcription-PCR 
kek4 CDS was amplified from larval and pupal RNA by RT-PCR. 10 yw larvae and 10 yw 
pupae were frozen in liquid nitrogen and homogenized. RNA was extracted using the RNeasy 
Mini Kit (Qiagen) as per kit instructions. Genomic DNA was removed using TurboDNase 
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(Ambion) as per kit instructions. kek4 cDNA was synthesized from purified ssRNA using 
Superscript II reverse transcriptase (Invitrogen) and primer kek4CDSattB3′Rv. kek4 CDS was 
amplified from cDNA by Phusion PCR using primers kek4CDSattB5′Fw and 
kek4CDSattB3′Rv as per section 2.2.3. 
2.2.5 Gel electrophoresis and DNA purification 
DNA fragments and Phusion DNA polymerase products were run at 60V on 0.8% agarose 
(Bioline) gels in 1X TAE buffer with ethidium bromide (Sigma) for DNA detection. DNA 
was labelled using DNA loading buffer and compared with 5ng/μl 1kb DNA ladder (NEB) 
run in outside lanes. Gels were photographed under UV light using a G:BOX Chemi gel dock 
(Syngene). kek CDS and toll6 DNA fragments were excised from gels under UV and purified 
using the QIAquick Gel Extraction kit (Qiagen) as per kit instructions for ‘gel extraction’.  
2.2.6 DNA ligation 
Purified kek3–6 and toll6 DNA fragments were digested using EcoRI (kek3, kek4, kek6 and 
toll6) or BamHI (kek5 and toll6). Digested fragments were purified using the QIAquick Gel 
Extraction kit (Qiagen) as per instructions for ‘PCR clean up’. Digested fragments were 
ligated at 18⁰C using 1μl T4 DNA ligase (NEB), 2μl 10X T4 DNA Ligase Buffer (NEB) and 
ddH2O up to 20μl. Ligated fragments were subsequently cloned into pDONR221 by Gateway 
cloning. 
2.2.7 Gateway cloning 
kek overexpression and kek≡toll6 constructs were generated by Gateway (Invitrogen) cloning. 
Gateway cloning involves the enzyme-mediated recombination of gene-flanking attB sites 
with entry clone attP sites. The kanamycin-resistant pDONR221 entry vector contains attP sites 
that flank a chloramphenicol resistance gene and the lethal DNA gyrase gene ccdB. 
Successful Gateway cloning using BP clonase II (Invitrogen) exchanges the 
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chloramphenicol–ccdB cassette for the gene of interest; thus, only successful clones will grow 
on kanamycin-containing media following bacterial transformation. Fusion of attB and attP 
sites forms a pDONR221 construct containing the gene of interest, flanked by attL sites. Entry 
clones can subsequently by recombined into destination vectors that contain a range of 
promoters and encode terminal tags. Recombination of attL sites with attR sites in ampicillin-
resistant destination vectors by LR clonase II (Invitrogen) exchanges a second lethal cassette 
for the gene of interest; thus, only successful clones will grow on ampicillin-containing media 
following bacterial transformation. BP and LR reactions were done following Invitrogen 
instructions. C terminal tag vectors were selected to minimise disruption to gene function by 
tag insertion into the intracellular Kek domain, which has no known functional domains. 
For use in cell culture, kek overexpression constructs were cloned from entry vectors into 
pAWC, which contained an N-terminal actin promoter and encoded C-terminal monomeric 
CFP tag, and pAWF, which encoded an N-terminal FLAG tag. kek≡toll6 chimaeras were 
cloned from entry vectors into pAWH, which encoded an N-terminal HA tag in each reading 
frame. For transgenesis, kek overexpression constructs were cloned from entry vectors into 
pTWR, which contained a UAS promoter and encoded a C-terminal monomeric RFP tag. At 
each stage, cloning was verified by restriction digests (see Chapter 4). Successfully cloned 
kek1–6+pTWR constructs were sent to BestGene, Inc. for transgenesis. 
2.2.8 Transformation of E. coli and DNA amplification 
All cloning constructs and template clones used for RNA probe synthesis were transformed 
into chemically competent DH5α or DH10β (small constructs; Invitrogen) or One Shot 
OmniMAX (large constructs; Invitrogen) E. coli cells prior to amplification. 1μl plasmid 
DNA was added to 25μl cells on ice for 30 minutes (for cDNA clones received from the 
DGRC, 25μl cells were added to pre-hydrated Whatman FTA clone discs). Cells were heat 
shocked at 42⁰C for 30 seconds in a water bath, cooled and grown for at least 1 hour at 37⁰C 
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with shaking (225rpm) in SOC media. Transformed media was spread on to LB agar plates 
with antibiotic and grown overnight at 37⁰C. 
Individual E. coli colonies were picked from plates and grown overnight in 2ml of LB media 
with antibiotic. DNA was harvested by miniprep boiling protocol: 1.5ml overnight media was 
pelleted at 13k rpm for <1 minute and supernatant discarded. Resuspended pellets were boiled 
at 100⁰C for 1 minute in 350μl pH8 STET buffer and 30μl 5mg/ml lysozyme solution 
(Sigma), cooled and centrifuged for 20 minutes. Pellets contained E. coli cell debris and were 
removed using a sterile pipette tip. DNA in the supernatant was precipitated with 5M 
ammonium acetate and 2 volumes isopropanol, frozen for ≥30 minutes, and pelleted by 15 
minute centrifugation. Washed DNA pellets were resuspended in TE. Miniprep DNA was 
tested by restriction digests. Colonies containing a successful clone were amplified by 
inoculating 100ml fresh LB+antibiotic media with 100μl of the corresponding single colony 
overnight miniprep culture, and growing overnight at 37⁰C with shaking (225rpm). DNA was 
harvested from large scale cultures using a PureLink HiPure Plasmid Filter Maxiprep Kit 
(Invitrogen) as per kit instructions. 
2.2.9 DNA sequencing 
kek1–6+pAWC and kek3–6≡toll6 constructs were sequenced. In each case, if the destination 
construct sequence was correct, the entry clone from which other constructs were generated 
was therefore assumed to be correct also. For each reaction, ≥500ng clone DNA was mixed 
with 3pmol primer and ddH2O and sequenced by the Genomics Facility, School of 
Biosciences, University of Birmingham. Full inserts (kek CDS or kek≡toll6 chimaera CDS) 
were sequenced. Sequencing primers were spaced 500nt apart and each nucleotide was 
verified by 2–3 overlapping sequences. Sequencing reaction data were aligned using the 
Kalign tool (European Bioinformatics Institute) against predicted sequence data obtained 
from FlyBase. No mutations were detected in kek CDS or kek≡toll6 inserts. 
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2.3 Cell culture 
2.3.1 S2 cell culture 
S2 cells (gift from Saverio Brogna, University of Birmingham) were maintained at 27⁰C in 
Insect-Xpress medium (Lonza)+penicillin/streptomycin/L-glutamine mix (Lonza) and 10% 
foetal bovine serum (Lonza). S2 cells stably transfected with drosomycin-luciferase (gift of 
Lynne Prince; Weber et al. (2003)) were grown in identical conditions, with media further 
supplemented with 1μg/ml puromycin (Invitrogen). 1ml suspended cells were passaged every 
two days into 4ml fresh medium. 6-well plate experiments required 3x106 cells seeded per 
2ml media, 24 hours prior to transfection. Per well of experiment, 250μl serum-free media, 
3μl TransIT-2020 (Mirus), and 2μg DNA (kek1–6+pAWC) or 2μg (kek3–6≡toll6+pAWH) 
plus 1μg (pAct-renilla-luciferase) were incubated at room temperature for 30 minutes, 
supplemented with 350μl serum-free media and added to aspirated cells. After 4 hours, 
transfection mixture was removed and 2ml supplemented medium added. All experiments 
were conducted 48 hours after transfection; imaging of Kek or Kek≡Toll6 distribution 
required 6h serum starvation prior to antibody labelling. 
2.3.2 Luciferase reporter assay 
S2 cells stably transfected with drosomycin-luciferase and transiently transfected with 
chimaeric constructs and pAct-renilla-luciferase were stimulated with DNT protein and Dif 
signalling quantified by luminescence. pAct-renilla was a gift from Saverio Brogna, 
University of Birmingham, and used as an internal control for transfection efficiency. DNT 
ligand (6 wells of S2 cell culture-produced DNT1/2 per 6-well plate experiment; 50nM 
Baculovirus DNT2 per well) was added 48 hours after transfection and luminescence 
quantified 24 hours after DNT stimulation. Transfected and stimulated cells were pelleted 
from single wells, resuspended in 400μl media and separated into three 50μl aliquots in an 
opaque 96-well plate. 40μl of Firefly Luciferase Substrate (Dual-Glo Luciferase Assay 
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System; Promega) was added per 50μl aliquot. Luminescence was measured after 10 minutes 
of incubation at room temperature using a Mithras LB 940 Multimode Microplate Reader 
(Berthold). 40μl Stop & Glo substrate (Dual-Glo Luciferase Assay System; Promega) was 
added to halt Dif signalling and to activate Renilla Luciferase. Renilla luminescence data was 
used to normalize Firefly Luciferase data. 
2.4 Protein expression and purification 
DNT1 and DNT2 were expressed in S2 cells transfected with V5-tagged pAct5c-DNT1/DNT2 
constructs generated by Graham McIlroy (University of Birmingham; see constructs in Table 
2.4), and purified from conditioned medium according to Arnot et al. (2010) (see below). 
Baculovirus DNT2 was produced by Graham McIlroy and Jukka Aurikko (University of 
Cambridge). 
2.4.1 DNT purification 
S2 cell-produced His-tagged DNT was generated in 6 well plates and purified 48 hours after 
transfection. 12ml supernatant was harvested by centrifugation and filtered through a 0.2μm 
Acrodisc (Pall) filter. Two rounds of centrifugation at 4⁰C and 5,000g were required to buffer 
exchange filtered supernatant to chilled PBS+20mM imidazole using a Vivaspin6 500MWCO 
Concentrator (Sartorius). Supernatant was concentrated to 400μl. Concentrated supernatant 
was purified using NiNTA spin columns (Qiagen) according to kit protocol. Purified protein 
in 500mM imidazole was subsequently further buffer exchanged to PBS without imidazole by 
further concentration at 5,000g. V5-tagged DNT1 and DNT2 were detected by dot blot: 10μl 
of each protein were blotted on to nitrocellulose membrane, blocked in 5% milk powder in 
TBS+0.05% Tween20 (Sigma), labelled using anti-V5 and peroxidase-labelled anti-mouse, 
and developed using SuperSignal West Pico Chemiluminescent Substrate (Thermo; Table 
2.6). Dot blots were photographed using a G:BOX Chemi dock (Syngene; Figure 4.4). 
 
Table 2.6  Antibodies 
Antibody Dilution Donor Source Use 
Primary antibodies 
Anti-GFP 1:1000 Rabbit Molecular probes A11122 Embryonic expression profiles, S2 cell protein distribution 
Anti-βgal 1:5000 Rabbit Cappel  Embryonic expression profiles, Axon guidance 
Anti-dsRed 1:100 Rabbit Clonteck 632496 Embryonic/larval expression profiles 
Anti-HA 1:200 Mouse Roche 11583816001 S2 cell protein distribution 
Anti-V5 1:5000 Mouse Invitrogen 46-0705 Dot blot, Western 
Anti-Broad 1:100 Mouse Dshb 25E9.D7 Ecdysone signalling 
Anti-FasII ID4 1:5 Mouse Hybridoma Bank ID4 Axon guidance 
Anti-Kek3 ASDN 1:100 Guinea Pig Davids Biotechnologie Kek3 protein distribution  
Anti-Kek4 DCG 1:50 Guinea Pig Davids Biotechnologie Kek4 protein distribution 
Anti-Kek6 HRS 1:1 Guinea Pig Davids Biotechnologie Kek6 protein distribution 
Anti-HB9 1:1000 Rabbit Gift of H T Broihier Motor neuron marker 
Anti-DIG-AP 1:1000 Sheep Boehringer Mannheim In situ hybridisation 
Anti-DIG-POD 1:500 Sheep Roche 11207733910 In situ hybridisation 
Secondary antibodies 
Biotinylated anti-guinea pig 1:300 Donkey Jackson 706-066-148 Immunohistochemistry 
Biotinylated anti-rabbit 1:300 Goat Vector BA-1000 Embryonic expression profiles, Axon guidance 
Biotinylated anti-mouse 1:300 Horse Vector BA-2000 Axon guidance 
Peroxidase-labelled anti-mouse 1:1000 Horse Vector PI-2000 Dot blot, Western 
Alexa488 anti-rabbit 1:250 Goat Molecular Probes A11034 Immunohistochemistry, Immunocytochemistry 
Alexa647 anti-rabbit 1:250 Goat Molecular Probes A21245 Immunohistochemistry 
Alexa488 anti-mouse 1:250 Mouse Molecular Probes A11029 Immunohistochemistry, Immunocytochemistry 
Alexa647 anti-mouse 1:250 Donkey Molecular Probes A31571 Immunohistochemistry 
Streptavidin488 1:250  Molecular Probes S11223 Immunohistochemistry 
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2.4.2 SDS-PAGE and Western blot 
Purified protein was boiled for 5 minutes in 4% SDS loading buffer (Maniatis et al., 1982), 
chilling on ice, then centrifuged for 3 minutes. Samples were run through a 5% stacking gel 
(5% acrylamide (Fisher), 0.1% ammonium persulfate (National Diagnostics), 0.1% TEMED 
(Sigma), 125 mM Tris pH6.8, 0.1% SDS) and a 12% resolving gel (12% acrylamide, 0.1% 
ammonium persulfate, 0.04% TEMED, 375mM Tris pH8.8, 0.1% SDS) at 100V for ~90 
minutes in a mini-PROTEAN 3 system (BioRad). Molecular weights were determined using 
the Prestained Protein Marker, Broad Range (NEB).  
Proteins were transferred to a nitrocellulose membrane at 30V, 4⁰C for 1 hour using an Xcell 
SureLock Mini-Cell at 30V for 1 hour. blocked for 1 hour in 5% non-fat milk powder in 
0.05% PBTween and incubated in primary antibody overnight at 4°C. Membranes were 
washed in in PBTween, incubated in secondary antibody in blocking solution for 2 
hours at room temperature, then washed again. Luminescence was detected by a G:BOX 
Chemi (Syngene) and Genesnap software after incubation with SuperSignal West Pico 
(Thermo) kit, as per kit instructions. 
 
2.5 Immunochemistry 
2.5.1 Fixation 
S2 cells used to detect Kek distribution were transfected on sterile coverslips; 48 hours post-
transfection, medium was aspirated and coverslips were removed to separate small Petri 
dishes. Coverslips were washed with PBS+0.1% Tween20 and fixed for 15 minutes with 4% 
formaldehyde in a humid chamber. Fixed cells were washed and blocked in 4% BSA (Sigma) 
prior to immunolabelling.  
Embryos were collected overnight (17 hours, 25⁰C) on grape juice agar plates. Collected 
embryos were dechorionated in 1:5 bleach solution and washed carefully prior to fixation. For 
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antibody labelling, dechorionated embryos were immediately added to a pre-mixed solution 
of 300μl 37% formaldehyde, 2700μl PBS, 3ml heptane, and fixed for 20 minutes at room 
temperature with rolling. For in situ hybridisation, dechorionated embryos were immediately 
added to a pre-mixed solution of 3ml 4% paraformaldehyde, 3ml heptane, and fixed for 20 
minutes at room temperature with rolling. Embryos were washed in methanol, and excess 
vitelline membrane removed by vortexing. 
L3 instar larvae were collected and stored in PBS on ice. Larval brains were dissected in PBS 
and fixed immediately in 4% formaldehyde in PEM during a 20 minute dissection window. 
Formaldehyde was then refreshed and samples fixed for a further 50 minutes, with rolling. 
Larval brains were washed in PBS with 0.3% Triton-X-100 and blocked in 10% normal goat 
serum (Vector labs) for 1 hour prior to storage or immunolabelling.  
2.5.2 Immunolabelling 
Antibodies used in this work are summarised in Table 2.6. Custom antibodies were raised 
against Kek3, Kek4 and Kek6 peptides. Unique peptide sequences from each protein were 
chosen in the N-terminal region to avoid labelling of repetitive, common domain sequences. 
Peptide selection was validated and approved, and antibodies purified from guinea pig 
polyclonal serum, by Davids Biotechnologie (Germany). Peptides chosen were: 
ASDNSAQRRTLATKVRRK (Kek3), DCGNCHCKWNSGKKTADC (Kek4) and 
HRSMDRRRSRTPRTLPVC (Kek6). These peptide sequences are highlighted in Figure 2.9 
(black brackets). Anti-Kek6 antibodies were validated by comparing immunolabelling in yw 
and kek634/Df(kek6) mutants (see Chapter 6). 
Antibody labelling was detected by HRP or fluorescence. Blocked S2 cells were washed with 
PBS+0.1% Tween20 and 60μl primary antibody was added per coverslip; coverslips were 
incubated overnight in a humid chamber, at 4⁰C with rocking. Coverslips were washed with 
PBS+0.1% Tween20 in 6 well plates and further stained with fluorescent secondary 
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antibodies, in a humid chamber, for 2 hours at room temperature in the dark. Washed 
coverslips were inverted and mounted on microscope slides using Vectashield with DAPI 
(Vector Labs). 
Fixed embryos were incubated overnight in primary antibody dilution, at 4⁰C with rocking. 
Stained embryos were washed for 1 hour in PBS+0.1% Triton-X-100. The correct secondary 
antibody dilution was added and embryos incubated for 2 hours at room temperature with 
rocking (in darkness for fluorescent secondary antibodies). Embryos were washed for a 
further 1 hour in PBS+0.1% Triton-X-100. Samples for fluorescence microscopy were 
mounted in Vectashield mounting medium (Vector Labs). Larval stains were conducted as per 
embryo stains but with PBS+0.3% Triton-X-100. 
For antibody labelling detection by HRP, secondary antibody-labelled embryos were 
incubated at room temperature, 30 minutes, in 0.5% Vectastain ABC reagent solution (Vector 
Labs) in PBS+0.1% Triton-X-100. ABC reagent was removed and embryos washed for 1 
hour. Embryos were aspirated in a clean 24-well plate and 300μl 0.7mg/ml SIGMAFAST 
3,3′-diaminobenzidine (DAB) solution (Sigma) in PBS+0.1% Triton-X-100 was added. 
Labelling patterns were detected with 3% final concentration H2O2 solution (Sigma). 
Reactions were stopped with ≥1 hour washing in PBS+0.1% Triton-X-100 and embryos 
mounted in 70% glycerol. For double immunolabelling, the procedure was repeated and 
separate labels detected separately, with black HRP staining generated by addition of 5μl 8% 
NiCl2 (Sigma) during H2O2 development.  
2.5.3 Antisense RNA probe transcription 
Antisense RNA probes were transcribed from linearised constructs as follows: kek1 
(SD01674+pOT2 cDNA clone; linearised with EcoRI, transcribed with SP6 RNA 
polymerase); kek2 (NB7+pNB40; HindIII; T7 RNA polymerase); kek3 (kek3 
558nt+pDONR221; HpaI; T7); kek4 (GH27420+pOT2; EcoRI; SP6); kek6 (kek6+pDONR221; 
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HpaI; T7); CG15744 (CG15744 569nt+pDONR221; HpaI; T7); CG16974 (CG16974 
548nt+pDONR221; HpaI; T7); lambik (lbk 551nt+pDONR221; HpaI; T7); rickets 
(DLGR2+pCR2.1-TOPO; HindIII; T7); wengen (RE29502+pFLC-I; SacI; T3 RNA 
polymerase). Restriction enzymes linearised 10μg of construct 5′ relative to the cDNA. All 
digests at 37⁰C. Linearised DNA was verified by agarose gel electrophoresis compared to 
uncut plasmid. To purify linearised DNA, 50μl phenol (Sigma), 49μl chloroform (Fisher) and 
1μl isoamyl alcohol (Fisher) were added to 50μl linearised DNA, samples centrifuged for 5 
minutes and the aqueous layer precipitated in 5μl 3M sodium acetate and 3 volumes ethanol. 
Samples were stored at -80⁰C for ≥30 minutes, DNA pelleted at 13k rpm for 10 minutes, 
washed in 70% ethanol and stored at -20⁰C in 20μl ddH2O+DEPC. Transcription reactions 
were conducted as follows: 1μg linearised template DNA, 2μl DIG RNA labelling mix 
(Roche), 2μl suitable RNA polymerase (see above), 2μl 20X transcription buffer (specific to 
polymerase); 1μl Recombinant RNasin Ribonuclease Inhibitor (Promega) in ddH2O+DEPC 
up to 20μl total volume; 2 hour incubation time at 37⁰C. Transcription reactions were stopped 
with 1μl DNase (RNase-free; NEB), incubated for 15 minutes 37⁰C and all enzymatic activity 
terminated by heat shock at 65⁰C for 15 minutes. Probes were precipitated in 2.5μl 4M LiCl 
(Fisher) plus 75μl ethanol and stored at -80⁰C for ≥30 minutes. Probes were pelleted by 15 
minutes centrifugation, washed with 70% ethanol in ddH2O+DEPC, dried and stored at -20⁰C 
in 50μl ddH2O+DEPC with 1μl Recombinant RNasin Ribonuclease Inhibitor.  
2.5.4 In situ hybridisation 
In situ hybridisation of antisense RNA probes was used in embryos to determine mRNA 
expression patterns of putative receptor genes. 
Day one of in situ hybridisation protocol: Fixed embryos were warmed slowly to room 
temperature and rehydrated by washing in 50% methanol:50% PBS+0.1% Tween20 for 15 
minutes, then for 15 minutes in PBS+0.1% Tween20. Washed samples were fixed again in 
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4% paraformaldehyde for 20 minutes with rolling and washed again in PBS+0.1% Tween20. 
Embryos were digested for 90 seconds in 125ng/ml RNase-free Proteinase K (Sigma) in 
PBS+0.1% Tween20. Digestion was halted by washing twice with 0.2% glycine (Fisher) in 
PBS+0.1% Tween20 and twice with PBS+0.1% Tween20. Samples were fixed for a third 
time in 4% paraformaldehyde for 30 minutes and washed for 30 minutes in PBS+0.1% 
Tween20. Hybridisation buffer was prepared by mixing 5ml formamide (MP Biomedicals), 
2.5ml 20X SSC, 100μl 10% Tween20 in PBS, 10μl heparin (50mg/ml stock; Sigma) and 
2.3ml ddH2O+DEPC and stored in a water bath at 55⁰C. Fixed and washed samples were 
gently warmed to 55⁰C by washing in 50% PBS+0.1% Tween20:50% hybridisation buffer for 
10 minutes at room temperature and 10 minutes at 55⁰C in the water bath. 100μl salmon 
testes ssDNA (10mg/ml stock; Sigma) was denatured for 10 minutes at 95⁰C, cooled on 
ice+methanol and added to the hybridisation buffer at 55⁰C (Complete hybridisation buffer). 
Warmed embryos were incubated in complete hybridisation buffer for 3 hours at 55⁰C. 
Antisense DIG-labelled RNA probe was denatured at 95⁰C for 10 minutes, cooled on 
ice+methanol for 10 minutes and added to samples at 1:20, 1:40 and 1:100 titrations in 
complete hybridisation buffer. Hybridisation mixtures were left overnight at 55⁰C.  
Day two of in situ hybridisation protocol: A 1:1000 dilution of alkaline-phosphatase (AP)-
conjugated anti-DIG in PBS+0.1% Tween20 was pre-absorbed with paraformaldehyde-fixed 
embryos for ≥1 hour at room temperature on a windmill mixer. Meanwhile, at 55⁰C, embryos 
were washed for 20 minutes in complete hybridisation buffer, 20 minutes in 50% PBS+0.1% 
Tween20:50% complete hybridisation buffer, and 5 x 20 minutes in PBS+0.1% Tween20. 
After the final wash, embryos were slowly cooled to room temperature. Washed embryos 
were incubated with rocking for 1 hour at room temperature in 1:100 pre-absorbed AP-
conjugated anti-DIG. Incubated samples were washed with PBS+0.1% Tween20 for 1 hour 20 
minutes and 3 x 5 minutes in staining solution (250μl 4M NaCl, 500μl 1M MgCl2, 1ml 1M 
Tris-HCl pH9.5 and 100μl 10% Tween20 in PBS, made up to 10 ml total volume with 
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ddH2O+DEPC). Samples were developed in the dark in a 24-well plate in 500μl volume of 
staining solution supplemented with 2.25μl NBT (100mg/ml) and 1.75μl BCIP (50mg/ml). 
Development was halted by washing with PBS+0.1% Tween20 and samples stored in 70% 
glycerol at 4⁰C prior to mounting. 
2.5.5 Fluorescent in situ hybridisation 
Fluorescent in situ hybridisation was used to detect kek6 mRNA localization in the embryo. 
The protocol is adapted from that of A. Bustos (Benjamin Altenhein laboratory, Johannes 
Gutenberg University, Mainz, Germany, personal communication). 
Day one: Fixed embryos were warmed slowly to room temperature and rehydrated by 
washing in 50% methanol:50% PBS+0.1% Triton-X-100 for 15 minutes, then 3 x 10 minutes 
in PBS+0.1% Triton-X-100 at room temperature. Embryos were next incubated at room 
temperature for 10 minutes in 50% PBS+0.1% Triton-X-100:50% hybridisation solution (5ml 
formamide, 2.5ml 20X SSC+DEPC, 2.5ml H2O+DEPC, 50μl Tween20) and 10 minutes in 
hybridisation solution. 100μl salmon testes ssDNA (10mg/ml stock; Sigma) was denatured for 
10 minutes at 95⁰C, cooled on ice+methanol and added to the hybridisation solution 
(complete hybridisation solution) at 55⁰C in a water bath. Embryos were incubated in 
complete hybridisation solution at 55⁰C for 3 hours. Antisense DIG-labelled RNA probe was 
denatured at 95⁰C for 10 minutes, cooled on ice+methanol for 10 minutes and added to 
samples at 1:20, 1:40 and 1:100 titrations in complete hybridisation solution. Hybridisation 
mixtures were left overnight at 55⁰C.  
Day two: Samples were washed in complete hybridisation solution for 30 minutes at 65⁰C, 30 
minutes in 50% complete hybridisation solution:50% PBS+0.1% Triton-X-100 at 65⁰C and 4 
x 20 minutes in PBS+0.1% Triton-X-100 at 65⁰C. After the final wash, embryos were cooled 
slowly to room temperature. Embryos were blocked for 30 minutes in TNB buffer (0.1M Tris-
HCl pH 7.5, 0.15M NaCl, 0.5% blocking reagent (TSA Fluorescein System; Perkin Elmer)). 
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Blocked embryos were incubated overnight at 4⁰C with rocking in 1:500 POD-conjugated 
anti-DIG (Roche) in TNB buffer. 
Day three: Samples were washed with PBS+0.1% Triton-X-100 for 1 hour and for 10 minutes 
with TNT buffer (0.1M Tris-HCl pH7.5, 0.15M NaCl, 0.05% Tween20). Tyramide 
Fluorescein (TSA Fluorescein System; Perkin Elmer) was pre-mixed 1:50 in amplification 
diluent and added to embryos (100μl per sample). Embryos were incubated for 10 minutes in 
the dark and amplification terminated by washing with TNT buffer. 
2.6 Microscopy 
Whole mount and dissected HRP-stained embryos (Gal4-driven expression patterns, anti-
Kek6 labelling, ISNb axon guidance), adult wings, fluorescent anti-Broad stained fat bodies 
and anti-Kek4 stained ring glands were viewed using an Axioplan 2 (Zeiss) light microscope 
at 20x, 40x (differential interference contrast (DIC), oil) and/or 63x (DIC, oil) magnification 
using Nomarski optics. Images were captured using a JVC 3CCD camera and Image Grabber 
software (Neotech) or AxioCam HRc (Zeiss) camera and Zen2012 (Zeiss) software.  
Fluorescent images of S2 cells (63x oil), anti-Kek4 stained larval ring glands (40x oil) and 
putative kek3Gal4>UASmyrTOMATO larval brains (20x oil) stained fluorescently with anti-
dsRed were captured using a Leica SP2 AOBS inverted laser scanning confocal microscope. 
Fluorescent images of anti-Kek6-stained embryos (40x oil) were captured using a Leica SP2 
upright laser scanning confocal microscope. Both microscopes are maintained by the 
Birmingham Advanced Light Microscope Facility (BALM, University of Birmingham). 
Images were captured at 200Hz, 1024x1024 pixel resolution and averaging of 3 slices. All 
images were processed in ImageJ (NIH), Photoshop (Adobe) and compiled using Illustrator 
(Adobe). 
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2.7 Phenotypic analysis 
2.7.1 Axon guidance 
Anti-FasII and HRP-stained late stage 17 embryos were filleted and imaged by light 
microscopy. Embryos with genotypes containing the lacZ-expressing enhancer trap 15A6 
were further stained using anti-βgal and NiCl to separate homozygous and heterozygous 
progeny. Abdominal segments A1–A5 were scored on both sides of the embryo for ISNb 
motor nerve terminal misrouting, loss and fan phenotypes at muscles 6, 7, 12 and 13.  
2.7.2 Locomotion 
Locomotion phenotypes were detected according to protocols outlined in McIlroy et al. 
(2013) and Sutcliffe (2010). Larvae and adults were incubated at 25⁰C in a 12 hour light/dark 
cycle (8am–8pm) and filmed between 10am and 12pm. Larvae were filmed crawling across a 
humid agar plate, and adult flies were filmed walking around the rim of a 46mm diameter 
Petri dish, using a Moticam 2000 camera (Motic) and Motic Images Plus 2.0 ML software. 
Dishes were placed on a LP812 light box (Jessops) to backlight the experimental setup. For 
larval recordings, the camera was clamped above the setup such that the dish perimeter was 
just outside the field of view; for adult recordings, the camera was positioned 95mm above 
the dish. Adult flies were anaesthetised and wings clipped using micro scissors; 1 hour of 
recovery time was permitted prior to filming. Videos were decompressed using VirtualDub 
software (www.virtualdub.org), and stacks of the first 400 continuous greyscale frames were 
compiled in ImageJ. Stacks were processed with the FlyTracker ImageJ plugin (Manuel 
Forero, Hidalgo laboratory; McIlroy et al. (2013)) to give trajectories and quantified speed, 
distance, resting and wobbling. 
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2.7.3 Developmental timing 
To determine phenotypes in developmental timing caused by ring gland gene mutations, cages 
of yw, kek420 x kek423 and spz6Gal4 x UASkek4RFP adults were incubated at 25⁰C with a 12 
hour light/dark cycle in cages closed with a grape juice agar plate. Grape juice plates were 
replaced at 9am, 10am and 2pm daily to stage embryo collections. Plates removed at 9am and 
10am were discarded, whereas plates removed at 2pm were incubated overnight. After 24 
hours incubation (12.30pm), 50 L1 larvae of each genotype were transferred to vials 
containing blue food. Food was prepared by pre-mixing 10ml Formula 4-24 Instant Medium, 
Blue (Carolina), 0.1g dried yeast and 20ml H2O. Excess water was removed and food left to 
set at room temperature prior to larvae addition. Vials were incubated at 25⁰C in an empty 
pipette tip box filled with 2cm water to create a humid microenvironment. At 4 hour intervals 
throughout the day, the number of L1/L2 instar larvae, wandering L3 instar (blue gut), 
wandering L3 instar (white gut), white puparia, brown pupae, black pupae and eclosed adults 
were scored until all flies were eclosed. Adult flies were removed upon eclosion to avoid 
miscounting a second generation of progeny. At each time point, cumulative percentage of 
larvae having passed an individual moult or developmental stage were calculated by 
deducting the percentage of larvae observed at all preceding stages from 100% (for example, 
if 80% of larvae are still at L1/L2 instar stage, and 10% are observed to be wandering L3 
larvae with blue guts, only 10% will have reached at least the white gut wandering L3 stage).  
2.7.4 Body growth assays 
Wandering L3 larvae, brown pupae and eclosed adults of yw, kek420 x kek423 and spz6Gal4 x 
UASkek4RFP crosses were collected and adhered to glass slides. All three genotypes were 
assembled on each slide. Slides were illuminated using a LP812 light box and photographed 
using a Moticam 2000 (Motic) camera or Pentax K-30 camera clamped above the slide. Body 
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lengths were measured using the ImageJ line tool, and body sizes measured using the ImageJ 
ROI manager tool. 
Adult wings were cut from flies using microscissors and mounted in glycerol on glass slides. 
Wing hairs were photographed using an AxioCam HRc (Zeiss) camera and Zen2012 (Zeiss) 
software at 20x magnification with the anterior crossvein aligned vertically on the left of the 
image (see (Gidaszewski et al., 2009) as a guide to wing morphology). Wing hair number was 
scored manually in a 700x450 pixel region of interest between longitudinal veins L3 and L4 
where the left side of the ROI connects the two veins. Each wing was counted three times and 
hair cell counts from the third count were used to maximise scoring proficiency. 
2.8 Statistical analysis 
Data was input to Excel (Microsoft) and analysed in SPSS Statistics 21 (IBM) and GraphPad 
Prism 6. Categorical data were tested using χ2, and χ2 with a Bonferroni correction for 
multiple comparisons. Distribution of continuous data with natural distribution was 
determined by kurtosis, skewness and Levene’s Test for Homogeneity of Variance. Data were 
considered not normally distributed if absolute kurtosis and skewness values for each 
genotype were greater than 1.96 x standard error of kurtosis/skewness. Variance of the 
populations of different samples were considered unequal if Levene’s test for homogeneity of 
variance gave a P value of <0.05. Means of parametric data were compared by One-Way 
ANOVA, unless data failed distribution or variance tests, in which case data were tested by 
Welch ANOVA. Multiple post hoc comparisons were compared using a Dunnett test (to 
compare all samples to a control), a Games-Howell test (to compare all samples to a control 
when a Welch ANOVA is required) or Student’s t-test with Bonferroni correction 
(comparisons between samples). Non-parametric data were analysed using a Kruskal-Wallis 
test around the median and multiple comparisons were made using a post-hoc Dunn test. In all 
results, * indicates P<0.05, ** indicates P<0.01 and *** indicates P<0.005.  
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CHAPTER 3 
CHARACTERISATION OF THE DROSOPHILA LIGs 
3.1 INTRODUCTION 
In this chapter, I investigated whether any of the nine Drosophila LIG proteins, as well as the 
non-LIGs CG17839, rk and wgn, could function as Drosophila neurotrophin (DNT) receptors 
according to three criteria.  
First, candidate genes were screened for neuronal central nervous system (CNS) gene 
expression. kek1, kek2 and kek5 are expressed in the embryonic CNS (Evans et al., 2009, 
Musacchio and Perrimon, 1996). Furthermore, Kek2 protein has been detected at the larval 
neuromuscular junction (NMJ; Guan et al. (2005)). To determine the embryonic expression 
patterns of each candidate gene, I followed three strategies: (1) RNA probes that hybridise to 
the mRNA of the genes of interest were transcribed for in situ hybridisation; (2) for kek3, kek5 
and CG17839, Gal4 insertion lines were available. These were crossed to a UASmyrTOMATO 
(red fluorescent protein) reporter, and expression was visualized in fixed embryos by 
immunolabelling. (3) To detect protein distribution, custom antibodies were generated to 
immunolabel unique peptide sequences of Kek3, Kek4 (Chapter 7) and Kek6 (Chapter 6).  
Second, candidate receptors were screened for genetic interaction with ligand mutants using 
the survival index (S.I.; see below)..  
Third, interactions between the dLIGs and the DNTs were determined using adult locomotion 
as a behavioural readout. Behavioural output is essential for putting subcellular and cellular 
phenotypes into perspective: “Nothing in neurobiology makes sense except in the light of 
behaviour” (Guo et al., 2009, Heisenberg, 1997). Using locomotion, the aim was to select the 
receptor candidates with suggested DNT interactions and/or suggested behavioural roles. 
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The aim of the chapter was to select the most suitable receptor candidates in the context of 
DNT signalling and nervous system development for further study. 
3.2 RESULTS 
3.2.1 Candidate receptor expression profiles 
The DNTs are expressed in the CNS and muscular targets (Sutcliffe et al., 2013, Zhu et al., 
2008). Therefore, a putative receptor for the DNTs is anticipated to be expressed in cell types 
that could interact with the ligand expressing cells and thus receive the ligand. This could 
include cells that express both the ligands and the receptors. 
3.2.1.1 dLIG expression profiles 
Expression profiles of candidate genes were determined by in situ hybridisation using 
antisense RNA probes. Hybridisation region of probes is shown in Figure 2.8. The primary 
aim of profiling was to identify genes clearly expressed in the CNS, for further analysis. 
Consequently, sense probes were not used to validate expression profiles. 
In situ hybridisation (Figure 3.1a) revealed that CG15744 may have early embryonic stage 
signal in the CNS (Figure 3.1b). By stage 16, signal was also observed in the gut (Figure 
3.1c). By stage 17, signal and background noise were difficult to distinguish (Figure 3.1d). 
Viewed ventrally, stage 14 embryos did reveal CG15744 signal in the ventral nerve cord 
(VNC; Figure 3.1e). Signal was detected in midline cells in stage 13 embryos (Figure 3.1f, 
arrowhead). From stage 15, CG15744 signal was detected throughout the VNC in the intra-
longitudinal axonal tract space (Figure 3.1g–h). Pairs of CG15744+ cells were observed 
adjacent to the midline in stage 16 embryos (Fig 3.1g, arrowheads). Stage 17 embryos 
expressed CG15744 in many neurons ventral to the neuropil (Figure 3.1h, left image). In 
addition, no signal was detected in longitudinal or midline glia in filleted stage 17 embryos 
(Figure 3.1h, white neuropil). Cell types could not be verified throughout.  
Figure 3.1  CG15744 is expressed in the CNS
a | BLAST search of the sequence of an antisense CG15744 RNA probe uncovers the exonic coding 
sequence of CG15744. b-e | Hybridisation of CG15744 mRNA in the CNS od whole mount embryos. 
f-h | Dissected embryos reveal  VNC signal including midline cells (black arrowhead) and cells 
immediately adjacent to the midline (white arrowhead). The embryonic midline is labelled with a 
black arrow. Scale bar, 10µm.
Stage 13 Stage 16
Stage 16
Stage 17
Stage 17
Stage 14
Stage 14
g h
a
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d e
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By contrast, CG16974 and lambik formed an outlier group with markedly different expression 
profiles to the other dLIGs (Figures 3.2–3.3). CG16974 signal was absent from the VNC 
throughout development (Figure 3.2b–d). Instead, CG16974 was detected from stage 14 in the 
periphery of the embryo in cell clusters. These may represent the peripheral nervous system 
(PNS) or muscle (Figure 3.2e–h). CG16974+ cell number in the periphery increased with 
development. Dissected embryos revealed CG16974 is expressed in stripes at the 
intersegmental boundaries of stage 13 embryos (Figure 3.2i, arrowheads). These resembled 
the expression pattern of the border cell transcription factor stripe at muscle attachment sites, 
which is required for muscle development (Frommer et al., 1996). Lateral cell clusters that 
resemble central PNS clusters were CG16974+ in stage 15 embryos (Figure 3.2j). Last, ventral 
muscle groups or muscle attachment sites adjacent to the VNC in stage 17 embryos were 
CG16974+ (Figure 3.2k).  
Lambik, similarly, was absent from the CNS in embryos, as determined by in situ 
hybridisation (Figure 3.3b–e). Instead, lambik transcript was enriched in the epidermis (Figure 
3.3f–h). Lambik was first detected in the periphery by stage 13 (Figure 3.3f). In stage 14 
embryos, lambik transcript formed two stripes of single cells or cell clusters along the length 
of the body (Figure 3.3g, boxed). These may be myoblast muscle precursors (Rau et al., 
2001). lambik+ cell number in the lateral flank of the embryo increased up to stage 17 (Figure 
3.3h).  
3.2.1.2 The kek genes are expressed in the CNS 
Embryos of the lacZ-containing P[1ArB] transposon insertion line 15A6 (located at 33F1–2 
on the second chromosome, adjacent to the kek1 gene at 34A1; Musacchio and Perrimon 
(1996)) were stained with anti-βgal and detected using HRP (Figure 3.4). In stage 12 
embryos, kek1 transcript was localised in discrete cells along the VNC (Figure 3.4a). By stage 
16, strong expression was observed in the VNC and central brain (Figure 3.4b). In stage 17 
Stage 14 Stage 15
Stage 15
Stage 16
Stage 16
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Figure 3.2  CG16974 is expressed in the PNS
a | BLAST search of the antisense CG16974 RNA probe sequence uncovers exonic 
coding sequence of the CG16974 gene. b-d | In situ hybridisation reveals 
that CG16974 transcript is not present in the embryonic CNS. e-h | CG16974 
mRNA is enriched in the epidermis in the periphery of the embryo. 
i-k | CG16974 transcript was detected in stripes at the intersegmental boundaries 
of stage 13 embryos (i), lateral cell clusters of stage 15 embryos (j) and ventral 
muscle attachment sites (k). The embryonic midline is labelled with a black arrow.
Scale bar, 10µm.
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Figure 3.3  lambik is expressed in the PNS
a | BLAST search of the antisense lbk RNA probe sequence uncovers exonic coding sequence of the 
lbk gene. a-e | lbk mRNA could not be detected in the CNS by in situ hybridisation. f-h | lbk mRNA 
was detected in the periphery, in epidermis, muscle or the PNS. 
d
ae f
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DorsalDorsal Ventral
Stage 16
15A6 lacZ transposon insertion line, stained with anti-βgal
Stage 16
Stage 17
Figure 3.4  kek1 is expressed in the CNS
Embryos containing the lacZ reporter enhancer trap 15A6 (Musacchio and Perrimon, 1996) 
were labelled with anti-βgal and detected using HRP.  a-c | kek1 expression was detected within the 
ventral nerve cord from stage 12 to stage 17. d | Anti-βgal labels kek1+ cells at the dorsal midline. 
e-f | Dorsal–ventral arranged whole mount VNC images and magnications. The embryonic midline 
is labelled with a black arrow. Scale bar, 10µm.
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embryos, signal remained exclusive to the CNS (Figure 3.4c), except for select cells along the 
dorsal midline (Figure 3.4d). These cells formed an elongated loop shape in the middle of the 
embryo, and may be cardioblasts or pericardial cells of the early Drosophila heart (Tao and 
Schulz, 2007). The VNC of whole mount embryos revealed kek1+ cells either side of the 
neuropil and the midline (Figure 3.4e). In the dorsal VNC, signal was detected in a repeating 
four cell pattern either side of the midline (Figure 3.4e, middle). Ventral to this, signal was 
detected in cell clusters that overlay the midline and longitudinal tracts (Figure 3.4f, 
magnified view 3.4g).  
In situ hybridisation using a full-length kek1 antisense probe (Figure 3.5a) revealed signal in 
putative cardioblasts along the epidermal leading edge, on the dorsal flank of the germ band 
(Figure 3.5b). In the CNS, kek1 transcript was strongly localized to the VNC by stage 14 
(Figure 3.5c). Additional lateral signal was detected at stage 14 in the epidermis. From stage 
15, kek1 signal was strongly detected in the VNC and brain (Figure 3.5d–f). In stage 16 
embryos, signal was further detected in discrete PNS clusters (Figure 3.5e,f). kek1 transcript 
may also have been present in the Bolwig’s organ, which is a cluster of photoreceptors 
(Figure 3.5e, arrowhead; Friedrich (2008)). In early embryos and eggs, kek1 transcript was 
localized in dorsal stripes (Figure 3.5g).  
kek1 signal was detected in the CNS from stage 12, in large cell bodies (Figure 3.5i). kek1+ 
cell number increased by stage 13 (Figure 3.5k). By stage 14, VNC signal remained strongest 
in cells ventral to the longitudinal axon tracts (Figure 3.5k). By stage 15, kek1+ signal ventral 
to the neuropil formed a distinct ‘V’ shape that resembles HB9+ motor neuron staining 
(Figure 3.5l). Paired cells adjacent to the midline, one pair per hemisegment, also revealed 
kek1 transcript signal (Figure 3.5l, arrowheads). By stage 16, kek1 was detected in touching 
paired cell bodies immediately adjacent to the midline (Figure 3.5m, boxed). Signal was 
further detected in paired nuclei either side of the midline in stage 17 embryos (Figure 3.5n). 
Figure 3.5  kek1 is expressed in the CNS and PNS
a | Probe hybridisation conrmed by BLAST. b–g | kek1 mRNA was detected in the embryonic CNS. 
Cardioblast signal was detected at stage 12. VNC expression was detected from stage 14. kek1 mRNA 
was detected in the epidermis from stage 14, and the PNS from stage 16 (Bolwig’s organ, arrowhead). 
h | kek1 transcript is enriched in the dorsal pole of the early embryo. i-n | Dissected embryos 
reveal kek1 trancript in the VNC (arrowheads, cells anking the midline; box, paired cells adjacent to 
the midline). The embryonic midline is labelled with a black arrow. Scale bar, 10µm.
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15A6 embryos stained with anti-βgal and in situ hybridisation using a kek1 antisense RNA 
probe both reveal kek1 signal in the embryonic VNC and central brain (Figure 3.4c, 3.5e), and 
signal in 2 paired cells either side of the midline (Figure 3.4e, 3.5o). Nonetheless, differences 
were observed: anti-βgal revealed 4 kek1+ paired cells per segment and ventral cell clusters 
overlaying the midline, whereas in situ hybridisation revealed putative kek1+ MP1 cells, V-
shaped kek1 signal suggestive of HB9+ cells, in addition to putative Bolwig’s organ signal 
(Figure 3.4e,f, 3.5a,d,j,l). Since the kek1 probe used hybridises to the kek1 mRNA (Figure 
3.5a), this signal can be attributed to kek1 gene activation and thus the cell-specific expression 
revealed by in situ hybridisation is more reliable than that of 15A6 embryos. Nonetheless, 
expression profile overlap across the CNS between both detection methods confirms the 
expression of kek1 in the CNS. 
kek2 transcript was enriched in the VNC and brain (Figure 3.6a–d). From stage 15, signal was 
detected in stripes along the flank of the embryo (Figure 3.6e–g). These stripes comprised the 
clusters of the PNS. By Stage 17, PNS signal was restricted to discrete clusters per 
hemisegment, ventral to the chordotonal organs (Figure 3.6g). kek2 signal was detected in the 
VNC from stage 13 in the intra-axonal tract region (Figure 3.6h,i), and later in the lower 
lateral muscle precursors or exit glia flanking the VNC (Figure 3.6h–j arrowheads). 
kek2 signal in the VNC was enriched in four cells per segment, akin to the aCC or pCC and 
RP2 pattern (Figures 1.8, 3.6j–n). Cells ventral to the neuropil also became kek2+ as the 
embryo developed (Figure 3.6l,n). In Stage 16 and 17 embryos, signal was absent from 
longitudinal and midline glia (Figure 3.6m,n). Ventral midline cell bodies were detected to be 
kek2+ in stage 17 embryos (Figure 3.6n). 
PCR amplification of ~500nt fragments (primers kek3558ntattBFw & kek3558ntattBRv and 
kek41.6kbinFwd & kek42kbinRev; see Table 2.3) was attempted from LD embryo cDNA 
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Figure 3.6  kek2 is expressed in the CNS
a-g | In situ hybridisation reveals kek2 mRNA is enriched in the embryonic CNS. h,i | kek2 mRNA was 
detected in lower lateral muscle precursors or exit glia (arrowheads). j-n | Dissected embryos reveal 
kek2 transcript in increasing numbers of neurons from stage 13. Signal was also detected in lower 
lateral muscle precursors or exit glia (arrowheads). The embryonic midline is labelled with a black arrow.
Scale bar, 10µm.
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libraries. kek3 and kek4 cDNA could not be detected in this library, suggesting that these 
genes are not expressed in embryos, or mRNA levels are extremely low. 
In situ hybridisation using a kek3 antisense probe (Figure 3.7a) revealed weak signal in the 
VNC of stage 17 embryos, evident in only isolated cells in each segment (Figure 3.7b,c). By 
comparison, kek3 was enriched in the larval brain, as detected by putative kek3Gal4-driven 
reporters (Figure 3.7d–f). However, it must be noted that this Gal4 insertion 
(Mi[ET1]CG15256MB09797) is 22kb upstream of the first exon (Figure 2.8), thus expression 
detected may be unrelated to normal expression. Viewed along the frontal plane (a cross 
section of the brain), membrane-tethered signal was observed throughout the nerve cord in 
discrete cell bodies and connections, and around the outside of the central brain (Figure 3.7d, 
left image). Viewed along the horizontal plane (ventral–dorsal), putative kek3Gal4 signal 
reached up to the boundary between the central brain and the optic lobe (Figure 3.7d, right 
image). Putative kek3Gal4 signal was absent from the majority of the optic lobe, apart from a 
single axon and cluster of cell bodies in the centre of the optic lobe (Figure 3.7d,e). Putative 
kek3Gal4 signal in the nerve cord was confined to repeating stripes of cell bodies detected 
dorsal to the neuropil, but only in the periphery of the nerve cord more ventrally, leaving the 
neuropil unstained (Figure 3.7f). Thus, this distant Gal4 insertion suggests that cell bodies of 
cortex or peripheral glia may be kek3+. Last, we raised custom antibodies against a non-
leucine rich repeat, non-immunoglobulin, unique extracellular Kek3 peptide sequence (see 
Chapter 2.5.2). Nerve cords labelled with Anti-Kek3 revealed Kek3 signal in the upper layer 
of the neuropil (Figure 3.7g).  
Putative kek5Gal4 (P[GawB]NP5933) was crossed to UASmCD8GFP (Figure 3.8a–f) or 
UASmyrTOMATO (Figure 3.8g–k) and stained with fluorescent secondary antibodies. As with 
kek3, it should be noted that the kek5Gal4 insertion is very far upstream (112kb) of the first 
kek5 exon (Figure 2.8), thus expression detected may be unrelated to normal kek5 expression. 
Putative kek5Gal4-driven GFP signal was detected in stage 10 embryos in isolated medial 
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a | Verication of probe hybridisation by BLAST. b,c | In situ hybridisation revealed only weak detection 
of kek3 mRNA in the embryonic CNS. d-f | Putative kek3Gal4-driven UASmyrTOMATO was detected in 
the larval ventral nerve cord, central brain, and a cell cluster and axon in the medial optic lobe. 
f | Putative kek3Gal4 signal surrounds the neuropil. g | anti-Kek3 reveals Kek3 protein in the upper layer 
of the neuropil. Target symbols indicate plane of view closest to the viewer, e.g. posterior (P) closest 
along posterior-anterior axis. Scale bar, 50µm.
Figure 3.7  kek3 is expressed in the larval CNS
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Figure 3.8  kek5 is expressed in the embryonic and larval CNS
a-c | Membrane-tethered GFP  reporter was detected in the VNC in dorsal clusters 
(arrowheads). d-f | Membrane-tethered GFP was detected in midline crossing contralateral 
neurons and neuronal cell bodies on the midline. g-j | myrTomato reporter indicates expression 
of kek5 in stage 17 embryos in longitudinal axons, commissures, ventral cell bodies and 
ventral (v) and lateral (l) PNS clusters. The embryonic midline is labelled with a black arrow. 
k | myrTomato reporter is detected in the larval ventral nerve cord and central brain. Scale bars: 
10µm (embryos), 50µm (larvae).
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cells parallel to the midline (Figure 3.8a). By stage 11, putative kek5Gal4-driven GFP was 
detected along the germ band in large cell clusters (Figure 3.8b). By stage 17, expression was 
restricted to the VNC, in localised dorsal clusters in each segment (Figure 3.8c, arrowheads). 
Dissected embryos revealed kek5Gal4-driven GFP expression in stage 15 and 16 midline-
crossing contralateral neurons (Figure 3.8d,e). kek5 GFP was also detected in neuronal cell 
bodies and axons ventral to and overlying the midline (Figure 3.8f).  
The membrane-tethered marker UASmyrTOMATO revealed very clear kek5+ CNS axonal 
signal in the stage 17 embryo (Figure 3.8g). Neuronal cell bodies lateral to the VNC projected 
kek5+ axons into the commissures and motor neurons that exit the VNC Putative kek5Gal4-
driven myrTomato was also present in neuronal cell bodies ventral to the neuropil, including 
cell bodies directly ventral to the longitudinal axon tracts and to the midline (Figure 3.8h). 
Stage 17 PNS cell bodies were also shown to be kek5+ (Figure 3.8i). kek5+ neurons were 
observed in the ventral (v and v′) and lateral (l) PNS neuronal clusters (Figure 3.8j). kek5-
driven myrTomato expression was also observed in the larval brain. Signal was enriched in 
the central brain and VNC (Figure 3.8k). 
The expression patterns of kek6 and kek4 are shown in Chapters 6 and Chapter 7, respectively.  
3.2.1.3 Expression profiles of non-LIG candidates 
Rickets could not be detected consistently in the embryonic nervous system (Figure 3.9a–c). 
Non-specific signal was observed adjacent to the midline in stage 12 embryos (Figure 3.9a). 
However, no VNC signal was detected in stage 16 embryos (Figure 3.9b) apart from a few, 
isolated ventral midline cells (Figure 3.9c, amplified in 3.9d). rk+ signal was detected in the 
brain and hindgut of stage 16 embryos (Figure 3.9b). 
CG17839-driven GFP was not detected in the stage 12 embryos (Figure 3.9e). Expression was 
observed in the VNC from stage 14, at the most ventral and most dorsal planes only (Figure 
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Figure 3.9  rickets and CG17839 expression proles
a-d | In situ hybridisation reveals only weak rickets signal in the CNS. d | Magnied view 
of VNC in image c reveals individual rickets+ cells along the midline. e-i | Putative 
CG17839Gal4-driven mCD8GFP reveals CG17839+ cells in the ventral and dorsal VNC 
from stage 14. CG17839 is enriched in the CNS by stage 17. h-i | Dissected embryos reveal
four CG17839+ cells per segment. The embryonic midline is labelled with a black arrow.
Scale bar, 10µm.
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3.9f). CG17839>GFP was enriched in the stage 17 VNC (Figure 3.9g). Dissected stage 15 
and 17 embryos revealed four CG17839+ cells per segment (Figure 3.9h,i). 
The expression profile of wengen was markedly different. In situ hybridisation using an 
antisense RNA probe revealed clusters of wengen transcript throughout the germ band of 
stage 11 embryos (Figure 3.10a–c). These clusters resemble oenocytes and tracheal precursors 
(Ebner et al., 2002, Sotillos et al., 2010). By stage 15, two bands of signal could be detected 
— one in the lateral musculature precursors or epidermis (Figure 3.10d, left image), and one 
in the tracheal system (Figure 3.10d, right image). By stage 16, signal was detected in 
segmental boundaries (Figure 3.10e, arrowheads). Dorsal and ventral views of whole mount 
stage 11 embryos revealed wengen transcript in large single cells along the germ band, medial 
to the midline (Figure 3.10f–h). Wengen transcript was also present in repeating U-shaped 
clusters throughout the germ band. These resemble the expression of tinman, which is 
required for the positioning of the Drosophila heart (Lockwood and Bodmer, 2002). 
Wengen+ cells in the VNC of stage 11 and stage 12 embryos divided to produce repeating 
pairs of cells over the longitudinal axonal tracts (Figure 3.10i). Wengen signal was also seen 
on the midline, suggesting that the role of wengen is glial (Figure 3.10j, arrowheads). In later 
stage embryos, wengen+ cells extended projections away from (arrowhead) and towards 
(white arrow) the midline (Figure 3.10k,l). These may be exit glia. Wengen transcript was 
enriched in the ventral lateral muscles or muscle attachment sites of stage 15 embryos (Figure 
3.10m).  
3.2.2 The dLIGs interact with the DNTs 
To determine whether the dLIGs interact with the DNTs, two assays were performed on 
dLIG–DNT combinations: a lethality assay, and a locomotion assay to determine behavioural 
phenotypes. 
 
Figure 3.10  wengen is expressed in trachea, the heart and glia
a | Probe hybridisation conrmed by BLAST. b,c | In situ hybridisation reveals wgn mRNA is 
localized to tracheal and oeonocyte precursors in the early embryo. d,e | wgn mRNA is enriched 
in the trachea by stage 15 and segmental boundaries by stage 16 (arrowheads). f-h | wgn mRNA 
was detected in single cells along the future nerve cord in stage 11 embryos. Lateral wgn mRNA 
signal resembles the U-shaped expression pattern of the heart positioning gene, tinman.  
i-m | Dissected embryos reveal  wgn mRNA on the midline, between the longitudinal tracts and 
in putative exit glia.  Scale bar, 10µm.
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3.2.2.1 Genetic interactions of the dLIGs 
At 18⁰C, DNT141 and DNT2e03444 single mutant alleles are viable (McIlroy et al., 2013): when 
crossed, DNT141/TM6B or DNT2e03444/TM6B parental lines yield homozygous 
DNT141/DNT141 (hereafter DNT1–/–) or DNT2e03444/DNT2e03444 (hereafter DNT2–/–) progeny, in 
addition to allele/balancer progeny. This can be quantified by scoring pupal phenotypes, since 
homozygous pupae are Tb+, whereas TM6B-balanced pupae are Tb– (tubby). Using the 
survival index (S.I.), a wild type S.I. of 1 equates to an expected Mendelian Tb+:Tb– progeny 
ratio of 1:2 (see Methods for further details). Under these conditions, DNT2e03444DNT141 
double mutants are homozygous lethal (hereafter DNT2–/–DNT1–/–), as there are no Tb+ 
progeny pupae from a cross of DNT2e03444DNT141/TM6B parents (Figure 3.11a). This suggests 
that DNT1 and DNT2 are functionally redundant (Zhu et al., 2008). If mutants for the 12 
candidate genes in this study interact with DNT mutants, dLIG–DNT double combinations 
may deviate the S.I. away from a S.I. of 1. Thus, dLIG–DNT combinations were balanced 
over TM6B and bred at 18⁰C, and pupal phenotypes were scored. Full genotypes and survival 
indices are shown in Table 3.1.  
Transposon-derived alleles used are summarised in Table 2.2 and Figure 2.8, and described in 
Chapter 2.1.3. In each protocol, isogenic balancer stocks were used at the G0 cross, and F2 
progeny double mutants were self-crossed en masse (10♀:8♂) to form stable stocks but not 
isogenized by 1:1 matings. Given the isogenic background, this was deemed unnecessary 
since phenotypes would derive only from the introduced alleles. How these alleles manifest 
phenotypes, and whether 1:1 stock matings would affect results, was unknown: this 
experiment was intended to diagnose notable phenotypic differences between different dLIG–
DNT genetic combinations only. kek1, kek2 and kek6 genetic interactions could not be assayed 
owing to a lack of available viable alleles. 
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Figure 3.11  dLIGs interact genetically with the DNTs
a | The survival index of single DNT1, DNT2 and double DNT2DNT1 mutants is shown. 
At 18°C, DNT2DNT1/TM6B mutants are embryonic lethal in homozygosis (no DNT2-/-DNT1-/-  
pupae detected, survival index=0), whereas single DNT1/TM6B or DNT2/TM6B mutants are not. 
Expected Mendelian segregation of viable alleles give a survival index value of 1. Double 
mutants combining DNT1 or DNT2 mutations with lbk (b), kek3, kek4 and kek5 (c) or rk and 
wgn mutations (d) are shown. Survival indices of double mutants are compared to single 
receptor mutants (black stars; χ2 with Bonferroni correction) and single DNT mutations (red 
stars; χ2 with Bonferroni correction). See Table 3.1 for full genotypes and raw data, and 
Appendix I for statistical values.
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Table 3.1  DNT–dLIG survival assays, Raw data, 18⁰C experiments 
Abbreviation Progeny of n Tb– Tb+ Survival index 
DNT1-/- DNT141/TM6B 446 341 105 0.616 
DNT2-/- DNT2e03444/TM6B 657 568 89 0.313 
DNT1-/-DNT2-/- DNT141DNT2e03444/TM6B 494 493 1 0.004 
lbk-/- lbkGS50104;+/SM6aTM6B 186 137 49 0.715 
lbk-/-;DNT1-/- lbkGS50104;DNT155/SM6aTM6B 424 424 0 0.000 
lbk-/-;DNT2-/- lbkGS50104;DNT2e03444/SM6aTM6B 316 316 0 0.000 
kek3-/- kek3f07029;+/SM6aTM6B 184 145 39 0.538 
kek3-/-;DNT1-/- kek3f07029;DNT155/SM6aTM6B 182 169 13 0.154 
kek3-/-;DNT2-/- kek3f07029;DNT2e03444/SM6aTM6B 294 231 63 0.545 
kek4-/- kek4f05454;+/SM6aTM6B 158 129 29 0.450 
kek4-/-;DNT1-/- kek4f05454;DNT155/SM6aTM6B 93 93 0 0.000 
kek4-/-;DNT2-/- kek4f05454;DNT2e03444/SM6aTM6B 189 188 1 0.011 
kek5-/- kek5e02482;;+/TM6B 177 138 39 0.565 
kek5-/-;;DNT1-/- kek5e02482;;DNT155/TM6B 537 428 109 0.509 
kek5-/-;;DNT2-/- kek5e02482;;DNT2e03444/TM6B 194 191 3 0.031 
rk-/-;DNT1-/- w;rk4;DNT155/SM6aTM6B 166 148 18 0.243 
rk-/-;DNT2-/- w;rk4;DNT2e03444/SM6aTM6B 233 203 30 0.296 
wgn-/- pBacwgne00637;;+/TM6B 408 308 100 0.649 
wgn-/-;;DNT1-/- pBacwgne00637;;DNT155/TM6B 280 229 51 0.445 
wgn-/-;;DNT2-/- pBacwgne00637;;DNT2e03444/TM6B 400 325 75 0.462 
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The lambik allele P[GSV2]GS50104 (hereafter lbk–) caused partially reduced embryonic 
viability. lbk mutants were homozygous lethal in combination with mutations of either DNT1 
or DNT2 (Figure 3.11b). Both combinations were statistically significant compared to lbk–/– 
(black stars; χ2 with Bonferroni correction applied in all S.I. cases) and to the respective single 
DNT mutation (red stars). 
Single kek3f07029, kek4f05454 or kek5e02482 mutations (hereafter kek3–, kek4–, kek5–) partially 
impaired viability (Figure 3.11c). Compared to kek3–/– single mutations, kek3DNT1 double 
mutants resulted in viability being further reduced. Furthermore, compared to single DNT1–/– 
mutants, kek3DNT1 double mutants had reduced viability. kek4DNT1 and kek4DNT2 double 
mutants were homozygous lethal and significantly different compared to single receptor and 
single DNT mutations. kek5DNT2 double mutants were semi-lethal and significantly different 
from kek5–/– and DNT2–/– single mutants. This suggested specific interactions between kek3–5 
and the DNTs, discussed below. 
Combinations of the rickets allele rk4 (hereafter rk–) with DNT alleles also reduced viability. 
However, there was no difference between the two combinations (Figure 3.11d). Similarly, 
although combinations of wengene00637 (hereafter wgn–) and the DNTs partially reduced 
viability compared with single receptor mutants, no difference was observed between the 
combinations. Survival indices of wgnDNT combinations were not significantly different 
from either wgn–/– mutants alone or the single DNT mutation. 
3.2.2.2 kek3 and kek4 interact with DNTs to effect locomotion phenotypes 
Mutant alleles of toll6 and toll7 cause motor axon and locomotion phenotypes (McIlroy et al., 
2013). Additional putative receptors could have related or reciprocal phenotypes, depending 
on their ligand and whether they have functions in activating, inhibiting or modulating 
signalling.  
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In Drosophila, involuntary locomotion behaviour is controlled by rhythmic firing within the 
motor circuit, which can persist in an uncoordinated fashion in the absence of sensory input 
(Brown, 1911, Wilson, 1961, Glanzman, 2010, Suster and Bate, 2002). Locomotion can be 
measured by a number of assays. Climbing assays, as well as horizontal phototaxis, smell or 
taste chemotaxis assays require minimal setup, but results vary significantly between trials 
and measure only voluntary behaviour, thus requiring central processing of stimuli — indeed, 
these assays are used to assess neurodegeneration in fly disease models (Barone and 
Bohmann, 2013, Feany and Bender, 2000, Nichols et al., 2012, Vang et al., 2012). Data of 
involuntary locomotion and movement in response to stimuli can be obtained en masse using 
systems that record adult movement as it interrupts an infrared beam (Chiu et al., 2010, 
Dimitrijevic et al., 2004, Parr et al., 2001), but data output is binary.  
Tracking software can determine single fly location or track multiple flies simultaneously to 
yield custom parameter data (Branson et al., 2009, Diaper et al., 2013, Donelson et al., 2012, 
Humphrey et al., 2012, Kabra et al., 2012, Simon and Dickinson, 2010). Here, an inexpensive 
setup was used to record single receptor or receptor–DNT double mutant adults walking 
around a Petri dish. Flies were tracked and trajectories quantified using the FlyTracker ImageJ 
plugin (McIlroy et al., 2013), a modification of the MTrack2 ImageJ plugin (Hand et al., 
2009) that tracks migrating cells. FlyTracker provided distance, moving speed, resting and 
wobbling data from individual films of flies (McIlroy et al., 2013, Sutcliffe, 2010). The 
method was used to identify dLIG–DNT interactions, rather than mechanisms of receptor 
function. 
All single DNT and receptor mutations caused a decrease in total distance and speed travelled. 
DNT2–/– mutants had a more pronounced locomotion phenotype than DNT1–/– (Figure 3.12).  
With regards to moving speed, kek3–/–DNT1–/– and kek3–/–DNT2–/– double mutants travelled 
faster than kek3–/– single mutants (Figure 3.12b). Furthermore, the moving speed variation 
Figure 3.12  dLIGs interact with DNTs to induce locomotion phenotypes
Adult single and double mutant ies were lmed walking around a Petri dish and their 
trajectory parameters quantied. a | Example trajectories of control (yw) and mutant 
genotypes. b | Speed histograms of double receptor-ligand mutants compared with single 
receptor mutants. Statistics shown compare double mutants. Frame numbers, full genotypes 
and statistical values are shown in Appendix I. c-e | DNT1 and DNT2 mutations interact 
dierently with kek3 and kek4 mutations in the context of total distance travelled (c), time 
spent resting (d) and wobbling (e). Total lm numbers are shown for each genotype in c; 
frame numbers for wobbling and resting calculations are shown in Appendix I. Statistics 
compare double mutants against single mutants (black stars) and double mutants against 
single DNT mutations (red stars).
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between these two double mutants was significant, indicating specificity in ligand–receptor 
interactions (Kruskal-Wallis with Dunn’s post hoc; see Appendix I for statistical values). 
Similarly, kek4–/–DNT1–/– and kek4–/–DNT2–/– double mutants displayed significantly different 
speed behaviours from each other. kek4–/–DNT1–/– double mutants walked slower, and kek4–/–
DNT2–/– double mutants travelled faster, than kek4–/– single mutants. Differences in moving 
speed variation were not observed between kek5–/–DNT1–/– and kek5–/–DNT2–/– double 
mutants. 
In accordance with speed results, kek3–/–DNT2–/– double mutants travelled further than kek3–/– 
single mutants (Figure 3.12c; Student’s t-test with Bonferroni correction applied in all cases). 
Furthermore, kek3–/–DNT1–/– and kek3–/–DNT2–/– travelled significantly different distances 
compared to one another, indicating ligand specificity. kek4–/–DNT1– and kek4–/–DNT2–/– 
displayed opposite distance phenotypes. kek4–/–DNT1–/– double mutants travelled less far than 
kek4–/– single mutants. Conversely, kek5–/–DNT1–/– and kek5–/–DNT2–/– double mutants did not 
display different distance phenotypes compared to one another or to kek5–/– single mutants. 
kek4–/–DNT1–/– double mutants had the strongest phenotype of all genotypes tested (Figure 
3.12a). The interaction of kek4–/– and DNT1–/– produced flies that rested much more than 
single receptor mutants (Figure 3.12d; χ2 with Bonferroni correction in all cases).When 
moving, kek4–/–DNT1–/– double mutants wobbled extensively (Figure 3.12e; χ2 with 
Bonferroni correction in all cases). kek3–/–DNT1–/– adults also wobbled more than kek3–/–
DNT2–/– double mutants and kek3–/– single mutants. It is possible that wobbling data may have 
skewed speed data, which could account for the conflicting conclusions that kek3–/–DNT1–/– 
double mutants travelled faster, but less far, than kek3–/– single mutants. Indeed, time spent 
resting by kek3–/–DNT1–/– adults was comparable to kek3–/–. Conversely, kek3–/–DNT2–/– 
double mutants rested significantly less than single receptor mutants (Figure 3.12c).  
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For all four locomotion variables, kek3–/–DNT1–/– double mutants behaved differently to kek3–
/–DNT2–/–, and kek4–/–DNT1–/– double mutants behaved differently to kek4–/–DNT2–/– double 
mutants. Results suggested an interaction between kek3– or kek4– with DNT1 alleles in the 
control of locomotor behaviour. 
3.3 DISCUSSION 
In this chapter, experiments showed that the kek family and CG15744 are expressed in the 
CNS; whereas lambik and CG16974 are absent from the CNS but present in the PNS. Of the 
other genes tested, rickets was detected weakly in the VNC and more strongly in the brain, 
CG17839 was localized to a low number of specific CNS cells, and wengen was expressed in 
glia of early embryos, the trachea and a low number of VNC cells. 
My data concur with the published expression patterns of kek1 localization (Derheimer et al., 
2004, Ghiglione, 2003, Ghiglione et al., 1999, Musacchio and Perrimon, 1996). Further kek1 
signal in midline cells was detected in some samples (Figure 3.5m). Loss of kek1 leads to 
dorsalized egg shells (Zartman et al., 2009). Furthermore, Kek1 upregulation antagonizes 
EGFR signalling to induce ventralized embryos (Ghiglione et al., 1999); in this respect, the 
role of Kek1 resembles Spz–Toll signalling, as gain of function spz and toll alleles also 
produce ventralized embryos (Anderson et al., 1985, Morisato and Anderson, 1994). The 
dorsal localization of kek1 in early embryos observed here confirms that kek1 has a role in the 
establishment of polarity (Figure 3.5g), and the presence of kek1 mRNA in the dorsal embryo 
warrants further investigation. Last, the possible detection of kek1 in cardioblasts suggests a 
further function of the gene outside of the nervous system. 
kek2 mRNA localization concurred with published expression data. Furthermore, kek2 
expression was detected in a segmentally repeating 4 cell pattern along the VNC. This pattern 
resembles aCC/RP2 or pCC/RP2 pioneer motor neuron pairings (Hidalgo and Brand, 1997, 
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Sanchez-Soriano and Prokop, 2005). Therefore, the role of kek2 in motor neuron development 
could be investigated. 
There are restrictions to interpretation inherent in the use of the Gal4/UAS system. First, the 
further away from the start codon a Gal4 element is inserted, the lower the likelihood it is 
positioned in the promoter of the gene of interest. At 22kb upstream of the kek3 coding 
sequence and 112kb upstream of kek5, the expression profiles driven by 
Mi[ET1]CG15256MB09797 and P[GawB]NP5933 should be interpreted as not fully 
representative of kek3 or kek5 localization (Figure 2.8). The expression profile of kek3 had not 
previously been reported, and cell-specific expression of kek5 in the CNS was unknown. 
Putative kek3Gal4-driven reporter was detected in the optic lobe and in glia that surround the 
neuropil and central brain. Given the detection of putative kek3Gal4 in the optic lobe, larval 
photoreceptor axon guidance would be the ideal place to start in the analysis of kek3 function. 
Genetic stocks combining kek3 null mutants and roTaulacZ have been generated for this 
purpose. Putative kek5Gal4 data suggest that kek5 is present in axons of the longitudinal axon 
tract, commissures, motor neurons and the PNS. Furthermore, kek5 may be expressed in large 
cell clusters throughout the larval central brain.  
Both putative kek3 and kek5 expression were determined here using the same reporter line, 
and similarities in larval VNC and optic lobe signal were detected between the two genes. To 
exclude signal noise caused by the reporter, expression results should be separately verified 
by antibody labelling and/or in situ hybridisation. Nonetheless, the putative kek3 and kek5 
Gal4 results using the UASmyrTOMATO reporter did show gene-specific expression — kek3 
in the centre of the larval optic lobe, and kek5 in the embryonic VNC and PNS clusters. 
The remaining candidate genes had interesting expression profiles, between them displaying 
expression in the PNS and glia. However, the abundant expression of the kek genes 
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throughout the CNS made them the more important candidates for further study, subject to 
interaction with the DNTs. 
The S.I. assay indicates that DNT1 and DNT2 may be redundant (Figure 3.11a; Zhu et al. 
(2008)). The difference in the effect of DNT mutant allele combinations with kek3–, kek4– and 
kek5– highlighted potential specificities of receptor–ligand interactions. If the assumption is 
made that Kek receptors interact with specific DNT ligands, the redundancy of DNT1 and 
DNT2 suggests that the loss of DNT1 and its Kek receptor should be viable, because 
neurotrophin signalling can still occur via DNT2 and a different Kek. Conversely, the loss of 
DNT1 and the Kek that might bind DNT2 will increase lethality in the S.I. assay because both 
pathways have been interrupted. By this model, data here suggest that Kek3 protein may bind 
DNT2, Kek5 protein may bind DNT1, and Kek4 protein bind either DNT1 or DNT2. Of note 
also is the Lambik protein, which may bind DNT1 or DNT2. 
The phenotypic effect of these genetic combinations was determined by locomotion assay. 
Again, kek3–/–DNT1–/– and kek4–/–DNT1–/– double mutants displayed enhanced phenotypes 
compared to single mutations, further suggesting that the Kek3 and Kek4 proteins may 
interact with DNT2.  
Two points should be considered regarding the locomotion data. First, the n numbers of kek3–
/–DNT1–/– and kek4–/–DNT1–/–, which exhibit prominent phenotypes, are low. This resulted 
from the strong homozygous lethality of these genotypes (Figure 3.11). kek3–/–DNT1–/– and 
kek4–/–DNT1–/– were viable at 25⁰C, but lethality remained high and flies were difficult to 
breed. By contrast, lbk–/–DNT1–/– and lbk–/–DNT2–/– homozygous flies were lethal at 25⁰C, and 
could not be tested by the locomotion assay. It is possible that higher n numbers would dilute 
these results, although traces do suggest a behavioural phenotype was induced. 
Second, adult flies may not have been the most suitable developmental stage to study 
locomotion. Adult gene expression was not studied, so it is not possible to compare kek+ 
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embryonic and adult cell types, nor whether embryonic expression is maintained through to 
adulthood. The larval nervous system is extensively remodelled during metamorphosis; thus, 
the effect on the adult locomotor circuit of a mutation in a gene required in the embryo is 
undefined and not possible to deduce (Tissot M and RF, 2000, Truman, 1990). The effect of 
genetic interactions on locomotion behaviour is more reliably translated to embryonic 
expression when studied in larvae, a method adopted in later chapters. However, the purpose 
of the locomotion assay in this chapter was not to link embryonic expression to adult function 
but to test whether the kek genes interact with the DNTs. To this end, Kek3 and Kek4 
interactions with DNT2 were suggested. 
The positions of the P element transposon insertion lines are shown in Figure 2.8. It is unclear 
how significant the genetic interactions observed were, since the phenotypic effect of the 
mutations was unknown. Nonetheless, distinct interactions were observed with the DNTs, 
indicating indirect or direct receptor–ligand specificity. Such interactions need to be 
confirmed using null mutants and overexpression constructs in which the nature of the alleles 
is known. The purpose of this chapter was to identify candidate genes for further study; in 
Chapters 4 and 5 the generation of overexpression constructs and null mutants is discussed.  
Based on initial criteria, the Kek family were selected for further study: they were expressed 
in the CNS; kek3–, kek4– and kek5– interacted genetically with specific DNTs; and kek3– and 
kek4– interacted with DNT1– to manifest behavioural phenotypes. The remaining candidates, 
although interesting, were excluded. The most promising remaining candidate for further 
study was lbk, which interacted genetically with both DNTs. Lbk function is not considered 
further in this thesis, but should be investigated further in future work in the context of PNS 
functions of the DNTs. 
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CHAPTER 4 
GAIN OF FUNCTION ANALYSIS REVEALS KEK  
INTERACTIONS WITH THE DNTS 
 
4.1 INTRODUCTION  
To study the function of the kek genes, overexpression and loss of function tools needed to be 
built. This chapter focuses on the generation of overexpression tools for kek1–6 for use in cell 
culture and in vivo, and to assay putative Drosophila neurotrophin (DNT)–Kek interactions. 
There are a number of methods to create overexpression constructs for activated receptors. 
One option is to mutagenize key amino acids required for ligand-specific activation. In the 
case of the Toll10b allele, for example, a Cys–Tyr substitution in the juxtamembrane cysteine-
rich region releases receptor autoinhibition, a function that is usually ligand-dependent 
(Schneider et al., 1991, Hu, 2004). Another option is to delete the entire ligand-binding region 
to release the requirement of ligand for activation, as is the case for Toll∆LRR (Winans and 
Hashimoto, 1995). However, because the Kek proteins lack intracellular signalling domains, 
the mechanism of signalling, the key intracellular residues for signalling, and whether the 
proteins dimerize or interact with a co-receptor, are all unknown. As such, the region of the 
protein to target by point mutation or peptide deletion was unknown. Instead, wild type, full 
length forms were cloned.  
The resulting overexpression constructs may not induce activity alone except by membrane 
saturation and ectopic dimerization. However, TrkA can exist as an inactive, preformed dimer 
in cell culture (Shen and Maruyama, 2011); thus ectopic Kek6 dimerization might still require 
ligand or point mutation to signal. Nevertheless, others have used overexpression of wild type 
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forms, e.g. of the Tolls, resulting in gain of function phenotypes (for example, Yagi et al. 
(2010)). 
Putative receptor–ligand interactions can be tested biochemically, as in the case of Toll7 and 
Toll6 with DNT1 and DNT2 (McIlroy et al., 2013), or functionally, as in the case of 
Jellybelly (Jeb) and ALK (Englund et al., 2003). Mutation of a receptor may phenocopy loss 
of the ligand (for example, mesodermal disorganization in jeb and ALK mutants (Englund et 
al., 2003) or developmental delays induced by prothoracicotropic hormone (PTTH) and torso 
mutants in the PG (Rewitz et al., 2009)). Alternatively, receptor and ligand mutations may 
have reciprocal phenotypes owing to the release of an endogenous inhibitory function (for 
example, BDNF)-mediated inhibition of RhoGTPase signalling via release of RhoGDI 
sequestration by TrkB.T1 (Ohira et al., 2005)). A simple readout of functional interactions can 
be determined in cell culture by quantifying signalling of expressed receptors in response to 
ligand stimulation. To this end, here, Kek≡Toll6 chimaeras were generated for use in cell 
culture. Chimaeric proteins have been used previously to determine interactions or signalling 
ability of transmembrane receptors lacking signalling domains (Alvarado et al., 2004a, 
Ormond et al., 2004). In this chapter, the intracellular domain of Toll6 was chosen because it 
signals via NFκB.  
4.2 RESULTS 
4.2.1 Molecular cloning of kek genes into pAct5c and UAS vectors 
The coding sequences of kek1–6 were amplified by PCR from cDNA libraries, genomic 
clones or RT-PCR from larval and pupal tissue (see Appendix II for maps and supporting 
data). Amplified coding sequences were recombined into pDONR221 and verified using 
restriction digests. pDONR+kek1–6 entry clones were further recombined with pAct5c-attR-
mCFP (pAWC) and verified by restriction digests and sequencing (Appendix II; 5′ and 3′ 
fragment ends are shown; no mutations or nucleotide omissions were detected throughout the 
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fragments). Since the destination insert sequence was correct, the pDONR221 insert sequence 
was also correct and therefore pDONR+kek1–6 could be used for further cloning. actin 
promoter-driven expression of kek genes in S2 cells revealed outer membrane-localised 
expression of Kek2–6, indicating that the constructs were correctly processed (Figure 4.1). 
Sites of receptor enrichment at sites of cell–cell contact were detected for Kek2, Kek3 and 
Kek6 (arrows). 
pDONR+kek1–6 entry clones were used to further recombine the kek genes into pAct–attR–
FLAG (pAWF) for use in cell culture (Appendix II, verified by restriction digests), and 
pUASt–attR–mRFP (pTWR) for fly transgenesis (Appendix II, verified by restriction digests 
and PCR). 
4.2.2 Phenotypic analysis of kek overexpression mutants 
Overexpression of the EGFR antagonist kek1 in the eye, using the GMRGal4 driver, induces a 
rough eye phenotype (Alvarado et al., 2004b). The mode of function of other kek genes is 
unknown. To ascertain whether other kek genes might share the same signalling properties as 
kek1s, and whether to investigate kek2-6 signalling via EGFR,UASkek1RFP–UASkek6RFP 
(kek1–6+pTWR; hereafter UASkek1–UASkek6) were overexpressed in the eye and flies were 
inspected for rough eye phenotypes. GMRGal4-driven expression of UASkek1 resulted in a 
rough eye phenotype (Figure 4.2). GMRGal4>UASkek2–6, conversely, did not induce eye 
phenotypes. This suggested that the different kek genes activate different signalling pathways 
or bind specific co-receptors. This agrees with Alvarado et al. (2004a), which finds that Kek1 
is the only family member involved in EGFR signalling.  
The double mutant DNT2e03444DNT141 is semi-lethal at 18⁰C when balanced over TM6B (no 
DNT2–/–DNT1–/– progeny survive to pupation; see Chapter 3.2.2.1). At 25⁰C, DNT2–/–DNT1–/– 
homozygotes have a S.I. of 0.02 (Table 4.1). Neuronal expression of UASkek2, UASkek3 and 
UASkek6 in a double DNT mutant background rescued this lethality (Figure 4.3; χ2 analysis 
Kek2
Kek3
Kek4
Kek5
Kek6
Figure 4.1  Overexpression constructs target the cell membrane in S2 cells
kek2-6+pAWC constructs were expressed in S2 cells and uorescently stained with anti-GFP. 
mCFP would be detected at the cell membrane for each construct, suggesting that constructs 
had been correctly processed. Enrichment of protein at sites of intercellular contact is highlighted 
with an arrow. Scale bar, 10µm.
kek1 kek2 kek3
kek4 kek5 kek6
Figure 4.2  kek1 overexpression induces a rough eye phenotype
Transgenic UASkek1-6 constructs were overexpressed in the eye using GMRGal4. Of these, 
GMRGal4>UASkek1RFP induced a rough eye phenotype, whereas the other transgenic kek 
constructs displayed no abnormal eye phenotype.
27
0
43
1
37
6
17
1
16
8
20
9
16
0
27
6
26
2
28
3
19
5
19
3 52 31
3
D
N
T2
-/
- D
N
T1
-/
-
Su
rv
iv
al
 In
de
x
D
N
T2
-/
- D
N
T1
-/
- e
la
vG
al
4
U
AS
ke
k1
U
AS
ke
k2
U
AS
ke
k3
U
AS
ke
k4
U
AS
ke
k5
U
AS
ke
k6
U
AS
ke
k1
U
AS
ke
k2
U
AS
ke
k3
U
AS
ke
k4
U
AS
ke
k5
U
AS
ke
k6
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
* ***
Controls elavGal4
*** ns
wt
******
DNT2-/-DNT1-/-DNT2-/-DNT1-/-
Figure 4.3  kek gene overexpression rescues lethality in DNT mutants
Survival index of UASkek1-6 constructs alone and driven by elavGal4 in a DNT2e03444DNT141/TM6B
background at 25ºC was calculated. Neuronal overexpression of kek2, kek3, kek5 and kek6 rescued 
the lethality of homozygous DNT double mutations. Wild type viability is indicated by the red line. 
Statistics compare genetic rescues with DNT2-/-DNT1-/-elavGal4 (black stars). See Table 4.1 for 
full genotypes and raw data, and Appendix I for statistical values.
Table 4.1  kek overexpression rescues DNT2-/-DNT1-/- lethality, Raw data, 25⁰C 
experiments 
Abbreviation Progeny of n Tb– Tb+ Survival index 
DNT2-/-DNT1-/- DNT2e03444DNT141/TM6B 270 267 3 0.02247191 
DNT2-/-DNT1-/-elavGal4 DNT2e03444DNT141elavGal4/TM6B 431 428 3 0.014018692 
DNT2-/-DNT1-/-      
    UASkek1 UASkek1RFP; DNT2e03444DNT141/SM6aTM6B 376 374 2 0.010695187 
    UASkek2 UASkek2RFP; DNT2e03444DNT141/SM6aTM6B 171 171 0 0 
    UASkek3 UASkek3RFP; DNT2e03444DNT141/SM6aTM6B 168 168 0 0 
    UASkek4 UASkek4RFP; DNT2e03444DNT141/SM6aTM6B 209 208 1 0.009615385 
    UASkek5 UASkek5RFP; DNT2e03444DNT141/SM6aTM6B 160 159 1 0.012578616 
    UASkek6 UASkek6RFP; DNT2e03444DNT141/SM6aTM6B 276 276 0 0 
DNT2-/-DNT1-/- 
elavGal4>      
    UASkek1 DNT2e03444DNT141elavGal4/TM6B  x 
UASkek1RFP; DNT2e03444DNT141/SM6aTM6B 262 252 10 0.079365079 
    UASkek2 DNT2e03444DNT141elavGal4/TM6B  x 
UASkek2RFP; DNT2e03444DNT141/SM6aTM6B 283 176 107 1.215909091 
    UASkek3 DNT2e03444DNT141elavGal4/TM6B  x 
UASkek3RFP; DNT2e03444DNT141/SM6aTM6B 195 154 41 0.532467532 
    UASkek4 DNT2e03444DNT141elavGal4/TM6B  x 
UASkek4RFP; DNT2e03444DNT141/SM6aTM6B 193 187 6 0.064171123 
    UASkek5 DNT2e03444DNT141elavGal4/TM6B  x 
UASkek5RFP; DNT2e03444DNT141/SM6aTM6B 52 45 7 0.311111111 
    UASkek6 DNT2e03444DNT141elavGal4/TM6B  x 
UASkek6RFP; DNT2e03444DNT141/SM6aTM6B 313 182 131 1.43956044 
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with Bonferroni correction in all cases; see Appendix I for statistical values). Conversely, 
neuronal expression of UASkek1 and UASkek4 did not rescue this lethality. The S.I. of DNT2–
/–DNT1–/–neurons>UASkek5 flies was increased compared to DNT1–/–DNT2–/– double 
mutants, but the observed n number was low; it is thus likely that with a larger sample size, 
viability would be more apparent. The ability of kek3 overexpression to rescue DNT2–/–DNT1–
/– lethality matches its genetic interaction with DNT2 shown in Chapter 3.  
4.2.3 DNT2 can interact with Kek≡Toll6 chimaera receptors to induce NFκB signalling 
DNT1 and DNT2 binding to full length Toll6 induces nuclear localization of the NFκB 
homologue Dif (McIlroy et al., 2013). In the innate immune response to fungal infection, Spz 
binding to Toll stimulates translation of the peptide Drosomycin via Dif nuclear localization 
(Manfruelli et al., 1999, Meng et al., 1999, Hu, 2004, Zhang and Zhu, 2009). S2 cells stably 
transfected with a drosomycin promoter–luciferase coding sequence fusion construct provide 
a means to quantify stimulation of drosomycin expression, and thereby upstream Spz–Toll 
and DNT–Toll6 receptor activation, by measuring luminescence (Tauszig et al., 2000, 
McIlroy et al., 2013, Weber et al., 2003). Potential DNT–Kek interactions were tested by 
measuring luminescence of drosomycin-luciferase S2 cells expressing Kek≡Toll6 chimaeras 
and stimulated by DNT1 and DNT2 (purified according to Arnot et al. (2010)) or DNT2 
produced using the Baculovirus system (McIlroy et al., 2013). 
First, Kek≡Toll6 chimaeras were cloned for use in cell culture. Kek3, Kek4, Kek5 and Kek6 
ectodomains and Toll6 intracellular regions were amplified by PCR (see Appendix II). kek1 
and kek2 mutants are embryonic lethal (Musacchio and Perrimon, 1996), and thus no data 
could be obtained to indicate putative kek1/2–DNT interactions in Chapter 3. It was decided to 
focus on kek3–kek6, for which a complete data set could be obtained, and for which few data 
have been published. Kek3, Kek4, Kek5, Kek6 and Toll6 fragments were ligated, recombined 
into pDONR221 and confirmed by restriction digests (see Appendix II for maps and supporting 
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data). Entry clones were subsequently recombined into the destination vector pAct5c-attR-
3xHA (pAWH) and confirmed by restriction digests and sequencing. No mutations or 
nucleotide omissions were detected in the chimaera sequences. 
48 hours post-transfection, Kek3≡Toll6, Kek4≡Toll6, Kek5≡Toll6 and Kek6≡Toll6 chimaeras 
were detected at the cell membrane of S2 cells, thus indicating that the proteins were 
processed normally (Figure 4.4a). V5-tagged constructs used to synthesize full length DNT1 
pro-domain, CysKnot and C-terminal domain, and DNT2 pro-domain (subsequently cleaved 
in cell culture) and CysKnot, from 6-well plates of seeded S2 cells, were a gift from Graham 
McIlroy (Hidalgo laboratory; Figure 4.4b): pro-domains of both proteins were cleaved in cell 
culture, as verified by Western blot (Figure 4.4c). Stimulation of chimaera-expressing cells 
with DNT1 and DNT2 produced and purified from S2 cell culture induced an increase in 
luciferase activity in positive controls — S2 cells transfected with pAct-Toll6 (full length 
Toll6) — compared to cells transfected with a blank pDONR221 plasmid (Figure 4.5a,b, all 
results were normalized against pActin-renilla luciferase luminescence). For all statistical 
values, see Appendix I. 
Although stimulation with DNT1 in PBS induced a significant increase in luciferase activity 
in S2 cells transfected with Kek3≡Toll6, Kek4≡Toll6 and Kek6≡Toll6 chimaeras compared to 
the blank plasmid control (Figure 4.5a, black labels; Student’s t-test with Bonferroni 
correction applied in all cases; see Appendix I for statistical values), this increase was not 
significant compared to the chimaeras with PBS alone (red labels). Similarly, addition of 
DNT2 in PBS induced a significant increase in luciferase activity in S2 cells transfected with 
Kek3≡Toll6, Kek4≡Toll6 and Kek6≡Toll6 chimaeras only when compared to the blank 
plasmid control (Figure 4.5b; black stars), not when compared to chimaeras overexpression 
alone (red labels). This indicated that chimaera overexpression was sufficient to increase 
endogenous NFκB signalling, perhaps by ectopic dimerization of Toll6 Toll/Interleukin-1 
receptor (TIR) domains. 
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Figure 4.4 KekΞToll6 chimaeras localize to the cell membrane
a | HA-tagged kek3-6Ξtoll6 chimaeras were transfected into S2 cells and uorescently labelled with 
anti-HA.  Translated chimaeras were distributed at the cell membrane 48 hours after transfection. 
Kek6 images are a composite of 4 dierent cells. Scale bar, 10µm. b | pAct5c-DNT1/2 construct models, 
showing the proteins produced by translation, including protein sizes, His/V5 tags and TEV site for 
articial pro-domain cleavage. Both DNT1 and DNT2 spontaneously cleaved in S2 cells and TEV cleavage 
was unnecessary. Constructs were driven by an actin promoter. c | Protein puried according to the 
method in Chapter 2.4.1 was veried by dot blot analysis and Western blot using anti-V5. SP, signal 
peptide. 
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Figure 4.5  DNT2 can interact with KekΞToll6 chimaeras to induce NFκB signalling
S2 cells stably transfected with drosomycin-luciferase and transiently transfected with 
kekΞtoll6 chimaera constructs were stimulated (+) by DNT1 or DNT2 produced by small scale DNT 
culture from S2 cells (a,b) or Baculovirus (c). Unstimulated controls were treated with PBS (-).
Luciferase activity was measured by luminescence upon addition of DualGlo substrate.  a,b | S2 
cell-produced DNT1 and DNT2 stimulation induced an increase in signalling by Kek3, Kek4 and 
Kek6 chimaeras compared with untranfected controls (black stars) but not with unstimulated 
transfected controls (red stars). c | Baculovirus DNT2 stimulation induced a notable increase in signalling 
by all chimaeras compared with untranfected controls and with unstimulated transfected controls. 
Kek3ΞToll6 and Kek6ΞToll6 chimaera signalling exceeded that of full length Toll6.
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Baculovirus-derived DNT2, by contrast, induced a marked increase in NFκB luciferase 
activity (Figure 4.5c, note the increased order of magnitude compared with Figure 4.5a,b). 
DNT2 stimulation induced a two–three-fold increase in luciferase activity in all chimaeras 
compared to the blank plasmid control (black stars). DNT2 stimulation also triggered a 
significant increase in signalling in all chimaeras compared to chimaera upregulation alone 
(red stars). The greatest increase in activity was shown by Kek3≡Toll6, which had a 78-fold 
increase in luciferase activity. Furthermore, both Kek3≡Toll6 and Kek6≡Toll6 had increased 
activity compared to Toll6 upregulation alone. This suggested that Kek3 and Kek6 can signal 
upon binding DNT2. 
The different responses to the two sources of DNT may reflect differences in ligand folding or 
sensitivity caused by their methods of production. The pro-domain was cleaved from both 
proteins in S2 cell culture, a step that is required for signalling (DeLotto and DeLotto, 1998, 
McIlroy, 2011). However it is unknown whether S2 cell produced DNTs are correctly folded 
(Arnot et al., 2010). The Baculovirus system, by comparison, uses insect cells to generate and 
fold proteins prior to secretion.  
4.3 DISCUSSION 
In this chapter, I cloned the coding sequence of the six Kek family members into Gateway 
entry vectors, and subsequently into pAct5c-attR-FLAG (pAWF), pAct5c-attR-mCFP (pAWC) 
and pUASt-attR-mRFP (pTWR) for use in cell culture and for transgenesis.  
Next, I cloned Kek≡Toll6 chimaeras comprising the extracellular (ligand-binding), 
transmembrane and juxtamembrane regions of Kek3–6. Differences in luminescence in cells 
expressing these constructs reflected differences in Dif signalling by the chimaeras in 
response to DNT stimulation. Although the endogenous signalling role of Kek proteins 
remains unknown, these data indicate that DNT2–Kek interactions can induce signalling. 
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S2 cells express Toll family members, but lack many surface proteins present in neurons in 
vivo (Brillet et al., 2010, Tauszig et al., 2000). It was therefore important to compare 
signalling results with pDONR221-transfected cells exposed to DNT stimulation to account for 
endogenous Toll6 signalling. Such signalling could be induced by ligand binding, or ectopic 
dimerization caused by Toll6 ICD overexpression. 
A negative control comprising a blank or absent ectodomain with the Toll6 TIR domain was 
not used. The purpose of the experiment was to determine whether DNT addition could 
induce an increase in signalling by Kek chimaeras. Therefore, of interest was whether a 
difference in signalling could be induced by ligand addition, indicative of a ligand–receptor 
interaction, regardless of whether a basal level of NFκB signalling was induced by negative 
control. Without a ligand-binding site, signalling via a blank negative control would not be 
induced by ligand addition but by Toll6 ICD overexpression, which may result in release of 
signalling autoinhibition via homotypic dimerization or heterotypic dimerization with 
endogenous S2 cell-expressed Toll6. This basal level of signalling was therefore represented 
in the experimental setup by the PBS-induced chimaeras, e.g. in the chimaera+PBS to 
chimaera+DNT comparisons. The effect of DNT addition on endogenous Toll6 signalling was 
accounted for by the pDONR+DNT control. Nonetheless, of note were DNT2 stimulated 
Kek3≡Toll6 and Kek6≡Toll6, which had increased luciferase activity compared to 
Toll6+DNT2, thus greater than the combination of activity induced by endogenous Toll6 and 
by upregulation of the Toll6 TIR domain. 
These results agreed with indications from Chapter 3 that the Kek proteins have roles related 
to the DNTs, and can bind them to induce signalling. In the next Chapter, loss of function 
tools were engineered for further study of this family.  
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CHAPTER 5 
LOSS OF FUNCTION ANALYSIS REVEALS KEK  
INTERACTIONS WITH THE DNTS 
5.1 INTRODUCTION 
In Chapter 3, kek3 and kek4 were identified as potential Drosophila neurotrophin (DNT) 
interacting partners. In Chapter 4, a potential interaction between kek6 and DNT2 was also 
identified. However, the functions of kek6 could not be analysed further, as alleles were 
unavailable. Furthermore, kek3 and kek4 mutants used in Chapter 3 were transposon 
insertions, rather than gene deletions. In this chapter, loss of function mutants for kek3, kek4 
and kek6 were generated by Flippase recognition target (FRT)-mediated null mutagenesis 
according to the protocol in Parks et al. (2004). I determined DNT–kek genetic interactions 
using these alleles and survival assays. Furthermore, behavioural phenotypes of kek3 and kek4 
were quantified. The mutants are then studied in further detail in Chapters 6 and 7. 
Drosophila is ideally suited to genetic manipulation. Deletions can be generated by imprecise 
excision of P elements or chemical mutagenesis (Hummel and Klambt, 2007, Bökel, 2007). 
Excision of transposons by FRT-mediated null mutagenesis requires two FRT-containing 
piggyBac transposons that flank the region of interest, and that are in the correct orientation 
relative to the genome and to each other (Parks et al., 2004). An advantage of this method is 
that it creates a mutation of predictable size in the region of interest. The transposons are 
genetically combined with heat-shock Flippase, and crossed to one another. Heterozygous 
progeny bearing both transposons are subjected to heat shocks to induce recombination 
between the FRT elements, resulting in the break and elimination of the intervening 
sequences and creating a deletion (Figure 2.7). Putative mutants are then balanced to generate 
a stable stock. Recombination success is determined by at least two methods of PCR 
verification: internal genomic PCRs amplify a region internal to the deletion that should be 
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absent in successful recombinants, and two-sided PCR, which amplifies DNA fragments from 
the transposon to the flanking genomic region for each parental transposon (see Methods). 
This protocol is dependent on the availability of suitable transposons: kek3, kek4 and kek6-
flanking transposon lines were available, whereas suitable kek5 transposons could not be 
obtained for the generation of a kek5 null mutant by this method. Results in previous chapters 
identified kek5 as a putative DNT-interacting partner; a kek5 null, kek5fe148, is published, but 
could not be obtained (Evans et al., 2009). Consequently, the role of kek5 was not studied 
further. 
kek3, kek4 and kek6 null mutants were here used to identify and verify DNT–kek genetic 
interactions, as per Chapter 3. This chapter further aimed to identify potential downstream 
components of Kek signalling by means of genetic rescue. Last, null mutants were used to 
determine adult locomotion phenotypes corresponding to total loss of function of kek3 and 
kek4. 
5.2 RESULTS 
5.2.1 Generation of kek3, kek4 and kek6 null mutants by FRT mediated mutagenesis 
I first tried to generate kek3 null mutants using the 5′–3′ parental insertion lines 
PBac[WH]CG15256f04709 (left isolate) and PBac[WH]kek3f07027 (right isolate), which would 
have resulted in a 21 kb deletion (Figure 5.1a). 50 lines were generated using these parental 
transposons and tested by internal genomic PCR and two-sided PCR (Figure 5.2, see 
Appendix III for all lines tested). 42 lines produced an internal kek3 500nt fragment and were 
discarded. 2 lines did not yield an internal kek3 fragment using internal genomic primers. (To 
confirm that the absence of a band was not the result of a poor DNA preparation, the 2 lines 
were tested by internal genomic PCR to the unaffected kek6 CDS. For both lines a 500nt kek6 
fragment was obtained) Two-sided PCR using these lines did not yield expected 200nt bands. 
Thus, the lines were disregarded. The parental line kek3f04709 did not yield an expected 200nt 
Figure 5.1  kek3 mutagenesis
a | piggyBac transposon lines kek3f07029 and kek3f07041 were used to generate a 44kb 
deletion encompassing the entire coding sequence of kek3.  b | Two mutant alleles, kek312 
and kek326 were identied by two-sided PCR. Both lines tested positive for both left and right 
isolate parental transposon elements. c | kek3 deletion was veried in both lines by internal 
genomic PCR. Homozygous kek312 and kek326 ies lacked an internal kek3 fragment. 
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fragment from left isolate two-sided PCR primers, and was therefore deemed to be the cause 
of the unsuccessful mutagenesis. Thus, this method was unsuccessful. 
The generation of an alternative 44 kb deletion between the 3′–5′ parental insertion lines 
PBac[WH]kek3f07029 (left isolate) and pBac[WH]f07041 (right isolate) was attempted (Figure 
5.1a). Parental lines tested positive for two-sided PCR fragments (Appendix III). 108 lines 
were generated by Alicia Hidalgo, of which 54 were tested by myself by two-sided and 
internal genomic PCRs (Figure 5.2). 13 lines tested positive for the left isolate two-sided PCR 
fragment (Figure 5.1b). Of these, 2 lines, kek312 and kek326, further tested positive for the 
right isolate two-sided PCR fragment (Figure 5.1b). kek312 and kek326 were verified as nulls 
by internal genomic PCR using homozygous flies (Figure 5.1c). 
The generation of a 0.9 kb kek4 deletion between the 3′–5′ parental insertion line 
pBac[WH]kek4f05454 (left isolate) and the 5′–3′ parental line pBac[RB]e04257 (right isolate) 
was attempted (Figure 5.3a). I generated 50 lines using these parental transposons and tested 
by PCR (Appendix III, Figure 5.4). No nulls were generated, but parental lines tested positive 
using respective two-sided PCR primersThe protocol was repeated and a further 63 lines were 
generated and tested. 35 lines tested positive for the left isolate two-sided PCR fragment 
(Figure 5.3b). Four of these lines — kek420, kek423, kek442, kek450 — also tested positive for 
the right isolate two-sided PCR fragment (Figure 5.3b). kek420 and kek423 were confirmed as 
successful mutants by internal genomic PCR (Figure 5.3c). 
The generation of a 41.9 kb kek6 deletion between the 5′–3′ parental insertion line 
pBac[RB]e00907 (left isolate) and the 3′–5′ parental line pBac[WH]f05733 (right isolate) 
were attempted (Figure 5.5a). Parental lines tested positive for respective two-sided PCR 
fragments. I generated 50 lines using these parental transposons and tested by PCR (Appendix 
III, Figure 5.4). Two lines —kek634 and kek635 — tested positive for the left isolate two-sided 
PCR fragment (Figure 5.5b). Both of these lines also tested positive for the right isolate two-
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sided PCR fragment (Figure 5.5b). kek634 and kek635 were crossed in trans with 
Df(3R)ED6361 (hereafter Df(kek6)) to test by internal genomic PCR. No internal band could 
be amplified, thereby confirming the lines as mutants (Figure 5.5c). DNA preparation validity 
was confirmed by internal genomic PCR to the unaffected kek3 locus. 
Parental transposon lines chosen for kek3 and kek6 mutagenesis flanked the entire translated 
region of the genes, whereas parental transposon lines for the kek4 deletion exposed some of 
the kek4 coding sequence but deleted the start codon (Figures 5.1, 5.3, 5.5). 
5.2.2 DNT–kek genetic interactions 
When balanced over TM6B and kept at 18⁰C, the viability of single DNT mutant alleles is 
impaired relative to an expected Mendelian S.I. of 1 (Figure 3.11a, Figure 5.6). Under these 
same conditions, the double mutant DNT2e03444DNT141 is homozygous lethal (DNT2–/–DNT1–
/–; see Chapter 3.2.2.1). In Chapter 3, I recreated these conditions and tested the survival of 
single and double mutants of the candidate receptors, using transposon insertion alleles. Here, 
I test the viability of FRT mutagenesis-derived kek3, kek4 and kek6 null mutants. I calculated 
the S.I. for kek312, kek326, kek420, kek423, kek634 and kek635 alleles. Furthermore, I tested the 
viability of DNT–kek double mutants to determine ligand–receptor genetic interactions. Raw 
data and full genotypes are shown in Tables 5.1 and 5.2, statistical values are shown in 
Appendix I. 
At 18⁰C, parental kek312/TM6B flies were crossed and pupal phenotypes of progeny were 
scored. If kek312 were lethal, only heterozygous, Tb- pupae would be observed, whereas a 
viable allele would yield Tb+ (kek312/12) progeny. Using this experimental setup, the single 
alleles kek312, kek326, kek420, kek423 were viable (Figure 5.6a, Table 5.1). In addition, the 
heteroallelic mutants kek312/26 and kek420/23 were viable, as determined by crossing 
kek312/TM6B with kek326/TM6B and kek420/TM6B with kek423/TM6B, and scoring pupal 
phenotypes. Under these same experimental conditions, kek312/12;DNT1–/– and 
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Figure 5.6  kek3 and kek4 interact genetically with the DNTs
Interactions between kek3 and kek4 alleles and DNT alleles were determined using the survival index. 
a | Single receptor mutants are not lethal. b,c | Survival indices of kek3DNT and kek4DNT double mutants 
in homozygosis and heteroallelic combinations are compared. kek3 mutants genetically 
interact with both DNT1 and DNT2, whereas in heteroallelic genotypes, kek4 mutants interact genetically 
with DNT1 alleles only. All parental lines balanced over TM6B and reared at 18ºC. Statistics compare 
double mutants with single receptor mutants (black stars) or with single DNT mutants (red stars). See 
Table 5.1 for full genotypes and raw data, and Appendix I for statistical vaues. Df(DNT1) = Df(3L)Exel6101, 
Df(DNT2) = Df(3L)ED6092.
Table 5.1  kek null allele survival assays, Raw data, 18⁰C experiments 
Abbreviation Progeny of n Tb– Tb+ Survival 
index 
DNT1-/- DNT1
41/TM6B 446 341 105 0.616 
DNT2-/- DNT2
e03444/TM6B 657 568 89 0.313 
DNT1-/-DNT2-/- DNT1
41 DNT2e03444/TM6B 494 493 1 0.004 
kek312/12 kek312;+/SM6aTM6B 41 33 8 0.485 
kek326/26 kek326;+/SM6aTM6B 289 206 83 0.806 
kek312/26 kek312;+/SM6aTM6B x kek326;+/SM6aTM6B 113 82 31 0.756 
kek420/20 kek420;+/SM6aTM6B 77 54 23 0.852 
kek423/23 kek423;+/SM6aTM6B 222 158 64 0.810 
kek420/23 kek420;+/SM6aTM6B x kek423;+/SM6aTM6B 122 85 37 0.871 
      
kek312/12DNT1–/– kek312;DNT155/SM6aTM6B 232 228 4 0.035 
kek326/26DNT1Df(DNT1)/Df(DNT1) kek326;Df(3L)Exel6101/SM6aTM6B 197 197 0 0 
kek312/12DNT2–/– kek312;DNT2e03444/SM6aTM6B 442 442 0 0 
kek326/26DNT2Df(DNT2)/Df(DNT2) kek326;Df(3L)ED6092/SM6aTM6B 350 350 0 0 
kek312/26 
  DNT1–/Df(DNT1) 
 
kek326;Df(3L)Exel6101/SM6aTM6B x 
kek312;DNT155/SM6aTM6B 290 261 29 0.222 
  DNT237/Df(DNT2) kek312;DNT237/SM6aTM6B x 
kek326;Df(3L)ED6092/SM6aTM6B 229 177 52 0.588 
  DNT2–/Df(DNT2) kek312;DNT2e03444/SM6aTM6B x 
kek326;Df(3L)ED6092/SM6aTM6B 85 82 3 0.073 
      
kek420/20DNT1–/– kek420;DNT155/SM6aTM6B 120 114 6 0.105 
kek423/23DNT1Df(DNT1)/Df(DNT1) kek423;Df(3L)Exel6101/SM6aTM6B 157 157 0 0 
kek420/20DNT2–/– kek420;DNT2e03444/SM6aTM6B 333 306 27 0.176 
kek423/23DNT2Df(DNT2)/Df(DNT2) kek423;Df(3L)ED6092/SM6aTM6B 136 136 0 0 
kek420/23 
  DNT1–/Df(DNT1) 
 
kek420;DNT155/SM6aTM6B x 
kek423;Df(3L)Exel6101/SM6aTM6B 433 373 60 0.322 
  DNT237/Df(DNT2) kek423;Df(3L)ED6092/SM6aTM6B x 
kek420;DNT237/SM6aTM6B 47 35 12 0.686 
  DNT2–/Df(DNT2) kek420;DNT2e03444/SM6aTM6B x 
kek423;Df(3L)ED6092/SM6aTM6B 253 185 68 0.735 
      
kek634 kek634/TM6B 482 482 0 0 
kek634/Df(kek6) kek634/TM6B x Df(3R)ED6361/TM6BlacZ 479 263 216 1.643 
kek635 kek635/TM6B 190 187 3 0.032 
kek635/Df(kek6) kek635/TM6B x Df(3R)ED6361/TM6BlacZ 87 64 23 0.719 
kek634/35 kek634/TM6B x kek635/TM6B 392 379 13 0.069 
      
kek634/35 
  DNT1–/Df(DNT1) 
 
kek634Df(3L)ED4342/TM6B x 
DNT141Df(3R)ED6361/TM6B 169 102 67 1.314 
  DNT2–/Df(DNT2) Df(3R)ED6361DNT2e03444/TM6B x 
kek634Df(3L)6092/TM6B 78 61 17 0.557 
  Tie5/Df(Tie) kek634Df(3L)ED4342/TM6B x 
Tie5Df(Q3R)ED6361/TM6B 236 168 68 0.810 
 
Table 5.2  kek null allele survival assays, Raw data, 25⁰C experiments 
 
Abbreviation Progeny of n Tb– Tb+ Survival 
index 
kek634/35 kek634/TM6B x kek635/TM6B 435 400 35 0.175 
kek634/34elavGal4 kek634elavGal4/TM6BlacZ 148 147 1 0.014 
kek634/3424BGal4 kek63424BGal4 401 401 0 0 
UASDNT1CK3′+;kek635/35 UASDNT1CK3'+;kek635/TM6BlacZ 208 207 1 0.010 
UASkek6;kek635/35 UASkek6RFP;kek635/SM6aTM6B 110 110 0 0 
kek634/35 
   elavGal4>UASDNT1CK3′+ 
kek634elavGal4/TM6BlacZ x 
UASDNT1CK3'+;kek635/TM6BlacZ 251 178 73 0.820 
   24BGal4>UASDNT1CK3′+ kek63424BGal4/TM6BlacZ x 
UASDNT1CK3'+;kek635/TM6BlacZ 97 90 7 0.156 
      
kek634/35, elavGal4 
   UASactRho 
kek634elavGal4/TM6B x 
UASRho1V14–E40L;kek635/TM6B 188 158 30 0.380 
   UASactCdc42 kek634elavGal4/TM6B x 
UAScdc42V12;kek635/TM6B 162 130 32 0.492 
   UASkek6 kek634elavGal4/TM6B x 
UASkek6RFP;kek635/SM6aTM6B 245 211 34 0.323 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
 
 84 
kek312/12;DNT2–/– double mutants were lethal (Figure 5.6b). Comparing heteroallelic double 
mutants, viability was reduced in kek312/26;DNT1–/Df(DNT1) and kek312/26;DNT2–/Df(DNT2) double 
mutants compared to kek312/26 (Figure 5.6b, black stars; χ2 with Bonferroni correction in all 
cases — Df(DNT1) is Df(3L)Exel6101, and Df(DNT2) is Df(3L)ED6092). Viability was also 
reduced in kek312/26;DNT1–/Df(DNT1) double mutants compared to DNT1–/– (red stars).This 
suggested a genetic interaction between kek3 and DNT1 alleles. 
Homozygous kek420/20;DNT1–/– and kek420/20;DNT2–/– double mutants had reduced viability 
compared to single receptor mutants (Figure 5.6c). Viability of heteroallelic kek420/23;DNT1–
/Df(DNT1) double mutants was reduced compared to kek420/23 (Figure 5.6c; black stars), and 
compared to DNT1–/– (red stars). Conversely, kek420/23;DNT2–/Df(DNT2) and 
kek420/23;DNT237/Df(DNT2) double mutants were viable (Figure 5.6c). This suggested a genetic 
interaction between kek4 and DNT1 alleles. 
The two kek6 null alleles kek634 and kek635 caused embryonic lethality in homozygosis but 
were viable over Df(kek6) (Figure 5.7a; see Appendix I for full genotypes and statistics). 
Heteroallelic kek634/35 single mutants were also lethal. 
The heteroallelic DNT1–/Df(DNT1)kek634/Df(kek6) double mutant was viable (Figure 5.7b). 
Conversely, viability was reduced in DNT2–/Df(DNT2)kek634/Df(kek6) and Tie5/Df(Tie)kek634/Df(kek6) 
double mutants compared with kek634/Df(kek6) (Figure 5.7b; black stars — Df(Tie) is 
Df(3L)ED4342). The tie5 mutant allele was generated by Alice Lowry, in our laboratory, by 
FRT-mediated mutagenesis. This result suggested a genetic interaction between kek6 and 
DNT2, and kek6 and tie. 
At 25⁰C, kek634/35 single mutants were partially viable (Figure 5.7c, Table 5.2). This was 
rescued by neuronal expression of UASDNT1CK3′+, which encodes the DNT1 CysKnot and a 
3′ tail. By contrast, overexpression of UASDNT1CK3′+ at the muscle did not rescue kek634/35 
lethality. Furthermore, kek634/35 lethality was rescued by neuronal expression of activated Rho 
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Figure 5.7  kek6 genetically interacts with DNT2
Interactions between kek6 null alleles and DNT alleles were determined using the survival index. 
a | Single receptor mutants were lethal in homozygosis and in heteroallelic combinations, but were 
viable over the deciency Df(kek6). b | kek6 mutants interacted genetically with DNT2 and Tie to 
reduce viability. kek6DNT1 double mutants were viable.  Statistics compare double mutants with 
single receptor mutants (black stars) or with single DNT mutants (red stars). c | The lethality of 
heteroallelic kek6 loss of function alleles could be rescued by neuronal, but not muscular, 
upregulation of the DNT1 CysKnot and 3’ tail. d,e | The lethality of heteroallelic kek6 loss of function 
alleles could be partially rescued by neuronal upregulation of activated Rho and Cdc42 (d), and by 
neuronal overexpression of kek6 (e). See Tables 5.1-5.2 for full genotypes and raw data, and Appendix I 
for statistical values. Df(kek6) = Df(3R)ED6361, Df(Tie) and Df(DNT1) = Df(3L)ED4342. 
Df(DNT2) = Df(3L)ED6092.
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and activated Cdc42 alleles (Figure 5.7d). kek634/35 lethality was partially rescued by neuronal 
expression of UASkek6 (Figure 5.7e).  
5.2.3 kek3 and kek4 nulls affect locomotion 
To test the function of kek3 and kek4, homozygous kek312/12 and kek420/20 adults were filmed 
as per the locomotion assay used in Chapter 3. kek312 and kek420 alleles were generated in a 
w– background. Both kek312/12 and kek420/20 travelled significantly less far than yw (Figure 
5.8a; One-Way ANOVA with Dunnett’s post hoc, see Appendix I for statistical values). kek3 
and kek4 nulls rested significantly more often than yw (Figure 5.8b; χ2 with Bonferroni 
correction in both cases). When moving, both null alleles wobbled more than yw controls, the 
phenotype strongest in kek420/20 adults (Figure 5.8c; χ2 with Bonferroni correction in both 
cases). The stronger phenotype of kek420/20 adults was reflected by short locomotion traces 
(Figure 5.8d). Both null allele traces revealed that movement of kek3 and kek4 mutant adult 
flies was dramatically reduced compared to yw controls, which walked around the perimeter 
of the Petri dish. Travelling speed histograms reveal that both kek312/12 and kek420/20 flies 
moved at slower speeds far more frequently than yw (Figure 5.8e; Kruskal-Wallis with 
Dunn’s post hoc). 
5.3 DISCUSSION 
In this chapter, I generated null mutant alleles of kek3, kek4 and kek6, with the help of A. 
Hidalgo, by a genetic method that recombines FRT-containing transposons, deleting the 
genomic region in between. Using these mutants, I determined interactions between these 
genes and the DNTs. Potential components in the kek6 signalling pathway were also identified 
using genetics. Last, kek3 and kek4 null adults had locomotion phenotypes.  
Of the Kek family, transposon lines were only available to carry out the genomic deletion of 
kek3, kek4 and kek6 by the Parks et al. (2004) method. Along with the kek1RM2 and kek1RA5 
(Musacchio and Perrimon, 1996), and kek5fe148 alleles (Evans et al., 2009), these new alleles 
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Figure 5.8  kek3 and kek4 are required for adult locomotion
Adult single and double mutant ies were lmed walking around a Petri dish and their 
trajectory parameters quantied. a-c | kek312/12 and kek420/20 mutant ies travel shorter 
distances (a), rest more frequently (b) and wobble more (c) compared with yw controls. 
Total lm numbers are shown for each genotype in a. d | Example trajectories of control (yw) 
and mutant genotypes. e | Speed histograms of mutant ies compared with yw. kek3 and 
kek4 alleles signicantly reduce adult walking speed. Frame numbers, full genotypes and 
statistical values are shown in Appendix I.
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create a set of null mutants for all kek genes, except kek2. kek2 knockdown could be studied 
using available RNAi lines in future studies (Guan et al., 2005). 
kek312, kek326, kek420 and kek423 alleles were viable in homozygosis. Furthermore, each line 
had a comparable effect on lethality. The lower S.I. of kek312;+/SM6aTM6B may be attributed 
to a low sample size.  
It is unclear which S.I. results to focus on among the DNT–kek combinations. In Chapter 3, 
viability was assessed in homozygous single and double mutant progeny — for example, 
kek4f05454/f05454 (kek4–/–) — by crossing parents with the allele balanced over TM6B. In this 
chapter, heterozygous single and double mutant progeny were scored as well as homozygous 
progeny — for example, kek420/23 as well as kek420/20. These revealed that kek312/12;DNT1–/– 
and kek312/12;DNT2–/– double mutants were homozygous lethal. kek420/20;DNT1–/– and 
kek420/20;DNT2–/– double mutants were partially viable in homozygosis. These results confirm 
the findings of Chapter 3, from which Kek3 and Kek4 were thought to bind DNT2. The 
results in this chapter also suggest that Kek3 could interact with DNT1.  
However, conclusions differ when comparing heteroallelic single and double mutants (Figure 
5.6b,c). In these cases, kek312/26;DNT1–/Df(DNT1) and kek312/26;DNT2–/Df(DNT2) double mutants 
had reduced viability. However, kek420/23;DNT2–/Df(DNT2) double mutants were viable. 
Nonetheless, interactions between kek3 and both DNTs, and kek4 and DNT1, agreed with the 
same interactions implied from genetic and locomotion data in Chapter 3. 
Although kek3 and kek4 null alleles were viable in homozygosis, kek634 and kek635 were not. 
However, these lines were viable when crossed with Df(kek6). This suggested that there was 
something in the genetic background of the kek6 parental transposon lines, as opposed to the 
deletion itself, that caused lethality in homozygosis and had been retained throughout the 
mutagenesis protocol. A second possibility is that the genetic discrepancy arose from the third 
chromosome of the parental heat-shock Flippase line used at the G0 generation for kek6 
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mutagenesis. Alternatively, the heat shock-activated Flippase method may have deleted 
additional genomic regions in these lines. 
The viability of kek634 and kek635 over the Df(kek6) deficiency shows that loss of kek6 
function does not affect viability. Therefore, the rescue of kek634/35 by neuronal upregulation 
of Kek6, DNT1 CysKnot, activated Rho and activated Cdc42 could simply result from 
consequences of genetic debris within these lines. It was interesting, nonetheless, that 
neuronal, but not muscular, overexpression of UASDNT1CK3′+ could rescue this phenotype.  
The reduction in viability in DNT2–/Df(DNT2)kek634/Df(kek6) mutants was suggestive of weak 
interactions between Kek6 and DNT1. This will need to be studied by further phenotypic 
analysis and biochemical means. Interactions between Kek6 and Tie, as a co-receptor, were 
not implied, since Tie5/Df(Tie)kek634/Df(kek6) had a nearly wild type S.I.  
Locomotion analyses were not conducted with DNT–kek double mutants. Nonetheless, it was 
interesting to see what phenotypes these mutations alone could cause. Loss of kek3 and kek4 
mutants travelled significantly shorter distances than yw control flies. Consequently, these 
mutants moved slower than controls. Furthermore, kek3 and kek4 mutants rested and wobbled 
more than yw. These results concurred with the phenotypes of transposon lines used in 
Chapter 3. The phenotypes of kek420/20 were more pronounced than those of kek4–/– 
(kek4f05454), although the sample size was small. Because of the problems associated with 
studying adult locomotion behaviour discussed in Chapter 3, locomotion phenotypes in kek3 
and kek4 mutant larvae were studied in Chapter 7. 
kek3, kek4 and kek6 are the least studied Kek family members. Thus, for the rest of this thesis 
I made use of loss and overexpression tools. Experiments focused primarily on kek4 and kek6. 
With these tools it was possible to study the roles of the genes alone, regardless of any context 
with the DNTs, as well as their roles in combination with the DNTs.  
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CHAPTER 6 
KEK6 FUNCTION IN THE CENTRAL NERVOUS SYSTEM 
6.1 INTRODUCTION 
In Chapter 3, kek1, kek2 and kek5 were detected in the embryonic central nervous system 
(CNS). This chapter aimed to: (1) investigate the function of Kek6 in the CNS; (2) test 
functional interactions between Kek6 and the Drosophila neurotrophins (DNTs), (3) and 
investigate potential downstream pathways. To do this, the expression pattern of kek6 was 
analysed by in situ hybridisation and antibody staining. The developmental expression of kek6 
was profiled in the embryonic CNS, in order to test if it could correspond functionally with 
the localisation of DNTs, and motor neurons. modENCODE and FlyAtlas data reveal that 
kek6 is expressed strongly in the larval CNS and adult brain, in addition to the gut, adult heart 
and adult female gonads (Celniker et al., 2009, Chintapalli et al., 2007). However, detailed 
embryonic expression patterns have not been published, and the function of Kek6 is unknown 
for any tissue. 
I next tested whether interfering with kek6 function either in loss of function mutants, or upon 
kek6 overexpression, resulted in axon guidance phenotypes in the intersegmental nerve b 
(ISNb) motor neuron projections. I used antibodies to FasII to label all motor neurons (FasII; 
Lin et al. (1994b)).  
Finally, using the same loss and gain of function alleles, I tested whether kek6 is necessary for 
normal locomotion behaviour. In Chapters 3 and 5, adult locomotion was used as an assay for 
behaviour, although embryonic expression profiles were detailed. However, the embryonic 
CNS and peripheral nervous system (PNS) are remodelled throughout metamorphosis (Tissot 
and Stocker, 2000, Truman, 1990). Furthermore, the central pattern generator underlying 
larval locomotion behaviour includes the segmental nerve (SN) and ISN nerves (Fox et al., 
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2006). Thus, it was more appropriate to compare kek6 embryonic expression patterns and 
misrouting in ISNb motor axons with larval locomotion, prior to metamorphic rewiring. I 
tested whether kek6 loss and gain of function have locomotion phenotypes.  
Using the same phenotypic assays, I also tested interactions between Kek6 and the DNTs, and 
whether interfering with downstream signalling components could rescue kek6 overexpression 
phenotypes. Growth cone extension is controlled by rearrangements of microtubules and the 
actin cytoskeleton (Dent and Gertler, 2003). Growth cone movement requires the growth and 
retraction of filopodia and lamellipodia, which are supported by actin microfilaments and 
microtubules. Actin rearrangements are also required for the formation of synapses (Dillon 
and Goda, 2005). In neurons, actin rearrangements are controlled by the Rho GTPase 
superfamily, including Rho, Rac and Cdc42, which are activated and deactivated by Guanine 
exchange factor (GEF; including ephexin1) and GTPase-activating protein (GAP) proteins, 
respectively (Dent and Gertler, 2003, Dillon and Goda, 2005, Huang and Reichardt, 2001, Shi 
et al., 2010). RhoGTPase signalling is downstream of Ras–phosphatidylinositol 3-kinase 
(PI3K) signalling, and Ras can further promote axon growth via extracellular signal-regulated 
kinase (ERK; Markus et al. (2002).  
6.2 RESULTS 
6.2.1 kek6 is expressed in the embryonic nervous system 
The distribution of kek6 transcripts was analysed by in situ hybridisation (Figure 6.1). kek6 
mRNA was present from stage 13 along the length of the ventral nerve cord (VNC), with 
signal detected in each segment. By stage 15, kek6 mRNA expression was enriched along the 
VNC in a distinct segmented pattern on either side of the midline (Figure 6.1b). Four stripes 
of transcript were observed in the VNC (arrowheads). By stage 16, mRNA signal was seen 
throughout the VNC in two distinct stripes parallel but lateral to the midline (Figure 6.1c). By 
stage 17, transcript signal was uniform throughout the CNS, and therefore indicated a likely 
Stage 13
ba
c d e
f g
Stage 15
Dorsal Ventral Dorsal Ventral
Stage 16 Stage 17
Figure 6.1  kek6 is expressed in the CNS
In situ hybridisation
a | Probe hybridisation conrmed by BLAST. b-e | In situ hybridisation of antisense kek6 RNA probe 
reveals hybridisation with kek6 mRNA in the VNC and embryonic brain from stage 13. Transcript was 
detected in stripes along the VNC (arrowheads). f | Dissected embryos reveal kek6 mRNA is 
enriched in the VNC surrounding the neuropil and on the midline (arrowhead). g | Slices of the VNC 
uorescently labelled using an antisense kek6 RNA probe reveals kek6 mRNA anking the neuropil in 
the dorsal VNC, pairs of kek6+ neuronal cell bodies ventral to the neuropil, and epidermal stripes. Scale 
bar, 10µm.
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neuronal role for kek6 (Figure 6.1d). Filleted stage 16 and 17 embryos showed kek6 
expression surrounding the axons of the longitudinal tracts (Figure 6.1e,f). Kek6 transcript 
was also detected in the cortex, ventral to the neuropil (Figure 6.1f, arrowhead). 
Fluorescent in situ hybridisation revealed kek6 transcript throughout the VNC in stage 17 
embryos (Figure 6.1g). kek6 mRNA was detected in soma lateral to the neuropil in the dorsal 
VNC, and pairs of kek6+ nuclei were detected ventral to the neuropil, either side of the 
midline. On the epidermis, kek6 signal was detected in stripes. This was not detected by 
alkaline phosphatase (non-fluorescent) in situ hybridisation, and may reflect background 
sticking of the RNA probe to the embryo.  
Kek6 protein was detected in the longitudinal axons of the VNC with anti-Kek6 (Figure 6.2a): 
antibodies were designed by selecting a unique peptide sequence from Kek6 in the N-terminal 
region to avoid labelling of repetitive, common domain sequences (see Chapter 2.5.2). Anti-
Kek6 did not stain neurons in kek634/Df(kek6) null mutant embryos at any developmental stage 
(Figure 6.2d; Df(kek6) is Df(3R)ED6361). HRP developed embryos revealed Kek6 
distribution along the neuropil (Figure 6.2a, left image). Kek6+ signal was detected both in 
longitudinal connectives and along commissures crossing the midline (Figure 6.2a, right 
image). Fluorescent anti-Kek6 stains further revealed the presence of Kek6 in pioneer neurons 
in stage 12 embryos (Figure 6.2b). The arc away from the midline and the proximity of the 
start of these axons suggested an MP1 or ventral unpaired median (VUM; arrowhead) neuron-
like origin, although cell bodies could not be discerned. In stage 16 and 17 embryos, Kek6 
was present in many CNS axons. Kek6+ axons extended along the length of the VNC and 
crossed the midline. By stage 17, signal was detected in axons leaving the VNC perpendicular 
to the midline (Figure 6.2b, right image; Figure 6.2c, arrowheads). These projections are 
likely to be motor neurons.  
Stage 17Stage 17 Stage 12 Stage 16
b
c
a
d
Stage 12 Stage 16 Stage 17
anti-Kek6 anti-HB9 Mergee
Figure 6.2 Kek6 is distributed in motor neurons
a | HRP-detected anti-Kek6 labels axons in the embryonic longitudinal tracts and the commissures 
in stage 17 embryos. b | Fluorescent anti-Kek6 labelling reveals Kek6 is distributed in pioneer 
interneurons and putative motor neurons (arrowheads) in stage 12 embryos, throughout the VNC, 
and in motor neurons in stage 17 embryos. c | Magnied view of Kek6+ motor neurons in stage 17 
embryos (arrowheads). d | Anti-Kek6 does not label kek634/Df(3R)ED6361 embryos. e | Stage 12 
embryos co-labelled with anti-Kek6 (green) and anti-HB9 (magenta). Scale bars, 10µm.
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To determine whether the neuronal signal observed from kek6 in situ hybridisations is present 
in motor neurons, yw embryos were double stained with anti-Kek6 and anti-HB9. HB9+ is a 
nuclear marker. I detected HB9+ signal in the nuclei of cells that were surrounded by Kek6+ 
cell membrane signal: given their location relative to the pioneer axon projections, these cells 
may correspond to the MP2 (arrowhead) pioneer neurons, and the RP motor neurons, which 
are posterior to the aCC and the Us (Figure 1.8; Figure 6.2e). 
In situ hybridisation and anti-Kek6 staining both confirm that kek6 is required in the CNS, in 
the embryonic brain and VNC. In situ stains reveal kek6 mRNA expression in nuclei 
throughout the VNC, suggestive of a neuronal localization: anti-Kek6 staining localizes to 
axons along the VNC, and motor neurons that exit perpendicular to the VNC. The in situ and 
antibody expression profiles therefore overlap. 
6.2.2 kek6 is required for axon targeting 
To test if kek6 is involved in axon targeting, I studied the effect of kek6 loss and gain of 
function on ISNb motor neuron projection targeting to the boundaries of muscles 12–13, 6–13 
and 6–7. Late stage 17 embryos were stained with the motor axon marker anti-FasII and ISNb 
projections in abdominal hemisegments A1–A5 (10 hemisegments per embryo) were scored 
for misrouting phenotypes. Phenotypes were scored for each projection in each hemisegment, 
then grouped into the categories ‘fan’, ‘loss of 1 projection’ and ‘misrouting and 2 or more 
projections affected’ (Zhu et al., 2008). A fan phenotype was defined as multiple, misdirected 
thin projections originating from the location of an absent ‘b’ projection. Loss of 1 projection 
and fan phenotypes occur at a combined basal rate of around 12–15% of hemisegments. This 
did not vary between genotypes. Misrouting refers to aberrant projections to another muscle 
or axon, an unusual route taken by the axon or lack of final targeting. 
All lines tested had a w– genetic background, and transgenes bore the w+ minigene. In yw 
controls, 20% of hemisegments exhibited a misrouting phenotype. Neuronal overexpression 
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of kek6 resulted in an increase in misrouting (Figure 6.3a; χ2 with Bonferroni correction 
applied in all cases, see Appendix I for statistical values). kek6 overexpression using the 
elavGal4 neuronal driver introduced novel misrouting phenotypes, including bifurcation and 
overgrowth of projection ‘b’, and looping and overshooting of projection ‘a’ (Figure 6.3b, red 
arrowheads). Misrouting also increased in kek6 loss of function mutants. Typically, 
kek634/Df(kek6) embryos had similar misrouting phenotypes to yw, although anterior targeting of 
projection ‘b’, projection sprouting at muscle boundary 6–13, and lack of projection ‘a’ 
targeting was observed (Figure 6.3b, blue arrowheads). Finally, elavGal4-driven kek6 
overexpression rescued projection misrouting caused by kek634/Df(kek6) loss of function (Figure 
6.3a). Motor axon misrouting caused by kek6 loss of function and overexpression contrasted 
with the lack of an overall effect induced by kek1 loss and overexpression (Figure 6.3c,d), 
despite kek1 being similarly expressed in the embryonic CNS. Nonetheless, unique 
misrouting phenotypes, including ectopic projection sprouting, were observed for both kek1 
genotypes, suggesting that a statistical difference might be observed with a larger sample size 
(Figure 6.3d, arrowheads).  
Phenotypes associated with loss of kek6 function correlate with loss of DNT1, but not DNT2 
(Zhu et al., 2008). Loss of DNT1 induced misrouting of projection a and projection b towards 
adjacent segments, and bifurcation of projection b (Zhu et al., 2008), as observed in the 
images shown in Figure 6.3b. The correlation of phenotypes, however, does not imply that 
Kek6 and the DNTs are in the same functional pathway, simply that Kek6 has a role in motor 
axon targeting. 
To test the function of kek6 in relation to DNT signalling, I quantified motor axon 
mistargeting in two genetic contexts: (1) to test whether kek6 null embryos could rescue the 
sprouting induced by overexpression of UASDNT1CK3′+ in the muscle (with 24BGAL4); (2) 
and to test whether neuronal overexpression of kek6 could rescue the phenotype of 
DNT2e03444DNT141 double mutant embryos. Muscle-driven expression of the DNT1 CysKnot-
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Figure 6.3  kek6 is required for motor axon targeting
ISNb motor neurons were labelled with anti-FasII and projections to muscles 6–7, 6–13 and 
12–13 were scored for misrouting or loss phenotypes. a | Neuronal overexpression and 
kek6 loss of function mutations induced an increase in axon misrouting compared to yw. 
Misrouting phenotypes were rescued by kek6 overexpression in a kek6 mutant background. 
b | ISNb misrouting phenotypes in yw and kek6 mutants. c,d | Loss or gain of function of kek1 
had no overall eect on motor axon targeting compared to yw. See Appendix I for statistical 
values. Arrowheads label misrouting phenotypes referenced in main text. Scale bar, 15µm.
Df(kek6) = Df(3R)ED6361
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3’+ induced motor axon projection misrouting and ectopic sprouting (Figure 6.4a,b, red 
arrowheads). These phenotypes were rescued when DNT1 was overexpressed in a kek6 null 
genetic background (Figure 6.4a; χ2 with Bonferroni correction applied in all cases, see 
Appendix I for statistical values). This suggests that Kek6 functions downstream of DNT1. 
By contrast, neuronal overexpression of kek6 in a DNT2e03444DNT141 genetic background did 
not rescue the sprouting (red arrowheads) and misrouting (blue arrowheads) phenotypes of the 
double DNT mutant (Figure 6.4a,b). This suggests that Kek6 is not sufficient for signalling 
downstream of the DNTs. 
I next asked what downstream signalling pathway may function downstream of kek6. For this, 
I tested whether mutations in downstream signalling components might suppress or enhance 
the kek6 loss of function or overexpression phenotypes. For example, to test if kek6 might 
activate Ras, I asked whether a dominant negative form of Ras might rescue the kek6 
overexpression misrouting phenotype. Since Kek6 lacks a tyrosine kinase (TyrK) domain, I 
did not explore whether it can directly influence cell survival or cell proliferation. Instead, I 
focused on signalling components known to influence the actin cytoskeleton directly, or those 
known to influence cell migration and cell shape. Kek6 could influence these events by 
directly recruiting such components without the need of a catalytic motif. Thus, I tested 
dominant negative forms of Cdc42, PI3K, Rac, Ras and Rho.  
Of these, dominant negative Ras and PI3K rescued motor axon misrouting induced by 
neuronal overexpression of kek6 (Figure 6.5a,b; χ2 with Bonferroni correction applied in all 
cases, see Appendix I for statistical values). This suggests that Kek6 may signal via Ras and 
PI3K pathways. Conversely, dominant negative Rac, Rho and Cdc42 did not rescue axon 
misrouting caused by kek6 gain of function (Figure 6.5a,b). This suggests that Kek6 does not 
function via activation of RhoGTPase signalling. In the kek6 overexpression background, 
dominant negative Cdc42 embryos had ectopic projections (Figure 6.5b, red arrowheads); 
dominant negative Rac induced some super-sprouting (blue arrowhead); and dominant 
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Figure 6.4  kek6 interacts with DNTs in motor axon targeting
a | ISNb motor axons labelled with anti-FasII reveal that axon misrouting induced by 
muscle-driven overexpression of DNT1 did not occur in a kek6 null genetic background. 
Conversely, misrouting phenotypes induced by homozygous DNT2e03444DNT141 (DNT2-/-DNT1-/-) 
double mutations could not be rescued by neuronal kek6 overexpression. b | ISNb misrouting 
phenotypes exhibited by genotypes in part a. Arrowheads label misrouting phenotypes 
referenced in main text. See Appendix I for statistical values. Scale bar, 15µm.
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Figure 6.5  kek6 is upstream of Ras and PI3K in motor axon targeting
a | ISNb motor axons labelled with anti-FasII reveal that axon misrouting induced by neuronal 
overexpression of kek6 can be rescued by simultaneous expression of dominant-negative 
Ras and PI3K, but not dominant-negative Cdc42, Rac or Rho. b | ISNb misrouting phenotypes 
exhibited by genotypes in part a. Arrowheads indicate phenotypes referenced in main text.
See Appendix I for statistical values. Scale bar, 15µm.
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negative Rho induced predominantly misrouting phenotypes, including a looped projection 
‘b’ (green arrowhead). In a kek6 gain of function background, dominant negative Ras and 
PI3K resulted in motor axons that looked predominantly wild type. Any misrouting 
phenotypes observed in these genotypes were shared with kek6 overexpression mutants. This 
suggests that Kek6 is upstream of Ras-activated PI3K signalling. 
6.2.3 kek6 is required for normal larval locomotion behaviour 
To investigate whether loss or gain of kek6 function affected locomotion, I filmed mutant 
larvae crawling on agar plates for 1 minute, using the ImageJ plugin FlyTracker, modified by 
Manuel Forero in our lab from an existing plug-in, to quantify speed and to plot larval 
movement (McIlroy et al., 2013). Three separate controls were tested — yw, yw/OregonR and 
elavGal4 — to account for the potential impact of the white gene on locomotor behaviour, 
given its role in serotonin and dopamine uptake (Borycz et al., 2008, McIlroy et al., 2013). 
Thus, the three controls were w–, w+/w– and homozygous mini-white, respectively. All 
transgenic and mutant lines had w– backgrounds, but insertions and Flippase recognition 
target (FRT)-mediated null alleles bore mini-white constructs (one per null, Gal4 or UAS 
allele).  
Larva movement traces suggested that all three controls travelled similar distances. 
Furthermore, all three controls had comparable speed profiles, although yw/OregonR 
heterozygotes travelled at slower speeds slightly less frequently (Figure 6.6a,b). Homozygous 
elavGal4 was used as the control for future analysis because it contains 2 miniwhite 
constructs, as do most mutant genotypes tested. kek6 loss of function resulted in an increase in 
crawling speed (Figure 6.6b; Kruskal-Wallis with Dunn’s post hoc, see Appendix I for 
statistical values). Neuronal overexpression of kek6 also increased crawling speed.  
Although not obvious from trajectories, neuronal overexpression of kek6 partially rescued the 
speed phenotype of kek6 loss of function (Figure 6.7a,b; Dunn’s post hoc).  
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Figure 6.6  kek6 is required for larval locomotion behaviour
a | Trajectories of control and kek6 mutant larvae reveal dierent larval activity.
b | Speed histogram of larval movement per video frame reveals kek6 loss and gain of function 
mutations increase larval speed. See Appendix I for statistical values and frame numbers. Df(kek6) = 
Df(3R)ED6361
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Figure 6.7  Neuronal overexpression of kek6 partially rescues kek6 
  loss of function locomotion phenotypes
a | Trajectories of control, kek6 mutant and kek6 rescue larvae. b | Neuronal overexpression of 
kek6 in kek6 null mutant larvae partially rescues movement speed. Comparison of speeds 
between loss of kek6 and kek6 rescue is signicant. See Appendix I for statistical values and 
frame numbers. Df(kek6) = Df(3R)ED6361
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To examine interactions between Kek6 and the DNTs, kek6–DNT double mutants were tested 
for locomotion phenotypes. In addition, the tie5 mutant allele (generated by Alice Lowry, 
Hidalgo laboratory) was combined with kek634 to test Tie as a potential downstream partner of 
the receptor. Trajectories revealed that DNT1–/Df(DNT1)kek634/Df(kek6) and 
Tie5/Df(Tie)kek634/Df(kek6) double mutants had similar locomotion behaviours to kek634/Df(kek6) 
single mutants (Figure 6.8a — Df(Tie) and Df(DNT1) are Df(3L)ED4342). However, DNT2–
/Df(DNT2)kek634/Df(kek6) double mutant larvae crawled more slowly, as their trajectories were 
considerably shorter (Df(DNT2) is Df(3L)ED6092). Contrary to the increased distance 
observed in kek6 mutants, the distance travelled by DNT2–/Df(DNT2)kek634/Df(kek6) double mutants 
was comparable to that by elavGal4 control larvae (Figure 6.8b). However, the decrease in 
travelling distance of DNT2–/Df(DNT2)kek634/Df(kek6) double mutants was not statistically 
significant when compared with single kek634/Df(kek6) heteroalleles (Student’s t-test with 
Bonferroni correction, see Appendix I for statistical values). It is likely that this would be 
significant with a sample size n>25. By contrast, when analysing speed, DNT2–
/Df(DNT2)kek634/Df(kek6) double mutants crawled significantly slower than kek634/Df(kek6) single 
mutants (Figure 6.8c; Dunn’s post hoc). Together, these data suggest that there is a functional 
relationship between Kek6 and the DNTs. 
To test whether the loss of signalling components downstream of Kek6 could rescue 
behavioural phenotypes as well as motor axon guidance phenotypes, I filmed larvae co-
expressing kek6 and dominant negative Ras, PI3K or Rho alleles under the control of the 
elavGAL4 neuronal promoter. Trajectories revealed that dominant negative PI3K and Rho 
were unable to rescue the locomotion phenotype of larvae overexpressing kek6 (Figure 6.9a). 
By comparison, co-expression of dominant negative Ras and kek6 by elavGal4 decreased 
distance travelled compared with kek6 overexpression alone (Figures 6.9a,b; Student’s t-test 
with Bonferroni correction, see Appendix I for statistical values). Larvae with neuronal co-
expression of kek6 and dominant negative Ras also travelled significantly slower than kek6 
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comparable to controls. See Appendix I for statistical values and frame numbers. Df(kek6) = 
Df(3R)ED6361, Df(Tie) and Df(DNT1) = Df(3L)ED4342, Df(DNT2) = Df(3L)ED6092.
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Figure 6.9 kek6 is upstream of Ras in locomotion behaviour
a | Trajectories of kek6 overexpression mutants reveal simultaneous neuronal overexpression 
of dominant negative Ras reduces locomotion activity in larvae. b | elavGal4>UASkek6,UASDNRas 
larvae travel shorter distances than elavGal4>UASkek6 mutants. c | Neuronal overexpression 
of dominant negative PI3K or Rho do not aect locomotion behaviour in an elavGal4>UASkek6 
background. By contrast, co-expression of dominant negative Ras and UASkek6 results in larvae
that crawl as slowly as wild type larvae. See Appendix I for statistical values and frame numbers.
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overexpression alone (Figure 6.9c). Furthermore, larvae in which dominant negative Rho was 
co-expressed with kek6 travelled significantly faster than elavGal4>UASkek6 (Dunn’s post 
hoc). Altogether, these data suggest that Ras and Rho function downstream of Kek6, possibly 
in an antagonistic manner. 
6.3 DISCUSSION  
In this chapter, kek6 mRNA expression and protein distribution were visualised by in situ 
hybridisation and antibody labelling, respectively. kek6 mRNA was enriched in the embryonic 
CNS, in the VNC and brain from stage 13 to stage 17. Kek6 protein was localized to pioneer 
neurons of the VNC in stage 12 embryos, and longitudinal tract fascicles in stage 16 and stage 
17 embryos. Kek6 protein was also detected in motor axons.  
The role of kek6 in nervous system development was tested by quantifying misrouting of 
ISNb motor axons. Loss and gain of function of kek6 caused an increase in projection 
misrouting compared to yw controls. Neuronal expression of kek6 in kek6 null embryos was 
sufficient to rescue misrouting phenotypes. Misrouting of projections associated with muscle-
driven expression of the UASDNT1CK3’+ did not occur in a kek6 null genetic background; by 
contrast, the misrouting phenotypes of DNT1–/–DNT2–/– double mutants could not be rescued 
by kek6 overexpression. Last, simultaneous neuronal overexpression of kek6 and dominant 
negative alleles of Rho, Rac and Cdc42 did not rescue projection misrouting induced by kek6 
overexpression, whereas overexpression of dominant negative Ras and PI3K did. 
The function of kek6 in behaviour was tested by recording larval locomotion. Loss and gain of 
function kek6 mutants moved faster than controls. This phenotype was partially rescued by 
the overexpression of kek6 in a kek6 null background. kek6DNT interactions revealed 
locomotion phenotypes for DNT2–/Df(DNT2)kek634/Df(kek6) double mutants, but not DNT1–
/Df(DNT1)kek634/Df(kek6) or Tie5/Df(Tie)kek634/Df(kek6). Last, overexpression of dominant negative Ras 
rescued the locomotion phenotype induced by kek6 overexpression in neurons, whereas 
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dominant negative Rho or PI3K could not. Thus, kek6 is neuronal, and kek6 mutants have 
neuronal phenotypes in axon guidance and locomotion. 
Although I have not been able to identify the specific motor neurons expressing kek6, there is 
abundant evidence that motor neurons express kek6. First, FISH labelling of kek6 mRNA 
revealed ventral cells. Second, Kek6 antibodies revealed signal in axons extending anteriorly 
from the midline; this could correspond to the VUMs, which project anteriorly then away 
from the midline (Landgraf et al., 2003). Finally, anti-Kek6 antibodies reveal signal along the 
motor axons exiting the CNS. 
Consistently with its neuronal expression, misrouting and locomotion data revealed that kek6 
has roles in neuronal development. Furthermore, neuronal expression of kek6 in a kek6 null 
background was sufficient to rescue ISNb projection misrouting in embryos, and partially 
rescued locomotion phenotypes in larvae. The partial rescue of the kek6 null larval 
locomotion phenotype suggests that further roles of Kek6 may exist in other tissues, such as 
muscle; that overexpression did not restore endogenous protein levels; or that the construct is 
not functional (for example, the RFP tag may interfere with function). Nonetheless, both loss 
and gain of function of kek6 resulted in phenotypes, suggesting that Kek6 levels are important 
for normal function. This confirms that the phenotypes I reported for the mutants were indeed 
caused by the specific loss of kek6. 
Since it was not known how Kek6 signals, there was uncertainty as to whether kek6 
overexpression would have any effect in vivo. In survival assays (Chapter 5), overexpression 
of kek6 only partially rescued the lethality of kek634/35 heteroallelic flies. However, each of 
these alleles over the deficiency for the locus was fully viable, implying that the lethality of 
single homozygous mutants for each of the kek634 and kek635 alleles is unrelated to the loss of 
kek6. Hence, the partial rescue of overexpressing kek6 in a kek634/Df(kek6) heteroallelic 
background indicates that the kek6 transgene is functional. 
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There is further evidence that the kek6 transgene used for overexpression is functional: (1) the 
fact that kek6 overexpression rescues the loss of function mutant kek6 phenotype in axon 
guidance and (2) larval locomotion, and (3) the rescue of DNT2–/–DNT1–/– lethality by 
neuronal expression of kek6 in the survival assay (see Chapter 5). Furthermore, motor axon 
misrouting caused by kek6 overexpression was reproducible. How kek6 overexpression 
phenotypes were manifested is an unsolved question, although a role in cell adhesion cannot 
be discounted, given that Kek6 was detected at cell–cell boundaries in Figure 4.1.  
I have provided multiple evidence that Kek6 interacts with the DNTs: (1) In motor axon 
targeting, overexpression of kek6 could not induce signalling in the absence of DNTs. (2) In 
motor axon targeting, loss of kek6 rescued the phenotype caused by ectopic DNT1. (3) NFκB 
signalling was induced in response to DNT2 stimulation in S2 cells transfected with 
Kek6≡Toll6 chimaeric constructs (Figure 4.5); (4) genetic interaction data in survival assays 
(Figure 5.7), and (5) the synergistic locomotion phenotype of DNT2–/Df(DNT2)kek634/Df(kek6) 
double mutants.  
My data suggest that Kek6 signals via Ras and PI3K. Dominant negative Ras and PI3K 
rescued the misrouting of ISNb projections caused by kek6 overexpression. In addition, 
dominant negative Ras could rescue the locomotion phenotype of larvae overexpressing kek6. 
Ras is a signalling hub protein upstream of ERK, CREB, Rho, Akt and BAD signalling 
(Figure 1.2). The role of PI3K in axon guidance, but not locomotion, indicates that Kek6 may 
function via specific signalling pathways depending on functional context.  
In this chapter I showed that kek6 is neuronal and has important roles in CNS development. 
Vertebrate neurotrophins also have roles in immunity and the systemic control of growth. In 
the next chapter, I tested the expression pattern and function of kek4 in hormonal regulation 
and whole organism development.  
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CHAPTER 7 
KEK4 FUNCTION IN THE RING GLAND  
7.1 INTRODUCTION  
This chapter aimed to investigate the functions of Kek4 in the systemic control of growth. In 
previous chapters I showed that kek4 can interact with both Drosophila neurotrophin 1 
(DNT1) and DNT2 genetically. Furthermore, in adults, kek4–/–DNT1–/– double mutants, using 
kek4f05454, had locomotion phenotypes. FlyAtlas data reports kek4 to be abundantly expressed 
in the larva (Chintapalli et al., 2007), and preliminary analysis of the kek4 expression pattern 
here detected Kek4 in the ring gland rather than the central nervous system (CNS). 
Mammalian neurotrophins have functions involved in the systemic, hormonal control of 
growth (Levi-Montalcini et al., 1990). Since the kek genes interact with the DNTs, it is 
conceivable that members of the kek family might also have non-neuronal functions. Thus, in 
this chapter I investigated the functions of kek4 in the ring gland.  
7.2 RESULTS 
7.2.1 kek4 is expressed in the ring gland 
The expression profile of kek4 was analysed by in situ hybridisation to kek4 mRNA 
transcripts, and antibody stains using anti-Kek4 (Figures 7.1,7.2). kek4 mRNA was not 
detected in the embryonic ventral nerve cord (VNC) in stages 15, 16 or 17 (Figure 7.1a,b). 
Instead, kek4 transcript was detected in the mid- and hindgut, and in structures anterior to the 
developing central brain. These structures may include the ring gland and/or stomatogastric 
nervous system. 
To analyse Kek4 distribution in the larval brain, the putative kek4Gal4 line P[GT1]BG00800 
was crossed with UASmyrTOMATO and larval brains were fluorescently stained with anti-
dsRed (Figure 7.1c). kek4Gal4-driven myrTomato was detected in a single axonal stripe along 
aStage 15 Stage 16 Stage 17
b
c d
Figure 7.1  kek4 is expressed in the ring gland
In situ hybridisation
a | Hybridisation of RNA probe, transcribed from DGRC clone, conrmed by BLAST (probe spans exon). 
b | In situ hybridisation reveals kek4 mRNA is absent from the embryonic CNS. c,d | Putative 
kek4Gal4 (P[GT1]BG00800)-driven UASmyrTOMATO was detected in axons of the larval VNC and 
enriched in the ring gland (RG). OL, optic lobe. Scale bar, 50µm. 
kek4Gal4>UASmyrTOMATO
OL
RG
CA
CC
PG
anti-Kek4
Anti-Kek4 reveals Kek4 protein in the ring gland. Kek4 is enriched in the corpus allatum (CA) 
and corpora cardiaca (CC), but is absent from the prothoracic gland (PG). Scale bar, 50µm.
Figure 7.2  kek4 is expressed in the corpus allatum and corpora cardiaca
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the length of the nerve cord, either side of the neuropil (Figure 7.1c). Putative kek4Gal4-
driven reporter was also detected in the ring gland (Figure 7.1d). 
To further determine Kek4 distribution, custom anti-Kek4 antibodies were raised from 
peptides. Unique peptide sequences from Kek4 were chosen in the N-terminal region to avoid 
labelling of repetitive, common domain sequences (see Chapter 2.5.2). Strikingly, anti-Kek4 
labelled specific glands of the ring gland, and did not label the CNS (Figure 7.2). The ring 
gland is composed of three endocrine glands (Figure 1.9) (Edgar, 2006, Richard et al., 1989, 
Siegmund and Korge, 2001). The prothoracic gland (PG) releases ecdysone, which is 
processed to an active form, 20E, and furthers larval development (Riddiford, 1993). The 
corpus allatum (CA) releases juvenile hormone (JH), which prohibits 20E signalling and 
maintains the larval state (Richard et al., 1989, Flatt et al., 2005). The paired corpora cardiaca 
(CC) release the lipid and sugar mobilising adipokinetic hormone (AKH) (Nässel and 
Winther, 2010). Kek4 was detected specifically in the CA and the CC, but absent from the PG 
(Figure 1.9; Figure 7.2). 
7.2.2 kek4 controls larval developmental timing 
The period between the final larval moult (L3) and pupariation is defined by distinct stages 
and checkpoints (Edgar, 2006): the minimum viable weight, below which the larva will not 
survive metamorphosis (Edgar, 2006); the critical weight, which marks the end of feeding; 
and the onset of larval wandering. Wandering larvae permanently leave the food prior to 
pupariation and can no longer feed. To determine variation in checkpoint timing in mutants, 
larval instars can be temporally staged and moults can be timed by onset of morphological 
changes in mouth hooks or behavioural traits such as wandering (King-Jones et al., 2005, 
Mirth et al., 2005, Ou et al., 2011, Rewitz et al., 2009). Furthermore, the timing of the critical 
weight can be determined using larvae reared on food supplemented with blue colouring, 
which is cleared from the gut once feeding has ended (King-Jones et al., 2005, Ou et al., 
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2011). To determine whether Kek4 has a role in the timing of larval development, pupariation 
and pupation, controls, kek420/23 heteroallelic mutants and larvae overexpressing kek4 in the 
whole ring gland (spz6Gal4>UASkek4) were staged at the L1 larval instar and timed as they 
progressed through L3 wandering instar, white pupa (puparia or prepupa), brown pupa, black 
pupa and eclosed adult stages (Figure 7.3). spz6Gal4 was used as a ring gland-specific driver, 
as it drives expression in CA, PG and CC cells (S. AlAhmed, Hidalgo laboratory, personal 
communication). ‘Wandering L3, clear gut’ was also recorded as a developmental marker, 
corresponding to the wandering L3 larvae that have digested all food consumed during the 
terminal growth period. 
Both yw and spz6Gal4 larvae had very similar developmental profiles at 25⁰C (Figure 7.3a,b). 
L3 larvae began to wander out of their food from 76 hours after L1 staging (T50=86 hours, 
where T50 corresponds to the time at which half of recorded larvae have passed the 
development stage). Subsequent stages up to forming brown pupae followed in quick 
succession. Full pupation of all larvae was reached at ~104 hours post-L1 staging. Adult 
eclosion followed approximately 4.5 days later (T50= ~218 hours). Compared to controls, 
spz6Gal4>UASkek4 L3 larvae moulted early (Figure 7.3c). By contrast, the kek420/23 L3 
larvae moult was delayed (Figure 7.3d). Timing between moults, post-wandering L3 instar, 
was similar for all genotypes.  
Phenotypic effects were also compared by stage (Figure 7.4). Compared to controls, 
spz6Gal4>UASkek4 L3 larvae wandering was premature (Figure 7.4a; χ2 with Bonferroni 
correction in all cases, see Appendix I for statistical values). kek420/23 single mutants, 
conversely, displayed delayed onset of wandering. Thus, spz6Gal4>UASkek4 accelerated 
larval wandering, whereas kek4 mutation significantly delayed development. Subsequent 
development through pupariation and pupation was concordantly brought forward or delayed 
(Figure 7.4b,c). 
Figure 7.3  kek4 controls developmental timing, by genotype
Developmental proles of yw (a), spz6Gal4 (b), spz6Gal4>UASkek4 (c) and kek420/23 (d) 
larvae were recorded. kek4 overexpression accelerated larval developmental stages, but 
caused 40% pupal lethality: kek4 loss of function delayed larval development. 
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Figure 7.4  kek4 controls developmental timing, by stage
a-e | kek4 gain of function accelerates larval development. Comparison by developmental stage 
reveals timing dierences originate pre-L3 larval moult, as delays are consistent for later 
stages. f | Development time courses highlight shifts in developmental timing. kek420/23 
wandering onset occurs over an extended period compared with controls and spz6Gal4>UASkek4.
n=150 for each genotype. See Appendix I for statistical values.
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Control genotypes and kek420/23 mutants reached T50 black pupae at the same time (~190–194 
hours; Figure 7.4d). Not all Spz6Gal4>UASkek4 pupae, by comparison, reached this stage. 
When recalculated to consider only those pupae that reached eclosion, spz6Gal4>UASkek4 
T50=~178 hours, nearly one day earlier than controls. Accordingly, spz6Gal4>UASkek4 adult 
eclosion was premature compared with controls (Figure 7.4e). Nearly half of 
spz6Gal4>UASkek4 larvae died during metamorphosis and did not eclose (Figure 7.4e). 
Developmental time courses confirmed that kek420/23 mutants had delayed development, 
whereas kek4 overexpression accelerated development (Figure 7.4f). 
7.2.3 kek4 inhibits juvenile hormone signalling 
JH has a crucial role in maintaining larval growth, since loss of JH-secreting cells in the CA 
accelerates pupation (Riddiford et al., 2010). The direct downstream targets of JH signalling 
are not known (Riddiford et al., 2010). Therefore, an alternative is to test for ecdysone target 
activation, which coincides with termination of JH signalling at the critical weight checkpoint.  
20E activates early regulatory transcription factors, including Broad-Core (BR-C). JH and 
20E signalling were tested by labelling BR-C in the fat body. BR-C is an early 20E-regulated 
gene required for successful metamorphosis (Guay and Guild, 1991, Kiss et al., 1988). BR-C 
is directly stimulated by 20E, but this is inhibited by JH (Huang et al., 2011a, Konopova and 
Jindra, 2008). Therefore, BR-C should only be detected during the larval–pupal transition. 
However, BR-C transcript is present in the early L3 instar, and thus aberrant JH signalling can 
result in early BR-C upregulation (Galcerán et al., 1990, Huang et al., 2011a). 
BR-C was absent from the fat body of yw larvae (Figure 7.5). Fat body BR-C was also absent 
in kek420/23 mutants. However, BR-C was upregulated in the fat body cells of 
spz6Gal4>UASkek4 larvae. This suggested that ectopic kek4 signalling inhibits JH signalling 
or activates ecdysone, permitting BR-C upregulation. Given that kek4 is not expressed in the 
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Figure 7.5  kek4 inhibits juvenile hormone signalling
Fat bodies of early L3 larvae were uorescently labelled with anti-Broad, which labels the 
pro-metamorphosis early transcription factor Broad-Core (BR-C). BR-C is activated by 
ecdysone signalling only in the absence of juvenile hormone. yw and  kek420/23 mutant 
larval fat bodies displayed no BR-C upregulation, whereas spz6Gal4>UASkek4 mutants did. 
Thus, kek4 overexpression in the ring gland may reduce juvenile hormone signalling and 
permit BR-C upregulation. Scale bar, 10µm.
 103 
PG, and JH signalling must be terminated prior to BR-C upregulation, this implied that kek4 
most likely inhibits JH. 
7.2.4 kek4 does not influence larval or pupal body size 
Altered timing of wandering onset would affect total feeding time and thereby nutritional 
uptake (Wegman et al., 2010). Therefore, I next asked whether the delayed or accelerated 
developmental phenotypes of kek4 mutants affected body size. 20E-dependent developmental 
progression forms a negative feedback loop with insulin-like growth (Colombani et al., 2005). 
Induced overexpression of phosphatidylinositol 3-kinase (PI3K) in the CA and PG increases 
ring gland growth, but decreases larval and adult body sizes through premature 20E activation 
(Caldwell et al., 2005, Colombani et al., 2005, Mirth et al., 2005). The same phenotypes are 
induced by activation of Ras and Raf, and 20E food supplements (Caldwell et al., 2005). 
Conversely, loss of insulin signalling, 20E or PTTH in the ring gland, and ecdysone receptors 
in the fat body, delay wandering, and produce smaller ring glands and larger adults 
(Colombani et al., 2005, McBrayer et al., 2007). Therefore, the PG and CA regulate incoming 
signals from stretch receptors, insulin, 20E and the fat body to define the critical weight 
checkpoint and body size. Body size can be measured by organism volume, according to 
Colombani et al. (2005). 
Larval, pupal and adult body sizes and lengths were measured using the ImageJ ROI manager 
(Figure 7.6a). Body size was measured as the area within the maximum circumference of the 
body stage, as photographed from above. Larval body size did not significantly vary between 
yw, kek420/23 and spz6Gal4>UASkek4 genotypes (Figure 7.6b). Furthermore, pupal length did 
not vary between genotypes (Figure 7.6c). By comparison, spz6Gal4>UASkek4 pupal body 
size was slightly increased compared with yw (Figure 7.6d; Welch ANOVA with Games-
Howell post hoc, see Appendix I for statistical values). No difference was observed in adult 
body size between genotypes (Figure 7.6e). 
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Figure 7.6  kek4 does not control body size
a | yw, kek420/23 and spz6Gal4>UASkek4 body sizes were measured using the ImageJ 
ROI manager tool. b | No eect was observed in larval sizes by genotype. c | No change in 
body length could be observed between genotypes. d | spz6Gal4>UASkek4 pupae were 
slightly bigger than yw and kek4 loss of function mutants. e | No eect on adult body size 
was observed between genotypes. See Appendix I for statistical values and larval/pupal/adult 
numbers.
 104 
An alternative method to assay body growth is to count wing hairs in a defined area of the 
wing (McBrayer et al., 2007). Each hair correlates with one cell. Since body size did not 
change in kek4 mutants, a change in wing cell density might indicate changes in wing cell 
division or wing cell size. I counted the hairs in a region of interest of female wings for each 
genotype (Figure 7.7a). Compared to yw, kek4 loss of function significantly increased hair, 
and therefore cell, density (Figure 7.7b; Welch ANOVA with Games-Howell post hoc, see 
Appendix I for statistical values). This implied that cell size must be smaller in kek4 mutants.  
7.2.5 kek4 is required for normal locomotion behaviour 
The CC is not involved in developmental timing. Instead it releases AKH to metabolise stored 
sugars and lipids in the fat body (Kim and Rulifson, 2004, Nässel and Winther, 2010). AKH 
controls heartbeat, life span, starvation response and locomotion. For example, starvation 
results in hyperactivity in Drosophila adults as the animal searches for food; this response 
was lost when AKH neurons were ablated (Lee and Park, 2004). Furthermore, AKH can 
directly stimulate motor neurons in other insects, and AKH loss leads to docile Drosophila 
adults (Isabel et al., 2005, Milde et al., 1995, Nässel and Winther, 2010). Here, I tested the 
role of Kek4 in locomotion behaviour. 
To do this, I analysed the locomotion behaviour of elavGal4>kek4 and kek420/23 larvae (Figure 
7.8). Trajectories of larval movement revealed that loss of kek4 function resulted in increased 
locomotion of larvae, whereas gain of kek4 function resulted in reduced locomotion 
(Fig.7.8a). kek420/23 larvae also travelled significantly further than elavGal4 controls, as 
defined by the sum of distances moved by larvae between each video frame (Figure 7.8b; 
Welch ANOVA with Games-Howell post hoc, see Appendix I for statistical values), whereas 
kek4 overexpression produced larvae that travelled significantly less far. Furthermore, kek4 
mutants travelled significantly faster than controls (Figure 7.8c; Kruskal-Wallis with Dunn’s 
post hoc), whereas the opposite phenotype was observed with elavGal4>UASkek4 larvae.  
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Figure 7.7  kek4 controls cell number in the wing
a | Hairs were scored in a dened ROI in the adult wing (see Methods). b | kek4 loss of function 
mutants displayed increased cell number in the adult wing. See Appendix I for statistical values.
Scale bar, 50µm.
Figure 7.8 kek4 is required for larval locomotion
a | Trajectories of kek4 overexpression and loss of function mutants reveal dramatic 
dierences in locomotion behaviour. b | kek420/23 mutant larvae travel longer distances than 
controls, whereas elavGal4>UASkek4 move less far. c | Neuronal overexpression of kek4 
signicantly slowed larval movement compared with control larvae. Reciprocally, kek4 loss 
accelerated larval movement behaviour. See Appendix I for statistical values and frame 
numbers.
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To control for phenotypes caused by unwanted genetic changes introduced during tool 
generation, the locomotion assay was repeated using kek3 mutants, also generated in Chapters 
4 and 5. Neither loss nor gain of Kek3 protein resulted in locomotion speed phenotypes 
compared with elavGal4 (Figure 7.9a,b). These results indicate that kek4 loss and gain of 
function had reciprocal phenotypic effects in these experiments. 
7.3 DISCUSSION  
In this chapter, kek4 expression patterns were detected by in situ hybridisation and antibody 
labelling of both a kek4Gal4 insertion reporter and of endogenous Kek4 protein. Notably, 
anti-Kek4 showed striking specificity to the CA and CC of the ring gland, but not the PG.  
Development of kek4 loss of function mutants was delayed up to pupariation compared to 
controls; conversely, larvae in which kek4 was overexpressed by spz6Gal4 displayed 
accelerated pupariation and pupation. Furthermore, nearly half of the spz6Gal4>UASkek4 
mutants tested died prior to adult eclosion. BR-C was upregulated in spz6Gal4>UASkek4 
mutants. Together, these data suggested that Kek4 inhibits JH, thereby promoting 20E 
signalling through BR-C.  
The role of Kek4 in systemic control of growth was tested by measuring body sizes and 
counting wing hair cell number. No difference in larval area, pupal length or adult area could 
be detected between yw controls, kek420/23 or spz6Gal4>UASkek4 mutants. By contrast, 
spz6Gal4>UASkek4 pupae were mildly larger than controls. Cell number increased in kek4 
loss of function mutants, suggesting that cells are smaller in these mutants. One method to 
verify this might be clonal analysis, whereby the growth of an individual cell (wing, or 
elsewhere) and its daughter cells could be labelled and directly compared between genotypes 
(Petit et al., 2005). 
The absence of Kek4 from the larval brain, particularly the neurosecretory neuron clusters 
that innervate the CA, suggests that Kek4 is a receptor of secreted or paracrine ligands that 
elavGal4
elavGal4>UASkek3
kek312/26
0.1 0.2 0.3 0.4 0.5 0.6
Speed (cm/s)
Pe
rc
en
ta
ge
 o
f f
ra
m
es
a
b
14
12
10
8
6
4
2
kek312/26
w- background, 2x miniwhite
elavGal4>UASkek3
w- background, 2x miniwhite
Figure 7.9  kek3 is not required for larval locomotion
a | Trajectories of kek3 overexpression and loss of function mutants reveal no noticeable 
dierences in locomotion behaviour. b | Speed histogram revealing kek312/26 and 
elavGal4>UASkek3 mutants do not behave dierently to controls. See Appendix I for statistical 
values and frame numbers.
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target the CA. In moths, the pro-JH neuropeptide allatotropin is detected in the CC; signalling 
is then relayed to the CA by the inhibition of short neuropeptide F (sNPF), which targets the 
CA and inhibits JH production (Yamanaka et al., 2008). In Drosophila, no allatotropins or 
true allatostatins have been identified (Yoon and Stay, 1995). However, the Drosophila CC 
does express sNPF (Nassel et al., 2008). It would be interesting to test whether Kek4 can 
interact with CC-derived sNPF. Alternatively, Kek4 may interact with neuropeptides released 
from neurosecretory cells that directly innervate the CA, such as ion transport peptide (ITP; 
Dircksen et al. (2008)).  
Loss of kek4 delayed the onset of wandering in L3 larvae, whereas kek4 overexpression 
accelerated development. This is consistent with the finding that kek4 functions upstream of 
and antagonizes JH function. The accelerated development of spz6Gal4>UASkek4 larvae 
resulted in ~40% pupal lethality. Thus, kek4 overexpression alone can initiate metamorphosis 
before the critical weight checkpoint has been passed. Ectopic PI3K signalling in the ring 
gland can also initiate precocious metamorphosis, regardless of larval size (Colombani et al., 
2005). Thus, Kek4 may signal via PI3K. To investigate this, the phenotypes of kek4 loss and 
gain of function mutations combined with dominant negative and activated forms of PI3K 
should be tested: kek4 loss of function should delay accelerated development caused by ring 
gland upregulation of PI3K signalling. Observed delays could not be attributed to specific 
larval stages, which each undergo distinct morphological and signalling changes. To delineate 
the contribution of each larval instar to observed delays, the experiment should be repeated 
with larvae separately staged at L1, L2 and L3 instars.  
Ectopic Kek4 signalling induced BR-C activity in the fat body. This agreed with the 
hypothesis that Kek4 inhibits JH signalling, since endogenous BR-C transcript cannot be 
translated in the presence of JH (Huang et al., 2011a). This result does not preclude the 
possibility that Kek4 signalling simultaneously promotes the 20E cascade, rather than simply 
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permitting it, although secondary messengers that link these processes and their distinct tissue 
localizations are unclear. 
Given that development was slowed in kek4 mutants, it was a surprise that this was not 
reflected in the body size of larvae, pupae or adults. It would be expected that longer 
developmental times would increase body size. This would probably be remedied with larger 
sample sizes, particularly in adult body sizes (n=10, P=0.116). Nevertheless, the increased 
wing hair number in kek4 mutants suggested that body cell density was increased by the delay 
in development.  
kek4 loss and gain of function mutants had reciprocal locomotion phenotypes. It is likely that 
these phenotypes are the result of Kek4 function in AKH signalling within the CC: AKH 
promotes activity via motor neurons (Isabel et al., 2005, Milde et al., 1995, Nässel and 
Winther, 2010). These results suggest that Kek4 antagonises or inhibits AKH signalling.  
CC cells secrete sNPF, which must be downregulated to permit JH release from the CA (see 
above). However, sNPF downregulation also corresponds with the onset of wandering (Wu et 
al., 2003). Furthermore, sNPF also promotes feeding behaviours and enhances activity during 
starvation (Lee et al., 2004). In this respect it has similar roles to AKH; thus sNPF–Kek4 
interactions could be tested in the context of locomotion, as well as JH signalling. 
In conclusion, Kek4 has a role in the systemic control of timing. Next, studies could attempt 
to decipher the downstream signalling response to Kek4 activation, to determine how Kek4 
activation inhibits JH signalling and thereby permits the PTTH–20E cascade. Furthermore, 
the Kek4 ligand should be searched for: it would be interesting to repeat the above 
experiments incorporating DNT mutants, since putative interactions were suggested in 
Chapters 3–5. This would provide another example of non-CNS functions of the neurotrophin 
family, along with the endocrine and immune system roles outlined in Chapter 1.1.4. 
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CHAPTER 8 
DISCUSSION AND CONCLUSIONS 
8.1 Main outcomes 
This thesis provides evidence of genetic and functional interactions — in vivo and in cell 
culture — between the Drosophila neurotrophins (DNTs) and the Kek family, as DNT 
receptors, in the central nervous system (CNS). Specifically, it provides functional evidence 
of neurotrophic roles of Kek6 in axon guidance and behaviour, and of a role for Kek4 in 
developmental timing. Individual findings by gene are summarised in Table 8.1.  
These findings are important because Drosophila was long presumed to lack neurotrophin-
binding Trk receptors. Initially, Drosophila melanogaster was considered too simplistic to 
require and use neurotrophism (Jaaro et al., 2001). Furthermore, analysis of the Drosophila 
kinome showed a complete absence of proteins containing a Trk family TyrK (Manning et al., 
2002). Nonetheless, evidence emerged of neurotrophism in insects, and the Drosophila 
neurotrophins DNT1 and DNT2 were recently discovered (Hidalgo, 2002, Zhu et al., 2008). 
DNT1 and DNT2 can bind and signal via Toll receptors (McIlroy et al., 2013), but reasons to 
search for Trk proteins in Drosophila remained: vertebrate neurotrophic ligand–receptor 
interactions are promiscuous (Huang and Reichardt, 2001), suggesting that Drosophila 
neurotrophin interactions might also require other receptors ; Trk proteins were found in non-
insect invertebrates (for example, (Kassabov et al., 2013)), and thus Trks are evolutionarily 
ancient ; and domain shuffling from ancestral Trk superfamily proteins yielded Drosophila 
leucine rich repeat (LRR) and immunoglobulin (Ig)-containing (LIG) proteins (Dolan et al., 
2007), of which the Kek family cluster phylogenetically with the vertebrate Trks, despite 
lacking intracellular TyrK domains (Mandai et al., 2009). Evidence provided here suggests 
that the Kek proteins are insect Trks. 
Table 8.1  Summary of thesis, by gene 
 
Gene Expression Figure Functional analysis Figure Genetic analysis Figure 
kek1 Embryo: 
CNS: VNC and brain; neuronal 
nuclei 
PNS: chordotonal organs 
Heart precursors 
3.4,3.5 Axon guidance assay: 
LOF/GOF mutants exhibit ISNb phenotypes 
GMRGal4 assay: 
UASkek1 induces a rough eye phenotype 
 
6.4 
 
4.32 
SurvivaI Index assay: 
Neuronal overexpression of kek1:  
no effect 
 
4.33 
kek2 Embryo: 
CNS: VNC and brain; neuronal 
nuclei 
PNS: ventral clusters 
Muscle precursors 
3.6 GMRGal4 assay: 
No phenotype 
 
4.32 
SurvivaI Index assay: 
Neuronal overexpression of kek2 rescues 
DNT2–/–DNT1–/– lethality 
 
4.33 
kek3 Embryo:  
weak/absent expression 
Larva: 
CNS: Central brain and glia 
surrounding VNC; central optic lobe 
axon 
3.7 Locomotion assay: 
kek3f07029 interacts with DNTs  
kek3 nulls exhibit adult, but not larval, phenotypes 
Luciferase assay: 
DNT2 induces Kek3≡Toll6 signalling in culture 
GMRGal4 assay: 
No phenotype 
 
3.12 
5.8,7.8 
 
4.47 
 
4.32 
SurvivaI Index assay: 
kek3f07029 interacts with DNTs 
kek312 and kek326 interact with DNTs 
Neuronal overexpression of kek3 rescues 
DNT2–/–DNT1–/– lethality 
 
 
3.11 
5.6 
4.33 
kek4 Embryo:  
mid/hindgut, ring gland precursors 
Larva:  
CA and CC of ring gland 
7.1 Locomotion assay: 
kek4f05454interacts with DNTs  
kek4 nulls exhibit adult and larval locomotion 
phenotypes 
Luciferase assay: 
DNT2 induces Kek4≡Toll6 signalling in culture 
Ring gland assays: 
Kek4 delays developmental timing 
Kek4 inhibits juvenile hormone signalling 
Kek4 controls cell number, but not body size 
GMRGal4 assay: 
No phenotype 
 
3.12 
5.8,7.7 
 
 
4.47 
 
7.2,7.3 
7.4 
7.5,7.6 
 
4.32 
SurvivaI Index assay: 
kek4f05454 interacts with DNTs 
kek420 and kek423 interact with DNT1 
Neuronal overexpression of kek4:  
no effect 
 
3.11 
5.6 
4.33 
kek5 Embryo: 
CNS: contralateral neurons and 
longitudinal fascicles of VNC 
PNS: chordotonal organs and 
ventral/lateral neuron clusters 
Larva: 
VNC and central brain 
3.8 Locomotion assay: 
kek5e02482 does not interact with DNTs 
Luciferase assay: 
DNT2 induces Kek5≡Toll6 signalling in culture 
GMRGal4 assay: 
No phenotype 
 
3.12 
 
4.47 
 
4.32 
SurvivaI Index assay: 
kek5e02482 interacts with DNTs 
Neuronal overexpression of kek5 may 
rescue DNT2–/–DNT1–/– lethality 
 
3.11 
4.33 
kek6 Embryo: 
CNS: brain and VNC: longitudinal 
axons, pioneer neurons and 
motorneurons 
6.1,6.2 Axon guidance assay: 
LOF/GOF mutants exhibit ISNb phenotypes 
LOF rescues DNT1 overexpression ISNb phenotypes 
Kek6 is upstream of Ras and PI3K 
 
6.4 
6.5 
6.6 
SurvivaI Index assay: 
kek634 interacts with DNT2 and tie 
DNT1 GOF rescues kek6 null lethality 
Rho and Cdc42 rescue kek6 lethality 
 
5.7 
5.7 
5.7 
Locomotion assay: 
LOF/GOF mutants exhibit locomotion phenotypes 
Kek6 function is neuronal 
kek6 interacts with DNT2 
Kek6 is upstream of Ras 
Luciferase assay: 
DNT2 induces Kek6≡Toll6 signalling in culture 
GMRGal4 assay: 
No phenotype 
 
6.7 
6.8 
6.9 
6.10 
 
4.47 
 
4.32 
kek6 is neuronal 
Neuronal overexpression of kek6 rescues 
DNT2–/–DNT1–/– lethality 
5.7 
4.33 
lbk Embryo: 
CNS: absent 
Epidermis and/or muscle precursors 
or PNS neuronal clusters 
3.3   SurvivaI Index assay: 
lbkPGS50104 interacts with DNTs 
 
3.11 
CG15744 Embryo: 
CNS: VNC and brain; undefined 
signal 
Hindgut 
3.1     
CG16974 Embryo: 
CNS: absent 
Epidermis and/or PNS neuronal 
clusters Muscle precursors and/or 
muscle attachment sites 
3.2     
rk Embryo: 
CNS: weak signal in early embryo 
VNC 
Brain and hindgut signal by stage 16 
3.9   SurvivaI Index assay: 
rk4 does not interact with DNTs 
 
3.11 
wgn Embryo: 
CNS: select nuclei in VNC, exit glia 
Oenocytes and tracheal precursors 
Heart precursors 
Lateral muscles/attachment sites 
3.10   SurvivaI Index assay: 
wgne00637 does not interact with DNTs 
 
3.11 
CG17839 Embryo: 
CNS: VNC and brain 
3.9     
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That a TyrK-lacking protein could be considered a Trk might be controversial. However, 
these results are important because they provide an invertebrate example of a functional role 
for truncated Trks, naturally expressed TyrK-less Trk isoforms found in vertebrates (Ohira 
and Hayashi, 2009). Truncated Trks were originally assumed to be dominant negative Trk 
receptors that function as ligand sinks. This work indicates that, in the absence of full length 
Trks, invertebrate truncated Trks can function as neurotrophin receptors. 
In the absence of full length Trks in insects, Drosophila neurotrophin signalling therefore 
occurs via NGF CysKnot-containing ligands and LIG-containing truncated Trks — the Keks 
— in addition to Tolls. This work is the first to support this neurotrophic model in 
Drosophila, supports the recognition of neurotrophism outside of the vertebrates, and 
indicates the importance of evolutionary conservation of protein modules in neurotrophism 
throughout the metazoa. 
8.2 The LIGs function in the Drosophila nervous system  
Data in this thesis reveal that the dLIGs have distinct roles in the Drosophila nervous system. 
Each gene had a distinct expression profile; only kek1 overexpression in the eye induced a 
rough eye phenotype; kek4 mutants affected JH signalling and developmental timing in 
larvae; kek6 mutants displayed motor axon misrouting phenotypes, whereas kek1 mutants did 
not; and both kek4 and kek6 mutant larvae had locomotion phenotypes, whereas kek3 mutant 
larvae did not. Thus, diversification of Kek functions in the nervous system paralleled their 
duplication. It was not determined whether kek1–3, kek5 and kek6 have larval brain 
expression or whether the Kek family are involved in adult brain function. It would therefore 
be a natural extension of the project to determine the roles of these genes in such contexts. For 
Kek6, the first step would be to determine synaptogenesis phenotypes in the larval 
neuromuscular junction (NMJ), a common paradigm for testing the roles of genes in synaptic 
plasticity. Furthermore, the function of Kek3 in the adult should be tested: kek3 loss of 
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function had no effect on larval locomotion, but Kek3 was required for normal adult 
behaviour. It is possible, therefore, that the temporal expression of kek3 function is delayed 
compared to the other Kek protein family members and that kek3 is required in the adult. 
Indeed, FlyAtlas and modENCODE data suggest that kek3 is weakly expressed in the larval 
brain and abundantly expressed in the adult brain (Celniker et al., 2009, Chintapalli et al., 
2007). 
The specificity of lambik and CG16974 expression in the peripheral nervous system (PNS) 
warrants further attention. In particular, localized expression to the chordotonal organs 
suggests that these proteins are required for behavioural responses. Chordotonal organs are 
internal mechanoreceptors, including stretch receptors, and provide sensory feedback to the 
locomotor central pattern generator circuit (Field and Matheson, 1998, Caldwell et al., 2003). 
Thus, lambik and CG16974 may also exhibit locomotion phenotypes or, via their stretch 
receptor role, be required at the critical weight checkpoint. The roles of lambik and CG16974 
in sensory perception would be interesting to pursue further. The genetic interactions 
suggested by lbk–DNT1– and lbk–DNT2– double mutants suggests an interplay between the 
PNS and the neurotrophins, thereby linking the roles of the DNTs in the CNS with systemic 
growth and behaviour. In vertebrates, peripheral nerves are enriched in truncated Trks, and 
NGF supports the growth of PNS neurons throughout development and into adulthood 
(Raivich and Kreutzberg, 1993, Valenzuela et al., 1993). 
8.3 dLIGs and the DNTs 
The 12 candidate receptor genes were initially characterised with a view to selecting 
candidates for further study. The candidates were chosen according to the following criteria: 
1. dLIG expression enriched in the neurons of the CNS. DNTs are expressed in neuronal 
targets and have trophic effects on innervating neurons, including motor neurons, and 
interneurons within the ventral nerve cord (VNC; Zhu et al. (2008). Neurotrophin–
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receptor signalling can also be autocrine, or create coincident positive feedback loops; 
for example, during exercise and learning, synaptic BDNF upregulates transcription of 
TrkB and BDNF itself (Vaynman et al., 2003). Receptors with complementary or 
coincident expression profiles to the DNTs would therefore be strong candidates to 
function as DNT receptors. By this criterion, lbk, CG16974, rk, CG17839 and wgn 
were eliminated as candidates because they were detected primarily in the PNS, glia or 
were absent from the VNC. This does not preclude a role for these genes in the 
nervous system, but allowed the project to focus on a subset of candidates. 
2.  dLIGs with a role in CNS development and function. The DNTs maintain neuronal 
survival and targeting (Zhu et al., 2008). Putative receptors, therefore, are likely to 
share similar or related phenotypes in CNS development, although ligand and receptor 
promiscuity, antagonistic functions of ligands and domineering non-autonomous 
phenotypes caused by receptor mutations must be considered. Roles for the dLIGs in 
the CNS were initially selected using adult locomotion as a phenotype. These data 
highlighted the Kek protein family as the most suitable receptor candidates. 
Subsequently, kek6 was shown to be required for motor axon targeting and correct 
locomotion behaviour in larvae. 
3.  dLIGs that interact with the DNTs in vivo and/or in cell culture. This was assessed by 
genetic interactions and using lethality as a phenotype. Survival assays revealed 
transposon-derived alleles of kek3, kek4, kek5 and lambik genetically interacted with 
specific DNT alleles. Subsequent genetic analysis with Flippase recognition target 
(FRT)-derived null alleles confirmed the importance of kek3 and kek4 genetic 
interactions with the DNTs. Furthermore, survival indices of kek6–DNT double 
mutants revealed a potential interaction between Kek6 and DNT1.  
dLIG–DNT interactions were next tested in cell culture, by expressing Kek≡Toll6 
chimaeras, stimulating with DNT protein, and measuring activation of NFkB 
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signalling as readout. NFkB has a role in synaptic plasticity and is conserved 
throughout the bilateria (for example, NFkB is involved in the induction of long term 
memory in crabs (Freudenthal and Romano, 2000)). In flies, NFkB signalling is 
triggered in response to DNT binding to Toll6 and Toll7 (McIlroy et al., 2013). It is 
not known whether endogenous Kek proteins can signal via NFkB, although this is 
unlikely due to the absence of appropriate intracellular domains in full length Keks. 
Nonetheless, the ability of Kek≡Toll6 chimaeras to signal through NFkB indicated an 
ability of the extracellular domain of Kek proteins, Kek3 and Kek6, in particular, to 
functionally interact with the DNTs.  
 According to these criteria, the Kek protein family were selected for further study.  
  
Putative DNT–Kek interactions do not preclude the possibility of alternative Kek ligands. 
Vertebrate neurotrophins have a conserved six cysteine CysKnot homodimer structure, 
defined by the first defined neurotrophin, NGF (Sun, 1995). Active DNT1, DNT2 and Spz 
form CysKnot dimers, and the tertiary structure of Spz overlaps closely with NGF (Arnot et 
al., 2010, Zhu et al., 2008). The Kek protein family may interact with other CysKnot dimers. 
Alternatively, EGF- or Dpp-like TGFβ ligands may signal through the Kek family. Kek1 
interacts with EGFR, whereas Kek5 extracellular LRRs bind and sequester bone 
morphogenetic protein (BMP) (Derheimer et al., 2004, Evans et al., 2009, Ghiglione et al., 
1999, Ghiglione, 2003). The possibility of Kek ligand promiscuity warrants further 
investigation.  
 
8.4. Downstream signalling of Kek6 
Ras and phosphatidylinositol 3-kinase (PI3K) belong to many essential pathways, including 
the actin cytoskeleton-regulating pathways. It was therefore unsurprising that dominant 
negative forms of these hub proteins disrupted phenotypes caused by kek6 overexpression in 
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neurons. More surprising was the absence of an effect caused by dominant negative Cdc42, 
Rac or Rho, which should suppress ectopic cytoskeletal rearrangements during growth cone 
targeting in a kek6 neuronal overexpression background. 
 
In canonical Trk signalling, ligand-induced receptor activation leads to Ras, PI3K and 
phospholipase Cγ (PLCγ; signalling (Figure 1.2). Furthermore, the recruitment of the SHC–
SOS complex to phosphorylated tyrosine residues on the intracellular TyrK domain facilitates 
the activation of Rac and subsequent Rho-mediated cytoskeletal rearrangements. Rac GEF 
activity of SOS is further enhanced by Ras signalling through PI3K (Nimnual et al., 1998). 
Thus, phenotypes caused by excessive signalling could be rescued by expression of dominant 
negative Rho, Rac or Cdc42 alleles. However, dominant negative Rho, Rac or Cdc42 did not 
rescue axon misrouting phenotypes induced by neuronal overexpression of kek6. By contrast, 
binding of BDNF to truncated TrkB.T1 provokes its dissociation from RhoGDI1, an inhibitor 
of Rho, thus permitting Rho inactivation (Figure 1.6; Ohira et al. (2006)). If the mechanism of 
Kek6 signalling resembles that of truncated Trks, activated Kek6 signalling might also result 
in the inhibition of Rho. This might explain why dominant negative Rho did not rescue kek6 
overexpression phenotypes in these assays. To test this hypothesis, simultaneous elavGal4-
driven kek6 and constitutively-activated rho should be compared for axon guidance defects 
and locomotion phenotypes; kek6 overexpression-mediated RhoGTPase inhibition could be 
rescued by expression of activated rho. Since Rac and Cdc42 are required for axon growth, it 
is possible that dominant negative isoforms in these assays generated axon misrouting 
phenotypes independently of aberrant Kek6 levels. 
 
The ability of Kek6 to signal via CREB was not considered and would be a logical extension 
of the work. CREB proteins are associated with memory formation, a role that is conserved 
from mammals to Lymnaea, and neurogenesis (Dworkin and Mantamadiotis, 2010, Kandel, 
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2012, Merz et al., 2011). CREB transcription increases in response to BDNF signalling 
through TrkB (Vaynman et al., 2003), linking the CREB pathway to the neurotrophins. CREB 
signalling can be activated by phosphorylated ERK, CREB-1 is phosphorylated by protein 
kinase A and the memory suppressor protein CREB-2 is downregulated by MAPK signalling 
(Kandel, 2012, Xing et al., 1998). The role of Kek signalling in the CREB pathway via Ras 
therefore warrants investigation. 
As previously discussed, Kek6 may signal to the actin cytoskeleton directly via a RhoGDI-
type mechanism. Alternatively, since LRR and Ig domains are associated with protein–protein 
interactions, and the extracellular domain of Kek1 can bind EGFR, Kek6 may function via a 
co-receptor (de Wit et al., 2011, Ghiglione, 2003, Kobe and Kajava, 2001, Vaughn and 
Bjorkman, 1996, Williams and Barclay, 1988). The protein–protein interaction prediction 
database STRING (Search Tool for the Retrieval of Interacting Genes) is unable to identify 
interacting partners with Kek6 (Szklarczyk et al. (2011); http://string-db.org/).  
The effect on protein function of combining protein domains with distinct roles is synergistic 
(Bashton and Chothia, 2007). As such, single domain proteins from the same protein family 
have a 67% chance of having similar functions, whereas two multidomain proteins with one 
domain in common have similar functions only 35% of the time (Hegyi and Gerstein, 2001). 
For example, ‘paired receptors’, which have similar extracellular domains but have different 
cytoplasmic domains, often have opposing functions as activators and inhibitors (Akkaya and 
Barclay, 2013). These opposing functions arise because of pathogen-driven evolutionary 
pressures, and are implemented through protein–protein communication via their extracellular 
Ig domains or specific amino acids in their transmembrane domains (Akkaya and Barclay, 
2013, Nakayama et al., 2007). These receptors may hint at potential Kek6-interacting 
partners.  
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‘Activating paired receptors’ with one or more Ig domains contain a characteristic positively 
charged arginine, lysine or histidine in their transmembrane domain (Takai, 2005). These 
residues interact with the ITAM (immunoreceptor tyrosine-based activation motif) domains of 
adaptor proteins and co-receptors. ‘Inhibitory paired receptors’, by comparison, contain 
cytoplasmic ITIM domains, which recruit phosphatases upon ligand binding. An example of 
an inhibitory paired receptor is PIR-B, which interacts with Toll-like receptor 2 (TLR-2) in 
response to Staphylococcus aureus infection to modulate cytokine release (Nakayama et al., 
2007).  
ITAM domains are characterised by the consensus motif YxxI/Lx(6–12)YxxI/L, and ITIM 
domains by S/I/V/LxYxxI/V/L (Takai, 2005). The Kek proteins lack ITAM and ITIM 
sequences. However, the transmembrane domains of the Kek proteins are rich in positively-
charged lysine residues (Figure 2.9), and thus may interact with ITAM domain-containing 
adaptors or co-receptors, in the manner of activating paired receptors. An example of 
receptor–ITAM domain binding in Drosophila involves Draper, which recognises and 
promotes the engulfment of axonal debris and dying neuronal cells (Logan et al., 2012). The 
intracellular ITAM domain of Draper forms a complex with the cytosolic TyrKs Src42A and 
Shark (Ziegenfuss et al., 2008). Src42A is predicted to interact with Ras85D (Therrien et al. 
(2000); and Shark has a role upstream of the JNK pathway during dorsal closure (Fernandez 
et al., 2000). 
An alternative co-receptor is Tie. Tie was discovered by homology to the TyrK of PDGFR, 
and is characterised by an intracellular TyrK, a transmembrane domain, and no recognisable 
extracellular domains (Mitsuhiro et al., 1994). It therefore resembles the intracellular portion 
of Trks, although predicted phosphorylation sites differ between the TyrK domains of Tie and 
human TrkB (NetPhos2.0; Blom et al. (1999)). Known roles of Tie include border cell 
migration in egg chambers, and it is involved in JAK/STAT and Hedgehog signalling (Wang 
et al., 2006, Nybakken et al., 2005). In this thesis, Tie was briefly studied in combination with 
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kek6 alleles. kek6 viability was slightly reduced in kek6Tie double mutants, but this 
combination had no discernible locomotion phenotype compared with kek634/Df(kek6) alone. 
In Chapter 5, DNT2–/Df(DNT2)kek634/Df(kek6) double mutants had impaired viability compared 
with kek6 loss alone (Figure 5.7). These data might suggest that Kek6 is a receptor for DNT1: 
if DNT2 simply bound Kek6, then the phenotype of loss of DNT2 should be equivalent to that 
of kek6 mutants, and of the double mutants. If Kek6 binds DNT1, then losing both DNT2 and 
Kek6 in the double mutants is equivalent to losing two ligand-receptor pathways rather than 
one. However, this conclusion is difficult to draw in the light of axon misrouting data 
presented in Chapter 6, and is further complicated by the fact that DNTs bind Toll6 and Toll7 
receptors (McIlroy et al., 2013). Overexpression of DNT1 in muscles resulted in 
intersegmental nerve b (ISNb) projection misrouting, which was rescued in a kek6 null 
genetic background. This is consistent with the fact that the loss of a receptor should abrogate 
the effect of exogenous ligand. However, kek63424BGal4 x UASDNT1CK3′+;kek635 rescued 
misrouting to the level of the yw control, rather than to the level of kek6 loss of function alone 
(Figure 6.4). DNT1 binds the Toll7 receptor, also in the context of motor axon targeting 
(McIlroy et al., 2013). One possible interpretation for these data is that Kek6 may interact 
with Toll7, modulating its function. On the other hand, luciferase assay data revealed that 
Kek6 can bind DNT2 (Figure 4.5). If Kek6 binds DNT2, DNT2–/Df(DNT2)kek634/Df(kek6) double 
mutants should not have different phenotypes to kek6 or DNT2 single mutants. However, in 
the locomotion assay, DNT2–/Df(DNT2)kek634/Df(kek6) larvae crawled significantly slower than 
kek634/Df(kek6) single mutants. These conflicting data suggest that Kek6 ligand binding is 
promiscuous, that other receptors are required for Kek6 function and/or Kek6 is a co-receptor 
that modulates other receptors, perhaps Toll6 and Toll7. 
One possibility to test whether Kek6 may modulate Toll6 or Toll7 function is to manipulate 
Toll6 or Toll7 and Kek6 simultaneously. If Kek6 modulates Toll6 or Toll7, this could result 
in synergistic activation or in repression, in two possible scenarios: (1) If Kek6 represses 
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Toll6 function: the rescue of axon targeting in kek63424BGal4 x UASDNT1CK3′+;kek635 may 
result from the enhancement of the DNT2–Toll6 pathway in the absence of Kek6, plus the 
combined activation of the Toll7 pathway when DNT1 is overexpressed (McIlroy et al., 2013, 
Zhu et al., 2008). (2) If Kek6 activates Toll7 function: the loss of kek6 may impair the 
function of Toll7 if DNT1 is in limiting levels, and this is overcome by the overexpression of 
DNT1, which activates Toll7.  
To test the hypothesis that Kek6 modulates Toll6 or Toll7, kek6 and toll6 or toll7 could be 
simultaneously overexpressed in neurons (e.g. elavGal4>UASkek6RFP;UASToll6). If Kek6 
negatively modulates Toll6, then kek6 overexpression should partially rescue any phenotype 
caused by the overexpression of toll6 (for example, upregulation of Toll6 downstream 
signalling, as measured by immunolabelling and detection by Western blot). If Kek6 were to 
promote Toll7 signalling, then overexpression of both toll7 and kek6 could result in a stronger 
phenotype than overexpressing either kek6 or toll7 alone. For instance, overexpression of one 
dose of either toll6 or toll7 in neurons (with elavGAL4) is not sufficient to cause misrouting 
phenotypes in axon guidance (McIlroy et al., 2013). To affect axon guidance, either two 
copies of UASToll6 or two copies of GAL4 (Toll7GAL4;elavGAL4) had to be employed 
(McIlroy et al., 2013). If Kek6 enhances the functions of Toll6 or Toll7, expressing both kek6 
and toll6 or toll7 may induce a stronger axon guidance phenotype than expressing either of 
them alone. 
8.5 Evolution of domain shuffling 
Exon shuffling by intronic recombination, gene rearrangements and intronic mutations 
expands proteomes. Organism complexity correspondingly increases. But complexity alone is 
not an advantageous trait without a selective pressure that necessitated expanded domain 
architecture repertoires: thus, what is the evolutionary driving force behind domain shuffling? 
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Domain shuffling allows for rapid novelty in protein evolution, which is required for the 
myriad self–non-self and antigen recognition combinations for which the immune system is 
responsible (Soding and Lupas, 2003). This same process drives the evolution of pathogen 
surface proteins seeking to evade immune capture. Alternative splicing of Ig domain proteins 
is essential in Drosophila innate immunity, and the adaptive immune system of jawless 
vertebrates relies on the recombination of a large cluster of diverse LRR sequences (Hirano et 
al., 2011, Kurata, 2010). Indeed, since LRRs and Igs are involved in protein–protein 
interactions, they are frequently involved in the innate immune system (Nurnberger et al., 
2004). Pattern recognition receptors (PRRs), such as Tolls and TLRs, which recognise 
microbial-associated molecular patterns, are typically rich in LRRs (Dishaw et al., 2012, 
Tauszig et al., 2000). Furthermore, the innate immune system of Amphioxus has an 
extensively expanded repertoire of intracellular PRRs compared with sea urchin, of which 
LIG proteins are one of the most expanded families (Dishaw et al., 2012, Huang et al., 2008, 
Huang et al., 2011b). 
On a molecular level, the immune and nervous systems have many common links. Many gene 
and protein families have roles in both immunity and the nervous system. For example, in C. 
elegans, innate immunity and pathogen avoidance is regulated by NPR-1+ neurons (Aballay, 
2009, Styer et al., 2008). Some mammalian TLRs, which are involved in the innate immune 
system, are expressed and function in neurons (Ma et al., 2006); and Drosophila Toll6 and 
Toll7 can interact with the DNTs in the CNS (McIlroy et al., 2013). p75NTR belongs to the 
tumour necrosis factor (TNF) receptor superfamily, members of which are primarily involved 
in the innate/adaptive immune system, making the role of p75NTR in nervous system 
development ‘atypical’ (Bothwell, 2006). It is uncertain whether TNF receptor superfamily 
roles in immunity or the nervous system are the ancestral function. 
The CNS is immunologically active: the blood–brain barrier, which is rich in LRR and Ig 
domain-rich cell–cell adhesion molecules, is the first line of defence against brain infections 
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and CNS injuries (Lampron et al., 2013, Schulze and Firth, 1993). Microglia, astrocytes, 
oligodendrocytes, endothelial cells and neurons also express functional PRRs (Hanamsagar et 
al., 2012). When the pro-inflammatory cytokine IL-1β is activated in response to TLR 
activation, subsequent signalling enhances the production of insulin-like growth factor-1 and 
NGF (Mason et al., 2001, Spranger et al., 1990). 
The characteristics that make tandem, shuffled domains suitable for innate and adaptive 
immunity also support nervous system functions. For example, alternative splicing can create 
functionally distinct cell adhesion molecules, such as FasII, in neurons (Walsh and Doherty, 
1997). Alternative splicing of Ig and LRR domains also underlie neurite self-avoidance during 
neurodevelopment (Zipursky and Grueber, 2013). DSCAM, which is an Ig domain-rich 
transmembrane protein required for neuronal connectivity, has >38,000 splice isoforms 
(Wojtowicz et al., 2004), permitting complexity of neuron to neuron contacts. Indeed, the 
mechanism of alternative splicing balances the mathematical conundrum posed within the 
nervous system: the human brain, for example, comprises 1012 neurons with at least 1,000 
more connections, but axonal and synaptic development rely on a limited repertoire of 
signalling factors (Loya et al., 2010). Such components are enriched in Ig and/or LRR 
domains, for example, NCAM, Semaphorins, Robo and Slit (Tessier-Lavigne and Goodman, 
1996). Alternative splicing amplifies this repertoire, often from single loci, to thousands of 
components required throughout the development of connectivity. In vertebrates, for example, 
alternative splicing of neurexins and neuroligins mediates synapse differentiation. In 
Drosophila, alternative splicing of Robo3 generates proteins with reciprocal functions, as 
Robo3.1 promotes midline crossing of axons, whereas Robo3.2 repels contralateral 
commissural neuron growth cones once they have crossed the midline (Chen et al., 2008).  
Thus, the mechanisms that underlie the diversity of protein domains in the immune system 
overlap with the nervous system. A system that creates cell–cell signalling complexity to 
evade infection produced domains and modules that could be co-opted by domain shuffling 
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into proteins with roles in the nervous system, and/or vice versa. It is unclear which arose 
first, although it is interesting that the ability to signal via action potentials, and thus a 
defining characteristic of the nervous system, is conserved throughout the eukaryotes 
(including in plants; Volkov et al. (2013)). Here, I showed that a protein family unique to the 
insects that features commonly shuffled domains is required for nervous system development. 
8.6 Implications: Evolution of receptors in the nervous system by domain shuffling 
Above I considered the Keks as co-receptors or novel modulators of DNT receptor signalling, 
focusing on models of Kek6–Toll6/7 interactions. Alternatively, Keks may function as ligand 
sinks and dominant negative inhibitors of DNT signalling, as was the presumed role of 
truncated Trks on their discovery; this would tally with the known antagonistic roles of Kek1 
and Kek5. Because they are unique to the insects, the Keks may be evolutionary artefacts that 
arose by retrotransposition of truncated Trk-like proteins and that were subsequently retained 
in the insect lineage. Below, I consider the evolution of the Trk family, and of Keks as Trk-
like proteins, 
The TyrK of Trks, which has traditionally been used as the defining feature from which to 
identify Trk orthologues, is one of three domains that are essential for its functions. The 
remaining domains, Igs and LRRs, in combination, are essential for ligand identification and 
binding to Trks. Thus, the contention that there are no Trks in Drosophila is not very helpful. 
Whilst there may not be full length canonical Trks, by comparing full length protein 
sequences that include LIG modules, the Kek protein sequences cluster phylogenetically with 
the vertebrate Trks (Mandai et al., 2009), implying that, regarding the extracellular domain, 
the Keks are possibly orthologues of TrkB.T1. 
Domain shuffling throughout evolution has created separate protein families with distinct 
roles and highlights modular conservation between species. On a smaller scale, domain 
splicing and recombination mediate receptor specificity to neurotrophins (Clary and 
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Reichardt, 1994). For example, TrkA has an alternative splice form containing an additional 
18bp exon that translates to the extracellular domain. This mediates the specificity of TrkA 
ligand binding: NT-3 binding requires the translation of the exon, whereas NGF does not 
(Clary and Reichardt, 1994). TrkB splice variants also have different affinities for BDNF 
(Strohmaier et al., 1996). TrkB.T1, TrkB.T2 and TrkC.T1 are functional isoforms with roles 
distinct from full length Trks (Ohira and Hayashi, 2009). In addition, cell type-specific 
binding of co-receptors such as Linx mediate neurotrophic signalling in vertebrates (Mandai 
et al., 2009). Thus, the context-specific use of protein domains and peptides complements the 
promiscuity of neurotrophin ligand–receptor interactions that underlie neuronal network 
complexity. In Drosophila, LIG proteins may have arisen from a common metazoan ancestor, 
and the generation of lineage-specific proteins by domain shuffling permitted the co-option of 
the LIG module for novel functions. 
This domain shuffling yielded Kek6, which can interact with the DNTs in vivo and is required 
for motor axon targeting and locomotion; Kek4, which is required in the ring gland for 
temporal regulation of development; and Lbk and CG16974 in the PNS. I have also shown 
that Kek3 and Kek4 can functionally interact with the DNTs in cell culture and in vivo. 
Despite the lack of an intracellular TyrK, therefore, the Kek protein family appear to be 
functional truncated Trk-like proteins. The LIG module is thus a crucial component of the 
nervous system throughout metazoan proteomes. 
It is unclear whether the ancestral protein from which the Trk and Kek families arose 
contained an intracellular kinase. On the one hand, the conservation of the TyrK in Trk and 
Trk-like proteins in other invertebrates suggests that an ancestral kinase was lost in the insect 
lineage (Figure 8.1) (Kassabov et al., 2013, van Kesteren et al., 1998, Wilson, 2009). The loss 
of the TyrK would have impacted the signalling ability of these proteins and necessitated 
signalling diversity by means of, for example, gene duplication, co-receptor binding or ligand 
promiscuity. On the other hand, truncated Trks are naturally occurring isoforms in vertebrates 
Ancestral Truncated Trk
Ancestral Trk
?
TrkProtostome Trk Kek1-6
InsectsInsectsInsectsInsects Non-insects Non-insects
Trk.T1
Recombination?
Trk.T1Kek1-6
Retrotransposition Alternative 
splicing
Figure 8.1  Evolution of the Trk family
Potential evolutionary expansion of the Trk and Trk-like families in the metazoa. Kek proteins 
are Trk-like proteins that lack an intracellular tyrosine kinase (TyrK) domain. Potential 
mechanisms of TyrK acquisition or loss from an ancestral Trk or truncated Trk are shown.
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with distinct roles. Such roles could be an ancestral function that was subsequently 
supplemented by the addition of a kinase, except in the insects (Figure 8.1). If the former is 
true, Drosophila may encode further receptors that are distinct from the Trk family TyrK 
domain-containing receptor TyrKs (RTKs) but fulfil the role of the Trk TyrK, and may 
function as co-receptors to the Kek proteins; in the latter scenario, other protostomes may 
encode functional truncated Trk-like proteins comprising extracellular LIG motifs but lack an 
intracellular kinase. Given the presence of an LIG module-lacking Trk-like transmembrane 
TyrK protein in Aplysia, it would be interesting to explore metazoan proteomes further for 
conservation of truncated proteins. Kek downstream signalling must next be investigated, to 
determine whether the mechanism of truncated Trk signalling has been conserved in 
Drosophila: if so, there is a possibility that this is an ancestral role or that the Keks arose from 
truncated Trk retrotransposition. If Kek proteins signal differently to truncated Trks, this 
would suggest that the TyrK-lacking domain of Kek proteins is a recent loss from a metazoan 
TyrK-containing Trk precursor and that the truncated Kek protein has been co-opted for 
another role. Last, the importance of the LIGs in modulating vertebrate neurotrophic 
signalling strongly suggests that the dLIGs modulate Toll6 and Toll7; this should be explored 
further.  
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Statistical tests, Chapter 3 
GENOTYPE n COMPARISON  NORMALITY H.OF VAR. 
DESCRIPTIVE 
STATISTICS 
DF & TEST 
VALUE P 
MULTIPLE 
COMPARISONS & 
CORRECTIONS 
Survival index 
Genotype Pupae   N/A N/A categorical data χ2 P χ2 Bonf.x22 
DNT1[55]/TM6B 446 All together     X=444.984 d.f.=19 <0.001   
DNT2[e03444]/TM6B 657 
          DNT2[e03444]DNT1[41]/TM6B 494 
          w;lbk[PGSV250104];+/SM6aTM6B 186 
          w;lbk[PGSV250104];DNT1[55]/ 
SM6aTM6B 424 w;lbk[PGSV250104];+/SM6aTM6B vs w;lbk[PGSV250104];DNT1[55]/SM6aTM6B 
     
X=121.455 d.f.=1 
 
<0.001 <0.001 
w;lbk[PGSV250104];DNT2[e03444]/
SM6aTM6B 316 w;lbk[PGSV250104];+/SM6aTM6B vs w;lbk[PGSV250104];DNT2[e03444]/SM6aTM6B 
     
X=92.252 d.f.=1 
 
<0.001 <0.001 
  
DNT1[55]/TM6B vs w;lbk[PGSV250104];DNT1[55]/SM6aTM6B 
     
X=113.521 d.f.=1 
 
<0.001 <0.001 
  
DNT2[e03444]/TM6B vs w;lbk[PGSV250104];DNT2[e03444]/SM6aTM6B 
     
X=47.116 d.f.=1 
 
<0.001 <0.001 
w;kek3[f07029];+/SM6aTM6B 184 
          w;kek3[f07029];DNT1[55]/ 
SM6aTM6B 182 w;kek3[f07029];+/SM6aTM6B vs w;kek3[f07029];DNT1[55]/SM6aTM6B 
     
X=14.824 d.f.=1 
 
<0.001 <0.001 
w;kek3[f07029];DNT2[e03444]/ 
SM6aTM6B 294 w;kek3[f07029];+/SM6aTM6B vs w;kek3[f07029];DNT2[e03444]/SM6aTM6B 
     
X=0.004 d.f.=1 
 
0.952 20.944 
  
DNT1[55]/TM6B vs w;kek3[f07029];DNT1[55]/SM6aTM6B 
     
X=22.782 d.f.=1 
 
<0.001 <0.001 
  
DNT2[e03444]/TM6B vs w;kek3[f07029];DNT2[e03444]/SM6aTM6B 
     
X=9.397 d.f.=1 
 
0.002 0.044 
w;kek4[f05454];+/SM6aTM6B 158 
          w;kek4[f05454];DNT1[55]/ 
SM6aTM6B 93 w;kek4[f05454];+/SM6aTM6B vs w;kek4[f05454];DNT1[55]/SM6aTM6B 
     
X=19.299 d.f.=1 
 
<0.001 <0.001 
w;kek4[f05454];DNT2[e03444]/ 
SM6aTM6B 189 w;kek4[f05454];+/SM6aTM6B v w;kek4[f05454];DNT2[e03444]/SM6aTM6B 
     
X=34.621 d.f.=1 
 
<0.001 <0.001 
  
DNT1[55]/TM6B vs w;kek4[f05454];DNT1[55]/SM6aTM6B 
     
X=27.192 d.f.=1 
 
<0.001 <0.001 
  
DNT2[e03444]/TM6B vs w;kek4[f05454];DNT2[e03444]/SM6aTM6B 
     
X=26.162 d.f.=1 
 
<0.001 <0.001 
kek5[e02482];;+/TM6B 177 
          kek5[e02482];;DNT1[55]/TM6B 537 kek5[e02482];;+/TM6B vs kek5[e02482];;DNT1[55]/TM6B 
     
X=0.244 d.f.=1 
 
0.621 13.662 
kek5[e02482];;DNT2[e03444]/TM6B 194 kek5[e02482];;+/TM6B vs kek5[e02482];;DNT2[e03444]/TM6B 
     
X=38.697 d.f.=1 
 
<0.001 <0.001 
  
DNT1[55]/TM6B vs kek5[e02482];;DNT1[55]/TM6B 
     
X=1.506 d.f.=1 
 
0.22 4.84 
  
DNT2[e03444]/TM6B vs kek5[e02482];;DNT2[e03444]/TM6B 
     
X=22.368 d.f.=1 
 
<0.001 <0.001 
w;rk[4];DNT1[55]/SM6aTM6B 166 DNT1[55]/TM6B vs w;rk[4];DNT1[55]/SM6aTM6B 
     
X=12.149 d.f.=1 
 
<0.001 <0.001 
w;rk[4];DNT2[e03444]/SM6aTM6B 233 DNT2[e03444]/TM6B vs w;rk[4];DNT2[e03444]/SM6aTM6B 
     
X=0.067 d.f.=1 
 
0.796 17.512 
pBac{RB}wgn[e00637];;+/TM6B 408 
          
pBac{RB}wgn[e00637];; 
DNT1[55]/TM6B 280 pBac{RB}wgn[e00637];;+/TM6B vs pBac{RB}wgn[e00637];;DNT1[55]/TM6B 
     
X=3.842 d.f.=1 
 
0.05 1.1 
pBac{RB}wgn[e00637];; 
DNT2[e03444]/TM6B 400 pBac{RB}wgn[e00637];;+/TM6B vs pBac{RB}wgn[e00637];;DNT2[e03444]/TM6B 
     
X=3.949 d.f.=1 
 
0.047 1.034 
  
DNT1[55]/TM6B vs pBac{RB}wgn[e00637];;DNT1[55]/TM6B 
     
X=2.895 d.f.=1 
 
0.089 1.958 
  
DNT2[e03444]/TM6B vs pBac{RB}wgn[e00637];;DNT2[e03444]/TM6B 
     
X=5.136 d.f.=1 
 
0.023 0.506 
Adult locomotion: Distance 
Genotype Flies   Kurt. Skew. Levene's Mean±s.e.m. One-Way ANOVA P t-test Bonf.x15 
yw 22 All together  -0.112 -0.672 P=0.792 3742.13±217.09 
F=7.829 d.f.1=13 
d.f.2=244 <0.001   
DNT1[55] 21   -0.485 0.158  3120.85±252.50     
DNT2[e03444] 21   1.538 0.845  1801.27±217.06     
kek3[f07029] 21   -0.999 0.504  1900.56±252.22     
kek3[f07029]DNT1[55] 10 kek3[f07029]DNT1[55] vs DNT1[55]  0.871 1.026 0.433 1301.09±317.70 d.f.=29 t=4.259  <0.001 <0.001 
  kek3[f07029]DNT1[55] vs kek3[f07029]    0.357  d.f.=29 t=1.404  0.171 2.565 
kek3[f07029]DNT2[e03444] 19 kek3[f07029]DNT2[e03444] vs DNT2[e03444]  0.085 -0.455 0.525 3034.00±257.96 d.f.=38 t=-3.679  0.001 0.015 
  kek3[f07029]DNT2[e03444] vs kek3[f07029]    0.543  d.f.=38 t=-3.137  0.003 0.045 
  kek3[f07029]DNT1[55] vs kek3[f07029]DNT2[e03444]    0.751  d.f.=27 t=-4.084  <0.001 <0.001 
kek4[f05454] 23   -1.187 -0.114  2693.19±224.63     
kek4[f05454]DNT1[55] 7 kek4[f05454]DNT1[55] vs DNT1[55]  -1.02 0.508 0.318 1054.64±325.21 d.f.=26 t=4.320  <0.001 <0.001 
  kek4[f05454]DNT1[55] vs kek4[f05454]    0.364  d.f.=28 t=3.669  0.001 0.015 
kek4[f05454]DNT2[e03444] 9 kek4[f05454]DNT2[e03444] vs DNT2[e03444]  -0.894 -0.26 0.564 3252.23±379.80 d.f.=28 t=-3.508  0.002 0.03 
  kek4[f05454]DNT2[e03444] vs kek4[f05454]    0.872  d.f.=30 t=-1.299  0.204 3.06 
  kek4[f05454]DNT1[55] vs kek4[f05454]DNT2[e03444]    0.565  d.f.=14 t=-4.237  0.001 0.015 
kek5[e02482] 21   -0.496 -0.039  1796.60±191.78     
kek5[e02482]DNT1[55] 21 kek5[e02482]DNT1[55] vs DNT1[55]  -0.665 -0.262 0.387 2255.64±219.18 d.f.=40 t=2.588  0.013 0.195 
  kek5[e02482]DNT1[55] vs kek5[e02482]    0.493  d.f.=40 t=-1.576  0.123 1.845 
kek5[e02482]DNT2[e03444] 20 kek5[e02482]DNT2[e03444] vs DNT2[e03444]  -1.162 -0.015 0.166 2251.05±263.63 d.f.=39 t=-1.323  0.194 2.91 
  kek5[e02482]DNT2[e03444] vs kek5[e02482]    0.077  d.f.=39 t=-1.404  0.168 2.52 
  
kek5[e02482]DNT1[55] vs 
kek5[e02482]DNT2[e03444]    0.283  d.f.=39 t=0.013  0.989 14.835 
lbk[GSV2]50104 22   -0.226 0.12  2245.38±197.63     
wgn[e00637] 21   -0.954 -0.243  2686.04±253.78     
 
 
 
 
 
Adult locomotion: Moving speed 
Genotype Frames   distribution not normal Histogram Kruskal-Wallis P Dunn post-hoc  
yw 8230 All together      
d.f.=13, Kruskal-
Wallis:6883.510 <0.001   
DNT1[55] 7356           
DNT2[e03444] 8179           
kek3[f07029] 8703           
kek3[f07029]DNT1[55] 3612 kek3[f07029]DNT1[55] vs DNT1[55]      Dunn's: 18919  <0.001  
  kek3[f07029]DNT1[55] vs kek3[f07029]      Dunn's: 2620  <0.001  
kek3[f07029]DNT2[e03444] 7149 kek3[f07029]DNT2[e03444] vs DNT2[e03444]      Dunn's: -12710  <0.001  
  kek3[f07029]DNT2[e03444] vs kek3[f07029      Dunn's: -14741  <0.001  
  kek3[f07029]DNT1[55] vs kek3[f07029]DNT2[e03444]      Dunn's: -17360  <0.001  
kek4[f05454] 8552           
kek4[f05454]DNT1[55] 2614 kek4[f05454]DNT1[55] vs DNT1[55]      Dunn's: 28081  <0.001  
  kek4[f05454]DNT1[55] vs kek4[f05454]      Dunn's: 21403  <0.001  
kek4[f05454]DNT2[e03444] 3435 kek4[f05454]DNT2[e03444] vs DNT2[e03444]      Dunn's: -13351  <0.001  
  kek4[f05454]DNT2[e03444] vs kek4[f05454]      Dunn's: -5760  <0.001  
  kek4[f05454]DNT1[55] vs kek4[f05454]DNT2[e03444]      Dunn's: -27163  <0.001  
kek5[e02482] 8217           
kek5[e02482]DNT1[55] 7927 kek5[e02482]DNT1[55] vs DNT1[55]      Dunn's: 8704  <0.001  
  kek5[e02482]DNT1[55] vs kek5[e02482]      Dunn's: -6639  <0.001  
kek5[e02482]DNT2[e03444] 7953 kek5[e02482]DNT2[e03444] vs DNT2[e03444]      Dunn's: -4716  <0.001  
  kek5[e02482]DNT2[e03444] vs kek5[e02482]      Dunn's: -5791  <0.001  
  kek5[e02482]DNT1[55] vs kek5[e02482]DNT2[e03444]      Dunn's: 848.3  n.s  
lbk[GSV2]50104 8453           
wgn[e00637] 7919           
Adult locomotion: Percentage time resting 
Genotype Frames   N/A  N/A Categorical data χ2 P χ2 Bonf.x15 
yw 8272 All together      X=4805.067 d.f.=13 <0.001   
DNT1[55] 7801           
DNT2[e03444] 8230           
kek3[f07029] 8338           
kek3[f07029]DNT1[55] 3850 kek3[f07029]DNT1[55] vs DNT1[55]      X=472.569 d.f.=1  <0.001 <0.001 
  kek3[f07029]DNT1[55] vs kek3[f07029]      X=31.023 d.f.=1  <0.001 <0.001 
kek3[f07029]DNT2[e03444] 7199 kek3[f07029]DNT2[e03444] vs DNT2[e03444]      X=656.453 d.f.=1  <0.001 <0.001 
  kek3[f07029]DNT2[e03444] vs kek3[f07029      X=1108.452 d.f.=1  <0.001 <0.001 
  kek3[f07029]DNT1[55] vs kek3[f07029]DNT2[e03444]      X=498.399 d.f.=1  <0.001 <0.001 
kek4[f05454] 8594           
kek4[f05454]DNT1[55] 2628 kek4[f05454]DNT1[55] vs DNT1[55]      X=1278.864 d.f.=1  <0.001 <0.001 
  kek4[f05454]DNT1[55] vs kek4[f05454]      X=482.147 d.f.=1  <0.001 <0.001 
kek4[f05454]DNT2[e03444] 3466 kek4[f05454]DNT2[e03444] vs DNT2[e03444]      X=250.345 d.f.=1  <0.001 <0.001 
  kek4[f05454]DNT2[e03444] vs kek4[f05454]      X=118.828 d.f.=1  <0.001 <0.001 
  kek4[f05454]DNT1[55] vs kek4[f05454]DNT2[e03444]      X=742.956 d.f.=1  <0.001 <0.001 
kek5[e02482] 8249           
kek5[e02482]DNT1[55] 8113 kek5[e02482]DNT1[55] vs DNT1[55]      X=191.478 d.f.=1  <0.001 <0.001 
  kek5[e02482]DNT1[55] vs kek5[e02482]      X=245.564 d.f.=1  <0.001 <0.001 
kek5[e02482]DNT2[e03444] 7976 kek5[e02482]DNT2[e03444] vs DNT2[e03444]      X=102.872 d.f.=1  <0.001 <0.001 
  kek5[e02482]DNT2[e03444] vs kek5[e02482]      X=202.668 d.f.=1  <0.001 <0.001 
  kek5[e02482]DNT1[55] vs kek5[e02482]DNT2[e03444]      X=1.878 d.f.=1  0.171 2.565 
lbk[GSV2]50104 8343           
wgn[e00637] 7973           
Adult locomotion: percentage wobbling 
Genotype Flies   N/A  N/A Categorical data χ2 P χ2 Bonf.x15 
yw 8272 All together      X=1083.745 d.f.=13 <0.001   
DNT1[55] 7801           
DNT2[e03444] 8230           
kek3[f07029] 8338           
kek3[f07029]DNT1[55] 3850 kek3[f07029]DNT1[55] vs DNT1[55]      X=372.333 d.f.=1  <0.001 <0.001 
  kek3[f07029]DNT1[55] vs kek3[f07029]      X=177.782 d.f.=1  <0.001 <0.001 
kek3[f07029]DNT2[e03444] 7199 kek3[f07029]DNT2[e03444] vs DNT2[e03444]      X=50.277 d.f.=1  <0.001 <0.001 
  kek3[f07029]DNT2[e03444] vs kek3[f07029      X=13.406 d.f. =1  <0.001 <0.001 
  kek3[f07029]DNT1[55] vs kek3[f07029]DNT2[e03444]      X=256.351 d.f.=1  <0.001 <0.001 
kek4[f05454] 8594           
kek4[f05454]DNT1[55] 2628 kek4[f05454]DNT1[55] vs DNT1[55]      X=249.218 d.f.=1  <0.001 <0.001 
  kek4[f05454]DNT1[55] vs kek4[f05454]      X=233.242 d.f.=1  <0.001 <0.001 
kek4[f05454]DNT2[e03444] 3466 kek4[f05454]DNT2[e03444] vs DNT2[e03444]      X=64.133 d.f.=1  <0.001 <0.001 
  kek4[f05454]DNT2[e03444] vs kek4[f05454]      X=0.862 d.f.=1  0.353 5.295 
  kek4[f05454]DNT1[55] vs kek4[f05454]DNT2[e03444]      X=159.625 d.f.=1  <0.001 <0.001 
kek5[e02482] 8249           
kek5[e02482]DNT1[55] 8113 kek5[e02482]DNT1[55] vs DNT1[55]      X=84.965 d.f.=1  <0.001 <0.001 
  kek5[e02482]DNT1[55] vs kek5[e02482]      X=16.661 d.f.=1  <0.001 <0.001 
kek5[e02482]DNT2[e03444] 7976 kek5[e02482]DNT2[e03444] vs DNT2[e03444]      X=1.369 d.f.=1  0.242 3.63 
  kek5[e02482]DNT2[e03444] vs kek5[e02482]      X=2.442 d.f.=1  0.118 1.77 
  kek5[e02482]DNT1[55] vs kek5[e02482]DNT2[e03444]      X=6.234 d.f.=1  0.013 0.195 
lbk[GSV2]50104 8343           
wgn[e00637] 7973           
 
GENOTYPE n COMPARISON  NORMALITY H. OF VAR. 
DESCRIPTIVE 
STATISTICS 
DF & TEST 
VALUE P 
MULTIPLE 
COMPARISONS & 
CORRECTIONS 
Survival index 
Genotype Pupae   N/A N/A categorical data χ
2  χ
2 Bonf.x6 
DNT2[e03444]DNT1[41]/TM6B 270 All together      X=908.085 d.f.=13 <0.001   
DNT2[e03444]DNT1[41]elavGal4/TM6B 431           
UASkek1RFP;DNT2[e03444] 
DNT1[41]/TM6B 
376 
          
UASkek2RFP;DNT2[e03444] 
DNT1[41]/TM6B 
171 
          
UASkek3RFP;DNT2[e03444] 
DNT1[41]/TM6B 
168 
          
UASkek4RFP;DNT2[e03444] 
DNT1[41]/TM6B 
209 
          
UASkek5RFP;DNT2[e03444] 
DNT1[41]/TM6B 
160 
          
UASkek6RFP;DNT2[e03444] 
DNT1[41]/TM6B 
276 
          
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek1RFP;DNT2[e03444] 
DNT1[41]/SM6aTM6B 
262 
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek1RFP;DNT2[e03444]DNT1[41]/SM6aTM6B vs 
DNT2[e03444]DNT1[41]elavGal4/TM6B 
     X=8.621 d.f.=1  0.003 0.018 
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek2RFP;DNT2[e03444] 
DNT1[41]/SM6aTM6B 
283 
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek2RFP;DNT2[e03444]DNT1[41]/SM6aTM6B vs 
DNT2[e03444]DNT1[41]elavGal4/TM6B 
     X=180.546 d.f.=1  <0.001 <0.001 
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek3RFP;DNT2[e03444] 
DNT1[41]/SM6aTM6B 
195 
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek3RFP;DNT2[e03444]DNT1[41]/SM6aTM6B vs 
DNT2[e03444]DNT1[41]elavGal4/TM6B 
     X=84.912 d.f.=1  <0.001 <0.001 
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek4RFP;DNT2[e03444] 
DNT1[41]/SM6aTM6B 
193 
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek4RFP;DNT2[e03444]DNT1[41]/SM6aTM6B vs 
DNT2[e03444]DNT1[41]elavGal4/TM6B 
     X=5.459 d.f.=1  0.019 0.114 
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek5RFP;DNT2[e03444] 
DNT1[41]/SM6aTM6B 
52 
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek5RFP;DNT2[e03444]DNT1[41]/SM6aTM6B vs 
DNT2[e03444]DNT1[41]elavGal4/TM6B 
     X=37.294 d.f.=1  <0.001 <0.001 
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek6RFP;DNT2[e03444] 
DNT1[41]/SM6aTM6B 
313 
DNT[e03444]DNT1[41]elavGal4/TM6B x 
UASkek6RFP;DNT2[e03444]DNT1[41]/SM6aTM6B vs 
DNT2[e03444]DNT1[41]elavGal4/TM6B 
     X=207.992 d.f.=1  <0.001 <0.001 
 
 
 
 
 
 
Statistical tests, Chapter 4 
 
Drosomycin-luciferase: Dif reporter DNT1CK stimulation, small scale DNT production 
Genotype Repeats   N/A  Levene's Mean±s.e.m. Welch ANOVA  t-test Bonf.x9 
pDONR 15 (5x in triplicate) All together    0 0.254±0.002 
F=14.912 d.f.1=11 
d.f.2=39.663 <0.001   
pDONR+DNT1CK 15 (5x in triplicate)      0.290±0.002     
Toll6 9 (3x in triplicate)      0.061±0.006     
Toll6+DNT1CK 9 (3x in triplicate) pDONR+DNT1CK vs Toll6+DNT1CK    0 0.084±0.010 d.f.=25 t=-7.651  <0.001 <0.001 
kek3≡Toll6 chimaera 9 (3x in triplicate)      0.058±0.006     
kek3≡Toll6 chimaera+DNT1CK 9 (3x in triplicate) pDONR+DNT1CK vs kek3≡Toll6 chimaera+DNT1CK    0 0.076±0.007 d.f.=25 t=-8.374  <0.001 <0.001 
  kek3≡Toll6 chimaera vs kek3≡Toll6 chimaera+DNT1CK    0.366  d.f.=16 t=-1.883  0.078 0.702 
kek4≡Toll6 chimaera 9 (3x in triplicate)      0.039±0.002     
kek4≡Toll6 chimaera+DNT1CK 9 (3x in triplicate) pDONR+DNT1CK vs kek4≡Toll6 chimaera+DNT1CK    0.006 0.047±0.005 d.f.=25 t=-4.398  <0.001 <0.001 
  kek4≡Toll6 chimaera vs kek3≡Toll6 chimaera+DNT1CK    0.042  d.f.=16 t=-1.453  0.165 1.485 
kek5≡Toll6 chimaera 9 (3x in triplicate)      0.028±0.002     
kek5≡Toll6 chimaera+DNT1CK 9 (3x in triplicate) pDONR+DNT1CK vs kek5≡Toll6 chimaera+DNT1CK    0.002 0.038±0.005 d.f.=25 t=-2.358  0.026 0.234 
  kek5≡Toll6 chimaera vs kek3≡Toll6 chimaera+DNT1CK    0.002  d.f.=16 t=-2.100  0.052 0.468 
kek6≡Toll6 chimaera 9 (3x in triplicate)      0.063±0.010     
kek6≡Toll6 chimaera+DNT1CK 9 (3x in triplicate) pDONR+DNT1CK vs kek6≡Toll6 chimaera+DNT1CK    0 0.062±0.007 d.f.=25 t=-6.325  <0.001 <0.001 
  kek6≡Toll6 chimaera vs kek3≡Toll6 chimaera+DNT1CK    0.463  d.f.=16 t=0.053  0.959 8.631 
Drosomycin-luciferase: Dif reporter DNT2CK stimulation, small scale DNT production 
Genotype Repeats   N/A  Levene's Mean±s.e.m. Welch ANOVA  t-test Bonf.x9 
pDONR 15 (5x in triplicate) All together 
 
 
 
0 0.025±0.002 
F=20.429 d.f.1=11 
d.f.2=39.850 <0.001 
  pDONR+DNT2CK 15 (5x in triplicate) 
  
  
  
0.033±0.003 
    Toll6 9 (3x in triplicate) 
     
0.061±0.006 
    Toll6+DNT2CK 9 (3x in triplicate) pDONR+DNT2CK vs Toll6+DNT2CK 
   
0.001 0.117±0.011 d.f.=25 t=-10.005 
 
<0.001 <0.001 
kek3≡Toll6 chimaera 9 (3x in triplicate) 
     
0.058±0.006 
    kek3≡Toll6 chimaera+DNT2CK 9 (3x in triplicate) pDONR+DNT2CK vs kek3≡Toll6 chimaera+DNT2CK 
   
0.001 0.084±0.008 d.f.=25 t=-7.642 
 
<0.001 <0.001 
  
kek3≡Toll6 chimaera vs kek3≡Toll6 
chimaera+DNT2CK 
   
0.2 
 
d.f.=16 t=-2.546 
 
0.022 0.198 
kek4≡Toll6 chimaera 9 (3x in triplicate) 
     
0.039±0.002 
    kek4≡Toll6 chimaera+DNT2CK 9 (3x in triplicate) pDONR+DNT2CK vs kek4≡Toll6 chimaera+DNT2CK 
   
0.006 0.060±0.007 d.f.=25 t=-4.442 
 
<0.001 <0.001 
  
kek4≡Toll6 chimaera vs kek3≡Toll6 
chimaera+DNT2CK 
   
0.003 
 
d.f.=16 t=-2.763 
 
0.014 0.126 
  
 
kek5≡Toll6 chimaera 9 (3x in triplicate) 
     
0.028±0.002 
    kek5≡Toll6 chimaera+DNT2CK 9 (3x in triplicate) pDONR+DNT2CK vs kek5≡Toll6 chimaera+DNT2CK 
   
0.118 0.042±0.006 d.f.=25 t=-1.741 
 
0.094 0.47 
  
kek5≡Toll6 chimaera vs kek3≡Toll6 
chimaera+DNT2CK 
   
0.012 
 
d.f.=16 t=-2.381 
 
0.03 0.27 
kek6≡Toll6 chimaera 9 (3x in triplicate) 
     
0.063±0.010 
    kek6≡Toll6 chimaera+DNT2CK 9 (3x in triplicate) pDONR+DNT2CK vs kek6≡Toll6 chimaera+DNT2CK 
   
0.004 0.100±0.014 d.f.=25 t=-6.481 
 
<0.001 <0.001 
  
kek6≡Toll6 chimaera vs kek3≡Toll6 
chimaera+DNT2CK 
   
0.548 
 
d.f.=16 t=-2.078 
 
0.054 0.486 
Drosomycin-luciferase: Dif reporter DNT2CK stimulation, Baculovirus 
Genotype Repeats   N/A  Levene's Mean±s.e.m. Welch ANOVA  t-test Bonf.x9 
pDONR 9 (3x in triplicate) All together 
 
  
0 0.0277±0.001 
F=66.12 d.f.1=11 
d.f.2=37.190 <0.001 
  pDONR+DNT2CK 9 (3x in triplicate) 
     
1.6265±0.085 
    Toll6 9 (3x in triplicate) 
     
0.0640±0.003 
    
Toll6+DNT2CK 9 (3x in triplicate) 
pDONR+DNT2CK vs 
Toll6+DNT2CK 
   
0.112 3.4821±0.154 d.f.=16 t=-10.582 
 
<0.001 <0.001 
kek3≡Toll6 chimaera 9 (3x in triplicate) 
     
0.0568±0.003 
    kek3≡Toll6 chimaera+DNT2CK 9 (3x in triplicate) pDONR+DNT2CK vs kek3≡Toll6 chimaera+DNT2CK 
   
0 4.4033±0.575 d.f.=16 t=-4.778 
 
0.001 0.009 
  
kek3≡Toll6 chimaera vs kek3≡Toll6 chimaera+DNT2CK 
   
0 
 
d.f.=16 t=-7.560 
 
<0.001 <0.001 
kek4≡Toll6 chimaera 9 (3x in triplicate) 
     
0.0420±0.002 
    kek4≡Toll6 chimaera+DNT2CK 9 (3x in triplicate) pDONR+DNT2CK vs kek4≡Toll6 chimaera+DNT2CK 
   
0.024 3.3021±0.276 d.f.=16 t=-5.798 
 
<0.001 <0.001 
  
kek4≡Toll6 chimaera vs kek4≡Toll6 chimaera+DNT2CK 
   
0.001 
 
d.f.=16 t=-11.779 
 
<0.001 <0.001 
kek5≡Toll6 chimaera 9 (3x in triplicate) 
     
0.0265±0.001 
    kek5≡Toll6 chimaera+DNT2CK 9 (3x in triplicate) pDONR+DNT2CK vs kek5≡Toll6 chimaera+DNT2CK 
   
0.003 2.5050±0.217 d.f.=16 t=-3.773 
 
0.003 0.027 
  
kek5≡Toll6 chimaera vs kek5≡Toll6 chimaera+DNT2CK 
   
0 
 
d.f.=16 t=-11.429 
 
<0.001 <0.001 
kek6≡Toll6 chimaera 9 (3x in triplicate) 
     
0.0622±0.004 
    kek6≡Toll6 chimaera+DNT2CK 9 (3x in triplicate) pDONR+DNT2CK vs kek6≡Toll6 chimaera+DNT2CK 
   
0.011 4.0023±0.314 d.f.=16 t=-7.303 
 
<0.001 <0.001 
  
kek6≡Toll6 chimaera vs kek6≡Toll6 chimaera+DNT2CK 
   
0.001 
 
d.f.=16 t=-12.543 
 
<0.001 <0.001 
Statistical tests, Chapter 5 
GENOTYPE n COMPARISON  NORMALITY H. OF VAR. 
DESCRIPTIVE 
STATISTICS 
DF & TEST 
VALUE P 
MULTIPLE 
COMPARISONS & 
CORRECTIONS 
Survival index 
Genotype Pupae   N/A N/A categorical data χ
2 P χ2 Bonf.x21 
DNT1[41]/TM6B 446 All together      X=711.616 d.f.=18 <0.001   
DNT2[e03444]/TM6B 657           
DNT2[e03444]DNT1[41]/TM6B 494           
kek3[12];+/SM6aTM6B 41           
kek3[12];+/SM6aTM6B x 
kek3[26];+/SM6aTM6B 
113           
kek3[12];DNT1[55]/TM6B  232 kek3[12];DNT1[55]/TM6B vs kek3[12];+/SM6aTM6B 
     X=26.234 d.f.=1 <0.001 <0.001 
  kek3[12];DNT1[55]/TM6B vs DNT1[41]/TM6B      X=53.847 d.f.=1 <0.001 <0.001 
kek3[26];Df(3L)Exel6101/TM6B x 
kek3[12];DNT1[55]/TM6B 
290 kek3[26];Df(3L)Exel6101/TM6B x kek3[12];DNT1[55]/TM6B vs kek3[12];+/SM6aTM6B x 
kek3[26];+/SM6aTM6B      X=19.503 d.f.=1 <0.001 <0.001 
  kek3[26];Df(3L)Exel6101/TM6B x kek3[12];DNT1[55]/TM6B vs DNT1[41]/TM6B      X=21.643 d.f.=1 <0.001 <0.001 
kek3[12];DNT2[e03444]/TM6B 442 kek3[12];DNT2[e03444]/TM6B vs kek3[12];+/SM6aTM6B 
     X=87.696 d.f.=1 <0.001 <0.001 
  kek3[12];DNT2[e03444]/TM6B vs DNT2[e03444]/TM6B      X=65.151 d.f.=1 <0.001 <0.001 
kek3[12];DNT2[e03444]/TM6B x 
kek3[26];Df(3L)6092/TM6B 
85 kek3[12];DNT2[e03444]/TM6B x kek3[26];Df(3L)6092/TM6B vs kek3[12];+/SM6aTM6B x 
kek3[26];+/SM6aTM6B      X=19.489 d.f.=1 <0.001 <0.001 
  kek3[12];DNT2[e03444]/TM6B x kek3[26];Df(3L)6092/TM6B vs DNT2[e03444]/TM6B      X=6.953 d.f.=1 0.008 0.168 
kek4[20];+/SM6aTM6B 77 
          
kek4[20];+/SM6aTM6B x 
kek4[23];+/SM6aTM6B 
122 
          
kek4[20];DNT1[55]/TM6B 120 kek4[20];DNT1[55]/TM6B vs kek4[20];+/SM6aTM6B 
     X=23.109 d.f.=1 <0.001 <0.001 
  kek4[20];DNT1[55]/TM6B vs DNT1[41]/TM6B      X=20.622 d.f.=1 <0.001 <0.001 
kek4[20];DNT1[55]/TM6B x 
kek4[23];Df(3L)Exel6101/TM6B 
433 kek4[20];DNT1[55]/TM6B x kek4[23];Df(3L)Exel6101/TM6B vs kek4[20];+/SM6aTM6B x 
kek4[23];+/SM6aTM6B      X=17.904 d.f.=1 <0.001 <0.001 
  kek4[20];DNT1[55]/TM6B x kek4[23];Df(3L)Exel6101/TM6B vs DNT1[41]/TM6B      X=13.518 d.f.=1 <0.001 <0.001 
kek4[20];DNT2[e03444]/TM6B 333 kek4[20];DNT2[e03444]/TM6B vs kek4[20];+/SM6aTM6B 
     X=27.660 d.f.=1 <0.001 <0.001 
  kek4[20];DNT2[e03444]/TM6B vs DNT2[e03444]/TM6B      X=6.318 d.f.=1 0.012 0.252 
kek4[20];DNT2[e03444]/TM6B x 
kek4[23];Df(3L)6092/TM6B 
253 kek4[20];DNT2[e03444]/TM6B x kek4[23];Df(3L)6092/TM6B vs kek4[20];+/SM6aTM6B x 
kek4[23];+/SM6aTM6B      X=0.486 d.f.=1 0.486 10.206 
  kek4[20];DNT2[e03444]/TM6B x kek4[23];Df(3L)6092/TM6B vs DNT2[e03444]/TM6B      X=22.738 d.f.=1 <0.001 <0.001 
kek6[34]/TM6B x 
Df(3R)ED6361/TM6BlacZ 
479 
          
kek6[34]Df(3L)ED4342/TM6B x 
DNT1[41]Df(3R)ED6361/TM6B 
169 kek6[34]Df(3L)ED4342/TM6B x DNT1[41]Df(3R)ED6361/TM6B vs kek6[34]/TM6B x 
Df(3R)ED6361/TM6BlacZ      X=1.508 d.f.=1 0.219  
  kek6[34]Df(3L)ED4342/TM6B x DNT1[41]Df(3R)ED6361/TM6B vs DNT1[41]/TM6B      X=15.774 d.f.=1 <0.001 <0.001 
Df(3R)ED6361DNT2[e03444]/TM6B 
x kek6[34]Df(3L)6092/TM6B 
78 Df(3R)ED6361DNT2[e03444]/TM6B x kek6[34]Df(3L)6092/TM6B vs kek6[34]/TM6B x 
Df(3R)ED6361/TM6BlacZ      X=14.964 d.f.=1 <0.001 <0.001 
  
Df(3R)ED6361DNT2[e03444]/TM6B x kek6[34]Df(3L)6092/TM6B vs 
DNT2[e03444]/TM6B      X= 3.844 d.f.=1 0.05 1.05 
kek6[34]Df(3L)ED4342/TM6B x 
Tie[5]Df(3R)ED6361/TM6B 
236 kek6[34]Df(3L)ED4342/TM6B x Tie[5]Df(3R)ED6361/TM6B vs kek6[34]/TM6B x 
Df(3R)ED6361/TM6BlacZ      X=17.502 d.f.=1 <0.001 <0.001 
Survival index 
Genotype Pupae   N/A N/A categorical data χ
2 P χ2 Bonf.x4 
kek6[34]/TM6B x kek6[35]/TM6B 435 All together      X=218.327 d.f.=7 <0.001   
kek6[34]elavGal4/TM6BlacZ 148           
kek6[34]24BGal4 401           
UASDNT1CK3'+;kek6[35]/TM6BlacZ 208           
kek6[34]elavGal4/TM6BlacZ x 
UASDNT1CK3'+;kek6[35]/TM6BlacZ 
251 kek6[34]elavGal4/TM6BlacZ x UASDNT1CK3'+;kek6[35]/TM6BlacZ vs kek6[34]/TM6B x kek6[35]/TM6B  X=53.105 d.f.=1 <0.001 <0.001 
kek6[34]24BGal4/TM6BlacZ x 
UASDNT1CK3'+;kek6[35]/TM6BlacZ 
97 kek6[34]24BGal4/TM6BlacZ x UASDNT1CK3'+;kek6[35]/TM6BlacZ vs kek6[34]/TM6B x kek6[35]/TM6B  X=0.075 d.f.=1 0.784 3.136 
kek6[34]elavGal4/TM6B x 
UASActRho;kek6[35]/TM6B 
188 kek6[34]elavGal4/TM6BlacZ x UASActRho;kek6[35]/TM6BlacZ vs kek6[34]/TM6B x kek6[35]/TM6B  X=8.792 d.f.=1 0.003 0.012 
kek6[34]elavGal4/TM6B x 
UASActcdc42;kek6[35]/TM6B 
162 kek6[34]elavGal4/TM6BlacZ x UASActCdc42;kek6[35]/TM6BlacZ vs kek6[34]/TM6B x kek6[35]/TM6B  X=16.238 d.f.=1 <0.001 <0.001 
Survival index 
Genotype Pupae   
 
N/A N/A categorical data χ
2 P χ2  
kek6[34]elavGal4/TM6BlacZ 148 All together      X=35.368 d.f.=2 <0.001  
UASkek6RFP;kek6[35]/SM6aTM6B 110           
kek6[34]elavGal4/TM6B x 
UASkek6RFP;kek6[35]/SM6aTM6B 
245 kek6[34]elavGal4/TM6BlacZ vs kek6[34]elavGal4/TM6B x 
UASkek6RFP;kek6[35]/SM6aTM6B   X=19.822 d.f.=1 <0.001  
Adult locomotion: speed 
Genotype Frames   
Distribution not 
normal N/A Histogram Kruskal-Wallis  Dunn  
yw 8230 All together     
d.f.=2, Kruskal-
Wallis:3859.663 <0.001  
kek3[12] 6587 yw vs kek3[12]      Dunn's: 4472 <0.001  
kek4[20] 1988 yw vs kek4[20]      Dunn's: 5162 <0.001  
Adult locomotion: Distance 
Genotype Flies   Kurt. Skew. Levene's Mean±s.e.m. One-Way ANOVA  Dunnett  
yw 22 All together  -0.112 -0.672 0.369 3742.13±217.1 F=33.549 d.f.1=2 d.f.2=41 <0.001   
kek3[12] 17 yw vs kek3[12]  -0.133 0.858 0.747 1374.32±263.5 Mean difference: 2367.81 Sig to 0.05 level 
kek4[20] 5 yw vs kek4[20]  0.025 1.023 0.21 862.53±267.6 Mean difference: 2879.60 Sig to 0.05 level 
Adult locomotion: Resting 
Genotype Frames    N/A N/A Categorical data χ
2  χ
2 Bonf.x2 
yw 8272 All together      X=2786.335 d.f.=2 <0.001   
kek3[12] 6615 yw vs kek3[12]      X=2245.728 d.f.=1 <0.001 <0.001 
kek4[20] 1994 yw vs kek4[20]      X=1783.997 d.f.=1 <0.001 <0.001 
Adult locomotion: wobbling 
Genotype Frames    N/A N/A Categorical data χ
2  χ
2 Bonf.x2 
yw 8272 All together      X=407.725 d.f.=2 <0.001   
kek3[12] 6615 yw vs kek3[12]      X=174.537 d.f.=1 <0.001 <0.001 
kek4[20] 1994 yw vs kek4[20]      X=417.102 d.f.=1 <0.001 <0.001 
 
Statistical tests, Chapter 6 
GENOTYPE n COMPARISON  NORMALITY 
H. OF 
VAR. 
DESCRIPTIVE 
STATISTICS 
DF & TEST 
VALUE P 
MULTIPLE 
COMPARISONS & 
CORRECTION 
Axon guidance 
Genotype HS   N/A N/A Categorical data χ
2  χ
2 Bonf.x10 
yw 382 All together      X=158.843 d.f.=12 <0.001   
elavGal4>UASkek6RFP 328 yw x elavGal4>UASkek6RFP      X=66.125 d.f.=1 <0.001 <0.001 
kek6[34]/Df(3R)ED6361 407 yw x kek6[34]/Df(3R)ED6361      X=14.987 d.f.=1 <0.001 <0.001 
kek6[34/Df(3R)ED6361] 
elavGal4>UASkek6RFP 
212 yw x kek6[34/Df(3R)ED6361]elavGal4>UASkek6RFP X=0.025 d.f.=1 0.875 8.75 
24BGal4>UASDNT1CK3'+ 191 
          
kek6[34/35]24BGal4>UASDNT1CK3'+ 205 24BGal4>UASDNT1CK3'+ vs kek6[34/35]24BGal4>UASDNT1CK3'+      X=30.770 d.f.=1 <0.001 <0.001 
DNT2[e03444]DNT1[41] 152 
          
DNT2[e03444]DNT1[41] 
elavGal4>UASkek6RFP 
199 DNT2[e03444]DNT1[41] vs DNT2[e03444]DNT1[41]elavGal4>UASkek6RFP X=2.226 d.f.=1 0.136 1.36 
elavGal4>UASDNRas;UASkek6RFP 225 elavGal4>UASkek6RFP vs elavGal4>UASDNRas;UASkek6RFP      X=38.308 d.f.=1 <0.001 <0.001 
elavGal4>UASDNdRac;UASkek6RFP 176 elavGal4>UASkek6RFP vs 
elavGal4>UASDNdRac;UASkek6RFP      X=8.224 d.f.=1 0.004 0.1408 
elavGal4>UASkek6RFP; 
UASMycAFGDP110 
136 elavGal4>UASkek6RFP vs elavGal4>UASkek6RFP;UASMycAFGDP110 X=23.998 d.f.=1 <0.001 <0.001 
elavGal4>UAScdc42[N17]; 
UASkek6RFP 
74 elavGal4>UASkek6RFP vs elavGal4>UAScdc42[N17];UASkek6RFP X=0.002 d.f.=1 0.962 9.62 
elavGal4>UASkek6RFP;UASDNRho 188 elavGal4>UASkek6RFP vs elavGal4>UASkek6RFP;UASDNRho X=5.138 d.f.=1 0.023 0.23 
Axon guidance 
Genotype HS   N/A N/A Categorical data χ
2  χ
2 Bonf.x2 
yw 382       X=5.064 d.f.=1 0.079   
RA5/RM2 153 yw vs RA5/RM2      X=0.012 d.f.=1 0.914 1.828 
elavGal4>UASkek1RFP 120 yw vs elavGal4>UASkek1RFP      X=4.916 d.f.=1 0.027 0.054 
Larval locomotion: speed 
Genotype Frames   Distribution not normal Histogram Kruskal-Wallis  Dunn  
yw 19837 All together     
d.f.=5, Kruskal-
Wallis:1414.429 <0.001   
yw/OregonR 19497           
elavGal4 19950           
kek6[34]/Df(3R)ED6361 19562 elavGal4 vs kek6[34]/Df(3R)ED6361      Dunn's: -9244 <0.001  
elavGal4>UASkek6RFP 19687 elavGal4 vs elavGal4>UASkek6RFP      Dunn's: -7215 <0.001  
kek6[34]elavGal4>UASkek6RFP 
Df(3R)ED6361 
9491 elavGal4 vs kek6[34]elavGal4>UASkek6RFP Df(3R)ED6361      Dunn's: -4046 <0.001  
  kek6[34]/Df(3R)ED6361 vs kek6[34]elavGal4>UASkek6RFP Df(3R)ED6361      Dunn's: 5199 <0.001  
Larval locomotion: Speed 
Genotype Frames   Distribution not normal Histogram Kruskal-Wallis P Dunn  
elavGal4 9975 All together     
d.f.=8, Kruskal-
Wallis:3090.657 <0.001   
kek6[34]/Df(3R)ED6361 9826           
kek6[34]DfED4342 
/Df(3R)ED6361DNT1[55] 
8743 elavGal4 vs kek6[34]DfED4342/Df(3R)ED6361DNT1[55]      Dunn's: -10037 <0.001  
kek6[34]Df6092/ 
Df(3R)ED6361DNT2[e03444] 
9975 elavGal4 vs kek6[34]Df6092/Df(3R)ED6361DNT2[e03444]      Dunn's: 1038 <0.05  
kek6[34]DfED4342 
/Df(3R)ED6361Tie[5] 
9928 elavGal4 vs kek6[34]DfED4342/Df(3R)ED6361Tie[5]      Dunn's: -9898 <0.001  
  kek6[34]/Df(3R)ED6361 vs kek6[34]DfED4342/Df(3R)ED6361DNT1[55] Dunn's: -2742 <0.001  
  kek6[34]/Df(3R)ED6361 vs kek6[34]Df6092/Df(3R)ED6361DNT2[e03444] Dunn's: 8332 <0.001  
  kek6[34]/Df(3R)ED6361 vs kek6[34]DfED4342/Df(3R)ED6361Tie[5] Dunn's: -2604 <0.001  
elavGal4>UASkek6RFP 9917 
          
elavGal4>UASkek6RFP; 
UASMycAFGDP110 
9975 elavGal4 vs elavGal4>UASkek6RFP;UASMycAFGDP110      Dunn's: -5673 <0.001  
elavGal4>UASDNRas;UASkek6RFP 9880 elavGal4 vs elavGal4>UASDNRas;UASkek6RFP      Dunn's: 2148 <0.001  
elavGal4>UASkek6RFP UASDNRho 9902 elavGal4 vs elavGal4>UASkek6RFP;UASDNRho      Dunn's: -10998 <0.001  
  elavGal4>UASkek6RFP vs elavGal4>UASkek6RFP;UASMycAFGDP110 Dunn's: 389.5 ns  
  
elavGal4>UASkek6RFP vs 
elavGal4>UASDNRas;UASkek6RFP      Dunn's: 8210 <0.001  
  
elavGal4>UASkek6RFP vs 
elavGal4>UASkek6RFP;UASDNRho      Dunn's: -4936 <0.001  
Larval locomotion: Distance 
Genotype Larvae  Kurt. Skew. Levene's Mean±s.e.m. Welch ANOVA t-test Bonf.x3 
elavGal4 25 All together  0.009 0.783 0 1.75±0.12 
F=7.054 d.f.1=8 
d.f.2=88.542 <0.001   
kek6[34]/Df(3R)ED6361 25   -1.525 0.367  2.47±0.21     
kek6[34]DfED4342 
/Df(3R)ED6361DNT1[55] 
22 kek6[34]/Df(3R)ED6361 vs 
kek6[34]DfED4342/Df(3R)ED6361DNT1[55] -0.608 0.218  2.45±0.11 d.f.=45 t=0.078 0.938 2.814 
kek6[34]Df6092 
/Df(3R)ED6361DNT2[e03444] 
25 kek6[34]/Df(3R)ED6361 vs 
kek6[34]Df6092/Df(3R)ED6361DNT2[e03444]  0.64 1.152  1.78±0.19 d.f.=48 t=2.471 0.017 0.051 
kek6[34]DfED4342 
/Df(3R)ED6361Tie[5] 
25 kek6[34]/Df(3R)ED6361 vs 
kek6[34]DfED4342/Df(3R)ED6361Tie[5]  -0.547 0.133  2.61±0.13 d.f.=48 t=-0.597 0.553 1.659 
elavGal4>UASkek6RFP 25 
  1.083 0.879  2.21±0.18     
elavGal4>UASkek6RFP; 
UASMycAFGDP110 
25 elavGal4>UASkek6RFP vs 
elavGal4>UASkek6RFP;UASMycAFGDP110  0.166 0.187  2.13±0.15 d.f.=48 t=0.309 0.309 0.927 
elavGal4>UASDNRas;UASkek6RFP 25 elavGal4>UASkek6RFP vs 
elavGal4>UASDNRas;UASkek6RFP  -1.118 -0.031  2.55±0.16 d.f.=48 t=3.129 0.003 0.009 
elavGal4>UASkek6RFP UASDNRho 25 elavGal4>UASkek6RFP vs elavGal4>UASkek6RFP 
UASDNRho  -0.205 0.737  1.54±0.11 d.f.=48 t=-1.445 0.155 0.465 
 
Statistical tests, Chapter 7 
GENOTYPE OR EXPERIMENT n COMPARISON  
 
NORMALITY 
H. OF 
VAR. 
DESCRIPTIVE 
STATISTICS 
DF & TEST 
VALUE P 
MULTIPLE 
COMPARISONS & 
CORRECTION 
Larval developmental timing – Onset of wandering L3 
Genotype Larvae  N/A N/A Categorical data χ
2  χ
2 Bonf.x2 
yw 150 All together 
  
  
 
X=317.733 d.f.=81 <0.001   
spz6Gal4 150 
          
spz6Gal4>UASkek4 150 spz6Gal4 vs spz6Gal4>UASkek4 
     
X=109.561 d.f=27 <0.001 <0.001 
kek4[20/23] 150 spz6Gal4 vs kek4[20/23] 
     
X=44.127 d.f.=25 0.01 0.02 
Larval developmental timing – Brown pupae 
Genotype Larvae  N/A  N/A Categorical data χ
2  χ
2 Bonf.x2 
yw 150 All together  
 
  
 
X=296.644 d.f.=69 <0.001   
spz6Gal4 150 
 
 
        
spz6Gal4>UASkek4 150 spz6Gal4 vs spz6Gal4>UASkek4 
     
X=90.701 d.f=23 <0.001 <0.001 
kek4[20/23] 150 spz6Gal4 vs kek4[20/23] 
     
X=36.551 d.f.=22 0.026 0.052 
Larval developmental timing – Eclosed adults 
Genotype Larvae  N/A  N/A Categorical data χ
2  χ
2 Bonf.x2 
yw 150 All together  
 
  
 
X=162.005 d.f.=21 <0.001   
spz6Gal4 150 
   
  
     
spz6Gal4>UASkek4 150 spz6Gal4 vs spz6Gal4>UASkek4 
     
X=124.648 d.f=7 <0.001 <0.001 
kek4[20/23] 150 spz6Gal4 vs kek4[20/23] 
     
X=71.438 d.f.=7 <0.001 <0.001 
Larval volume 
Genotype Larvae  Kurt. Skew. Levene's Mean±SD Welch ANOVA    
yw 10 All together 
 
0.267 -0.887 0.312 5851±428 
F=1.252 d.f.1=2 
d.f.2=17.588 0.224 
  
spz6Gal4>UASkek4 10 
  
-0.987 0.084 
 
5752±624 
    
kek4[20/23] 10 
  
-1.81 0.075 
 
5506±424 
    Pupal volume 
Genotype Pupae  Kurt. Skew. Levene's Mean±SD Welch ANOVA  Games-Howell 
yw 87 All together  0.032 -0.001 0.02 0.205±0.027 
F=5.465 d.f.1=2 
d.f.2=133.092 0.012  
 
spz6Gal4>UASkek4 66 yw vs spz6Gal4>UASkek4 
 
-0.617 0.206 
 
0.219±0.032 d.f.=151 t=-2.852 0.017 
 
kek4[20/23] 61 yw vs kek4[20/23] 
 
-0.17 -0.261 
 
0.205±0.024 d.f.=146 t=0 1 
 Pupal length 
Genotype Pupae  Kurt. Skew. Levene's Mean±SD Welch ANOVA  Games-Howell 
yw 100 All together  1.127 -0.6 0 0.84±0.05 
F=4.161 d.f.1=2 
d.f.2=193.592 0.033  
 
spz6Gal4>UASkek4 100 yw vs spz6Gal4>UASkek4  -0.1 -0.528 
 
0.82±0.07 d.f.=198 t=1.868 0.151 
 
kek4[20/23] 100 yw vs kek4[20/23]  -0.154 -0.029 
 
0.85±0.05 d.f.=198 t=-0.941 0.615 
 Adult body size 
Genotype Adults  Kurt. Skew. Levene's Mean±SD Welch ANOVA  Games-Howell 
yw 10 All together  -0.713 0.527 P=0.008 0.144±0.01 
F=3.821 d.f.1=2 
d.f.2=16.795 0.044  
 
spz6Gal4>UASkek4 10 yw vs spz6Gal4>UASkek4  -0.631 -0.477 
 
0.133±0.025 d.f.=18 t=1.247 0.45 
 
kek4[20/23] 10 yw vs kek4[20/23]  1.726 1.377 
 
0.154±0.012 d.f.=18 t=-2.113 0.116 
 Wing hair count 
Genotype Adults  Kurt. Skew. Levene's Mean±SD Welch ANOVA  Games-Howell 
yw 10 All together  -0.087 -0.806 P=0.517 126.3±7.2 
F=18.702 d.f.1=2 
d.f.2=15.882 <0.001  
 
spz6Gal4>UASkek4 10 yw vs spz6Gal4>UASkek4 
 
-1.021 -0.573 
 
122.6±5.9 d.f.=17 t=1.225 0.448 
 
kek4[20/23] 10 yw vs kek4[20/23] 
 
2.522 -1.65 
 
144.2±10.5 d.f.=17 t=-4.381 0.002 
 Larval locomotion - speed 
Genotype Frames  Distribution not normal Histogram Kruskal-Wallis  Dunn  
elavGal4 19950 All together 
 
  
 
d.f.=2, Kruskal-
Wallis:3459.228 <0.001 
  
kek4[20/23] 19746 elavGal4 vs kek4[20/23] 
 
  
  
Dunn's: -3424 <0.001 
 
elavGal4>UASkek4RFP 13463 elavGal4 vs elavGal4>UASkek4 
     
Dunn's: 6475 <0.001 
 Larval locomotion - distance 
Genotype Frames  Kurt. Skew. Levene's Mean±s.e.m. Welch ANOVA Games-Howell 
elavGal4 25 All together 
 
-0.834 -0.013 0.183 2.16±0.09 
F=49.329 d.f.1=2 
d.f.2=86.267 <0.001 
  
kek4[20/23] 24 elavGal4 vs kek4[20/23] 
 
-0.395 -0.145 
 
2.74±0.10 d.f.=47 t=-4.506 <0.001 
 
elavGal4>UASkek4RFP 15 elavGal4 vs elavGal4>UASkek4 
 
-0.048 0.784 
 
1.36±0.08 d.f.=38 t=3.183 <0.001 
  
  
 
 
 
 
 
APPENDIX II 
CLONING MAPS, SUPPORTING GELS AND SEQUENCING DATA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cloning of kek1-kek6 into pDONR221
For each construct: a | Plasmid maps of cloned constructs. Enzyme sites for restriction digest verication 
and primer sites for initial sequence amplication are shown. b | Amplied PCR fragment. Primers and 
source DNA are also shown. c | Restriction digest verication of cloned plasmids.
Cloning of kek1-6 into pAct-attR-mCFP (pAWC), pAct-attR-FLAG (pAWF), 
pUASt-attR-mRFP (pTWR)
pDONR+kek1-6 entry clones were recombined into pAct-attR-FLAG destination vector by 
Gateway cloning. For each construct: a | Plasmid map of cloned construct. Enzyme sites for 
restriction digest verication are shown. b | Cloned constructs were veried by restriction 
digest of maxiprep DNA/pAWC+kek1 only: cloned constructs were initially detected by PCR of 
transformed colonies - cloning was tested by amplication of the kek1 CDS into the actin promoter 
region. c | Cloning was veried by PCR amplication of the gene CDS into the UAS element 
(pTWR constructs only).
kek1 CDS PCR
SD01674 clone
3 kb
2 kb
1.5 kb
1 kb
0.5 kb
3 kb
2 kb
1.5 kb
1 kb
0.5 kb
Expected: 2480bp
a
b
Forward primer:  
kek1CDSattB5'Fw
Reverse primer:  
kek1CDSattB3'Rv
Cloning of kek1 into pDONR221
pDONR+kek1 Maxiprep digests
BamHI HpaI BamHI+EcoRV
1.5, 3.5 1.6, 3.3 0.8, 1.5, 2.7
c
kek2 CDS PCR
NB7 cDNA
pDONR+kek2 Maxiprep digests
PvuI+XhoIBamHI+EcoRV
3kb
2kb
1.5kb
1kb
0.5kb
3kb
2kb
1.5kb
1kb
0.5kb
a b
c
0.9, 1.8, 2.6
0.4, 0.8, 1.2, 2.8
Expected: 2719bp
Forward primer:  
kek2CDSattB5'Fw
Reverse primer:  
kek2CDSattB3'Rv
Cloning of kek2 into pDONR221
kek3 CDS PCR
GH cDNA library
Expected: 3106bp
pDONR+kek3 Maxiprep digests
BamHI
3kb
2kb
1.5kb
1kb
0.5kb
3kb
2kb
1.5kb
1kb
0.5kb
MluI+PvuI
1.5, 
4.1
    0.5, 
0.9, 4.2
a b
c
Forward primer:  
kek3CDS#2Fwd
Reverse primer:  
kek3CDS3'endRev
Cloning of kek3 into pDONR221
a
Cloning of kek4 into pDONR221
kek4 CDS PCR
RT-PCR from larvae/pupae
pDONR+kek4 Maxiprep digests
3kb
2kb
1.5kb
1kb
3kb
2kb
1.5kb
0.5kb
1kb
PvuI
b
c
Expected: 2014bp
PvuII: 1.9, 2.6
ScaI: 1.1, 3.4
ScaI
kek5 CDS PCR
LD cDNA library
pDONR+kek5 Maxiprep digests
EcoRI
3kb
2kb
1.5kb
1kb
0.5kb
3kb
2kb
1.5kb
1kb
0.5kb
EcoRI
+ClaI
BamHI
+EcoRV
a b
c
0.75, 4.6 2, 3.3 0.4, 1.6, 3.3
Expected: 2860bp
Forward primer:  
kek5CDSattB5'Fw
Reverse primer:  
kek5CDSattB3'Rv
Cloning of kek5 into pDONR221
a
Cloning of kek6 into pDONR221
Forward primer:  
kek6 5'end Fw
Reverse primer:  
kek6 3'end Rev
kek6 CDS PCR
GH cDNA library
pDONR+kek6 Maxiprep digests
PvuIPvuI
+BamHI
3kb
2kb
1.5kb
1kb
0.5kb
0.5, 0.9, 
1.4, 2.3
2.3, 
2.8
b
c
3kb
2kb
1.5kb
1kb
0.5kb
Expected:
0.6, 1.9, 
2.6, 3.6
Expected: 2574nt
PvuI
3kb
c
b
a
pAWC+kek1 Maxiprep digests
pAWC+kek1 colony PCR
2kb
1.5kb
1kb
0.5kb
Forward primer:  
pAc5.1B4MCSFwd
Reverse primer:  
kek1CDSattB3'Rv
Cloning of kek1 into pAct-attR-mCFP
a
Cloning of kek2 into pAct-attR-mCFP
3kb
b pAWC+kek2 Maxiprep digests
BamHI PvuI
2kb
1.5kb
1kb
0.5kb
BamHI: 0.2, 1.8, 
2.4, 4.6  
PvuI: 1.8, 3.1, 3.8
Gel partially melted
3kb
2kb
1.5kb
1kb
0.5kb
ba pAWC+kek3 Maxiprep digests
BamHI PvuI SacI
3kb
2kb
1.5kb
1kb
3kb
2kb
1.5kb
1kb
0.5kb
3kb
2kb
1.5kb
1kb
BamHI: 1.4, 
1.45, 1.8, 4.6
PvuI: 1.8, 7.4 SacI: 2.5, 6.8
Cloning of kek3 into pAct-attR-mCFP
3kb
b pAWC+kek5 Maxiprep digestsa
EcoRI
2kb
1.5kb
1kb
0.5kb
EcoRI: 2, 7
Cloning of kek5 into pAct-attR-mCFP
a
Cloning of kek6 into pAct-attR-mCFP
3kb
b pAWC+kek6 Maxiprep digests
BamHI
2kb
1.5kb
1kb
0.5kb
BamHI: 0.9, 1.4, 1.8, 4.6
Gel partially melted
a
Cloning of kek4 into pAct-attR-mCFP
3kb
b pAWC+kek4 Maxiprep digest
BamHI
2kb
1.5kb
1kb
0.5kb
BamHI: 1.5, 2.1, 4.6 
AT
G
kek1 CDS: 
expected sequence
Sequencing
reactions
St
op
 c
od
on
5’ sequence
3’ sequence
Sequencing of kek1+pAWC
Maxiprepped pAct-kek1-mCFP (kek1+pAWC) DNA was veried by sequencing. 5’ and 3’ 
fragment ends are shown only. No point mutations or substitutions were detected in the 
entire kek1 CDS. The STOP codon was successfully removed to allow the use of C-terminal 
Gateway tags. 
kek2 CDS: 
expected sequence
Sequencing
reactions
AT
G
5’ sequence
3’ sequence
St
op
 c
od
on
Sequencing of kek2+pAWC
Maxiprepped pAct-kek2-mCFP (kek2+pAWC) DNA was veried by sequencing. 5’ and 3’ 
fragment ends are shown only. No point mutations or substitutions were detected in the 
entire kek2 CDS. The STOP codon was successfully removed to allow the use of C-terminal 
Gateway tags. 
AT
G
kek3 CDS: 
expected sequence
Sequencing
reactions
St
op
 c
od
on
5’ sequence
3’ sequence
Sequencing of kek3+pAWC
Maxiprepped pAct-kek3-mCFP (kek3+pAWC) DNA was veried by sequencing. 5’ and 3’ 
fragment ends are shown only. No point mutations or substitutions were detected in the 
entire kek3 CDS. The STOP codon was successfully removed to allow the use of C-terminal 
Gateway tags. 
AT
G
kek4 CDS: 
expected sequence
Sequencing
reactions
St
op
 c
od
on
5’ sequence
3’ sequence
Sequencing of kek4+pAWC
Maxiprepped pAct-kek4-mCFP (kek4+pAWC) DNA was veried by sequencing. 5’ and 3’ 
fragment ends are shown only. No point mutations or substitutions were detected in the 
entire kek4 CDS. The STOP codon was successfully removed to allow the use of C-terminal 
Gateway tags. 
AT
G
kek5 CDS: 
expected sequence
Sequencing
reactions
St
op
 c
od
on
5’ sequence
3’ sequence
Sequencing of kek5+pAWC
Maxiprepped pAct-kek5-mCFP (kek5+pAWC) DNA was veried by sequencing. 5’ and 3’ 
fragment ends are shown only. No point mutations or substitutions were detected in the 
entire kek5 CDS. The STOP codon was successfully removed to allow the use of C-terminal 
Gateway tags. 
AT
G
kek6 CDS: 
expected sequence
Sequencing
reactions
St
op
 c
od
on
5’ sequence
3’ sequence
Sequencing of kek6+pAWC
Maxiprepped pAct-kek6-mCFP (kek6+pAWC) DNA was veried by sequencing. 5’ and 3’ 
fragment ends are shown only. No point mutations or substitutions were detected in the 
entire kek6 CDS. The STOP codon was successfully removed to allow the use of C-terminal 
Gateway tags. 
b pAWF+kek1 Maxiprep digestsa
a b
BamHI
3kb
2kb
1.5kb
1kb
0.5kb
3kb
2kb
1.5kb
1kb
0.5kb
BamHI: 0.3, 1.5, 1.6, 4.5 
PvuI
PvuI: 0.6, 1.8, 2.5, 2.9
I PvuI
Cloning of kek1 into pAct-attR-FLAG
Cloning of kek2 into pAct-attR-FLAG
3kb
4kb
5kb
6kb
7kb
pAWF+kek2 Maxiprep digest
XhoI
2kb
1.5kb
1kb
0.5kb
XhoI: 0.4, 7.9
b pAWF+kek3 Maxiprep digestsa
SacIPvuI
3kb
4kb
5kb
6kb
8kb
2kb
1.5kb
1kb
0.5kb
SacI: 2.5, 6.1
PvuI: 1.8, 6.8
Cloning of kek3 into pAct-attR-FLAG
aa
a
b
Cloning of kek4 into pAct-attR-FLAG
Cloning of kek5 into pAct-attR-FLAG
Cloning of kek6 into pAct-attR-FLAG
3kb
4kb
5kb
6kb
pAWF+kek4 Maxiprep digest
EcoRV PvuII
2kb
1.5kb
1kb
0.5kb
Expected:
EcoRV: 2, 5.5
PvuII: 0.3, 7.2 
3kb
4kb
5kb
6kb
8kb
b
b
pAWF+kek5 Maxiprep digests
BamHI EcoRI
2kb
1.5kb
1kb
0.5kbEcoRI: 2, 6.3
BamHI: 1.6, 2.2, 4.6
pAWF+kek6 Maxiprep digest
PvuIBamHI
BamHI: 0.9, 1.1, 1.4, 4.6
PvuI: 1.9, 2.6, 3.5
0.5kb0.5kb
3kb
PvuI: 1.9, 2.6, 3.5kb
2kb
1.5kb
1kb
3kb
2kb
1.5kb
1kb
BamHI: 0.3, 1.1, 1.4, 4.5kb
b pTWR+kek1 Maxiprep digestsa
a
BamHIPvuI
BamHI: 0.7, 1.5, 2.2, 7.8  
Expected fragment size: 2575nt
3kb
2kb
1.5kb
1kb
0.5kb
PvuI: 0.6, 2.3, 4.5, 4.7  
0.5kb
3kb
2kb
1.5kb
1kb
c pTWR+kek1 PCR
Forward primer:  
UASseqFor
Reverse primer:  
kek1CDSattB3'Rv
Cloning of kek1 into pUASt-attR-mRFP
Cloning of kek2 into pUASt-attR-mRFP
Forward primer:  
UASseqFor
Reverse primer:  
kek2CDSattB3'Rv
3kb
b pTWR+kek2 Maxiprep digests
XbaI
+XhoI HindIII
2kb
1.5kb
1kb
0.5kb
XbaI+XhoI: 
0.4, 1.5, 10.5 
HindIII: 
2.1, 3, 7.3
Expected fragment size: 2814nt
3kb
2kb
1.5kb
1kb
0.5kb
c pTWR+kek2 PCR
3kb
4kb
5kb
6kb
c
b
b
pTWR+kek3 Maxiprep digesta
a
SacI
2kb
1.5kb
1kb
0.5kb
SacI: 1, 2.5, 3.5, 5.9
Expected fragment size: 3300nt
pTWR+kek3 PCR
3kb
2kb
1.5kb
1kb
0.5kb
Forward primer:  
UASseqFor
Reverse primer:  
kek3CDS3'endRev
Cloning of kek3 into pUASt-attR-mRFP
Cloning of kek4 into pUASt-attR-mRFP
Forward primer:  
UASseqFor
Reverse primer:  
kek4CDSattB3'Rev
3kb
4kb
5kb
6kb
8kb
10kb
pTWR+kek4 Maxiprep digests
PvuII
2kb
1.5kb
1kb
0.5kb
PvuII: 2.2, 2.7, 6.8
Gel partially melted, 
image rotated for band alignment
Expected fragment size: 2109nt
3kb
2kb
1.5kb
1kb
0.5kb
c pTWR+kek4 PCR
3kb
4kb
5kb
6kb
8kb
10kb
b
b
pTWR+kek5 Maxiprep digestsa
a
BamHI PvuI
2kb
1.5kb
1kb
0.5kb
BamHI: 2.2, 2.6, 7.8
PvuI: 4.8, 7.8
Expected fragment size: 2955nt
3kb
2kb
1.5kb
1kb
0.5kb
c pTWR+kek5 PCR
Forward primer:  
UASseqFor
Reverse primer:  
kek5CDSattB3'Rv
Cloning of kek5 into pUASt-attR-mRFP
Cloning of kek6 into pUASt-attR-mRFP
Forward primer:  
UASseqFor
Reverse primer:  
kek6 3'end Rev
pTWR+kek6 Maxiprep digests
SacI PvuI
0.5kb
1kb
2kb
3kb
4kb
5kb
1.5kb
SacI: 1.1, 1.7, 3.4, 5.9
PvuI: 2.4, 4.7, 5
Expected fragment size: 2640nt
3kb
2kb
1.5kb
1kb
0.5kb
c pTWR+kek6 PCR
Chimaera cloning strategy
Regions of the kek3-6 coding sequences that correspond to the extracellular and 
transmembrane regions were determined using protein prediction algorithms (Table 4.2). 
These regions were amplied by PCR from pDONR221 constructs, along with the intracellular 
domain-encoding sequence of toll6. a | Fragments were ligated at a unique introduced 
restriction site (EcoRI or BamHI). b | Ligated cloned into pDONR221 entry clones and 
subsequently into pAct5c-attR-3xHA (pAWC). c | PCR products prior to  cloning.
Cloning of kek3-kek6Ξtoll6 chimaeras into pDONR221
For each construct: a | Plasmid maps of cloned constructs. Enzyme sites for restriction digest 
verication are shown. b | Restriction digest verication of cloned plasmids.
Cloning of kek3-6Ξtoll6 chimaeras into pAct5c-attR-3xHA
For each construct: a | Plasmid maps of cloned constructs. Enzyme sites for restriction digest 
verication are shown. b | Restriction digest verication of cloned plasmids.
Sequencing of kek3-6Ξtoll6+pAWH chimaeras
Maxiprepped pAct5c- kek3-6Ξtoll6-3xHA (kek3-6Ξtoll6 +pAWH) DNA sequences were veried 
by sequencing. 5’ and 3’ fragment ends of the insert are shown only (kek ATG to end of toll6 
intracellular domain-coding sequence). No point mutations or substitutions were detected 
in the fragments. 
Expected: 1437nt Expected: 1335nt Expected: 1347nt Expected: 1263nt Expected: 1263nt
3kb
2kb
1.5kb
1kb
3kb
2kb
1.5kb
1kb
kek3EC+TM-EcoRI kek4EC+TM-EcoRI kek5EC+TM-BamHI BamHI-Toll6 ICD EcoRI-Toll6 ICD
a
c
b
BP clonase II-mediated 
recombination into pDONR221
LR clonase II-mediated 
recombination into pAWH
Phusion PCR of Chimaera fragments
pAct-attR-3xHA
(pAWH)
7295 bp
pDONR221
4762 bp
Forward primer:
kek3CDS#2Fwd
Reverse primer:
kek3-EC-TM-RI
Reverse primer:
Toll6attB2RevTag
Toll6attB2RevTag
Forward primer:
Toll6-EcoRI-IC
kek4CDSattB5’Fw kek4-EC-TM-RI Toll6-EcoRI-IC
Toll6attB2RevTagkek5CDSattB5’Fw kek5-EC-TM-HI Toll6-BamHI-IC
Toll6attB2RevTagkek6 5’end Fwd kek6-EC-TM-RI Toll6-EcoRI-IC
3kb
4kb
5kb
EcoRI
+XhoI
1.1, 
4.1
Expected:
2.5, 
2.7
1.1, 
4.0
2.4, 
2.7
Kek3ΞToll6 Kek4ΞToll6
EcoRI
+XhoI
HpaI HpaI
Kek3 and Kek4 chimaeras, in pDONR221, Maxiprep digests
a
b
2kb
1.5kb
1kb
0.5kb
Cloning of kek3/4Ξtoll6 chimaeras into pDONR221
3kb
BamHI
+EcoRV
1.4, 3.8 2.5, 2.7 2.3, 2.9
HpaI EcoRI
+XhoI
2kb
1.5kb
1kb
0.5kb
Kek5 chimaera, in pDONR221, 
Maxiprep digests
a b
Cloning of kek5Ξtoll6 chimaera into pDONR221
a
Cloning of kek6Ξtoll6 chimaera into pDONR221
b Kek6 chimaera, in pDONR221, 
Maxiprep digests
3kb
4kb
5kb
BamHI
+XhoI
BglII
2kb
1.5kb
1kb
0.5kb
3kb
4kb
5kb
2kb
1.5kb
1kb
0.5kb
BamHI+XhoI: 1.5, 3.6
BglII: 0.8, 4.2
bb
pAWH+kek3ΞToll6 chimaera 
Maxiprep digests
a
a
BamHI
0.9, 1.4, 
1.5, 4.5 
1.8, 2.8,  
3.7
EcoRI
+PvuI
3kb
4kb
5kb
2kb
1.5kb
1kb
0.5kb
Cloning of kek3Ξtoll6 chimaera into pAct5c-attR-3xHA
Cloning of kek4Ξtoll6 chimaera into pAct5c-attR-3xHA
3kb
4kb
5kb
pAWH+kek4ΞToll6 chimaera 
Maxiprep digests
BamHI ScaI
2kb
1.5kb
1kb
0.5kb
BamHI: 0.9, 2.8, 4.5
ScaI: 3.2, 5
Gel partially melted
3kb
4kb
5kb
b pAWH+kek5ΞToll6 chimaera
Maxiprep digests
a
EcoRI
+XhoI
2.3, 5.9 0.9, 1.4, 1.4, 4.5
BamHI
2kb
1.5kb
1kb
0.5kb
3kb
4kb
5kb
2kb
1.5kb
1kb
0.5kb
Cloning of kek5Ξtoll6 chimaera into pAct5c-attR-3xHA
a
Cloning of kek6Ξtoll6 chimaera into pAct5c-attR-3xHA
3kb
4kb
5kb
b pAWH+kek6ΞToll6 chimaera 
Maxiprep digests
BamHI PvuI
2kb
1.5kb
1kb
0.5kb
BamHI: 0.9, 0.9,1.7, 4.5 PvuI: 1.9, 2.6, 3.6
Chimaera 
expected 
sequence
Sequencing
reactions
ke
k3
 E
C/
TM
 A
TG
5’ sequence
3’ sequence
En
d 
of
 To
ll6
 IC
D
Sequencing of kek3Ξtoll6+pAWH chimaera
Chimaera 
expected 
sequence
Sequencing
reactions
ke
k4
 E
C/
TM
 A
TG
5’ sequence
3’ sequence
En
d 
of
 To
ll6
 IC
D
Sequencing of kek4Ξtoll6+pAWH chimaera
Chimaera 
expected 
sequence
Sequencing
reactions
ke
k5
 E
C/
TM
 A
TG
5’ sequence
3’ sequence
En
d 
of
 To
ll6
 IC
D
Sequencing of kek5Ξtoll6+pAWH chimaera
Chimaera 
expected 
sequence
Sequencing
reactions
5’ sequence
3’ sequence
ke
k6
 E
C/
TM
 A
TG
En
d 
of
 To
ll6
 IC
D
Sequencing of kek6Ξtoll6+pAWH chimaera
  
 
 
 
 
 
APPENDIX III 
NULL MUTAGENESIS LINES SUMMARY 
Null mutagenesis lines summary 
Line Internal genomic PCR (homozygous flies only) 
Two-sided PCR 
DNA quality test 
Left isolate Right isolate 
kek3   
Primer kek3intgenF & kek3intgenR kek3FRT GP Fwd & WH-WH- 2sid LI R 
kek3FRT GP Rev & 
WH-WH- 2sid RI F   
Expected   
Mutant No band ~200nt ~200nt   
Not mutant 500nt No band No band   
Observed   
Parent: 
f04709 Not tested No band No band 
kek6 internal genomic 500nt 
band obtained 
Parent: 
f07027 Not tested No band 200nt - 
1 Deceased   - 
2–15 500nt band   - 
16 Heterozygous DNA only No band No band kek6 internal genomic 500nt band obtained 
17 500nt band   - 
18 Deceased   - 
19–20 500nt band   - 
21 Deceased   - 
22–37 500nt band   - 
38 No band No band No band kek6 internal genomic 500nt band obtained 
39 500nt band   - 
40 500nt band   - 
41 No band No band No band kek6 internal genomic 500nt band obtained 
42 Deceased   - 
43–45 500nt band   - 
46 Deceased   - 
47–50 500nt band   - 
Primer kek3intgenF & kek3intgenR kek3FRT GP Fwd & 
WH-WH- 2sid RI F 
kek3FRT GP Rev & 
WH-WH- 2sid LI R 
  
Expected   
Mutant No band 1.7kb ~250nt   
Not mutant 500nt No band No band   
Observed   
yw 500nt No band No band   
Parent: 
f07029 Not tested 1.7kb No band   
Parent: 
f07041 Not tested No band 250nt   
1–3  No band No band   
4  No band 250nt   
5–11  No band No band   
12 No band 1.7kb 250nt kek6 internal genomic 500nt band obtained 
13  1.7kb No band   
14  No band No band   
15  1.7kb No band   
16  1.7kb No band   
17  No band No band   
18  1.7kb No band   
19  1.7kb No band   
20  1.7kb No band   
21  1.7kb No band   
22–23  No band No band   
24  1.7kb No band   
25  1.7kb No band   
26 No band 1.7kb 250nt kek6 internal genomic 500nt band obtained 
27  No band 250nt   
28  No band 250nt   
29–50 Lines tested by 2-sided PCR, gels not run owing to verification of kek3
12 and kek326 
  
51–104 Reserve lines, not tested 
105  1.7kb No band   
106  No band 250nt   
107  No band 250nt   
108  1.7kb No band   
kek4   
Mutant No band ~200nt ~200nt   
Primer kek4intgenF & kek4intgenR kek4FRT GP Fwd & WH-WH- 2sid RI F 
kek4FRT GP Rev & 
WH-WH- 2sid RI F   
Expected   
Mutant No band ~200nt ~200nt   
Not mutant 500nt No band No band   
Observed   
Parent: 
f05454 Not tested 200nt No band   
Parent: 
e02457 Not tested No band 200nt   
1–4 500nt band     
5 Heterozygous DNA only No band No band kek6 internal genomic 500nt band obtained 
6 500nt band     
7 No band     
8 No band No band 200nt   
9–13 500nt band     
14 No band 200nt No band   
15 No band No band No band kek6 internal genomic 500nt band obtained 
16 No band     
17 500nt band     
18 No band     
19–21 500nt band     
22–23 Deceased     
24 500nt band     
25 Heterozygous DNA only 200nt No band   
26 No band No band No band kek6 internal genomic 500nt band obtained 
27 500nt band     
28 Heterozygous DNA only 200nt No band   
29–37 500nt band     
38 Deceased     
39 500nt band     
40 Deceased     
41 500nt band     
42 Deceased     
43–44 500nt band     
45 Heterozygous DNA only No band No band kek6 internal genomic 500nt band obtained 
46 500nt band     
47–50 Deceased     
 Repeat protocol   
yw 500nt No band No band   
1–8 Not tested     
9 Heterozygous DNA only No band 200nt   
10 Heterozygous DNA only 200nt No band   
11 Heterozygous DNA only 200nt No band   
12 Deceased     
13 Heterozygous DNA only 200nt No band   
14 Heterozygous DNA only 200nt No band   
15 Heterozygous DNA only 200nt No band   
16 Heterozygous DNA only 200nt No band   
17 Heterozygous DNA only 200nt No band   
18 Heterozygous DNA only 200nt No band   
19 Heterozygous DNA only 200nt No band   
20 No band 200nt 200nt kek6 internal genomic 500nt band obtained 
21 Heterozygous DNA only 200nt No band   
22 Heterozygous DNA only 200nt No band   
23 No band 200nt 200nt kek6 internal genomic 500nt band obtained 
24 Heterozygous DNA only 200nt No band   
25 Heterozygous DNA only 200nt No band   
26 Heterozygous DNA only No band No band   
27 Heterozygous DNA only 200nt No band   
28 Heterozygous DNA only No band No band   
29 Heterozygous DNA only 200nt No band   
30 Heterozygous DNA only 200nt No band   
31 Deceased     
32 Heterozygous DNA only 200nt No band   
33 Heterozygous DNA only 200nt No band   
34 Heterozygous DNA only 200nt No band   
35 Deceased     
36 Heterozygous DNA only 200nt No band   
37–38 Deceased  200nt   
39 Heterozygous DNA only No band No band   
40 Heterozygous DNA only 200nt No band   
41 Deceased     
42 Heterozygous DNA only 200nt 200nt   
43 Heterozygous DNA only 200nt No band   
44 Heterozygous DNA only No band No band   
45 Heterozygous DNA only 200nt No band   
46 Heterozygous DNA only 200nt No band   
47 Heterozygous DNA only No band No band   
48 Heterozygous DNA only 200nt No band   
49 Heterozygous DNA only No band No band   
50 Heterozygous DNA only 200nt 200nt   
51 Heterozygous DNA only 200nt No band   
52 Heterozygous DNA only No band No band   
53 Deceased     
54 Heterozygous DNA only No band 200nt   
55 Deceased     
56 Heterozygous DNA only 200nt No band   
57 Heterozygous DNA only 200nt No band   
58 Heterozygous DNA only No band No band   
59 Heterozygous DNA only 200nt No band   
60 Heterozygous DNA only 200nt No band   
61 Deceased     
 62 Heterozygous DNA only No band No band   
63 Heterozygous DNA only 200nt No band   
kek6   
Primer kek6intgenF & kek6intgenR kek6FRT GP Fwd & WH-WH- 2sid LI R 
kek6FRT GP Rev & 
WH-WH- 2sid LI R   
Expected   
Mutant No band ~200nt ~200nt   
Not mutant 500nt No band No band   
Observed   
yw 500nt No band No band   
Parent: 
e00907 Not tested 200nt No band   
Parent: 
f05733 Not tested No band 200nt   
1 Deceased     
2–3 Heterozygous DNA only No band No band kek3 internal genomic 500nt band obtained 
4 Deceased     
5–6 Heterozygous DNA only No band No band kek3 internal genomic 500nt band obtained 
7–10 Deceased     
11–12 Heterozygous DNA only No band No band kek3 internal genomic 500nt band obtained 
13 500nt band     
14 Heterozygous DNA only No band No band kek3 internal genomic 500nt band obtained 
15–16 Deceased     
17 Heterozygous DNA only No band No band kek3 internal genomic 500nt band obtained 
18 Deceased     
19 500nt band     
20–25 Deceased     
26–27 500nt band     
28 Heterozygous DNA only No band 200nt   
29 Deceased     
30 500nt band     
31–32 Deceased     
33 500nt band     
34 No band 200nt 200nt kek3 internal genomic 500nt band obtained 
35 No band 200nt 200nt kek3 internal genomic 500nt band obtained 
36      
37–38 Heterozygous DNA only No band No band   
39–40 Deceased     
41 Heterozygous DNA only No band 200nt   
42 Deceased     
43 Heterozygous DNA only No band 200nt   
44 Deceased     
45 500nt band     
46–50 Deceased     
